[
  "core set patient -report outcom measur measur qualiti life clinic obes care dijkhorst , p. j. , monpelli , v. m. , terwe , c. b. , liem , r. s. l. , van wagensveld , b. a. , janssen , i. m. c. , ottosson , j. , halpern , b. , flint , . w. , van rossum , e. f. c. , saadi , a. , west -smith , l. , \u2019 kane , m. , halford , j. c. g. , coulman , k. d. , al -sabah , s. , dixon , j. b. , brown , w. a. , ramo sala , x. , abbott , s. , & 14 other publish pdf deposit coventri univers \u2019 repositori origin citat : dijkhorst , pj , monpelli , vm , terwe , cb , liem , rsl , van wagensveld , ba , janssen , imc , ottosson , j , halpern , b , flint , sw , van rossum , efc , saadi , , west -smith , l , \u2019 kane , , halford , jcg , coulman , kd , al -sabah , , dixon , jb , brown , wa , ramo sala , x , abbott , , budin , aj , holland , jf , poulsen , l , welbourn , r , wijl , n , divin , l , isack , n , birney , , keenan , jmb , ky le , tk , bahlk , , heal , , patton , & de vri , cee 2024 , 'core set patient -report outcom measur measur qualiti life clinic obes care ' , obes surgeri , vol . ( -press ) , pp . ( -press ) . http : \/\/doi.org\/10.1007\/s11695 -024-0738 1-4 doi 10.1007\/s11695 -024-0738 1-4 issn 0960 -8923 essn 1708 -0428 publish : springer \u00a9 author ( ) 2024. articl licens creativ common attribut 4.0 intern licens , permit use , share , adapt , distribut reproduct medium format , long give appropri credit origin author ( ) sourc , provid link creativ common licenc , indic chang made . imag third parti materi articl includ articl \u2019 creativ common licenc , unless indic otherwis credit line materi . materi includ articl \u2019 creativ common licenc intend use permit statutori regul exce permit use , need obtain permiss directli copyright holder . view co py licenc , visit http : \/\/creativecommons.org\/licenses\/by\/4.0\/ne obtain permiss directli copyright holder . view copi licenc , visit http : \/\/creativecommons.org\/licenses\/by\/4.0\/ vol . : ( 0123456789 ) obes surgeri http : \/\/doi.org\/10.1007\/s11695-024-07381-4 origin contribut core set patient\u2011report outcom measur measur qualiti life clinic obes care phillip j. dijkhorst1 \u00b7 valeri m. monpellier2 \u00b7 carolin b. terwee3,4 \u00b7 ronald s. l. liem5,6 \u00b7 bart a. van wagensveld7 \u00b7 ignac m. c. janssen8 \u00b7 johan ottosson9 \u00b7 bruno halpern10,11 \u00b7 stuart w. flint12,13 \u00b7 elisabeth f. c. van rossum14,15 \u00b7 alend saadi16,17 \u00b7 lisa west\u2011smith18 \u00b7 mari \u2019 kane19 \u00b7 jason c. g. halford12 \u00b7 karen d. coulman20 \u00b7 salman al\u2011sabah21 \u00b7 john b. dixon22 \u00b7 wendi a. brown23 \u00b7 ximena ramo salas24,25 \u00b7 salli abbott26,27 \u00b7 alyssa j. budin23,28 \u00b7 jennif f. holland23 \u00b7 lott poulsen29,30 \u00b7 richard welbourn31 \u00b7 natasja wijling32 \u00b7 laura divine33 \u00b7 nadya isack34 \u00b7 susi birney35 \u00b7 j. m. bernadett keenan36 \u00b7 theodor k. kyle37 \u00b7 melani bahlke38 \u00b7 andrew healing35 \u00b7 ian patton39 \u00b7 clair e. e. de vries40 key point \u2022 eight patient-report outcom ( pro ) select inclus core set . \u2022 body-q , iwqol-lit , qolo select measur eight core pro . \u2022 pro pro measur repres outcom matter patient expert . \u2022 outcom must consid measur treatment effect obes treatment . extend author inform avail last page articlereceiv : 29 decemb 2023 \/ revis : 21 june 2024 \/ accept : 1 juli 2024 \u00a9 author ( ) 2024 abstract purpos focu measur success obes treatment shift weight loss patient \u2019 health qualiti life . object studi select core set patient-report outcom patient-report outcom measur use clinic obes care . materi method standard qualiti life obes treatment iii , face-to-fac hybrid consensu meet , includ peopl live obes well healthcar provid , held maastricht , netherland , 2022. preced two prior multin consensu meet systemat review . result meet attend 27 particip , repres twelv countri five contin . particip includ healthcar provid , surgeon , endocrinologist , dietitian , psychologist , research , peopl live obes , involv patient repres network . three patient-report outcom measur ( patient-report outcom ) select : impact weight qualiti life-lit ( self-esteem ) measur , body-q ( physic function , physic symptom , psycholog function , social function , eat behavior , bodi imag ) , qualiti life obes surgeri questionnair ( excess skin ) . patient-report outcom measur select stigma . conclus core set patient-report outcom patient-report outcom measur measur qualiti life clinic obes care establish incorpor patient \u2019 expert \u2019 opinion . set use minimum measur qualiti life routin clinic practic . essenti individu patient-report outcom measur score share peopl live obes order enhanc patient engag share decision-mak . obes surgeri graphic abstract philli pj.dijkhorst * , valeri m.monpelli , carolin b. terwe , p hd , ronald s.l . liem , barta.van wagensveld , ignac em.c.janssen , clairee. . de vri keyword obes treatment \u00b7 bariatr surgeri \u00b7 qualiti life \u00b7 outcom report \u00b7 clinic practic \u00b7 patient-report outcom \u00b7 patient-report outcom measur introduct obes chronic impair patient \u2019 health well- [ 1 , 2 ] . treatment includ lifestyl intervent , medic , metabol bariatr surgeri [ 3 ] . treat- ment signific impact weight also patient \u2019 qualiti life , rang bodi imag self- esteem social , mental , physic health [ 4 \u20136 ] . within last decad , interest measur patient-report out- come ( pro ) surgic non-surg treatment increas [ 7 , 8 ] , result develop numer patient-report outcom measur ( prom ) assess outcom [ 9 ] . prom use compar effect inter - vention research , improv qualiti registri , facilit share decision-mak clinic practic . date , prom use primarili obes research registri [ 10 , 11 ] . nevertheless , could also prove use clinic practic assess qualiti life improv individu patient care [ 12 , 13 ] . prom provid in-depth understand patient \u2019 experi impact treatment health sens well-b [ 8 ] . offer insight patient \u2019 symptom qualiti life obtain clinic measur , weight , blood pressur , laboratori test [ 12 , 14 , 15 ] . implement prom obes treatment enabl per - sonal care improv commun patient healthcar provid . exampl , healthcar provid could use prom deliv care align patient \u2019 prioriti , prom could aid share decision- make [ 12 ] . despit grow interest use prom clinic obe- siti care , sever major concern exist . includ measur pro might relev peopl live obes , wide variat prom current avail obes treatment , use prom insuffici valid evid [ 6 , 16\u201318 ] . address matter effect implement prom clinic practic , essenti develop core set pro prom high-qual valid evi- denc [ 15 ] . previous , multidisciplinari intern consensu meet [ 19 ] , initi standard qualiti life obes treatment ( s.q.o.t . ) initi , led develop core set pro prom measur qualiti life research ( submit ) . current studi report s.q.o.t . iii meet , establish definit set pro prom clinic practic , discuss implement core set . method s.q.o.t . iii meet held 2 3 may 2022 , maastricht , netherland . six author involv organ . particip could attend either live onlin . ethic approv obtain medic research eth- ic committe unit , netherland , refer number w21.227.obes surgeri goal s.q.o.t . iii meet follow : 1. select prom pro stigma . 2. select core set research . 3. select core set clinic practic . 4. discuss implement core set dissemin . select prom stigma develop core set research report separ ( submit ) . current articl describ select core set clinic practic report discuss regard implement . particip everi particip attend meet provid oral inform consent regist s.q.o.t . initi websit : http : \/\/ www . sqoti nitia tive . com\/ [ 20 ] . partici - pant recruit meet follow : 1. healthcar profession research differ - ent disciplin , experienc obes treatment patient-cent outcom research . recruit intern nation obes treatment net- work . particip previou meet invit . 2. peopl live obes involv obes patient repres network fluent eng- lish . either recruit patient repre- sent network , organ \u2019 network , network healthcar provid . particip previou meet invit . s.q.o.t . iii meet meet led independ moder special- ize develop prom core outcom set ( co ) also involv s.q.o.t . & ii meet . s.q.o.t . iii meet consist group discus- sion use nomin group techniqu [ 21 ] , delphi exercis [ 22 ] , anonym vote voxvot ( onlin vot- ing system allow anonym vote comput smartphon ) [ 23 ] . techniqu , involv systemat process expert opinion , lead substanti enhance- ment accuraci reliabl outcom commonli employ group meet objec- tive attain consensu particular subject . healthcar profession conflict interest permit particip group vote . pro prom pre- defin s.q.o.t . & ii meet endors core set clinic practic , provid major particip vote pro prom . discrep vote healthcar provid peopl live obes address group discuss and\/or re-vot ensu . 70 % peopl live obes vote favor specif pro prom , would - rule total number vote . organ modera- tor permit influenc discuss vote round . mere facilit meet . vote describ term number , total percentag favor ; per - centag favor healthcar provid , percentag favor peopl live obes . result particip s.q.o.t . iii meet attend 27 particip : nine peopl live obes 18 healthcar provid . healthcar provid compris six bariatr surgeon , two psychologist , three dietitian , two endocrinologist , three research , one plastic surgeon , one physician special obes treatment . particip repre- sent twelv differ countri five contin . seven particip particip onlin . thirteen particip particip s.q.o.t . ii meet . select pro prom first , group discuss , particip decid unani- mousli pro select research set also rele- vant clinic practic subject vote . held one vote round pro domain . result pro self-esteem , physic function , physic symptom , mental\/psi - cholog function , social function , eat , bodi imag , excess skin , stigma . second , particip vote select suitabl prom pro . prom select per pro impact weight qualiti life-lit ( iwqol-lit , self-esteem ) [ 24 , 25 ] , body-q ( physic function , physic symptom , psycholog function , social function , eat behav - ior , bodi imag ) [ 26 , 27 ] , qualiti life obes surgeri ( qolo , excess skin [ 28 ] questionnair ( tabl 1 ) . set ident core set select research ( submit ) . , describ select process . self\u2011esteem practic particip vote includ pro self-esteem ( 25 vote , 92 % , healthcar provid 93.8 % , particip live obes 87.5 % ) . select iwqol-lit self-esteem subscal suitabl prom ( 23 vote , 56.5 % , healthcar provid 50 % , partici- pant live obes 100 % ) [ 24 , 25 ] . healthcar obes surgeri provid express concern cost associ iwqol-lit questionnair [ 24 , 25 ] . realli consid worthi incorpor prom associ cost outcom set . self-esteem iwqol-lit similar body- q ( psycholog function subscal ) . therefor , may recommend consid remov self-esteem iwqol-lit scale due associ cost . ( quot endocrinologist ) . overlap iwqol-lit self-esteem body-q psycholog function . howev , self-esteem psycholog function clearli differ , self-esteem import concept measur obes treatment . domain incorpor outcom set . ( quot psychologist ) . physic function practic particip vote includ pro physic function ( 25 vote , 96 % , healthcar provid 100 % , particip live obes 85.7 % ) . select body-q physic function subscal suitabl prom ( 22 vote , 90.9 % , healthcar provid 100 % , par - ticip live obes 80 % ) [ 26 , 27 ] . physic symptom practic particip vote includ pro physic symptom ( 25 vote , 96 % , healthcar provid 93.3 % , particip live obes 100 % ) . select body-q physic symptom subscal suit- abl prom ( 23 vote , 100 % ) [ 26 , 27 ] . mental\/psycholog function well three-quart particip vote includ pro psycholog function ( 24 vote , 87.5 % , healthcar provid 86.7 % , particip live obes 85.7 % ) . select body-q psycholog function subscal suitabl prom ( 22 vote , 95.5 % , healthcar provid 92.3 % , particip live obes 100 % ) [ 26 , 27 ] . social function almost three-quart particip vote includ pro social function ( 22 vote , 72.7 % , healthcar provid 69.2 % , particip live obes 85.7 % ) . tabl 1 overview select patient-report outcom patient-report outcom measur core set abbrevi : pro patient-report outcom , prom patient-report outcom measur , s.q.o.t . standard qualiti life measur obes treatment , baro bariatr analysi report outcom system , boss bariatr obesity-specif survey , bql index bari- atric qualiti life index , giqli gastrointestin qualiti life index , iwqol-lit impact weight qualiti life-lit , iwqol-lit ct impact weight qualiti life-lit clinic trial , m-a qolqii moorehead-ardelt qualiti life questionnair ii , pbot post bariatr outcom tool , trim treatment relat impact measur , whoqol-bref world health organ qualiti life questionnaire-bref , qolo qualiti life obes surgeri , op scale obesity-rel problem scale , sf-36 36-item short form survey , wssq weight self- stigma questionnair , ssi-b stigmat situat inventory-brief versionpro prom avail first select prom core set clinic practic self-esteem iwqol-lit , iwqol-lit ct , pro , who- qol brefiwqol-lit iwqol-lit physic health physic function baro , body-q , boss , bql-index , eq- 5d-5l , giqli , iwqol-lit , iwqol-lit ct , m-a qol qii , op-scal , pbot , pro , qolo , sf-36 , trim , who-qol brefsf-36 , iwqol-lit , body-q body-q physic symptom body-q body-q mental\/psycholog health baro , body-q , bql-index , iwqol-lit ct , m-a qol qii , sf-36 , trim , who-qol brefbody-q body-q social health baro , body-q , boss , bql-index , eq- 5d-5l , giqli , iwqol-lit , iwqol-lit ct , m-a qol qii , op-scal , pbot , pro , qolo , sf-36 , trim , who-qol brefop scale , iwqol-lit , body-q body-q stigma wssq , ssi-b - eat body-q , boss , m-a qol qii body-q ( eat behavior ) bodi imag body-q , qolo body-q , qolo body-q excess skin body-q , qolo body-q , qolo qolosobes surgeri select body-q social function subscal suitabl prom ( 24 vote , 70.8 % , healthcar provid 61.5 % , particip live obes 100 % ) [ 26 , 27 ] . like body-q ( social function subscal ) question- nair includ situat encount daili life . ( quot particip live obes ) . eat almost particip vote includ pro eat ( 24 vote , 95.8 % , healthcar provid 100 % , particip liv - ing obes 87.5 % ) . select body-q ( eat behavior subscal ) suitabl prom ( 22 vote , 86.4 % , healthcar provid 92.9 % , particip live obes 66.7 % ) [ 26 , 27 ] . think coupl import aspect meas- ure eat : hunger , satieti , long satieti last . hear peopl live obe- siti , aspect seem import qual- iti life . body-q ( eat behavior subscal ) come closest measur aspect . ( quot psychologist ) . bodi imag two-third particip vote includ pro bodi imag ( 24 vote , 66.7 % , healthcar provid 78.6 % , partici- pant live obes 50 % ) . consider differ observ prefer healthcar provid partici- pant live obes . sever particip live obes mention want focu bodi imag physic aesthet . suggest prom assess bodi imag focu individu \u2019 percept bodi . convers , healthcar provid report prom avail assess bodi imag accur captur individu \u2019 feel toward bodi . emphas bodi imag chang drastic weight loss treatment , therefor , import measur . experi dietitian , bodi imag import domain weight loss intervent big effect bodi imag . patient tell perspect bodi chang drastic weight loss treatment . ( quot dietitian ) . group discuss , re-vot bodi imag result vote favor includ bodi imag ( 25 vote , 80 % , healthcar provid 92.3 % , particip live obes 62.5 % ) , body-q ( bodi imag subscal ) select suitabl prom ( 23 vote , 78.3 % , healthcar provid- er 69.2 % , particip live obes 100 % ) [ 26 , 27 ] .excess skin three-quart particip vote includ pro excess skin ( 23 vote , 78.3 % , healthcar provid- er 76.9 % , particip live obes 87.5 % ) . select qolo ( excess skin subscal ) suitabl prom ( 25 vote , 68 % ; healthcar provid 64.3 % , particip live obes 71.4 % ) [ 28 ] . like qolo questionnair cover excess skin make feel , stop sport , medic consequ excess skin hygien pain . ( quot particip live obes ) . stigma approxim three-quart particip vote includ pro stigma ( 24 vote , 70.8 % , healthcar provid 64.3 % , particip live obes 87.5 % ) . prom select none avail prom consid suitabl . reason includ absenc question gener experi stigma , inabl use questionnair longitudin , absenc valid evid peopl undergo obes treatment . , one healthcar provid highlight import assess intern weight stigma effect experi weight stigma . intern weight stigma refer stigma direct toward oneself . correl inter - naliz weight stigma impact accept weight stigma . import assess inter - naliz , also effect weight stigma , impact healthcar engag mental social health . ( quot research ) . healthcar provid support particip live obes also highlight import captur impact weight stigmat experi . none question assess impact stigma , focu preval stigma . scale consid suitabl use obes treatment . ( quot particip live obes ) . discuss studi describ select core set pro prom assess qualiti life clinic obes care . process includ systemat review multin con - sensu meet attend peopl live obes , healthcar provid variou disciplin . pro prom select iwqol-lit ( self-esteem ) [ 24 , 25 ] , obes surgeri body-q ( physic function , physic symptom , psycholog function , social function , eat behavior , bodi imag ) [ 26 , 27 ] , qolo ( excess skin ) [ 28 ] . prom contain good measur properti ensur measur qual- iti life provid valid reliabl outcom [ 17 ] . core set use differ cultur geograph set . spe- cific , prom avail 19 , 81 , 2 languag , respect [ 24\u2013 28 ] . prom select measur stigma avail prom consid unsuit . best knowledg , first multin multidis- ciplinari effort obes treatment achiev goal stand- ardiz qualiti life outcom matter patient . primari object core set improv qualiti care obes treatment reflect outcom import patient . end , incorpor extens input peopl live obes throughout develop set . core set repres select prom minim use clinic obes care . pro prom select clinic practic core set research core set , allow set use differ purpos . pro mostli align find coulman et al . [ 29 ] . identifi eight theme regard live outcom meta- bolic bariatr surgeri . despit frequent use sf-36 prior obes treatment research , includ core set particip favor prom base face valid [ 16 ] . recent valid studi de vri et al. , sf-36 support suffici valid evid patient undergo metabol bariatr surgeri due irrelev question lack relev item patient among reason [ 18 ] , align cur - rent find . recent , green et al . establish select prom implement metabol bariatr surgeri accredit qualiti improv program usa [ 30 ] . identifi health , self-confid , mobil , everyday activ highest-rank pro domain select promis-10 , obesity-rel problem scale ( op scale ) , obes weight-loss qualiti life instrument ( owqol ) inclus . s.q.o.t . consensu meet took differ approach select prom focus suitabl select pro domain . op scale consid suitabl measur social function , promis-10 owqol valid obes treatment [ 17 , 19 ] . point select prom research purpos clinic practic may thu far vari significantli use registri . number healthcar provid suggest prom could omit core set other contain mani question , seven ten , per pro . omit prom , feasibl might enhanc , less time would need complet questionnair . accord particip live obes meet , omiss necessari . consid complet multipl questionnair burdensom , provid purpos explain feedback provid . use prom clinic practic increasingli becom routin . treatment cancer , exampl , prom use monitor symptom qualiti life pre - oper postop period [ 31 ] . administr interpret led better identif posttreat symptom problem , enhanc clinic decision-mak process , improv commun patient healthcar provid [ 31 ] . abil prom improv out- come cancer care illustr basch et al . [ 32 ] . report comparison usual care , digit symp- tom monitor use prom significantli improv physic function , symptom control , overal qualiti life . even evid prom improv surviv cancer care [ 33 ] . obes treatment , prom data offer uniqu oppor - tuniti enrich consult redirect focu aspect concern patient problem would oth- erwis go undetect [ 34 ] . share prom data facilit activ patient particip progress track outcom assess- ment , therebi enhanc commun patient healthcar provid [ 12 , 13 , 35 , 36 ] . use prom obes treatment enabl healthcar provid deliv care align patient \u2019 need , ultim , provid value-bas high-qual care [ 14 , 15 ] . aid implement prom clinic practic , develop user manual core set ( appendix tabl 2 ) . despit benefit prom , challeng regard- ing implement . first , particip live obes surgeri obes indic lack feedback prom score withheld routin complet prom . conclud prom implement clin- ical practic score share patient . facili- tate process , digit platform requir automat dispatch prom consult allow prom score display dashboard healthcar provid peopl live obes see [ 12 ] . sever electron measur system propos literatur , mobil applic , web-bas system , email remind [ 37 ] . patient perceiv approach prom adminis- tration easi user-friendli [ 38\u2013 40 ] . second , appropri train prom administr interpret neces- sari healthcar provid [ 41 , 42 ] . use minim clinic import chang ( mcid ) , smallest chang treatment outcom individu would identifi import [ 43 ] , could aid healthcar provid interpret prom score . mcid iwqol-lit total score rang 7.7 12 point ( depend baselin sever ) [ 44 ] . mcid qualiti life domain body-q current determin . determin mcid qolo also necessari . key strength studi involv geo- graphic divers panel healthcar provid differ disciplin , well particip live obes , involv patient repres network . initi , goal involv healthcar provid particip liv - ing obes 1:1 ratio , account cancel , end 2:1 ratio . moder ensur particip live obes could voic opinion suffi- cientli . limit . first , due multipl subject need address strict time sched- ule , prolong discuss meet possi- ble . second , expert join meet onlin , may limit involv discuss . third , one healthcar provid , involv develop body- q , instruct vote , could particip discuss . see restrict appli one particip , unlik bias result . fourth , onlin particip particip entir two-day meet , either consequ differ time zone multipl meet plan prior combin congress european associ studi obes intern feder surgeri obes metabol disorders\u2014european chapter . futur meet , shall continu improv cur - rent core set prom , includ develop prom stigma , valid , addit translat qolo ( excess skin ) questionnair . moreov , issu cost associ iwqol-lit ( self-esteem ) questionnair shall address . contrari , body-q qolo avail- abl free charg . possibl new prom shall also need con- sider detail . discuss point extens previ- ou articl ( submit ) . futur s.q.o.t . meet shall necessari determin prom use registri . core set adopt implement , could potenti promot collect outcom clinic import patient expert alik , thu improv qualiti obes treatment global . ideal , set pro prom comple- ment set clinic outcom form core outcom set obes treatment . conclus core set pro prom measur qualiti life clinic obes care select heterogen group particip live obes healthcar provid . set includ subscal body-q ( physic function , physic symptom , psycholog function , social function , eat behavior , bodi imag ) , iwqol-lit ( self-esteem ) , qolo ( excess skin ) questionnair . prom stigma select avail prom consid- ere unsuit . prom select repres outcom matter patient serv minimum measur qualiti life clinic practic . obes surgeri appendix tabl 2 manual use core prom set clinic practic obes treatment name patient-report out- come measurepatient-report outcom number ques- tionsavail languag refer public request licens via contact person addit question impact weight qualiti life-lit ( iwqol-lit ) self-esteem 7 81 list see : http : \/\/ www . quali tyofl ifeco nsult ing . com\/ iwqol- lite- langu age . htmlkolotkin , r.l . et al . ( 2001 ) . link http : \/\/ doi . org\/ 10 . 1038\/ obi . 2001 . 13 kolotkin , r.l . et al . ( 2002 ) . link http : \/\/ doi . org\/ 10 . 1023\/a : 10150 81805 439 kolotkin , r.l . et al . ( 2002 ) . link http : \/\/ doi . org\/ 10 . 1038\/ obi . 2002 . 102http : \/\/ patt rn . health\/ excha nge\/ iwqol- impact- of- weight- on- quali ty- of- life\/ronett l. kolotkin , phd rkolotkin @ qualityoflifecon- sulting.com www . quali tyofl ifeco nsult ing . com body-q physic function 7 19 list see : http : \/\/ qport folio . org\/ wp- cont nt\/ uploa ds\/ 2023\/ 05\/ body-q- tran latio ns . pdfklassen a.f . et al . ( 2016 ) . link http : \/\/ doi . org\/ 10 . 1097\/ gox . 00000 00000 000665 klassen , a.f . et al . ( 2017 ) . link http : \/\/ doi . org\/ 10 . 1186\/ s12955- 017- 0802-x dalaei , f. et al . ( 2022 ) . link http : \/\/ doi . org\/ 10 . 1111\/ cob . 12528free download : http : \/\/ qport folio . org\/ body-q\/http : \/\/ qport folio . org\/ our- team\/ ann klassen : ac.retsamcm @ ssalkabody-q physic symptom 10 body-q psycholog function 10 body-q bodi imag 7 body-q social function 10 body-q eat behavior 9 de vri , c.e.e . et al . ( 2021 ) . link http : \/\/ doi . org\/ 10 . 1007\/ s11695- 021- 05462-2 qualiti life obes surgeri ( qolo ) excess skin 8 2 english germanm\u00fcl , a. et al . ( 2018 ) . link http : \/\/ doi . org\/ 10 . 1007\/ s11695- 017- 2864-6bi email : mueller.astrid @ mh-hannover.deastrid m\u00fcller : mueller . astrid @ mh-hannover.deobes surgeri fund none member organ committe none particip consensu meet receiv payment particip . meet venu , audiovisu support , cater , travel expens , hotel accommod fund medtron , johnson & johnson , novo nordisk , goodlif , fitform . addition- alli , sponsor also carri moder cost . sponsor play role select particip , select domain questionnair includ meet , vote round , writ- ing paper , research-rel activ . organ- ize committe receiv payment work s.q.o.t . initi . declar human anim right inform consent procedur per - form studi involv human particip accord ethic standard institut and\/or nation research committe 1964 helsinki declar later amend- ment compar ethic standard . inform consent obtain individu particip includ studi . conflict interest clair e. e. de vri valeri m. monpelli found s.q.o.t . initi . initi cofound bart a. van wagensveld , ignac m. c. janssen , ronald s. l. liem . phillip j dijkhorst join board s.q.o.t . initi 2021. clair e. e. de vri , ronald s. l. liem , lott poulsen involv develop- ing eat scale body-q . clair e.e . de vri ronald s. l. liem member organ committe permit- ted particip , influenc , discuss s.q.o.t . con- sensu meet vote round . lott poulsen permit particip vote round body-q avail specif- ic patient-report outcom domain . none aforement person receiv financi compens develop body-q body-q-rel activ . ignac m. c. janssen consult johnson & johnson dutch obes clinic . johan ottosson previ- ousli sat advisori board novo nordisk . univers leed receiv payment professor halford \u2019 work action-teen . last 3 year , stuart w. flint report research grant na- tional institut health research , offic health improv & dispar , public health england , doncast council , west york - shire combin author , johnson & johnson , novo nordisk , univers leed . report receiv person fee royal colleg gener practition institut fee public health england , receiv fund attend meet parliament uk , novo nordisk , johnson & johnson , safefood . stuart w. flint also report unpaid role obes uk . bruno halpern sat advisori board novo nordisk , lilli , astra zeneca . addition- alli , receiv lectur fee novo nordisk , astra zeneca , merck , abbott nutrit . furthermor , bh conduct clinic trial col- labor novo nordisk , lilli , boehring ingelheim . john b. dixon consult sat advisori board nestl health scienc reshap lifesci . also sat advisori board also receiv speaker fee novo nordisk lilli . open access articl licens creativ common attri- bution 4.0 intern licens , permit use , share , adapta- tion , distribut reproduct medium format , long give appropri credit origin author ( ) sourc , provid link creativ common licenc , indic chang made . imag third parti materi articl includ articl \u2019 creativ common licenc , unless indic otherwis credit line materi . materi includ articl \u2019 creativ common licenc intend use permit statutori regul exce permit use , need obtain permiss directli copyright holder . view copi licenc , visit http : \/\/creativecommons.org\/licenses\/by\/4.0\/ . refer 1. hrubi , manson je , qi l et al . determin consequ obes . j public health . 2016 ; 106 ( 9 ) :1656\u201362 . 2. wardl j , cook l. impact obes psycholog well- . best pract re clin endocrinol metab . 2005 ; 19 ( 3 ) :421\u201340 . 3. bray ga , fr\u00fchbeck g , ryan dh et al . manag obes . lancet ( london , england ) . 2016 ; 387 ( 10031 ) :1947\u201356 . 4. andersen jr , aasprang , karlsen t-i et al . health-rel qualiti life bariatr surgeri : systemat review prospect long-term studi . surg obe relat disea . 2015 ; 11 ( 2 ) :466\u201373 . 5. ballantyn gh . measur outcom follow bariatr surgeri : weight loss paramet , improv co-morbid condit , chang qualiti life patient satisfact . obe surg . 2003 ; 13 ( 6 ) :954\u201364 . 6. lindekild n , gladston bp , l\u00fcbeck et al . impact bariatr surgeri qualiti life : systemat review meta- analysi . obe rev . 2015 ; 16 ( 8 ) :639\u201351 . 7. intern consortium health outcom measur ( ichom ) . avail : [ http : \/\/ www . ichom . org\/ . 8. deshpand pr , rajan , sudeepthi bl et al . patient-report outcom : new era clinic research . perspect clin re . 2011 ; 2 ( 4 ) :137\u201344 . 9. coulman kd , blazebi jm . health-rel qualiti life bari- atric metabol surgeri . 2020 . 10. larsson , lawyer p , garellick g et al . use 13 diseas reg - istri 5 countri demonstr potenti use outcom data improv health care \u2019 valu . health aff ( millwood ) . 2012 ; 31 ( 1 ) :220\u20137 . 11. mou , sisodia rc , castillo-angel et al . surgeon \u2019 per - ceiv valu patient-report outcom measur ( prom ) : exploratori qualit studi 5 differ surgic subspecialti . ann surg . 2022 ; 275 ( 3 ) . 12. field j , holm mm , newel d. prom data : use make decis individu patient ? narr review . patient relat outcom mea . 2019 ; 10:233\u201341 . 13. fleischmann , vaughan b. challeng opportun use patient report outcom measur ( prom ) clinic practic . intl j osteopath med . 2018 ; 28:56\u201361 . 14. porter . value-bas health care deliveri . ann surg . 2008 ; 248 ( 4 ) :503\u20139 . 15. porter , larsson , lee th . standard patient outcom measur . n engl j med . 2016 ; 374 ( 6 ) :504\u20136 . 16. coulman kd , abdelrahman , owen-smith et al . patient- report outcom bariatr surgeri : systemat review standard report . obe rev . 2013 ; 14 ( 9 ) :707\u201320 . 17. de vri c , kalff , prinsen c et al . recommend suitabl quality-of-lif measur instrument bariat- ric bodi contour surgeri : systemat review . obe rev . 2018 ; 19 ( 10 ) :1395\u2013411 . 18. de vri cee , makarawung dj , monpelli vm et al . rand-36 adequ patient-report outcom measur assess health-rel qualiti life patient undergo bariat- ric surgeri ? obe surg . 2022 ; 32 ( 1 ) :48\u201354 . 19. de vri cee , terwe cb , al nawa et al . outcom first global multidisciplinari consensu meet includ per - son live obes standard patient-report outcom measur obes treatment research . obe rev offici j intl assoc studi obe . 2022 ; 23 ( 8 ) : e13452 . obes surgeri 20. monpelli v , vri cd . s.q.o.t . initi ( standard qual- iti life measur obes treatment ) [ avail : http : \/\/ www . sqoti nitia tive . com\/ . 21. harvey n , holm ca . nomin group techniqu : effec - tive method obtain group consensu . int j nur pract . 2012 ; 18 ( 2 ) :188\u201394 . 22. dalkey nc . delphi . introduct technolog forecast : routledg ; 2018. p. 25\u201330 . 23. voxvot . 2022. avail : http : \/\/ www . voxvo te . com\/ . 24. iwqol-lit . 2023. avail : http : \/\/ www . quali tyofl ifeco nsult ing . com\/ iwqol- lite . html . 25. kolotkin rl , crosbi rd , kosloski kd et al . develop brief measur assess qualiti life obes . obe re . 2001 ; 9 ( 2 ) :102\u201311 . 26. body-q . 2023. avail : http : \/\/ qport folio . org\/ body-q\/ . 27. klassen af , cano sj , alderman et al . body-q : patient- report outcom instrument weight loss bodi contour treatment . plastic reconstruct surgeri \u2013 global open . 2016 ; 4 ( 4 ) . 28. m\u00fcller , crosbi rd , sell j et al . develop evalu qualiti life obes surgeri ( qolo ) questionnair . obe surg . 2018 ; 28 ( 2 ) :451\u201363 . 29. coulman kd , mackichan f , blazebi jm et al . patient experi outcom bariatr surgeri : systemat review qualita - tive synthesi . obe rev . 2017 ; 18 ( 5 ) :547\u201359 . 30. green , goldman , hutter mm . select patient- report outcom measur implement metabol bariatr surgeri accredit qualiti improv program . surg obe relat di . 2023 . 31. di maio , basch e , deni f et al . role patient-report outcom measur continuum cancer clinic care : esmo clinic practic guidelin . ann oncol . 2022 ; 33 ( 9 ) :878\u201392 . 32. basch e , schrag , jansen j et al . digit symptom monitor patient-report outcom commun oncolog prac- tice : u.s. nation cluster random trial . j clin oncol . 2021 ; 39 ( 36_suppl ) :349527- . 33. basch e , deal , kri mg et al . symptom monitor patient-report outcom routin cancer treatment : ran- domiz control trial . j clin oncol . 2016 ; 34 ( 6 ) :557\u201365 . 34. basch e , jia x , heller g et al . advers symptom event report patient vs clinician : relationship clinic outcom . j natl cancer inst . 2009 ; 101 ( 23 ) :1624\u201332 . 35. chen j , ou l , holli sj . systemat review impact rou- tine collect patient report outcom measur patient , provid health organis oncolog set . bmc health serv re . 2013 ; 13:211 . 36. velikova g , booth l , smith ab et al . measur qualiti life routin oncolog practic improv commun patient well- : random control trial . j clin oncol . 2004 ; 22 ( 4 ) :714\u201324 . 37. jensen , snyder cf , abernethi ap et al . review electron patient-report outcom system use cancer clinic care . j oncol pract . 2014 ; 10 ( 4 ) : e215\u201322 . 38. engelhard mm , patek sd , sheridan k et al . remot engag : lesson remot monitor multipl sclerosi . int j med inform . 2017 ; 100:26\u201331 . 39. koevoet r , de gla na , le bourlout c et al . autonom onlin health assess questionnair registri daili clinic practic . rheumatolog ( oxford ) . 2013 ; 52 ( 5 ) :883\u20137 . 40. walker ua , mueller rb , jaeger vk et al . diseas activ dynam rheumatoid arthriti : patient \u2019 self-assess diseas activ via webapp . rheumatolog ( oxford ) . 2017 ; 56 ( 10 ) :1707\u201312 . 41. antun b , hard r , higginson ij . implement patient- report outcom measur palli care clinic practic : systemat review facilit barrier . palliat med . 2014 ; 28 ( 2 ) :158\u201375 . 42. duncan ea , murray j. barrier facilit routin outcom measur alli health profession practic : systemat review . bmc health serv re . 2012 ; 12:96 . 43. draak thp , de greef bta , faber cg et al . minimum clini- calli import differ : direct take . eur j neurol . 2019 ; 26 ( 6 ) :850\u20135 . 44. crosbi rd , kolotkin rl , william gr . integr method determin meaning chang health-rel qualiti life . j clin epidemiol . 2004 ; 57 ( 11 ) :1153\u201360 . publish 's note springer natur remain neutral regard jurisdict claim publish map institut affiliations.obes surgeri phillip j. dijkhorst1 \u00b7 valeri m. monpellier2 \u00b7 carolin b. terwee3,4 \u00b7 ronald s. l. liem5,6 \u00b7 bart a. van wagensveld7 \u00b7 ignac m. c. janssen8 \u00b7 johan ottosson9 \u00b7 bruno halpern10,11 \u00b7 stuart w. flint12,13 \u00b7 elisabeth f. c. van rossum14,15 \u00b7 alend saadi16,17 \u00b7 lisa west\u2011smith18 \u00b7 mari \u2019 kane19 \u00b7 jason c. g. halford12 \u00b7 karen d. coulman20 \u00b7 salman al\u2011sabah21 \u00b7 john b. dixon22 \u00b7 wendi a. brown23 \u00b7 ximena ramo salas24,25 \u00b7 salli abbott26,27 \u00b7 alyssa j. budin23,28 \u00b7 jennif f. holland23 \u00b7 lott poulsen29,30 \u00b7 richard welbourn31 \u00b7 natasja wijling32 \u00b7 laura divine33 \u00b7 nadya isack34 \u00b7 susi birney35 \u00b7 j. m. bernadett keenan36 \u00b7 theodor k. kyle37 \u00b7 melani bahlke38 \u00b7 andrew healing35 \u00b7 ian patton39 \u00b7 clair e. e. de vries40 * phillip j. dijkhorst phillip.dijkhorst @ gmail.com ; p.j.dijkhorst @ olvg.nl 1 depart surgeri , olvg hospit & nederlands obesita kliniek [ dutch obes clinic ] , jan tooropstraat 164 , 1061 ae amsterdam , netherland 2 depart scienc , nederlands obesita kliniek [ dutch obes clinic ] , hui ter heid , netherland 3 depart epidemiolog data scienc , amsterdam univers medic center , locat vrije universiteit amsterdam , amsterdam , netherland 4 amsterdam public health research institut , methodolog , amsterdam , netherland 5 depart surgeri , nederlands obesita kliniek [ dutch obes clinic ] , hagu , gouda , netherland 6 depart surgeri , groen hart ziekenhui , gouda , netherland 7 depart surgeri , nmc royal hospit , abu dhabi , unit arab emir 8 depart surgeri , nederlands obesita kliniek [ dutch obes clinic ] , hui ter heid , netherland 9 depart surgeri , faculti medicin health , \u00f6rebro univers , \u00f6rebro , sweden 10 obes center , 9 de julho hospit , s\u00e3o paulo , brazil 11 brazilian associ studi obes ( abeso ) , s\u00e3o paulo , brazil 12 school psycholog , univers leed , leed , uk 13 scale insight , nexu , univers leed , leed , uk 14 obes center cgg [ healthi weight centr ] , erasmu mc , univers medic center rotterdam , rotterdam , netherland 15 depart intern medicin , divis endocrinolog , erasmu mc , univers medic center rotterdam , rotterdam , netherland 16 depart surgeri , neuch\u00e2tel hospit , neuch\u00e2tel , switzerland 17 biolog medicin faculti , lausann univers , lausann , switzerland 18 depart surgeri , depart psychiatri behavior neurosci , univers cincinnati colleg medicin , cincinnati , oh , usa 19 depart nutrit dietet , leed teach hospit nh trust , leed , uk20 nation institut health research bristol biomed research centr , bristol centr surgic research , popul health scienc , bristol medic school , univers bristol , bristol , uk 21 depart surgeri , kuwait univers , kuwait citi , kuwait 22 iverson health innov research institut , swinburn univers technolog , melbourn , australia 23 depart surgeri , central clinic school , monash univers , melbourn , australia 24 obes canada , edmonton , ab , canada 25 european associ studi obes , teddington , uk 26 specialist weight manag servic , univers hospit coventri warwickshir nh trust , coventri , uk 27 research centr intellig healthcar , coventri univers , coventri , uk 28 bariatr surgeri registri , central clinic school , monash univers , melbourn , australia 29 research unit plastic surgeri , univers southern denmark odens univers hospit , odens , denmark 30 lontoft , nyhoj poulsen plastic surgeri , odens , denmark 31 depart upper gastrointestin bariatr surgeri , musgrov park hospit , taunton , uk 32 dutch associ overweight obes ( nvoo ) , utrecht , netherland 33 peopl live obes repres , kuwait , kuwait 34 patient advoc , truste obes empower network , london , uk 35 european coalit peopl live obes ( ecpo ) , dublin , ireland 36 irish coalit peopl live obes ( icpo ) , dublin , ireland 37 conscienhealth , obes action coalit , tampa , fl , usa 38 adipositascirurgi selbsthilf deutschland e.v . ( obes surgeri self-help organ ) , mannheim , germani 39 obes canada , edmonton , canada 40 depart surgeri , olvg hospit , amsterdam , netherlandsauthor affili",
  "healthi weight bodi mass index onset idiopath intracrani hypertens chang outcom ? unit kingdom prospect cohort studi thaller , m. , ho mer , v. , abbott , s. , hazlehurst , j. , molla n , s. p. & sinclair , a. j. publish pdf deposit coventri univers \u2019 repositori origin citat : thaller , , homer , v , abbott , , hazlehurst , j , mollan , sp & sinclair , aj 2024 , 'doe healthi weight bodi mass index onset idiopath intracr anial hypertens chang outcom ? unit kingdom prospect cohort studi ' , neuro - ophthalmolog , vol . ( -press ) , pp . ( -press ) . http : \/\/dx.doi.org\/ 10.1080\/01658107.2024.2341775 doi 10.1080\/01658107.2024.234 1775 issn 0165 -8107 essn 1744 -506x publish : taylor franci group open access articl distribut term creativ common attribut licens ( http : \/\/creat ivecommons.org\/licenses\/by\/4.0\/ ) permit unrestrict use , distribut , reproduct medium , provid origin work properli cite . term articl publish allow post accept manuscript repositori author ( ) consent . full term & condit access use found http : \/\/www.tandfonline.com\/action\/journalinform ? journalcode=ioph20 neuro-ophthalmolog issn : ( print ) ( onlin ) journal homepag : www.tandfonline.com\/journals\/ioph20 healthi weight bodi mass index onset idiopath intracrani hypertens chang outcom ? unit kingdom prospect cohort studi mark thaller , victoria homer , salli abbott , jonathan hazlehurst , susan p. mollan & alexandra j. sinclair cite articl : mark thaller , victoria homer , salli abbott , jonathan hazlehurst , susan p. mollan & alexandra j. sinclair ( 22 apr 2024 ) : healthi weight bodi mass index onset idiopath intracrani hypertens chang outcom ? unit kingdom prospect cohort studi , neuro-ophthalmolog , doi : 10.1080\/01658107.2024.2341775 link articl : http : \/\/doi.org\/10.1080\/01658107.2024.2341775 \u00a9 2024 author ( ) . publish licens taylor & franci group , llc . publish onlin : 22 apr 2024. submit articl journal articl view : 50 view relat articl view crossmark data origin articl healthi weight bodi mass index onset idiopath intracrani hypertens chang outcom ? unit kingdom prospect cohort studi mark thaller , b , c , victoria homer , salli abbott e , f , jonathan hazlehurstc , g , h , susan p. mollan , , alexandra j. sinclair , bc atransl brain scienc , institut metabol system research , univers birmingham , birmingham , uk ; bdepart neurolog , univers hospit birmingham nh foundat trust , birmingham , uk ; ccentr endocrinolog , diabet metabol , birmingham health partner , birmingham , uk ; dcancer research ( uk ) clinic trial unit , univers birmingham , birmingham , uk ; eresearch centr healthcar commun , institut health wellb , coventri univers , coventri , uk ; fdepart dietet , univers hospit coventri warwickshir nh trust , coventri , uk ; gdepart diabet endocrinolog , univers hospit birmingham nh foundat trust , birmingham , uk ; hinstitut appli health research , univers birmingham , birmingham , uk ; ibirmingham neuro-ophthalmolog , univers hospit birmingham nh foundat trust , birmingham , uk abstract idiopath intracrani hypertens ( iih ) predominantli affect reproductive-ag femal obes . howev , preval impact healthi weight bodi mass index ( bmi ) diseas present known . studi aim evalu visual headach outcom stratifi present bmi . longitudin prospect cohort studi ( iih life ) base tertiari neuro-ophthalmolog iih servic , univers hospit birmingham nh trust , unit kingdom , recruit consecut patient live iih 2012 2021. present bmi includ . outcom measur includ visual outcom logmar visual acuiti , humphrey visual field perimetr mean deviat ( pmd ) , optic coher tomo - graphi ( oct ) measur , headach outcom frequenc , sever , headach impact test-6 score . three hundr seventy-f peopl iih document baselin bmi . 3.7 % entir cohort healthi weight bmi iih present 15.5 % bmi < 30 kg\/m2 . baselin pmd wors patient without obes ; howev , oct papillo - dema measur similar . presenc obes associ small signific greater worsen visual acuiti slower macular ganglion cell layer loss . impact pmd papilloedema prognosi relat baselin obes . headach outcom show heterogen , wors baselin headach frequenc patient obes . bmi group associ wors headach outcom . patient healthi weight bmi without obes baselin make small proport iih patient . bmi present appear influenc long-term visual headach outcomes.articl histori receiv 2 octob 2023 revis 1 april 2024 accept 8 april 2024 keyword pseudotumor cerebri ; vision ; headach ; prognosi ; weight ; oct imag ; papilloedema introduct idiopath intracrani hypertens ( iih ) pre- dominantli affect reproductive-ag femal obesity.1,2 iih diseas rais intra - cranial pressur , lead chronic headach , visual loss , cognit dysfunction.3\u20138 atyp iih term given peopl meet diagnost criteria iih fit typic phenotyp , includ male femal live without obesity.3,9 obes defin world health organis bodi mass index ( bmi ) \u226530 kg\/m2,10 reduc 27.5 kg\/m2 ethnic group due increas cardiometabol risk lower bmi.11,12 adipos associ iih centripetal13,14 correl lumbar punctur open pressure.13 two-fold increas cardiovascular diseas risk found peopl live iih , comparison age- , sex- bmi-match controls.2 metabol complic associ iih , diabet mellitu , gestat diabet , pre-eclampsia , arteri hypertension.2,15,16 anim studi , high-fat diet iih- contact alexandra j. sinclair a.b.sinclair @ bham.ac.uk institut metabol system research , colleg medic dental scienc , univers birmingham , edgbaston , birmingham b15 2tt , ukneuro-ophthalmolog http : \/\/doi.org\/10.1080\/01658107.2024.2341775 \u00a9 2024 author ( ) . publish licens taylor & franci group , llc . open access articl distribut term creativ common attribut licens ( http : \/\/creativecommons.org\/licenses\/by\/4.0\/ ) , permit unrestrict use , distribut , reproduct medium , provid origin work properli cite . term articl publish allow post accept manuscript repositori author ( ) consent.associ inflammatori factor-expos femal rat show increas csf secretion.17 adi- pocyt iih appear metabol prime lipogenesis18 addit insulin leptin resist phenotyp excess driven obes alone.18,19 iih also associ hypertestosteron femal , independ obes , testosteron increas csf secret na+\/k+- atpas pump choroid plexus.20 also debat literatur whether iih caus problem csf secret drainag ( includ cerebr venou stenosi ) , combin , multipl factor like influenc mechanisms.21,22 current , disease-modifi ther - api iih weight loss,3,23 sinc weight loss shown associ diseas remission.- 24\u201326 iih weight trial , bmi \u226535 kg\/m2 diseas remiss , defin nor- malis intracrani pressur ( icp ) , may requir 24 % weight loss.27 presenc healthi weight bmi iih associ pathophysiolog previous studi singl retrospect studi , found better visual outcom healthi weight bmi compar increas bmi.9 lack lit- eratur area may healthi weight bmi iih diagnosi may uncom - mon . metabol alter relat obe- siti thought main patholog driver iih given improv - ment associ weight loss , known , subset iih healthi weight bmi , may differ underli pathogenesi . therefor , rare condit , despit rise preval , would difficult adequ statist power trial assess differ intervent subset.9,28,29 studi first prospect assess prognosi iih cohort peopl healthi weight bmi . hypothesi iih patient without obes would differ - ent visual headach outcom compar typic obes iih counterparts.method methodology5 prospect observ cohort studi publish ethic approv nh nation research ethic committe ( 14\/lo\/1208 ) , iih life studi . patient includ studi attend specialist iih clinic ( neuro-ophthalmolog neurolog joint clinic ) singl tertiari neurosci centr ( univers hospit birmingham nh foundat trust ( uhb ) , unit kingdom ) . patient gave written inform consent parti - cipat studi . consecut data col- lect april 2012 septemb 2021 , visit patient . elig patient includ met either definit probabl diagnosi iih base 2013 revis diagnost criteria iih30 baselin bmi record . revis diagnost criteria requir definit diagnosi iih ( adapt friedman et al.31 includ : ( ) presenc papilloedema , ( b ) normal neurolog examin ( except sixth nerv palsi ) , ( c ) normal brain parenchyma neuroimag ( hydrocephalu , mass , structur lesion , mening enhanc ) , exclus venou sinu thrombosi , ( ) normal csf constitu , ( e ) elev lumbar punctur open pressur \u226525 cm csf.30 probabl iih diagnosi could made typic patient , criteria met . patient secondari caus rais intracra - nial pressur iih without papilloedema excluded.3,31 secondari caus exclud cere- bral venou sinu thrombosi , mass lesion , infec - tive caus , medic contributor profound anaemia regular\/rec use tetra - cyclin . appropri imag perform patient either first visit previou hospit . studi stratifi patient accord bmi statu first visit ( baselin ) specia - list clinic . patient initi categoris 2 m. thaller et al.hav ( \u226530 kg\/m2 ) obes ( < 30 kg\/ m2 ) . , subsequ world health organis ( ) bmi categories,10 : healthi weight bmi ( 18.5\u201324.9 kg\/m2 ) , overweight ( 25.0\u2013 29.9 kg\/m2 ) , obes class 1 ( 30.0\u201334.9 kg\/m2 ) obes class 2 , ( \u226535.0 kg\/m2 ) . iih recognis obes relat diseas nation institut health clinic excel uk , regard criteria referr weight manag special clinic obes class 2 use highest grouping.12 bmi group adjust ethnic . visual outcom : logmar visual acuiti ( measur use logarithm minimum angl resolut ) , humphrey visual field peri- metric mean deviat ( pmd ) ( 24\u20132 sita stan- dard ) optic coher tomographi ( oct , heidelberg spectralis\u2122 ) measur averag global peripapillari retin nerv fibr layer thick ( rnfl ) , automat measur total retin thick - ness ( trt ) ( softwar rnfl circl extract trt ) macular ganglion cell layer ( gcl ) volum ( 1 , 2.22 , 3.45 mm etdr plot volum measur given softwar would includ nine sector , pre-set macular volum and\/or posterior pole method ) . ensur accuraci segment retin layer moderate-to-sever papilloedema , manual segment rnfl trt perform peripapillari scan cross-sect slice optic disc scan basement membran ( bm ) inner limit layer ( ilm ) , appropri . cours studi , scan pro- tocol gcl chang ; howev , excel correla - tion previous publish macular volum posterior pole measur ( pearson correl 0.98 ) .5 headach outcom clinic assess use follow indic : monthli headach day ( days\/month ) ; monthli migraine-lik headach day ( days\/month ) ; headach sever ( 0\u201310 numer rate scale , 0 pain 10 equat sever ) ; headach disabl use headach impact test-6 ( hit- 6 ) score ( score 36 78 ) . method data collect statist analysi previous reported.5 stati - tical analysi perform use r v4.1.0.32 continu variabl report mean ( stan - dard deviat ( sd ) ) categor variabl number ( percentag ) . lme433 use regress model continu form depend variabl assum independ model . statist signific indic 95 % confi - denc interv met interv cross zero overlap . adjust made multipl test . loess ( local weight scat- terplot smooth ) graph creat prior regress analysi ascertain variabl \u2019 rela- tionship trend . studi guid patient public involv iihuk , nation patient chariti ( regist chariti england wale 1,143,522 & scotland sco43294 ) support carer patient live iih . provid advic guidanc develop iih life questionnair . result nine-year longitudin cohort studi , 375 peopl iih document baselin bmi prospect recruit . healthi weight bmi uncommon present repres 3.7 % cohort ( 14\/375 ) . patient higher bmi categori common 11.7 % ( 44\/375 ) class overweight , 20 % ( 75\/375 ) obes class 1 , 64.5 % ( 242\/375 ) obes class 2 ( tabl 1 ) . therefor , 15.5 % ( 58\/375 ) bmi < 30 kg\/m2 , compar 84.5 % ( 317\/375 ) tabl 1. baselin tabl baselin bmi . allbaselin bmi ( kg\/m2 ) 18.5\u201324.9 25\u201329.9 30\u201334.9 35+ n 375 14 44 75 242 surgic 53 1 2 14 36 femal 370 13 43 75 239 age ( mean ( sd ) , n ) , year 31.7 ( 9.8 ) , 375 26.5 ( 6.6 ) , 14 33.5 ( 13.5 ) , 44 31.0 ( 9.5 ) , 75 31.9 ( 9.2 ) , 242 bmi ( mean ( sd ) , n ) , kg\/m238.8 ( 9.1 ) , 375 22.7 ( 1.4 ) , 14 27.1 ( 1.6 ) , 44 32.0 ( 1.5 ) , 75 43.9 ( 6.8 ) , 242 diagnost csf open pressur ( mean ( sd ) , n ) , cmcsf 35.6 ( 8.9 ) , 323 34.8 ( 6.5 ) , 14 36.5 ( 9.0 ) , 40 36.5 ( 11.0 ) , 64 35.1 ( 8.3 ) , 205neuro-ophthalmolog 3obes . patient healthi weight bmi lowest diagnost csf open pressur ( tabl 1 ) . cerebrospin fluid divers surgeri rate ( dur - ing cours follow-up studi ) lower healthi weight bmi present ( 7 % ) compar patient iih higher bmi , 3.5 % overweight , 19 % obes class 1 , 15 % obes class 2+ ( tabl 1 ) . howev , statist significantli differ group . similar proport patient treat icp lower medic group : 57 % healthi weight bmi , 61 % overweight , 63 % obes class 1 54 % obes class 2 + . durat follow-up cohort seen within specialist servic median 17 month ( rang 1\u201386 , interquartil rang 6\u201337 ) least one follow-up visit . analog bmi group : healthi weight bmi ( 21 ( 3\u201333 , 6\u201325 ) month ) , overweight ( 14 ( 1\u201386 , 7\u201337 ) month ) , obes class 1 ( 19 ( 1\u201370 , 6\u201340 ) month ) , obes class 2 ( 17 ( 1\u201380 , 7\u201338 ) month ) . presenc obes visual outcom presenc obes , howev , influenc baselin visual acuiti , papilloedema measur oct ( rnfl trt ) , macular ganglion cell layer volum ( tabl 2 ) . bmi < 30 kg\/m2 ( normal overweight bmi ) baselin visit associ wors baselin humphrey visual field pmd patient obes ( \u22125.65 db ( 95 % ci : \u22127.51 , \u22123.80 ) versu \u22123.20 db ( \u22123.98 , \u22122.41 ) ) ( tabl 2 ) . visual outcom time , howev , affect differ ( figur 1 ) . visual acuiti wors trajectori bmi < 30 kg\/m2 compar patient obes baselin ( tabl 2 , figur 1 ) . small addit statist signific worsen ( increas ) acuiti 0.004 logunits\/month ( 0.002 , 0.0061 ) former group compar latter , although would like remain clinic impercept . pmd trajectori differ group similar long-term outcom ( figur 1 ) . papilloedema oct trajectori similar group ( tabl 2 ) ; howev , initi six month follow baselin visit , patient bmi < 30 kg\/m2 rapid addit reduc - tion rnfl 10.79 \u00b5m\/month ( \u221226.51 , +4.92 ) trt 5.90 \u00b5m\/month ( \u221236.29 , +24.48 ) ( figur 1 ) . statist signific . macular ganglion cell layer volum declin slightli quicker patient without obes ( tabl 2 ) , statist signific greater declin 0.000559 mm3\/month ( \u22120.001068 , \u22120.00005 ) . tabl 2. baselin estim trajectori regress model obes bmi cut-off ( 30 kg\/m2 ) . baselin estim ( unit ) chang per month ( units\/month ) logmar visual acuiti , logunit bmi < 30 0.0146 ( 95 % ci : \u22120.0498 , 0.079 ) 0.0033 ( 95 % ci : 0.0014 , 0.0052 ) bmi > 30 0.0201 ( 95 % ci : \u22120.0076 , 0.0478 ) \u22120.0007 ( 95 % ci : \u22120.0015 , 0.0002 ) humphrey visual field pmd , db bmi < 30 \u22125.65 ( 95 % ci : \u22127.51 , \u22123.8 ) 0.06 ( 95 % ci : 0 , 0.13 ) bmi > 30 \u22123.2 ( 95 % ci : \u22123.98 , \u22122.41 ) 0.05 ( 95 % ci : 0.02 , 0.07 ) global peripapillari retin nerv fibr layer , \u00b5m bmi < 30 139.84 ( 95 % ci : 119.64 , 160.03 ) \u22121.98 ( 95 % ci : \u22123.18 , \u22120.77 ) bmi > 30 135.98 ( 95 % ci : 128.09 , 143.88 ) \u22121.27 ( 95 % ci : \u22121.7 , \u22120.84 ) global peripapillari total retin thick , \u00b5m bmi < 30 383.16 ( 95 % ci : 354.09 , 412.24 ) \u22122.98 ( 95 % ci : \u22124.49 , \u22121.48 ) bmi > 30 361.83 ( 95 % ci : 350.78 , 372.88 ) \u22121.96 ( 95 % ci : \u22122.44 , \u22121.47 ) macular ganglion cell layer volum , mm3 bmi < 30 0.440533 ( 95 % ci : 0.420416 , 0.46065 ) \u22120.000921 ( 95 % ci : \u22120.001407 , \u22120.000436 ) bmi > 30 0.442757 ( 95 % ci : 0.434659 , 0.450856 ) \u22120.000363 ( 95 % ci : \u22120.000516 , \u22120.000209 ) headach frequenc ( days\/month ) bmi < 30 15.95 ( 95 % ci : 12.02 , 19.87 ) \u22120.12 ( 95 % ci : \u22120.32 , 0.08 ) bmi > 30 20.32 ( 95 % ci : 18.63 , 22 ) \u22120.17 ( 95 % ci : \u22120.26 , \u22120.07 ) migraine-lik headach frequenc ( days\/month ) bmi < 30 8.41 ( 95 % ci : 5.06 , 11.77 ) \u2212 0.02 ( 95 % ci : \u22120.22 , 0.18 ) bmi > 30 9.16 ( 95 % ci : 7.69 , 10.63 ) \u22120.1 ( 95 % ci : \u22120.19 , \u22120.01 ) headach sever ( va 0\u201310 ) bmi < 30 5.34 ( 95 % ci : 4.32 , 6.35 ) 0.01 ( 95 % ci : \u22120.06 , 0.07 ) bmi > 30 6.19 ( 95 % ci : 5.75 , 6.63 ) \u22120.02 ( 95 % ci : \u22120.05 , 0.01 ) headach impact test ( hit-6 ) ( score 36\u201378 ) bmi < 30 61.57 ( 95 % ci : 58.04 , 65.09 ) \u22120.1 ( 95 % ci : \u22120.32 , 0.13 ) bmi > 30 61.27 ( 95 % ci : 59.74 , 62.80 ) \u22120.01 ( 95 % ci : \u22120.11 , 0.09 ) 4 m. thaller et al.pres obes headach outcom headach migraine-lik headach fre- quenci high iih cohort baselin ( tabl 2 , figur 2 ) . mean baselin frequenc lower patient bmi < 30 kg\/m2 ( 15.95 days\/month ( 12.02 , 19.87 ) versu 20.32 ( 18.63 , 22.00 ) obes ) ( tabl 2 ) , sig- nificantli lower non-obes group \u22124.37 days\/month ( 95 % ci : \u22128.64 , \u22120.11 ) ) . migraine-lik headach frequenc signifi - cantli differ patient without obes ( 9.16 ( 7.69 , 10.63 ) 8.41 ( 5.06 , 11.77 ) , respect ) ( tabl 2 , figur 2 ) . headach sever - iti moder group ( tabl 2 ) significantli differ baselin tra- jectori ( figur 2 ) . headach substanti impact qualiti life measur hit-6 , similar score confid interv ( baselin score 61.57 ( 58.04 , 65.09 ) 61.27 ( 59.74 , 62.80 ) bmi < 30 kg\/m2 \u226530 kg\/m2 , respect ) ( tabl 2 , figur 2 ) . tra- jectori significantli differ < 30 kg\/m2 \u226530 kg\/m2 group headach outcom . bmi group outcom pmd significantli wors ( neg ) baselin patient healthi weight bmi ( \u22129.0 ( \u221212.8 , \u22125.2 ) ) compar obes class 1 class 2+ ( \u22122.8 ( \u22124.4 , \u22121.2 ) \u22123.3 ( \u22124.2 , \u22122.4 ) , respect ) ( tabl 3 ) . also wors , significantli , compar overweight group ( \u22124.5 ( \u22126.6 , \u22122.4 ) ) ( tabl 3 , figur 3 ) . oct trt papilloedema measur significantli wors overweight patient compar healthi weight bmi , 80.54 \u00b5m ( 12.22 , 148.86 ) higher , either obes group ( figur 3 ) . macular gcl baselin healthi weight bmi group 0.3998 mm3 ( 0.3556 , 0.4441 ) ( tabl 3 ) significantli higher overweight obe- siti class 2+ categori compar healthi weight bmi , 0.0508 ( 0.0012 , 0.1004 ) 0.0451 ( 0 , figur 1. longitudin visual data baselin visit iih patient categoris whether bmi < 30 \u226530 kg\/m2 , loess smoother ad show trend across categori . ( ) logmar visual acuiti ( logunit ) ( b ) perimetr mean deviat measur humphrey visual field 24-2 test ( db ) ( c ) retin nerv fibr layer thick measur optic coher tomographi ( \u00b5m ) ( ) total retin thick optic nerv head measur optic coher tomographi ( \u00b5m ) ( e ) macular ganglion cell layer volum measur optic coher tomographi ( mm3 ) . figur 2. longitudin headach data baselin visit iih patient categoris whether bmi < 30 \u226530 kg\/m2 , loess smoother ad show trend across categori . ( ) headach frequenc ( day per month ) ( b ) migraine-lik headach frequenc ( day per month ) ( c ) headach mean sever predomin headach ( 0\u201310 numer rate scale ) ( ) headach impact test 6 ( hit6 ) ( qualiti life measur score 36\u201378 ) .neuro-ophthalmolog 5tabl 3. baselin estim trajectori visual headach outcom baselin bmi regress model . baselin estim ( unit ) chang per month ( units\/month ) logmar visual acuiti , logunit healthi weight bmi ( 18.5\u201324.9 kg\/m2 ) 0.0612 ( 95 % ci : \u22120.0709 , 0.1932 ) 0.0021 ( 95 % ci : \u22120.002 , 0.0062 ) overweight ( 25.0\u201329.9 kg\/m2 ) 0.0007 ( 95 % ci : \u22120.0731 , 0.0746 ) 0.0036 ( 95 % ci : 0.0015 , 0.0058 ) obes , class 1 ( 30.0\u201334.9 kg\/m2 ) \u22120.0165 ( 95 % ci : \u22120.0748 , 0.0417 ) 0.0001 ( 95 % ci : \u22120.0017 , 0.0019 ) obes , class 2 ( 35.0+ kg\/m2 ) 0.031 ( 95 % ci : \u22120.0006 , 0.0625 ) \u22120.0009 ( 95 % ci : \u22120.0019 , 0 ) humphrey visual field pmd , db healthi weight bmi ( 18.5\u201324.9 kg\/m2 ) \u22128.9967 ( 95 % ci : \u221212.7581 , \u22125.2354 ) 0.0326 ( 95 % ci : \u22120.1299 , 0.1951 ) overweight ( 25.0\u201329.9 kg\/m2 ) \u22124.5161 ( 95 % ci : \u22126.6363 , \u22122.3958 ) 0.0685 ( 95 % ci : \u22120.0009 , 0.138 ) obes , class 1 ( 30.0\u201334.9 kg\/m2 ) \u22122.8149 ( 95 % ci : \u22124.4375 , \u22121.1923 ) 0.0253 ( 95 % ci : \u22120.0243 , 0.0749 ) obes , class 2 ( 35.0+ kg\/m2 ) \u22123.321 ( 95 % ci : \u22124.2083 , \u22122.4336 ) 0.0564 ( 95 % ci : 0.0243 , 0.0885 ) global peripapillari retin nerv fibr layer , \u00b5m healthi weight bmi ( 18.5\u201324.9 kg\/m2 ) 109.36 ( 95 % ci : 65.85 , 152.86 ) \u22121.29 ( 95 % ci : \u22123.77 , 1.18 ) overweight ( 25.0\u201329.9 kg\/m2 ) 148.22 ( 95 % ci : 125.37 , 171.07 ) \u22122.19 ( 95 % ci : \u22123.56 , \u22120.81 ) obes , class 1 ( 30.0\u201334.9 kg\/m2 ) 126.43 ( 95 % ci : 109.82 , 143.04 ) \u22121.66 ( 95 % ci : \u22122.56 , \u22120.77 ) obes , class 2 ( 35.0+ kg\/m2 ) 138.54 ( 95 % ci : 129.55 , 147.53 ) \u22121.16 ( 95 % ci : \u22121.65 , \u22120.68 ) global peripapillari total retin thick , \u00b5m healthi weight bmi ( 18.5\u201324.9 kg\/m2 ) 321.39 ( 95 % ci : 261.78 , 381.01 ) \u22122.28 ( 95 % ci : \u22124.99 , 0.43 ) overweight ( 25.0\u201329.9 kg\/m2 ) 401.94 ( 95 % ci : 368.56 , 435.31 ) \u22123.37 ( 95 % ci : \u22125.17 , \u22121.56 ) obes , class 1 ( 30.0\u201334.9 kg\/m2 ) 352.69 ( 95 % ci : 329.5 , 375.89 ) \u22122.87 ( 95 % ci : \u22123.85 , \u22121.88 ) obes , class 2 ( 35.0+ kg\/m2 ) 363.9 ( 95 % ci : 351.38 , 376.42 ) \u22121.68 ( 95 % ci : \u22122.23 , \u22121.13 ) macular ganglion cell layer volum , mm3 healthi weight bmi ( 18.5\u201324.9 kg\/m2 ) 0.3998 ( 95 % ci : 0.3556 , 0.4441 ) \u22120.001 ( 95 % ci : \u22120.0018 , \u22120.0002 ) overweight ( 25.0\u201329.9 kg\/m2 ) 0.4506 ( 95 % ci : 0.4282 , 0.4731 ) \u22120.0009 ( 95 % ci : \u22120.0015 , \u22120.0003 ) obes , class 1 ( 30.0\u201334.9 kg\/m2 ) 0.4352 ( 95 % ci : 0.4183 , 0.4521 ) \u22120.0003 ( 95 % ci : \u22120.0007 , 0 ) obes , class 2 ( 35.0+ kg\/m2 ) 0.445 ( 95 % ci : 0.4358 , 0.4541 ) \u22120.0004 ( 95 % ci : \u22120.0005 , \u22120.0002 ) headach frequenc ( days\/month ) healthi weight bmi ( 18.5\u201324.9 kg\/m2 ) 13.5 ( 95 % ci : 4.72 , 22.28 ) \u22120.15 ( 95 % ci : \u22120.59 , 0.28 ) overweight ( 25.0\u201329.9 kg\/m2 ) 16.6 ( 95 % ci : 12.28 , 20.91 ) \u22120.1 ( 95 % ci : \u22120.34 , 0.14 ) obes , class 1 ( 30.0\u201334.9 kg\/m2 ) 19.44 ( 95 % ci : 16.34 , 22.54 ) \u22120.09 ( 95 % ci : \u22120.27 , 0.08 ) obes , class 2 ( 35.0+ kg\/m2 ) 20.74 ( 95 % ci : 18.76 , 22.72 ) \u22120.2 ( 95 % ci : \u22120.32 , \u22120.08 ) migraine-lik headach frequenc ( days\/month ) healthi weight bmi ( 18.5\u201324.9 kg\/m2 ) 4.34 ( 95 % ci : \u22122.32 , 10.99 ) 0.16 ( 95 % ci : \u22120.2 , 0.53 ) overweight ( 25.0\u201329.9 kg\/m2 ) 9.79 ( 95 % ci : 5.97 , 13.61 ) \u22120.09 ( 95 % ci : \u22120.33 , 0.15 ) obes , class 1 ( 30.0\u201334.9 kg\/m2 ) 6.52 ( 95 % ci : 3.96 , 9.07 ) 0 ( 95 % ci : \u22120.16 , 0.15 ) obes , class 2 ( 35.0+ kg\/m2 ) 10.46 ( 95 % ci : 8.68 , 12.23 ) \u22120.15 ( 95 % ci : \u22120.26 , \u22120.05 ) headach sever ( va 0\u201310 ) healthi weight bmi ( 18.5\u201324.9 kg\/m2 ) 5.73 ( 95 % ci : 3.54 , 7.93 ) \u22120.09 ( 95 % ci : \u22120.2 , 0.02 ) overweight ( 25.0\u201329.9 kg\/m2 ) 5.14 ( 95 % ci : 3.99 , 6.28 ) 0.06 ( 95 % ci : \u22120.02 , 0.14 ) obes , class 1 ( 30.0\u201334.9 kg\/m2 ) 6.55 ( 95 % ci : 5.67 , 7.43 ) \u22120.04 ( 95 % ci : \u22120.1 , 0.01 ) ( continu ) 6 m. thaller et al.0.0903 ) , respect , obes class 1 ( figur 3 ) . compar healthi weight bmi , group significantli differ base - line visual acuiti oct rnfl outcom ( figur 3 ) . trajectori visual outcom differ compar healthi weight bmi baselin group ( tabl 3 , figur 3 ) . higher headach frequenc report aver- age higher baselin bmi ( tabl 3 , figur 4 ) . group significantli differ healthi weight bmi baselin ( figur 4 ) due wide confid interv . similarli , migraine-lik headach frequenc , headach sever , hit6 differ bmi group baselin ( figur 4b\u2013d ) . trajectori headach outcom simi - lar outcom ( tabl 3 , figur 4 ) apart headach sever overweight group wors trajectori 0.15 units\/ month ( 0.02 , 0.29 ) compar healthi weight bmi patients.t 3 . ( continu ) . baselin estim ( unit ) chang per month ( units\/month ) obes , class 2 ( 35.0+ kg\/m2 ) 6.06 ( 95 % ci : 5.55 , 6.57 ) \u22120.01 ( 95 % ci : \u22120.04 , 0.02 ) headach impact test ( hit-6 ) ( score 36\u201378 ) healthi weight bmi ( 18.5\u201324.9 kg\/m2 ) 61.67 ( 95 % ci : 54.4 , 68.95 ) \u22120.27 ( 95 % ci : \u22120.67 , 0.13 ) overweight ( 25.0\u201329.9 kg\/m2 ) 61.33 ( 95 % ci : 57.28 , 65.37 ) 0 ( 95 % ci : \u22120.27 , 0.28 ) obes , class 1 ( 30.0\u201334.9 kg\/m2 ) 61.18 ( 95 % ci : 58.19 , 64.17 ) \u22120.07 ( 95 % ci : \u22120.27 , 0.14 ) obes , class 2 ( 35.0+ kg\/m2 ) 61.29 ( 95 % ci : 59.51 , 63.08 ) 0.01 ( 95 % ci : \u22120.1 , 0.13 ) figur 3. longitudin visual data baselin visit iih patient categoris baselin bmi group , loess smoother ad show trend across categori . ( ) logmar visual acuiti ( logunit ) ( b ) perimetr mean deviat measur humphrey visual field 24-2 test ( db ) ( c ) retin nerv fibr layer thick measur optic coher tomographi ( \u00b5m ) ( ) total retin thick optic nerv head measur optic coher tomographi ( \u00b5m ) ( e ) macular ganglion cell layer volum measur optic coher tomographi ( mm3 ) . figur 4. longitudin headach data baselin visit iih patient categoris baselin bmi group , loess smoother ad show trend across categori . ( ) headach frequenc ( day per month ) ( b ) migraine-lik headach frequenc ( day per month ) ( c ) headach mean sever predomin headach ( 0\u201310 numer rate scale ) ( ) headach impact test 6 ( hit6 ) ( qualiti life measur score 36\u201378 ) .neuro-ophthalmolog 7discuss prospect longitudin cohort peopl live iih , healthi weight bmi presenta - tion uncommon . visual outcom similar bmi group ; howev , improv papilloedema observ rapid patient without obes . headach frequenc higher iih patient obes compar without , time , headach out- come similar bmi group . preval healthi weight bmi studi similar previou larg studi iih.9 cohort , healthi weight bmi , includ - ing without obes , wors visual field function baselin , despit similar oct papillo - dema measur . could potenti reflect delay diagnosi due lower suspicion iih person healthi weight bmi . oct imag measur shown acut marker diseas activity,5 well better correl intracrani pressur clinic symptoms.34,35 thu , compar oct mea- sure , wors pmd , may indic delay pre- sentat disease.5 trend seen csf divers surgeri rate may reflect patient higher bmi like present fulmin iih thu requir surgeri , although requir evalu cohort statist signific cohort . statist signific differ seen visual acuiti macular ganglion cell layer volum trajectori obes without ( tabl 2 ) . howev , clinic signific uncertain due small magnitud variat like perceiv patient clinic signific . trajectori headach outcom significantli differ < 30 kg\/m2 \u226530 kg\/m2 . consist baselin bmi potenti greater influenc visual outcom headach outcom may influenc addit signific factor previou demonstr literature.5 although iih predominantli affect reproduc - tive-ag women obesity,3,5,36,37 aty- pical presentations.9,38 defin patient whether obes present baselin visit clinic use- ful potenti manag metabol syndrom , although involv arbitrari cut 30 kg\/m2 could miss patient could benefit . import clinician note baselin bmi impact trajectori visual headach outcom , could reassur ; import activ man - age obes . current disease-modifi therapi system manifest iih weight loss.3,5,23,26,27 role patient normal base- line bmi yet understood . would use futur analysi recent analysi iih life databas found chang bmi prognost marker visual outcomes.5 scenario pregnanc , role weight loss clear.16,39 although outcom base bmi similar peopl live iih , con- clude underli pathogenesi . iih shown associ hypert - tosteron independ obesity,20 meta - bolic prime toward lipogenesis.18,19 peopl obes , signific weight loss 24 % bodi weight often requir diseas remission.25,27,40 potenti pathogenesi lean iih could infer phenotyp similar condit poli - cystic ovarian syndrom ( pco ) . pco , one studi report 42 % patient healthi weight bmi ( defin bmi 18.5\u201323 kg\/ m2 ) significantli lower preval lean pco derang lipid profil , impair glucos toler test , insulin resistance.41 treat - ment insulin resist metformin shown lessen hyperandrogen pcos42 also shown potenti benefit iih.43 limit iih life databas metformin use routin document , therefor , analysi could done . iih normal baselin bmi , may role dietari modif pharmacoth - api avoid futur weight gain shown benefit lean pcos.44 anecdot , clinician recommend weight loss normal bmi direct histori weight gain prior iih diagnosi , long deem detriment patient \u2019 health.3 clear need research metabol profil iih live without obes , potenti , could 8 m. thaller et al.a similar metabol complic risk profil despit lower bodi weight , could warrant altern manag approach . iih healthi weight bmi , without obe- siti , may close reflect anoth condit , spaceflight associ neuro-ocular syndrom ( san ) given healthi weight bmi observ astronaut . san occur long durat spaceflight risk includ hyperop refract error shift , acut visual loss , cognit chang . oct chang note san similar iih , increas total retin thick 20 \u00b5m use earliest indic optic disc oedema.45,46 translat benefit condi - tion could establish underli patho - physiolog determin . major limit studi rel small sampl size healthi weight bmi patient . similar previou study9 like reflect rariti atyp iih alreadi rare condit . baselin bmi use cate- goris patient ; howev , lead-tim bia may induc initi visit elsewher prior tertiari neuro-ophthalmolog referr . minimis , creat surrog marker dis- eas durat defin time diagnost lumbar punctur first encount baselin visit , adjust multivari regress model . acknowledg patient report symptom onset record within iih life , may predat diagnosi uncer - tain variabl durat . visual function assess - ment challeng patient perform intra-visit inter-visit factor known influenc reliability.4,47,48 given real- world clinic practic studi , follow-up interv base decis attend clinician visit would influenc person \u2019 clinic factor diseas state , papilloedema sever , symptomatolog . result , individu whose diseas remiss would rapidli discharg care transfer back local hospit . henc , miss follow-up data increas cours time . addit , peopl lost follow-up . therefor , caution interpret long-term outcom seen loess smoother curv appli due reduc sampl size cours studi . diagnosi iih base revis diagnost criteria.30 howev , due referr pattern , cohort contain definit probabl diagnos iih . often challeng retriev initi diagnost lumbar punctur open - ing pressur measur . analysi prompt includ mani inquiri extern hos- pital unit piec essenti clinic data clinic record . lumbar punctur invas challenging.49,50 therefor import guidelin recommend adopt ensur accur record open pressur help reduc diagnost uncertainty.3,48,51 conclus peopl normal bmi make minor peopl diagnos iih . appear similar visual headach outcom peopl live iih obes . baselin visit , peopl without obes wors visual field function similar papilloedema measur , com - pare peopl live obes , long- term outcom similar . underli pathophysiolog without obes iih develop yet discov . acknowledg would like thank peopl live iih contribut studi iihuk ongo support research . disclosur statement mt vh report conflict . sa report consult fee ( johnson & johnson ) . jh report speaker fee ( novo nordisk ) . spm report consult fee ( invex therapeut ; velux foundat ) ; advisori board fee ( abbvi ; gensight ; invex ther- apeut ; ocular therapeutix ) speaker fee ( heidelberg engi- neer ) . aj report person fee invex therapeut conduct studi well share option sharehold , speaker fee ( novarti ; allergan ; teva uk ) consult fee ( allergan ; chiesi ; novarti ; lundbeck ) . fund iih life databas support healthcar qualiti improv partnership ( hqip ) iihuk regist patient chariti [ number 1143522 ] . aj neuro-ophthalmolog 9fund studi medic research council grant number [ mr\/ko15184\/1 ] , nation institut health research grant [ nihr-cs-011-028 ] ( clinician scientist fel- lowship ) , sir jule thorn award biomed scienc . author \u2019 contribut mt involv data acquisit , data analysi , interpret data , draft work , revis , final approv . vh involv data analysi , interpret data , manuscript revis , final approv . sa involv interpret data , manuscript revis , final approv . jh involv interpret data , manuscript revis , final approv . spm involv concept design project , data acquisit , data analysi , interpret data , manuscript revis , final approv . aj involv concept design project , data acquisit , data analysi , interpret data , manuscript revis , final approv . data avail statement professor sinclair take full respons data , ana- lyse interpret , conduct research . full access data right publish data separ apart sponsor . propos data access made correspond author . reason scientif sound propos , appropri qualifi research group , provid data begin 12 month end 3 year public articl research whose propos use data approv correspond author . request need sign data access agreement , cover term condit releas data includ public requir , authorship , acknowl - edgement , oblig respons use data . ethic statement research ethic approv nh nation research ethic committe ( 14\/lo\/1208 ) , iih life studi , compli declar helsinki . patient gave written inform consent particip studi . orcid mark thaller http : \/\/orcid.org\/0000-0001-7772-2157 victoria homer http : \/\/orcid.org\/0000-0003-3639-7874 salli abbott http : \/\/orcid.org\/0000-0002-1895-1942 susan p. mollan http : \/\/orcid.org\/0000-0002-6314-4437 alexandra j. sinclair http : \/\/orcid.org\/0000-0003-2777- 5132refer 1.yiangou , mollan sp , sinclair aj . idiopath intracra - nial hypertens : step chang understand diseas mechan . nat rev neurol . 2023 ; 19 ( 12 ) :769\u2013785 . doi:10.1038\/s41582-023-00893-0 . 2. adderley nj , subramanian , nirantharakumar k , et al . associ idiopath intracrani hypertens risk cardiovascular diseas women unit kingdom . jama neurol . 2019 ; 76 ( 9 ) :1088\u20131098 . doi:10.1001\/jamaneurol.2019 . 1812 . 3.mollan sp , davi b , silver nc , et al . idiopath intra - cranial hypertens : consensu guidelin manag . j neurol neurosurg psychiatri . 2018 ; 89 ( 10 ) :1088\u20131100 . doi:10.1136\/jnnp-2017-317440 . 4.grech , clouter , mitchel jl , et al . cognit per- formanc idiopath intracrani hypertens relev intracrani pressur . brain commun . 2021 ; 3 : fcab202 . doi:10.1093\/braincomms\/fcab202 . 5. thaller , homer v , hyder , et al . idiopath intracrani hypertens prospect cohort studi : evalu prognost factor outcom . j neurol . 2023 ; 270 ( 2 ) :851\u2013863 . doi:10.1007\/s00415- 022-11402-6 . 6. adderley nj , subramanian , perrin , nirantharakumar k , mollan sp , sinclair aj . headach , opiat use , prescrib trend women idio- pathic intracrani hypertens : population-bas match cohort studi . neurolog . 2022 ; 99 : e1968\u20131978 . doi:10.1212\/wnl.0000000000201064 . 7. mollan sp , wakerley br , alimajstorov z , et al . intracrani pressur directli predict headach mor- biditi idiopath intracrani hypertens . j headach pain . 2021 ; 22 ( 1 ) :118. doi:10.1186\/s10194- 021-01321-8 . 8. hyder yf , homer v , thaller , et al . defin phenotyp prognosi peopl idiopath intra - cranial hypertens cerebrospin fluid divers surgeri . j ophthalmol . 2023 ; 250:70\u201381 . doi:10.1016\/ j.ajo.2023.01.016 . 9. bruce bb , kedar , van stavern gp , corbett jj , newman nj , biouss v. atyp idiopath intracrani hypertens : normal bmi older patient . neurolog . 2010 ; 74 ( 22 ) :1827\u20131832 . doi:10.1212\/wnl . 0b013e3181e0f838 . 10. world health organis . bodi mass index \u2013 bmi [ onlin ] . http : \/\/www.who.int\/europe\/news-room\/ fact-sheets\/item\/a-healthy-lifestyl -- -who-recommen dation . 2010 . access juli 27 , 2023 . 11. consult whoe . appropri body-mass index asian popul implic polici intervent strategi . lancet . 2004 ; 363 ( 9403 ) :157\u2013163 . doi:10.1016\/s0140-6736 ( 03 ) 15268-3 . 12. nation institut health care excel . obes : identif , assess manag clinic guidelin [ cg189 ] . 2014 .10 m. thaller et al.13 . hornbi c , botfield h , \u2019 reilli mw , et al . evalu fat distribut idiopath intracrani hyperten - sion use dual-energi x-ray absorptiometri scan . neuroophthalmolog . 2018 ; 42:99\u2013104 . doi:10.1080\/ 01658107.2017.1334218 . 14. hornbi c , mollan sp , botfield h , \u2019 reilli mw , sinclair aj . metabol concept idiopath intracra - nial hypertens potenti therapeut intervent . j neuroophthalmol . 2018 ; 38:522\u2013530 . doi:10.1097\/wno.0000000000000684 . 15. fric r , pripp ah , eid pk . cardiovascular risk factor chiari malform idiopath intracrani hypertens . brain behav . 2017 ; 7 : e00677 . doi:10 . 1002\/brb3.677 . 16. thaller , mytton j , wakerley br , mollan sp , sinclair aj . idiopath intracrani hypertens : eva- luation birth fertil hospit epi- sode statist dataset . bjog . 2022 ; 129 ( 12 ) :2019\u20132027 . doi:10.1111\/1471-0528.17241 . 17. alimajstorov z , pascual-baixauli e , hawk ca , et al . cerebrospin fluid dynam modul diet cytokin rat . fluid barrier cn . 2020 ; 17 ( 1 ) :10. doi:10.1186\/s12987-020-0168-z . 18. westgat cs , botfield hf , alimajstorov z , et al . system adipocyt transcript metabol dysregul idiopath intracrani hypertens . jci insight . 2021 ; 6 : e145346 . doi:10.1172\/jci.insight . 145346 . 19. westgat csj , markey k , mitchel jl , et al . increas system adipos 11\u03b2-hsd1 activ idiopath intracrani hypertens . eur j endocrinol . 2022 ; 187:323\u2013333 . doi:10.1530\/eje-22-0108 . 20. \u2019 reilli mw , westgat cs , hornbi c , et al . uniqu androgen excess signatur idiopath intracrani hypertens link cerebrospin fluid dynam . jci insight . 2019 ; 4. doi:10.1172\/jci.insight . 125348 . 21. thaller , sinclair aj , tsermoula g , mollan sp . consider venou stenosi metabol underpin idiopath intracrani hypertens . cephalalgia . 2023 ; 43 ( 6 ) :3331024231184445. doi:10 . 1177\/03331024231184445 . 22. fargen km , coffman , torosian , brinjikji w , nye bl , hui f. \u201c idiopath \u201d intracrani hypertens : updat neurointervent research clin- ician . cephalalgia . 2023 ; 43 ( 4 ) :3331024231161323. doi:10.1177\/03331024231161323 . 23. mollan sp , tahrani aa , sinclair aj . potenti modifi risk factor idiopath intracrani hyper - tension : bodi weight . neurol clin pract . 2021 ; 11 : e504\u2013 e507 . doi:10.1212\/cpj.0000000000001063 . 24. thaller , tsermoula g , sun r , mollan sp , sinclair aj . neg impact covid-19 lockdown papilloedema idiopath intracrani hypertens . j neurol neurosurg psychiatri . 2021 ; 92 ( 7 ) :795\u2013797 . doi:10.1136\/jnnp-2020-325519 .25. mollan sp , mitchel jl , ottridg rs , et al . effect bariatr surgeri vs commun weight manag - ment intervent treatment idiopath intracrani hypertens : random clinic trial . jama neurol . 2021 ; 78 ( 6 ) :678\u2013686 . doi:10.1001\/jama neurol.2021.0659 . 26. sinclair aj , burdon , nightingal pg , et al . low energi diet intracrani pressur women idiopath intracrani hypertens : prospect cohort studi . bmj . 2010 ; 341 ( jul07 2 ) : c2701 . doi:10 . 1136\/bmj.c2701 . 27. mollan sp , mitchel jl , yiangou , et al . associ amount weight lost bariatr surgeri intra - cranial pressur women idiopath intracrani hypertens . neurolog . 2022 ; 99 : e1090\u2013e1099 . doi:10 . 1212\/wnl.0000000000200839 . 28.wall , kupersmith mj , kieburtz kd , et al . idio- pathic intracrani hypertens treatment trial : clinic profil baselin . jama neurol . 2014 ; 71 ( 6 ) :693\u2013701 . doi:10.1001\/jamaneurol.2014.133 . 29. sharma b , seervi n , sharma v , panagariya , goel d. clinic radiolog profil 122 case idiopath intracrani hypertens tertiari care centr india : observ studi . neurol india . 2022 ; 70 ( 2 ) :704\u2013709 . doi:10 . 4103\/0028-3886.344644 . 30. friedman di , liu gt , digr kb . revis diagnost criteria pseudotumor cerebri syndrom adult children . neurolog . 2013 ; 81 ( 13 ) :1159\u20131165 . doi:10.1212\/wnl.0b013e3182a55f17 . 31. mollan sp , chong yj , grech , sinclair aj , wakerley br . current perspect idiopath intra - cranial hypertens without papilloedema . life ( basel ) . 2021 ; 11 ( 6 ) . doi:10.3390\/life11060472 . 32.r core team . r : languag environ stati - tical comput [ onlin ] . http : \/\/www.r-project.org\/ . 33. bate , m\u00e4chler , bolker b , walker s. fit linear mixed-effect model use lme4 . j stat softw . 2015 ; 67 ( 1 ) :1\u201348 . doi:10.18637\/jss.v067.i01 . 34. vijay v , mollan sp , mitchel jl , et al . use optic coher tomographi surrog measur intracrani pressur idiopath intracrani hypertens . jama ophthalmol . 2020 ; 138 ( 12 ) :1264\u20131271 . doi:10.1001\/jamaophthalmol.2020.4242 . 35. mitchel jl , lyon hs , walker jk , et al . effect exenatid intracrani pressur idiopath intra - cranial hypertens : randomis clinic trial . brain . 2023 ; 146:1821\u20131830 . doi:10.1093\/brain\/awad003 . 36. mollan sp , hornbi c , mitchel j , sinclair aj . evalu manag adult idiopath intra - cranial hypertens . pract neurol . 2018 ; 18 ( 6 ) :485\u2013488 . doi:10.1136\/practneurol-2018-002009 . 37. mollan sp , aguiar , evison f , frew e , sinclair aj . expand burden idiopath intracrani hypertens . eye ( lond ) . 2019 ; 33 ( 3 ) :478\u2013485 . doi:10 . 1038\/s41433-018-0238-5 .neuro-ophthalmolog 1138. chen bs , newman nj , biouss v. atyp presenta - tion idiopath intracrani hypertens . taiwan j ophthalmol . 2021 ; 11 ( 1 ) :25\u201338 . doi:10.4103\/tjo.tjo_ 69_20 . 39. thaller , wakerley br , abbott , tahrani aa , mollan sp , sinclair aj . manag idiopath intracra - nial hypertens pregnanc : practic advic . pract neurol . 2022 ; 22 ( 4 ) :295\u2013300 . doi:10.1136\/practneurol- 2021-003152 . 40. aguiar , frew e , mollan sp , et al . health eco- nomic evalu bariatr surgeri versu commun weight manag intervent analysi idiopath intracrani hypertens weight trial ( iih : wt ) . life ( basel ) . 2021 ; 11 ( 5 ) :409. doi:10 . 3390\/life11050409 . 41. saxena p , prakash , nigam , mishra a. polycyst ovari syndrom : obes sine qua non ? clinic , hormon , metabol assess relat bodi mass index . indian j endocrinol metab . 2012 ; 16:996\u2013999 . doi:10.4103\/2230-8210.103011 . 42. nestler je , jakubowicz dj . lean women polycyst ovari syndrom respond insulin reduct decreas ovarian p450c17 alpha activ serum androgen . j clin endocrinol metab . 1997 ; 82:4075\u20134079 . doi:10.1210\/jc.82.12.4075 . 43. glueck cj , golnik kc , aregawi , goldenberg n , siev l , wang p. chang weight , papilledema , head - ach , visual field , life statu respons diet metformin women idiopath intracrani hypertens without concurr polycyst ovari syndrom hyperinsulinemia . transl re . 2006 ; 148:215\u2013222 . doi:10.1016\/j.trsl.2006.05.003 . 44. toosi , sodi r , pappachan jm . lean polycyst ovari syndrom ( pco ) : evidence-bas practic approach . j diabet metab disord . 2018 ; 17 ( 2 ) :277\u2013285 . doi:10.1007\/s40200-018-0371-5 . 45. lauri ss , lee smc , macia br , et al . optic disc edema choroid engorg astronaut space - flight individu expos bed rest . jama ophthalmol . 2020 ; 138 ( 2 ) :165\u2013172 . doi:10.1001\/ jamaophthalmol.2019.5261 . 46. scott ra , tarver wj , brunstett tj , urquieta e. optic nerv tortuos earth space . aerosp med hum perform . 2020 ; 91:91\u201397 . doi:10.3357\/amhp . 5406.2020 . 47. mollan sp , bodoza , ni mhealoid , et al . visual field pointwis analysi idiopath intracrani hyper - tension weight trial ( iih : wt ) . transl vi sci technol . 2023 ; 12:1. doi:10.1167\/tvst.12.5.1 . 48. mollan sp , fraser cl , digr kb , et al . guidelin intern headach societi control clinic trial idiopath intracrani hypertens . cephalalgia . 2023 ; 43 ( 8 ) :3331024231197118. doi:10 . 1177\/03331024231197118 . 49. mollan sp , momin sna , khatkar ps , grech , sinclair aj , tsermoula g. neuro-ophthalmologist \u2019 guid advanc intracrani pressur measur . eye brain . 2023 ; 15:113\u2013124 . doi:10.2147\/eb.s404642 . 50. scotton wj , mollan sp , walter , et al . characteris patient experi diagnost lumbar punctur idiopath intracrani hypertens : cross-sect onlin survey . bmj open . 2018 ; 8 ( 5 ) : e020445 . doi:10 . 1136\/bmjopen-2017-020445 . 51. hoffmann j , mollan sp , paemeleir k , lampl c , jensen rh , sinclair aj . european headach feder guidelin idiopath intracrani hypertens . j headach pain . 2018 ; 19 ( 1 ) :93. doi:10.1186\/s10194- 018-0919-2 .12 m. thaller et al .",
  "receiv : 15 novemb 2022 |accept : 31 march 2023 doi : 10.1111\/jhn.13176 meta \u2010analysi emot eat among adult healthi weight , overweight obes : systemat review meta \u2010analysi v. vasileiou1| . abbott2,3 1school nurs , midwiferi health , faculti health life scienc , coventri univers , coventri , uk 2depart dietet , univers hospit coventri warwickshir nh trust , coventri , uk 3research centr intellig healthcar , institut health wellb , coventri univers , coventri , uk correspond s. abbott , research centr intellig healthcar , coventri univers , richardcrossman bldg , coventri , cv1 5rw , uk . email : ac8926 @ coventry.ac.uk fund inform noneabstract background : emot eat ( ee ) disord eat behaviour may lead over . clear whether ee present equal degre among adult , regardless bodi mass index ( bmi ) statu . aim studi assess whether differ degre ee betweenadult healthi weight , overweight obes . method : medlin apa psycinfo databas search incept januari 2022 studi report ee score fromvalid questionnair . qualiti includ studi assess use axi tool . meta \u2010analysi use random effect standardis mean differ ( smd ) . heterogen investig use 2statist sensit analys . result : total 11 studi 7207 particip includ meta \u2010 analysi . degre ee greater adult bmi healthyrang , compar adult healthi bmi ( smd 0.31 , 95 % ci 0.17 0.45 ; 2= 85 % ) . howev , subgroup analysi found degre ee greater adult obes ( smd 0.61 , 95 % ci 0.41 0.81 ; i2= 62 % ) , differ degre ee adult overweight healthi bmi . conclus : degre ee greater among adul ts live obes , compar adult healthi bmi , indic need behaviour support support ee among peopl live obes seek weight manag . futur research examin long \u2010term effect intervent ee . keyword bmi , emot eat , obes , overweight , weight statu key point \u0081a systemat synthesi publish studi examin emot eat bodi mass index ( bmi ) statu conduct . \u0081thi meta \u2010analysi found degre emot eat greater adult bmi healthi rang , compar adult ahealthi bmi . \u0081howev , subgroup analysi found degre emot eat greater adult obes differ betweenadult overweight healthi bmi . \u0081these \ufb01nding indic need target screen behaviour support emot eat among peopl live obes seekingweight manag . j hum nutr diet . 2023 ; 1 \u20139 . wileyonlinelibrary.com\/journal\/jhn |1 open access articl term creativ common attribut licens , permit use , distribut reproduct dium , provid origin work properli cite . \u00a9 2023 author . journal human nutrit dietet publish john wiley & son ltd behalf british dietet association.introduct obes increas risk mani seriou diseas health impair cardiovascular diseas , type2 diabet certain cancer , lead caus mortal . 1obes de \ufb01ned bodi mass index ( bmi ) \u226530 kg\/m2and overweight de \ufb01ned bmi 25 kg\/m2and 29.9 kg\/m2.1obes recognis chronic , multifacet diseas , 2025 , predict 2.7 billion adult worldwid beaffect overweight , 1 billion obes . 2 disord eat term describ group maladapt attitud , belief behaviour arelink poor psycholog physiolog health . 3 disord eat behaviour , emotional ( ee ) , associ higher bmi waistcircumfer , 4which may result over . ee eat behaviour toward tendenc eat respons either pleasant unpleas emot , orboth . 5there diagnost criteria ee ; howev , literatur , usual identi \ufb01ed use valid questionnaires6\u201310 ( tabl 1 ) . grow bodi research explor possibl link ee obes adult . ee propos mediat associ betweendepress obes develop 11and increas suscept weight gain11and hinder weight maintenance.12a previou systemat review13investi- gate relationship emot eat behaviour among adult bmi 20 \u201330 kg\/m2 . nega- tive emot associ unhealthi eatingbehaviour , poorer dietari choic higher energi consumpt . therefor , ee neg impact dietari intak , result weight gain overtim , increas risk develop obes . knowledg , systemat synthesi studi examin ee bmi statu conductedbefor . aim conduct systemat review examin whether differ degre eeamong adult healthi weight , overweight and\/or obes , accord bmi classi \ufb01cation . method studi regist prospero ( identi \ufb01er crd42022352559 ) report accord prefer report item systemat review meta \u2010analys ( prisma ) standard.14 inclus criteria inclus criteria ( tabl 2 ) adult age \u226518 year old ; without speci \ufb01c medic condit , includ diagnosi eat disord ; report ee score measur use valid ee questionnair ( tabl 1 ) ; includ exposur group overweight and\/orobes ; compar group healthi bmi . studi includ observ peer \u2010review journal articl . literatur search full search strategi ( support inform : s1 ) test \ufb01ned maximis sensit retriev relev studi . databas medlin apa psycinfo search incept 29 januari 2022 via ebsco . literatur search werelimit studi english languag . refer import covid softwar 15for de\u2010dupl screen . two review ( vv sa ) independ duplic screen titl abstract n dt h e ns c r e e n e df u l l \u2010text report identi \ufb01ed studi . review blind 's respons eachscreen stage complet . disagr resolv consensu review . tabl 1 valid questionnair measur emot eat . questionnair outlin three \u2010factor eat questionnair 18 item ( tfeq \u2010r18 ) .6an 18 \u2010item self \u2010report questionnair evalu three dimens eat behaviour : ( 1 ) cognit restraint , ( 2 ) uncontrol eat ( 3 ) emot eat . three \u2010factor eat questionnair 21 item ( tfeq \u2010r21 ) .7a2 1 \u2010item version tfeq \u2010r18 three new item ad ee domain . dutch eat behaviour questionnair ( debq ) .8a3 3 \u2010item self \u2010report questionnair focus assess restrain , emot extern eat . emot eat scale ( ee ) .9a2 5 \u2010item self \u2010report questionnair design investig link speci \ufb01c neg emot over . item divid three subscal : ( 1 ) anger\/frustr , ( 2 ) anxieti ( 3 ) depress . emot eater questionnair ( eeq ) .10a1 0 \u2010item self \u2010report questionnair , creat determin extent emot in\ufb02uenc eat behaviour peopl obes . identi \ufb01e three factor : ( 1 ) \u2018 disinhibit \u2019 , ( 2 ) \u2018 type food \u2019 , ( 3 ) \u2018 guilt \u2019 .2 | emot eat bmi : systemat review 1365277x , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/jhn.13176 test , wiley onlin librari [ 19\/04\/2023 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens data extract data extract one review ( vv ) peer review ( sa ) use electron dataextract form . ee sco data extract accord bmi statu express either absolut score percentag maximumposs raw score , depend report within individu studi . qualiti assess axi qualiti apprais tool16wa use assess qualiti risk bia includ studi . one review ( vv ) complet qualiti apprais , thiswa peer review ( sa ) . statist analysi meta \u2010analysi undertaken use revman 517to examin ee score adult healthi weight healthi weight ( bmi \u226525 kg\/m2 ) . subgroup analysi also perform examin score adult ofhealthi weight compar overweight ( bmi 25\u221229.9 kg\/m 2 ) obes ( bmi \u226530 kg\/m2 ) . ac h \u2010squar base test homogen undertaken use cochran 's q statist i2 , describ percentag variabl effect estim result heterogen oppos sampl error.18du substanti heterogen de \ufb01ned i2 > 5 0 % n p\u22640.10,18the random \u2010effect model use dersimonian laird method use . data came sever differ ee screen tool , meta \u2010analysi per- form use standard mean differ ( smd ) . sensi-t analys also conduct explor hetero- geneiti exclud \u2018 outlier \u2019 studi . 18the subgroup analysi analys studi re- port ee score overweight obes popul separ . individu studi provid ee score overweight obes group , sampl sizeof healthi bmi compar group split equal avoid doubl count pool result . 18 result studi select studi select process outlin prisma \ufb02owchart14 ( figur 1 ) . duplic remov , databas search yield 343 studi , 76 studi potenti elig inclus titleand abstract screen . full \u2010text screen stage , main reason exclus due report ee score bmi \u226525 kg\/m 2. total 12 studies19\u201330 identi \ufb01ed inclus review . studi characterist characterist includ studi partici- pant detail tabl 3. sampl size particip vari 56 35,641 , mean age rang 19 50 year . one studi reportedethn . 21the particip studi either entir mostli women , except one study26wher men women equal repres . ee score : healthi bmi versu healthi bmi ( \u226525 kg\/m2 ) 12 includ studi , 1 study20report non \u2010 parametr data ee score , therefor 11 studi 7207 particip includ meta \u2010analysist 2 inclus exclus criteria . inclus criteria exclus criteria popul adult > 18 year old children\/adolesc < 18 year old without eat disord speci \ufb01c medic condit adult diagnos eat disord speci \ufb01c medic condit exposur overweight obes ( bmi > 25 kg\/m2 ) bmi report compar healthi weight de \ufb01ned studi healthi weight compar outcom ee score identi \ufb01ed use valid questionnair ( outlin tabl 1 ) studi use valid questionnair identifi ee studi observ studi qualit intervent studi peer \u2010review studi confer proceed studi dissertationsvasilei abbott |3 1365277x , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/jhn.13176 test , wiley onlin librari [ 19\/04\/2023 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens ( figur 2 ) . degre ee greater healthi bmi group , compar healthi bmi group ( smd0.31 , 95 % ci 0.17 \u20130.45 , p\u22640.0001 ; 2= 85 % ) . one includ studi convers found ee higher healthi bmi healthi bmicategori . 25sensit analysi perform remov- ing outlier studi ; howev , alter \ufb01nding ( smd 0.36 , 95 % ci 0.24 \u20130.47 , p\u22640.00001 ) heterogen ( i2= 77 % ) ( support inform : s2 ) . ee score : subgroup analysi healthi bmi versu overweight ( bmi 25 \u201329.9 kg\/m2 ) r obes ( bmi \u226530 kg\/m2 ) 11 studi , 7 studi 3517 particip report ee score accord bmi classi \ufb01cation overweight ( 25 \u201329.9 kg\/m2 ) obes ( \u226530 kg\/m2 ) separ includ subgroup analysi ( figur 3 ) . overal , ee score still greater healthi bmi compar healthi bmi group ( smd 0.37 , 95 % ci 0.13 \u20130.60 , p= 0.002 ; i288 % ) .howev , subgroup analysi reveal differ ( p= 0.0002 ) ee score overweight obes subgroup , compar healthi bmi . ee score greater obes group compar healthi bmi group ( smd 0.61 , 95 % ci 0.41 \u20130.81 , p < 0.00001 ; i2= 62 % ) . meanwhil , differ ee score overweight healthi bmi group ( smd 0.00 , 95 % ci \u22120.24 0.25 , p= 0.98 ; i2= 75 % ) . sensit analysi perform remov outlier study25from overweight subgroup , dealt heterogen ( i2= 0 % ) result stronger observ differ , albeit statist signi\ufb01c ( p= 0.07 ) ( support inform : s3 ) . qualiti assess risk bia mean axi score includ studi 16.3 24 ( support inform : s4 ) . reason ful\ufb01ll qualiti assess criteria predomin due justi \ufb01cation popul sampl size ( n= 10 ) report measur address figur 1 adapt prisma \ufb02ow chart.4 | emot eat bmi : systemat review 1365277x , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/jhn.13176 test , wiley onlin librari [ 19\/04\/2023 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens categoris ( n= 6 ) , describ ( n= 8 ) , non \u2010respond . outlier study25that remov sensit analys lowest axi score ( 14 24 ) . discuss \ufb01rst systemat review meta \u2010analysi compar degre ee among adult accord bmi statu . found degre ee wassigni\ufb01cantli greater among adult bmi healthi rang compar adult healthi bmi . howev , subgroup analysi reveal , compar toadult healthi bmi , ee score signi \ufb01cantli greater adult obes , adult overweight bmi . \ufb01nding align previou research found ee associ obes . 13although ourstudi focus popul without speci \ufb01c medic condit , \ufb01nding consist previou research demonstr higher degre ee among adult obes , popul comorbidities31 peopl bing \u2010eat disorder.3,32 studi establish degre ee greater adult obes compar healthi weightbmi ; howev beyond scope review determin causal . draw upon previou research , associ higher consumpt high \u2010energi food snack ee found , 33which may explain increas risk develop excess adipos . moreov , adult abdomin obes werecategoris emotional\/veri \u2010emot eater report lower intak \ufb01bre higher intak fat , 34which contribut greater energi intak overal . contrari , arguabl live obes may result ee behaviour . weight stigmat 3 characterist includ studi particip . studi countri sampl size , n= women , % age , mean ( sd ) non \u2010white ethnic , n= ( % ) aoun et al . ( 2019 ) 19lebanon 400 66 20.4 ( 1.8 ) report p\u00e9neau et al . ( 2013 ) 20franc 35,641 76 45.2 ( 14.4 ) report quick et al . ( 2014 ) 21u. . 1252 59 19.1 ( 1.2 ) 249 ( 19.9 ) vega et al . ( 2016 ) 22chile 344 58 39.1 ( 6.6 ) report ba\u00f1o et al . ( 2014 ) 23spain 291 100 30.5 ( 10.1 ) report rommel et al . ( 2012 ) 24franc 94 100 40.2 ( 11.9 ) report sanlier et al . ( 2015 ) 25turkey 503 74 20.2 ( 1.3 ) report van strien et al . ( 2012 ) 26netherland 590 48 40.2 ( 11.9 ) report van strien et al . ( 2009 ) 27netherland 1342 61 33.6 ( 9.4 ) report varela et al . ( 2019 ) 28spain 473 77 32.7 ( 11.4 ) report madal \u0131et al . ( 2021 ) 29turkey 1626 70 30 ( 11 ) report barc \u0131n\u2010g\u00fczelder & devrim \u2010lanpir ( 2021 ) 30turkey 506 76.5 32.5 ( 11.5 ) report figur 2 emot eat scores.vasilei abbott |5 1365277x , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/jhn.13176 test , wiley onlin librari [ 19\/04\/2023 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens experienc individu live obes link physiolog dysregulation,35lead disord eat behaviour , includ ee.36,37th preval depress among peopl obes isalso twice high peopl healthi weight , 38and depress ee posit correl , predict long \u2010term increas bmi.39rec , studi conduct covid \u201019 pandem , increas ee behaviour report , peopl use ee cope mechan mental health distur-b . 40therefor , seem ee may contribut factor , consequ , live obes . strength limit studi sever methodolog strength , includ- prospect registr prospero , ensur- transpar reduct potenti bia avoid unintent duplic review . 41 also , search strategi design achiev maximum sensit , reduc likelihood miss relev literatur . screen conduct two blind review , data extract peer review , minimis risk select bia data error . 42 final , studi includ use \ufb01ve valid questionnair ( tabl 1 ) identifi ee , maximis intern valid reliabl . studi limit relianc databas search , without handsearch relev journal , andtherefor sourc select bia elimin . search unpublish studi appli anenglish languag limit ; therefor review like suscept public bia . 43there studi conduct uk set , ethnic poorli report , therefor \ufb01nding studi may generalis uk popul across ethnic group . addit , particip pre- dominantli femal ; therefor , research \ufb01nding may less generalis male popul . end , includ studi use ethnic speci \ufb01c cut \u2010off point bmi , recommend nationalinstitut health care excel 44 ; therefor , may particip categoris appropri bmi classi \ufb01cation . moreov , emot eat questionnair valid among ethnic minor group . ethnic group , over- eat normalis seen mean strengthensoci bond , 45and therefor emot eat may perceiv problemat may requir differ approach screen across ethnic group . lastli , itwa possibl conduct meta \u2010regress explor heterogen detail due insuf \ufb01cient number includ studi . 18 implic practic review suggest degre ee greater inpeopl live obes . grow bodi ofresearch suggest obes intervent target treat ee support long \u2010term weight manage- ment . 3,46one studi report behaviour weight loss intervent led reduct ee 12\u2010month period increas likelihood figur 3 subgroup analysi emot eat score accord bodi mass index ( bmi ) classi \ufb01cation.6 | emot eat bmi : systemat review 1365277x , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/jhn.13176 test , wiley onlin librari [ 19\/04\/2023 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens achiev > 7 % weight \u2010loss 1.7 \u2010fold.31it therefor import healthcar profession , includ dieti- tian , screen treat ee , presenc ee neg impact weight statu may bea barrier weight manag . our\ufb01nd support adult obes routin screen emot eat use one ofth valid questionnair outlin tabl 1. how- ever , acknowledg time may constraint within weight manag consult ; thu ashort questionnair ( e.g. , eeq 10 ) may pragmat . although questionnair may support identi \ufb01cation ee , explor frequenc , caus consequ emot eat ; therefor , area requir explora- tion within consult . regard manag ee , mind self \u2010 compass import psycholog approach within weight \u2010loss intervent , associ improve- ment ee weight loss outcomes.47\u201352systemat review data shown intervent mixtur cognit behaviour therapi ( cbt ) , diet exerciseand mind improv ee weight loss outcom . 53 therefor , alongsid dietari intervent , dietitian andnutrit profession treat obes employcbt mind intervent . howev , lack con\ufb01denc train applic techniqu cbt previous report registereddietitian . 54therefor , train appli theori cbt mind improv effect ee intervent treatment obes requir fordietitian nutrit profession work weight manag . implic futur research although studi establish degre eei greater adult live obes , beyond scope review explor . present reviewhighlight need high \u2010qualiti studi examin ee caus and\/or consequ obes . although cbt , diet exercis mindfulnessintervent , combin , shown reduc emot eat enhanc short \u2010term weight loss treatment outcom , 53the long \u2010term effect inter- vention requir research . therefor , need rct longitudin studi assess long \u2010term effect ee intervent weight manag . conclus found degre ee signi \ufb01cantli greater among adult live obes compar adult healthi bmi . research need explor thecaus ee , ee affect weight statu weight manag , well long \u2010term effect intervent combin dietari intervent cbt mind manag ee . author contribut s.a. v.v . design studi independ andin duplic screen titl abstract full \u2010text report identi \ufb01ed studi . data extract v.v . peer review s.a. v.v . s.a.analys data contribut interpret of\ufb01nd write manuscript work . conflict interest statement author declar \ufb01nancial relation- ship organis could appear havein\ufb02uenc submit work . data availabili ty statement data support \ufb01nding studi avail correspond author upon reason- abl request . ethic statement research conduct part bsc ( hon ) dietet ; therefor , ethic approv grant ethic committe coventri univers ( p130039 ) . transpar declar lead author af \ufb01rm manuscript honest , accur transpar account studi beingreport . report work compliant prisma guidelin . lead author af \ufb01rm import aspect studi omit andthat discrep studi plan . refer 1. world health organ . obes overweight ; 2022. avail : http : \/\/www.who.int\/news-room\/fact-sheets\/ detail\/obesity-and-overweight ( access octob 2022 ) . 2. world obes feder . preval obes ; 2022. avail : http : \/\/www.worldobesity.org\/ab out\/about-obesity\/prevalence- of-obes ( access octob 2022 ) . 3. barnhart wr , braden al , price e. emot regul dif \ufb01cul- tie interact neg , posit , emot eat strengthen relationship disord eat : exploratori studi . appetit . 2021 ; 158:105038 . 4. k\u00e4rkk\u00e4inen u , mustelin l , raevuori , kaprio j , keski \u2010 rahkonen a. disord eat behaviour long \u2010term health \u2010relat consequ ? eur eat disord rev . 2017 ; 26:22 \u20138 . 5. wong l , stammer l , churilov l , price , ekinci e , sumithran p. emot eat patient attend specialist obes treatment servic . appetit . 2020 ; 151:104708 . 6. karlsson j , persson l \u2010o , sj\u00f6str\u00f6m l , sullivan m. psychometr properti factor structur three \u2010factor eat questionnair ( tfeq ) obes men women . sult swedish obes subject ( so ) studi . int j obe . 2000 ; 24:1715 \u201325 . 7. cappelleri jc , bushmakin ag , gerber ra , leidi nk , sexton cc , low mr , et al . psychometr analysi thevasilei abbott |7 1365277x , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/jhn.13176 test , wiley onlin librari [ 19\/04\/2023 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens three \u2010factor eat questionnair \u2010r21 : result larg divers sampl obes non \u2010obes particip . int j obe . 2009 ; 33 : 611 \u201320 . 8. van strien , frijter jer , berger gpa , defar pb . dutch eat behavior questionnair ( debq ) assess restrain , emot , extern eat behavior . int j eatdisord . 1986 ; 5:295 \u2013315 . 9. arnow b , kenardi j , agra ws . emot eat scale : develop measur assess cope neg affect eat . int j eat disord . 1995 ; 18:79 \u201390 . 10. garaulet , cantera , moral e , l\u00f3pez \u2010guimera g , s\u00e1nchez \u2010 carracedo , corbal\u00e1n \u2010tutau md . valid questionnair emot eat use case obes : emot eater questionnair ( eeq ) . nutr hosp . 2012 ; 27:645 \u201351 . 11. konttinen h. emot eat obes adult : role depress , sleep gene . proc nutr soc . 2020 ; 79:283 \u20139 . 12. frayn , kn\u00e4uper b. emot eat weight adult : review . curr psychol . 2018 ; 37:924 \u201333 . 13. devonport tj , nichol w , fullerton c. systemat review associ emot eat behaviour normal overweight adult popul . j health psychol . 2017 ; 24 : 3\u201324 . 14. prisma . prisma \ufb02ow diagram ; 2022. avail : http : \/\/ www.prisma-statement.org\/\/prismastatement\/flowdiagram ( access octob 2022 ) . 15. covid . better systemat review manag ; 2022. avail : http : \/\/www.covidence.org\/ ( access octob 2022 ) . 16. down mj , brennan ml , william hc , dean rs . develop critic apprais tool assess qualiti cross \u2010section studi ( axi ) . bmj open . 2016 ; 6 : e011458 . 17. cochran train . revman 5 download ; 2022. avail : http : \/\/training.cochrane.org\/online-learning\/core-software\/ revman\/revman-5-download ( access octob 2022 ) . 18. higgin j , green s. cochran handbook systemat review intervent ; 2019. avail : http : \/\/train . cochrane.org\/handbook ( access octob 2022 ) . 19. aoun c , nassar l , soumi , el osta n , papazian , rabbaa khabbaz l. cognit , behavior , emot aspect eat habit associ impuls , chronotyp , anxieti , depress : cross \u2010section studi . front behav neurosci . 2019 ; 13:204 . 20. p\u00e9neau , m\u00e9nard e , m\u00e9jean c , bellisl f , hercberg s. sex diet modifi associ emot eat weight statu . j clin nutr . 2013 ; 97:1307 \u201313 . 21. quick v , byrd \u2010bredbenn c , white aa , brown , colbi , shoff , et al . eat , sleep , work , play : associ weight statu health \u2010relat behavior among young adult colleg student . j health promot . 2014 ; 29 : e64 \u201372 . 22. vega ja , salazar g , hodgson mi , cataldo lr , valladar , obreg\u00f3n , et al . melanocortin \u20104 receptor gene variat associ eat behavior chilean adult . ann nutr metab . 2016 ; 68:35 \u201341 . 23. ba\u00f1o rm , cebolla , moragrega , van strien , fern\u00e1ndez \u2010 aranda f , ag\u00fcera z , et al . relationship eat style tempera anorexia nervosa , healthi control , morbid obes femal sampl . appetit . 2014 ; 76:76 \u201383 . 24. rommel , nandrino jl , ducro c , andrieux , delecourt f , antoin p. impact emot awar parent bond emot eat obes women . appetit . 2012 ; 59:21 \u20136 . 25. sanlier n , biyikli ae , biyikli et . evalu relationship eat behavior univers student bodi mass index self \u2010esteem . ecol food nutr . 2014 ; 54:175 \u201385 . 26. van strien , peter herman c , verheijden mw . eat style , over weight gain . prospect 2 \u2010year follow \u2010up studi repres dutch sampl . appetit . 2012 ; 59:782 \u20139 . 27. van strien , herman cp , verheijden mw . eat style , over , overweight repres dutch sampl . extern eat play role ? appetit . 2009 ; 52:380 \u20137.28 . varela c , andr\u00e9 , salda\u00f1a c. behavior pathway model overweight obes : cope strategi , eat behavior bodi mass index . eat weight disord . 2019 ; 25:1277 \u201383 . 29. madal \u0131b , alkan \u015fb , \u00f6r ed , ayranc \u0131m , ta \u015fk\u0131n h , kara hh . emot eat behavior covid \u201019 pandem : cross \u2010section studi . clin nutr espen . 2021 ; 46:264 \u201370 . 30. barc \u0131n\u2010g\u00fczelder hk , devrim \u2010lanpir a. associ bodi mass index , emot eat perceiv stress covid \u201019 partial quarantin healthi adult . public health nutr . 2021 ; 25:43 \u201350 . 31. braden , flatt sw , boutel kn , strong , sherwood ne , rock cl . emot eat associ weight loss success among adult enrol weight loss program . j behav med . 2016 ; 39:727 \u201332 . 32. wiedemann aa , ivezaj v , barn rd . character emot over among patient without bing \u2010eat disord primari care . gen hosp psychistri . 2018 ; 55:38 \u201343 . 33. asil e , yilmaz , bodur , ilhan esgin , yardimci h , keser , et al . effect emot eat bodi weight andeat habit adult . med sci . 2022 ; 11:1049 . 34. betancourt \u2010n\u00fa\u00f1ez , torr \u2010castillo n , mart\u00ednez \u2010l\u00f3pez e , de loera \u2010rodr\u00edguez co , dur\u00e1n \u2010baraja e , m\u00e1rquez \u2010sandov f , et al . emot eat dietari pattern : \ufb02ect food choic peopl without abdomin obes . nutrient . 2022 ; 14:1371 . 35. dali , sutin ar , robinson e. perceiv weight discrimin mediat prospect associ obes physio- logic dysregul : evid popul \u2010base cohort . psychol sci . 2019 ; 30:1030 \u20139 . 36. vartanian lr , porter . weight stigma eat behavior : review literatur . appetit . 2016 ; 102:3 \u201314 . 37. reinka , quinn dm , puhl rm . examin relationship weight control belief eat behavior : role intern weight stigma bmi . appetite.2021 ; 164:105257 . 38. konttinen h , van strien , m\u00e4nnist\u00f6 , jousilahti p , haukkala a. depress , emot eat long \u2010term weight chang : popul \u2010base prospect studi . int j behav nutr phi act . 2019 ; 16:28 . 39. natur . viciou cycl depress obes ; 2022. avail : http : \/\/www.nature.com\/articles\/d41586-022- 02207-8 ( access novemb 2022 ) . 40. burnatowska e , surma , olszanecka \u2010glinianowicz m. relationship mental health emot eat covid \u201019 pandem : systemat review . nutrient . 2022 ; 14:3989 . 41. stewart l , moher , shekel p. prospect registr systemat review make sens . syst rev . 2012 ; 1:7 . 42. viswanathan , patnod cd , berkman nd , bass eb , chang , hartl l , et al . recommend assess risk bia systemat review health \u2010care intervent . jce . 2018 ; 97 : 26\u201334 . 43. drucker , fleme p , chan \u2010w . research techniqu made simpl : assess risk bia systemat review . j invest dermatol . 2016 ; 136 : e109 \u201314 . 44. nation institut health care excel . obes : identi \ufb01cation , assess manag ; 2022. avail : http : \/\/www.nice.org.uk\/guidance\/cg189 ( access novemb 2022 ) . 45. gregersen sc , gillath o. food bring us togeth : tie attach food behavior . appetite.2020 ; 151:104654 . 46. ricca v , castellini g , mannucci e , lo sauro c , ravaldi c , rotella cm , et al . comparison individu group cognit behavior therapi bing eat disord . random , three \u2010year follow \u2010up studi . appetit . 2010 ; 55:656 \u201365 . 47. carri\u00e8r k , khouri b , g\u00fcnak mm , kn\u00e4uper b. mind \u2010 base intervent weight loss : systemat review meta \u2010 analysi . obe rev . 2017 ; 19:164 \u201377.8 | emot eat bmi : systemat review 1365277x , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/jhn.13176 test , wiley onlin librari [ 19\/04\/2023 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens 48. turk f , waller g. self \u2010compass relev patholog treatment eat bodi imag concern ? systemat review meta \u2010analysi . clin psychol rev . 2020 ; 79:101856 . 49. carbonneau n , goodman lc , robert lt , b\u00e9gin c , lussier , musher \u2010eizenman dr. look intergener associa- tion self \u2010compass , bodi esteem , emot eat within dyad mother adult daughter . bodi imag . 2020 ; 33:106 \u201314 . 50. palmeira l , cunha , pinto \u2010gouveia j. process chang qualiti life , weight self \u2010stigma , bodi mass index emot eat accept \u2010 , mind \u2010and compass \u2010base group intervent ( kg \u2010free ) women overweight obes . j health psychol . 2017 ; 24:1056 \u201369 . 51. katterman sn , kleinman bm , hood mm , nacker lm , corsica ja . mind medit intervent bing eat , emot eat , weight loss : systemat review . eat behav . 2014 ; 15:197 \u2013204 . 52. yu j , song p , zhang , wei z. effect mind \u2010base intervent treatment problemat eat behavior : systemat review . j alter complement med . 2020 ; 26:666 \u201379 . 53. chew hsj , lau st , lau y. weight \u2010loss intervent improv emot eat among adult high bodi mass index : systemat review meta \u2010analysi meta \u2010regress . eur eat disord rev . 2022 ; 30:304 \u201327 . 54. rapoport l , perri kn . dietitian feel adequ train behaviour chang method ? j hum nutr diet . 2000 ; 13:287 \u201398.author biographi v. vasilei ( bsc [ hon ] , rd ) clinic dietitian research interest focus dietari behaviour manag obes . s. abbott ( bsc [ hon ] , mre , rd ) clinic academ dietitian research int erest nutrit , behaviour psychosoci implic obes . support inform addit support inform found onlinein support inform section end articl . cite articl : vasilei v , abbott s. emot eat among adult healthyweight , overweight obes : systemat review meta \u2010analysi . j hum nutr diet . 2023 ; 1 \u20139.http : \/\/doi.org\/10.1111\/jhn.13176vasilei abbott |9 1365277x , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/jhn.13176 test , wiley onlin librari [ 19\/04\/2023 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens",
  "metabol chang intermitt fast lang , mg , coffey , aa , coleman , pc , barber , tm , van ren , , oyebod , , abbott , & hanson , p publish pdf deposit coventri univers \u2019 repositori origin citat : lang , mg , coffey , aa , coleman , pc , barber , tm , van ren , , oyebod , , abbott , & hanson , p 2023 , 'metabol chang intermitt fast ' , journal human nutrit dietet , vol . ( in-press ) , pp . ( -press ) . http : \/\/dx.doi.org\/ 10.1111\/jhn.13253 doi 10.1111\/jhn.13253 issn 0952 -3871 publish : wiley open access articl distribut term creativ common attribut licens ( http : \/\/creativecommons.org\/licenses\/by\/4.0\/ ) , permit unrestrict use , distribut , reproduct medium , provid origin work properli cite . receiv : 20 april 2023 |accept : 29 septemb 2023 doi : 10.1111\/jhn.13253 short report metabol chang intermitt fast maria g. lange1,2|alic a. coffey1|paul c. coleman1|thoma m. barber1,2| thij van rens3|oyinlola oyebode4|s abbott5,6|petra hanson1,2 1warwick medic school , univers warwick , coventri , uk 2warwickshir institut studi diabet endocrinolog metabol , univers hospit coventri andwarwickshir , coventri , uk 3depart econom , univers warwick , coventri , uk 4wolfson institut popul health , queen mari univers london , london , uk 5depart dietet , univers hospit coventri warwickshir nh trust , coventri , uk 6research centr intellig healthcar , coventri univers , coventri , uk correspond petra hanson , warwickshir institut studi diabet endocrinolog andmetabol , univers hospit coventri warwickshir , clifford bridg rd , coventri , cv2 2dx , uk.email : petra.hanson.1 @ warwick.ac.uk fund inform activ network support awarwick esrc iaa intern network grant , grant\/award number : es\/t502054\/1abstract background : preval obes rise global effect strategi treat obes need . intermitt fast , dietari intervent weight manag , receiv grow interest gener public , well healthcar profession , form lifestyl intervention.method : execut rapid review use pubm databas identifi systemat review examin impact intermitt fast metabol indic , publish 2011 2022.result : intermitt fast lead weight loss similar magnitud continu energi restrict . evid show intermitt fast lead greater fat loss measur fat mass ( kg ) bodi fatpercentag compar ad libitum diet , fat loss attain intermitt fast signi \ufb01cantli differ continu energi restrict , although recent evid show intermitt fast superior.ther mix evid impact intermitt fast insulin resist , fast glucos lipid pro \ufb01le . studi focus popul muslim peopl , show ramadan fast maylead weight loss improv metabol paramet fast , although effect revers fast \ufb01nish . conclus : intermitt fast effect ad libitum dietari intak , equal effect continu energi restrict , weight manag . howev , inconclus evid whether intermitt fast clinic bene \ufb01cial effect glucos lipid metabol . keyword altern day fast , intermitt fast , obes , weight loss key point \u0081intermitt fast ( ) encompass time restrict eat , altern day fast intermitt energi restrict \u0081if effect weight loss reduct respect bodi mass index ad libitum dietari intak \u0081if equal effect continu energi restrict weight manag j hum nutr diet . 2023 ; 1 \u201314 . wileyonlinelibrary.com\/journal\/jhn |1 open access articl term creativ common attribut licens , permit use , distribut reproduct dium , provid origin work properli cite . \u00a9 2023 author . journal human nutrit dietet publish john wiley & son ltd behalf british dietet associ . introduct global , 1980 2019 , preval obes increas 3.2 % 12.2 % men from6 % 15.7 % women . 1obes lead variou advers health outcom , includ type 2 diabet ( t2d ) , heart diseas cancer , highlight theimport weight manag . treat obes like cost \u2010effect , reduc preval associ diseas futur . 2until recent year , dietari intervent weight loss focus continu energi restrict ( cer ) , clinic guide- line recommend peopl live obesityshould aim daili energi intak 600 kcal less total energi expenditur . 3although effect strategi weight loss , adher cerha report low 32 % . 4,5consequ , weight mainten rare sustain long term . therefor , altern weight loss strategi need toprovid person \u2010centr approach . recent year , intermitt fast ( ) subject grow research interest . although de \ufb01nition vari slightli , concept energi restrict abstain food speci \ufb01ed amount time , rather cer cours whole day . 6 sever variat , includ : \u2212time restrict eat ( tre ) : fast period 3 21 h per day ( although commonli > 12 h ) . ramadan diurnal intermitt fast ( rdif ) fast period ramadan , practis muslim peopl sunris sunset consecut day 1 \u2010month period therefor align tre . energi restrict notrequir . \u2212altern day fast ( adf ) : individu restrict energi consumpt 25 % daili energyrequir 1 day , ad libitum diet follow next day , repeat basi . alterna- tive , 24 \u2010h fast period 1 day follow ad libitum diet next day , also known period fast . \u2212intermitt energi restrict ( ier ) : less de\ufb01n durat fast , individu undertak period energi restrict altern period habitu intak minimallyrestrict dietari intak . rational previou literatur suggest may moresustain approach weight loss durat restrict prolong . 7a popular increas interest grow , effect ifne apprais provid evid \u2010base sustain weight loss recommend . henc , aim tosynthesis avail evid metabol effect \ufb01nding publish , systemat review . method conduct rapid overview ( umbrella review ) systemat review publish medic literatur impact metabol effect . compar full review , rapid review incur discernibleimpact deriv conclus . 8rapid review summar- ise highest level academ evid provid healthcar profession clear summari existingevid . 9pubm search one research ( ml ) identifi relev literatur publish novemb 2011 novemb 2022. studi wereinclud systemat review written english languag . systemat review chosen robust narr review , clearlyde\ufb01n primari secondari object , explicit method extract synthesi data . includ systemat review observ effectsof dietari intervent compar control group , measur chang bodi composit metabol indic . bodi composit could includ bodymass index ( bmi ) ( kg\/m 2 ) , weight ( kg ) , bodi fat mass ( kg ) fat mass proport total bodi weight ( % ) . diabet control measur fast glucos ( mg\/dl ) hba1c ( mmol\/mol ) . insulin resist measur fast insulin ( miu\/ml ) homa \u2010ir . chang lipid measur total cholesterol ( tc ) ( mg\/dl ) , triglycerid ( tg ) ( mg\/dl ) , low \u2010densiti lipoprotein \u2010cholesterol ( ldl \u2010c ) ( mg\/dl ) high \u2010 densiti lipoprotein \u2010cholesterol ( hdl \u2010c ) ( mg\/dl ) . data collect use pre \u2010de\ufb01n framework includ surnam \ufb01rst author , public year , studi design , sampl size , analysi , popul , interven-tion\/exposur outcom . result review identi \ufb01ed 48 systemat review ( tabl 1 ) . number includ studi systemat review rang 4 101. individu studi includ combin interventiona l observ studi . nine review speci \ufb01calli examin effect fast ramadan , wherea remain studi examin rang convent approach . thestudi popul divers , includ predominantli adult overweight ( \u226525 kg\/m 2 ) ro b e ( \u226530 kg\/m2 ) , without associ metabol comorbid . themajor popul includ ramadan studi healthi adult . control diet use within includ systemat review either cer ad libitum diet ( consum normal diet non \u2010 restrict ) .2 | metabol chang follow intermitt fast 1365277x , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/jhn.13253 test , wiley onlin librari [ 18\/01\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens tabl 1 includ systemat review . main author refer titl date rang studi design includ popul intervent ( durat ) controlnumb studi r. adaf [ 10 ] food time , circadian rhythm chrononutrit : systemat review time \u2010restrict eat 's effect human health2014\u22122020 rct , non \u2010randomis clinic trial , singl \u2010armadult overweight obes . t2d\/pre \u2010diabetes.tr \u2013etr , dtre ( 4 day 4 month ) standard diet , extend feed window22 b. alhamdan [ 31 ] l e r n e \u2010day versu daili energi restrict diet : moreeffect weight loss ? systemat review meta \u2010analysis2000 \u20132015 experiment studi adult obes adf ( 3 12 week ) vlcd 28 m. allaf [ 11 ] intermitt fast prevent cardiovascular disease2011 \u20132019 rct adult 18 ier ( 4 week 6 month ) standard diet cer18 d. ashtari \u2010larki [ 12 ] effect intermitt fast combin resist train bodi composit : systematicreview meta \u2010analysis2010 \u20132020 rct healthi adult perform rt , 1 studi withoverweight\/obesetr , adf , ramadan ( 4 12 week ) standard diet +r t8 d. bitsani [ 41 ] effect earli time \u2010restrict feed glyceam pro \ufb01le adult : systemat review intervent studies2017 \u20132020 rct , non \u2010randomis clinic trialsadult normal weight , overweight , obes without metsetr ( 3 day 5 week ) standard diet dtre 5 j. bonnet [ 13 ] breakfast skip , bodi composit , cardiometabol risk : systemat review meta \u2010 analysi random trials1992 \u20132017 rct adult 18 omit breakfast ( 4 16 week ) breakfast 7 e. borgundvaag [ 14 ] metabol impact intermitt fast patient type 2 diabet mellitu : systemat review meta \u2010analysi intervent studies1991 \u20132018 rct adult t2d , mostli obesetr , ier , cer ( 7 168 day ) standard diet 7 j. chen [ 15 ] miss puzzl piec time \u2010restrict \u2010 eat ( tre ) long \u2010term weight \u2010 loss strategi overweight obes peopl ? systemat review meta \u2010analysi random control trials2016 \u20132021 rct , non \u2010 randomis clinicaltrialsadult overweight orobes . metstr ( 6 12 week ) standard diet extend eatingwindow12 y. cho [ 16 ] effect intermitt fast reduc bodi mass index andglucos metabol : systemat review meta \u2010analysis2011 \u20132018 rct adult 18 ier ( 4 24 week ) standard diet cer12 ( continu ) lang et al . |3 1365277x , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/jhn.13253 test , wiley onlin librari [ 18\/01\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens tabl 1 ( continu ) main author refer titl date rang studi design includ popul intervent ( durat ) controlnumb studi j. choi [ 32 ] effect carbohydr \u2010restrict diet intermitt fast obes , type 2 diabet mellitu , hypertens manag : consensu statement korean societi studi obes , korean diabet associ , andkorean societi hypertension2000 \u20132021 rct adult overweight obes ( bmi > 23 korean obesitycriteria ) tre , adf , ier ( 8 week 24 week ) standard diet cer8o ni f ( 50 carbo- hydraterestrict- ed diet ) i. ciof \ufb01 [ 33 ] intermitt versu continu energi restrict weight loss andcardiometabol outcom : systemat review meta \u2010analysi random control trials1998 \u20132018 rct adult overweight andobes , t2dier ( 8 24 week ) cer 11 j. m. correia [ 45 ] effect ramadan non \u2010 ramadan intermitt fast body1995 \u20132020 rct , observ studiesadult 18 34 studi ramadan , 32 tre ( 4 week ) standard diet 66 y. cui [ 17 ] health effect altern \u2010day fast adult : systemat review meta \u2010analysis2013 \u20132019 rct adult normal weight , overweight obesityadf ( 4 48 week ) standard diet 7 a. ezzati [ 4 ] effect isocalor intermitt fast vs daili calor restrict weight loss metabol risk factor fornoncommunic chronic diseas : systemat review random control orcompar trials2000 \u20132022 rct adult overweight obes . t2d metstr , adf , 4:3 , 5:2 ( 8 52 week ) cer 13 m. fari [ 51 ] systemat review , meta \u2010analysi , meta \u2010regress impact diurnal intermitt fast r ng l u c e b l cmarker healthi subjects1982 \u20132020 prospect observationalstudieshealthi adult rdif ( 4 week ) self \u2010control ( pre\/ post rdif ) 72 h. fernando [ 46 ] effect ramadan fast weight bodi composit healthi non \u2010athlet adult : systemat review meta \u2010analysis1982 \u20132018 observ studi adult 16 \u201370 yearsfast ramadan : 10 \u201317 h ( 4 week ) return normal diet post ramadan70 l. gu [ 6 ] effect intermitt fast human compar non \u2010 intervent diet caloric2007 \u20132021 rct adult overweight oradf , tre , ier , rdif ( median intervent time 3 month ) standard diet cer434 | metabol chang follow intermitt fast 1365277x , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/jhn.13253 test , wiley onlin librari [ 18\/01\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens tabl 1 ( continu ) main author refer titl date rang studi design includ popul intervent ( durat ) controlnumb studi restrict : meta \u2010analysi random control trialsobes . t2d met l. harri [ 18 ] intermitt fast intervent treatment overweight obes adult : systematicreview meta \u2010analysis1989 \u20132015 rct pseudo \u2010 randomis clinic trialsadult overweight obesityadf ( 3 12 month ) standard diet cer6 m. headland [ 19 ] w e g h \u2010loss outcom : systemat review meta \u2010analysi intermitt energi restrict trial last minimum 6 months1989 \u20132014 rct , randomis parallel studyadult overweight obes . t2dmier , modi \ufb01ed adf , 5:2 , intermitt use cer vlcd ( 8 week 2 year ) cer 9 b. horn [ 7 ] health effect intermitt fast : hormesi harm ? systemat review2008 \u20132013 rct , prospect observ trialsadult without t2d tre ( 2 day 12 week ) standard diet 7 h. jahrami [ 54 ] systemat review , meta \u2010analysi , meta \u2010regress impact diurnal intermitt fast r nb yw e g h ti nh e l h ysubject age 16 year above1982 \u20132019 prospect observ studi , interventionalclin studieshealthi adult rdif ( 4 week ) self \u2010control ( pre\/ post rdif ) 85 h. jahrami [ 55 ] four \u2010week consecut , dawn \u2010to\u2010 sunset intermitt fast ramadan affect cardiometabol risk factor healthi adult ? systemat review , meta \u2010analysi , meta \u2010regression1982 \u20132020 observ studi , rct , quasi \u2010 experiment , experimentaladult rdif ( 4 week ) self \u2010control ( pre\/ post rdif ) 91 h. jahrami [ 49 ] impact ramadan fast metabol syndrom sever relat ethnic sex : result systemat review meta \u2010 analysis1950 \u20132022 cohort studi healthi adult rdif ( 4 week ) self \u2010control ( pre\/ post rdif ) 101 j. kang [ 20 ] effect time \u2010restrict feed anthropometr , metabol , fit paramet : systemat review2000 \u20132021 rct , non \u2010randomis clinic trialsadult normal weight , overweight obesitytr ( 1 16 week ) standard diet cross \u2010over23 c. lima [ 34 ] impact intermitt fast bodi weight overweight obes individuals2015 \u20132019 rct adult overweight obesityif ( 8 week 4 month ) cer 4 ( continu ) lang et al . |5 1365277x , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/jhn.13253 test , wiley onlin librari [ 18\/01\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens tabl 1 ( continu ) main author refer titl date rang studi design includ popul intervent ( durat ) controlnumb studi l. liu [ 21 ] metabol ef \ufb01caci time \u2010restrict eat adult : systemat review meta \u2010analysi random control trials2016 \u20132022 rct adult normal weight , overweight obesitytr ( 4 week 12 month ) standard diet 17 m. mazidi [ 47 ] effect ramadan fast cardiometabol risk factor anthropometr paramet : systemat review1982 \u20132014 case seri , cohort studi , randomis studiesadult rdif ( 4 week ) self \u2010control ( pre\/ post rdif ) 16 h. meng [ 44 ] effect intermitt fast energi \u2010restrict diet lipid pro\ufb01l : systemat review meta \u2010analysis2006 \u20132019 clinic trial \u2014cross \u2010 parallel designadult overweight obes . somehealthi t2d metsif cer ( 4 week 12 month ) standard diet 35 p. mirmiran [ 50 ] effect ramadan intermitt fast lipid lipoprotein paramet : updat meta \u2010 analysis1978 \u20132019 observ studi clinic trialshealthi adult , pregnant women , athlet individualsrdif ( 4 week ) self \u2010control ( pre\/ post rdif ) , non \u2010fast control33 s. moon [ 22 ] bene \ufb01cial effect time \u2010restrict eat metabol diseas : system review meta \u2010 analysis2007 \u20132020 rct , non \u2010randomis clinic trialshealthi adult , metstr ( 25 day 12 week ) standard diet pre\/post tre21 e. moral \u2010 suarez \u2010varela [ 35 ] intermitt fast possibl bene\ufb01t obes , diabet , multipl sclerosi : systematicreview random clinic trials2015 \u20132020 rct review adult obes t2dif ( 2 day 4 week ) standard diet 31 j.park [ 23 ] effect altern \u2010day fast obes cardiometabol risk : systemat review meta \u2010 analysis2013 \u20132019 rct adult 18 altern day fast ( 4 24 week ) normal diet , cer , trf8 m. pellegrini [ 24 ] effect time \u2010restrict feed bodi weight metabol . systemat review meta \u2010 analysis2003 \u20132018 rct , prospect retrospect observ studyadult without t2d tre : studi ramadan 12 19 h fast . trial 16\u201320 h fast . ( 4 week ) standard diet 11 i.pureza [ 42 ] effect earli time \u2010restrict feed metabol pro \ufb01le adults2014 \u20132020 rct adult overweight orobesityetr without cer ( 1 day to12 week ) extend eat window,96 | metabol chang follow intermitt fast 1365277x , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/jhn.13253 test , wiley onlin librari [ 18\/01\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens tabl 1 ( continu ) main author refer titl date rang studi design includ popul intervent ( durat ) controlnumb studi excess weight : systemat review meta \u2010analysisdtr , standard diet y. roman [ 36 ] effect intermitt versu continu diet weight bodi composit obes andoverweight peopl : systemat review meta \u2010analysi random control trials1990 \u20132018 rct adult overweight obes . t2dif ( 12 52 week ) cer 9 b. sadeghirad [ 48 ] islam fast weight loss : systemat review meta \u2010 analysis1982 \u20132011 observ studi adult 18 rdif ( 4 week ) return normal diet post ramadan35 c. sandov [ 40 ] effect intermitt fast potenti weight loss muscl gain human younger 60 year old : systemat review2009 \u20132019 rct , cross \u2010section studiesadult normal weight , overweight obesityi , etr , rdif , tre ( provid ) standard diet , cross , pre\/ post rdif10 l. schwingshackl [ 5 ] impact intermitt energi restrict anthropometr outcom intermedi diseasemark patient overweight obes : systemat review meta \u2010analyses1989 \u20132019 rct adult overweight obes . mosthealthi , t2dier , adf ( 12 42 week ) standard diet cer17 r. seimon [ 25 ] intermitt diet provid physiolog bene \ufb01t continu diet weight loss ? asystemat review clinic trials1970 \u20132014 rct , pilot studi adult normal weight , overweight obesity.i , adf ( 2 104 week ) standard diet , cer , control40 e. thackrey [ 43 ] effect diet weight metabol outcom patient doubl diabet : systemat review2013 \u20132018 rct , non \u2010randomis clinic trial , observ studiesadult doubl diabet ( t1d ir , met , overweight\/ obes ) , cer , fast + cer , meddiet , low \u2010 fat diet ( 7 day 6 month ) standard diet differ intens dietari exposure6 ( 1 ) r. vital [ 37 ] effect intermitt fast glycem control bodi composit adult obes type 2 diabet : systemat review2000 \u20132021 rct adult t2d overweight obesityi , 5:2 , tre , modi \ufb01ed fast ( 12 24 week ) standard diet cer5 x. wang [ 38 ] intermitt fast versu continu energi \u2010restrict diet patient type 2 diabet mellitu and1998 \u20132020 rct adult t2d mets5:2 adf ( 8 week 12 month ) cer 5 ( continu ) lang et al . |7 1365277x , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/jhn.13253 test , wiley onlin librari [ 18\/01\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens tabl 1 ( continu ) main author refer titl date rang studi design includ popul intervent ( durat ) controlnumb studi metabol syndrom glycem control : systemat review meta \u2010analysi random control trial x. wei [ 26 ] intermitt energi restrict weight loss : systemat review cardiometabol , \ufb02ammatori appetit outcomes2012 \u20132020 rct adult overweight obes . t2d metsier , adf , 5:2 , tre , 6:1 , 1week on\/1 ( 8 52 week ) standard diet cer , without exercise27 s. welton [ 27 ] intermitt fast weight loss : systemat review2000 \u20132019 rct , clinic trial controlsadult overweight obes , somewith t2dif ( 2 52 week ) standard diet cer27 z. xie [ 28 ] effect time \u2010restrict feed differ feed window metabol health : systemat review human studies2005 \u20132021 rct , non \u2010randomis trial , cohort studiesadult overweight obes , prediabetes\/t2detr dtre ( 2 12 week ) standard diet cer19 f. yang [ 29 ] effect epidem intermitt fast cardiometabol riskfactor : systemat review meta \u2010analysi random control trials1998 \u20132020 rct adult ier ( provid ) standard diet cer55 x. yuan [ 30 ] effect intermitt fast diet glucos lipid metabol insulin resist patient withimpair glucos lipid metabol : systemat review meta \u2010analysis2011 \u20132020 rct adult met obesityif ( 7 day 12 month ) pre\/post intervention10 q. zhang [ 39 ] intermitt fast versu continu calori restrict : better weight loss ? 2000 \u20132020 rct , pilot trial adult overweight obes . t2dor metsif , adf , 5:2 ( 6 48 week ) cer 11 abbrevi : adf , altern day fast ; cer , continu energi restrict ; ier , intermitt energi restrict ; met , metabol syndrom ; rct , randomis control trial ; rdif , ramadan diurnal intermitt fast ; rt , resist train ; tre , time restrict eat ( etr earli , dtre delay ) ; t2d , type 2 diabet mellitu ; vlcd , low calori dieting.8 | metabol chang follow intermitt fast 1365277x , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/jhn.13253 test , wiley onlin librari [ 18\/01\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens effect weight\/bmi overal , review evid suggest regim consist result weight loss . durat ofintervent rang 1 104 week . versu ad libitum review conclud led weight loss compar ad libitum diet,5\u20137,10 \u201330with one review report reduct initi bodi weight 13 % .27the major studi conduct individu bmi \u226525 kg\/m2 , four review \ufb01nding effect weight loss higher bodi weight initially.14,20,23,29convers , one studi found signi \ufb01cant reduct bodi weight lean overweight among individu obesity.21two studi found chang weight lean metabol healthi participants.22,25bmi decreas compar ad libitum diet 13 14 reviews.6,11,12,15 \u201317,20,21,23 \u201325,27,29,30 versu cer nineteen review found compar weight loss follow cer.4\u20136,11,18,19,23,25 \u201327,31 \u201339in term bmi chang , \ufb01ve review compar cer , \ufb01nding signi \ufb01cant differ two interventions.11,25,27,38,39 fat mass chang fat mass follow compar controldiet ( cer ad libitum ) vari review , major studi support signi \ufb01cantli reduc fat loss compar ad libitum diet , differ cer diet . versu ad libitum seventeen review report effect fat mass compar ad libitum diet . studi popul highli heterogen across variou bmi categori . studi includ healthi adult , wherea other includ adult metabol diseas . thirteen reviewsst signi \ufb01cant reduct fat mass ( rang 0.46 kg 3.24 kg ) . 6,7,10,12,15,17,18,20 \u201323,26,29one meta \u2010 analysi show direct reduct reduc fm inif statist signi \ufb01cant ( p= 0.151 ) . 16 remain three studi show inconclus results,13,24,40although , studi found increas fat mass.if versu cer nine review report similar fat mass loss andcer . 4,25\u201327,32,33,36,37,39three meta \u2010analys interven- tional trial ( randomis non \u2010randomis ) state result higher level fat mass loss cer , mean differ rang \u22120.66 kg \u22123.31 kg.5,18,31 three review predominantli investig adf form , wherea nine review includ variou type . studi need determin whetheradf superior form respect achiev greater level fat mass loss cer . insulin resist diabet control twenti \u2010eight review report chang fast glucos , insulin , hba1c insulin resist , mix result . versu ad libitum compar ad libitum diet , 10 review found fast glucos signi \ufb01cantli reduc if,10,16,21,22,24,29,30,40 \u201342wherea nine review found signi \ufb01cant differ compar ad libitum diet.5,6,13,17,20,25,26,28,37al seven review re- port hba1c level found signi \ufb01cant differ control groups.5,14,21,25,29,30,37four review includ particip t2d therefor particip glucos abnorm atbaselin . 30two three review includ particip t2d show trend toward decreas hba1c meet statist signi \ufb01cance.14,37 twelv review analys fast insulin level versu ad libitum diet . number review identi \ufb01ed difference13,20,24,26,28,42wa equal number review identi \ufb01ed improv compar control.6,15,25,29,30,40similarli effect insulin level , evid insulin resist ifgroup compar ad libitum group inconclus . six review report signi \ufb01cant reduct insulin resist , 6,21,29,30,41,42four review found differ- ence13,17,24,28and one review mix result isol studi show decreas insulin sensitivity.20 versu cer twelv review compar fast glucos cerdiet . 4,6,11,18,19,25 \u201327,32,33,37,38these review includ 212 studi conduct predominantli indivi-du overweight obes . across 11 review , 17 studi includ particip t2d . remain review includ particip t2d notspecifi count . 26lang et al . |9 1365277x , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/jhn.13253 test , wiley onlin librari [ 18\/01\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens ten review found differ fast glucos cer . one review found mix result attribut heterogen studies.4on review found evid signi \ufb01cantli lower fast glucos level cohort compar cer ( \u22120.78 mmol\/l vs. \u22120.47 mmol\/l , p < 0.05 ) , although base singl study.27 evid differ fast insulin two group mix . five review found signi \ufb01cant differ two groups.19,26,27,32,38ezzati et al.4 found inconsist result across differ variat . one meta \u2010analysi found signi \ufb01cant effect ier compar cer insulin level ( wmd = \u22123.66 pmol\/l , 95 % con \ufb01- denc interv = \u22129.12 \u22120.19 , p= 0.041 ) , although 182 particip includ analysis.18no differ found hba1c4,26,27,32,33,37,38and homa \u2010ir26,32between cer . overal , result versu ad libitum vari ; therefor , hard draw robust conclus regard effect fast glucos , hba1c , insulin resist insulin level . convers , versu cer , result consist show differ two group . import tohighlight studi undertaken popula- tion without t2d therefor signi \ufb01cant chang indic may expect . lipid versu ad libitum chang lipid ( tc , tg , ldl \u2010c hdl \u2010c ) secondari outcom measur mani review , mix result . tc level vari review , show signi \ufb01cant reduct tc diet compar ad libitum diet . howev , review report increas tc difference.similarli , effect tg level ldl \u2010c mix , review \ufb01nding reduct , other chang increas . eight review found anincreas either ldl \u2010c tg , potenti concern given risk dyslipidaemia peopl overweight obes . 7,13,15,20,28,35,40,42 final , 14 review observ hdl level , 11 show effect . two review found possibl reduct hdl follow . bothconduct individu t2d anoth metabol disord . 28,30one review identi \ufb01ed studi found temporari rise morn hdl follow overnightfast , although result shoul interpret caution studi 's small sampl size ( n=1 1 ) . 43 versu cer nine review compar lipid pro \ufb01le cer found signi \ufb01cant differ two anyof parameters.4\u20136,11,18,19,26,32,38ther one except one review found cer superior respect reduc total cholesterol triglycerid , equival respect reduc ldl.44 overal , substanti conclus drawn result inconclus evid outcom diet lipid pro \ufb01le . could inadequ power underli primari studi , result inabl detect differ . howev , cer diet appear similareffect lipid pro \ufb01le . ramadan nine review describ effect rdif found weight signi \ufb01cantli reduc period ( rang \u22121.02 kg \u22121.34 kg ) . three review found bmi reduc ramadan.45\u201347howev , review also highlight weight signi \ufb01cantli increas follow \u2010 fast end , result overal non \u2010signi\ufb01c decreas weight.45,46,48w e g h tl sw sa l os e e nm r e predominantli overweight obes pre \u2010 ramadan.45,46fat mass shown signi \ufb01cantli decreas ramadan ; howev , also becam non \u2010signi\ufb01c follow \u2010up.46 sever review assess impact rdif metabol paramet variabl result . jahramiet al . 49suggest rdif decreas tg increas hdl \u2010c . anoth review concur improv lipoprotein paramet , particularli hdl \u2010c.50two review state de \ufb01nitiv answer lack impact rdif glucometabol lipoprotein markers.47,51 overal , rdif caus reduct weight , fat mass bmi . howev , maintain , , although ramadan may offer posit metabol effectsin short term , strategi need ensur mainten period . discuss overal , like lead signi \ufb01cant weight loss decreas bmi compar ad libitum diet . weight loss fat loss pronounc thosewith overweight obes compar normal weight control . rapid review evid cer compar weight loss result ; howev , newevid emerg case may effect . 52therefor , could recommend practition altern diet strategi who\ufb01nd cer dif \ufb01cult maintain . studi found reduct fat mass none found increas ; therefor , wish reduc fat mass couldundertak . notabl , reduct adipos directli translat improv metabolic10 | metabol chang follow intermitt fast 1365277x , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/jhn.13253 test , wiley onlin librari [ 18\/01\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens blood maker , clear effect lipid pro \ufb01le insulin level , similar lack clear effect cer diet paramet . case , initi need discuss healthcar profession toprovid safe support approach dietari intervent , ideal regist dietician . mechan result bene \ufb01cial effect remain unclear . propos reduct calor intak , also align circadian r hythm . previou data suggest disrupt circadian rhythm associ develop metabol diseas human ( well organ ) evolv optimisephysiolog process align endogen circadian clock . 53interestingli , rdif directli oppos circadian rhythm fast occur daytim hour . nevertheless , ramadan fast lead reduc weight , bmi fat mass ; ever , effect may sustain ramadan \ufb01nish . direct comparison rdif diet possibl sever reason . first , durat fast chang everi day account lunar calendar . second , ramadan isundertaken worldwid differ countri , climat season , also impact durat fast . final , given religi signi \ufb01canc ramadan , studi observ mani control . consequ , mani confound account . mani review includ overview sever limit . review examin outcom beyond 6 month . moreov , review includ present studi examin differ regim anddid compar differ type . review includ randomis non \u2010randomis studi , thu effect confound could beelimin . heterogen intervent preclud meta \u2010analysi systemat review . popul studi vari , review look healthyadult examin obes peopl live t2d , could explain vari outcom review . review comment potenti ofmetabol derang acut swing metabol indic could follow individu altern excess food intak . futur research focu provid long \u2010term data metabol effect mainten . studi accompani analysi subgroupdiffer gender , age , ethnic distinct metabol diseas . furth ermor , data adher , toler , dropout rate sustain need . implic public health clinic practic worldwid obes epidem necessit identifi effect dietari strategi . mani individu \ufb01nd current gold standard cer hard maintain \ufb01taround daili life . might favour emphasi restrict eat window calori . similar , superior , metabol effect cer short \u2010term ( 6 month ) 52 ; therefor , recommend dietari regim patient , could offer altern method struggl maintain cer . evid isneed long \u2010term effect . author contribut author contribut concept design part warwick obes network , draft revis articl approv \ufb01nal version manuscript . ml : methodolog , literatur search , analysi , write origin draft edit . ac : literatur search , initi analysi , write origin draft . pc : conceptualis , methodolog , analysi , write origin draft , edit . tb : conceptualis , write origin draft , edit . tvr : conceptualis , write origin draft , edit , fund acquisit . oo : conceptualis , methodol- ogi , write origin draft , edit . sa : write : review edit . ph : conceptualis , methodolog , litera-tur search , write origin draft , edit , supervis . acknowledg activ network support warwick esrc iaa intern network grant ( refer es\/ t502054\/1 ) . conflict interest statement author declar con \ufb02ict interest . data availabili ty statement data share applic articl nonew data creat analys studi . orcid maria g. lang http : \/\/orcid.org\/0000-0002-6685-8128 alic a. coffey http : \/\/orcid.org\/0000-0003-1059-4685 oyinlola oyebod http : \/\/orcid.org\/0000-0003- 0925-9839 petra hanson http : \/\/orcid.org\/0000-0002-6845-1049 peer review peer review histori articl avail http : \/\/www.webofscience.com\/api\/gateway\/wos\/peer-review\/10.1111\/jhn.13253 . refer 1. boutari c , mantzoro cs . 2022 updat epidemiolog obes call action : twin covid \u201019 pandem appear reced , obes dysmetabol pandem continu rage . metabol . 2022 ; 133:155217 . 2. wang yc , mcpherson k , marsh , gortmak sl , brown m. health econom burden project obes trend usa uk . lancet . 2011 ; 378 ( 9793 ) :815 \u201325 . 3. nice nifhac . obes : identi \ufb01cation , assess manage- ment . nice ; 2014.lang et al . |11 1365277x , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/jhn.13253 test , wiley onlin librari [ 18\/01\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens 4. ezzati , rosenkranz sk , phelan j , logan c. effect isocalor intermitt fast vs daili calor restrict weight loss metabol risk factor noncommunic chronic diseas : systemat review random control compar trial . j acad nutr diet . 2022 ; 123:318 \u201329 . 5. schwingshackl l , z\u00e4hringer j , nitschk k , torbahn g , lohner , k\u00fchn , et al . impact intermitt energi restrict anthropometr outcom intermedi diseas marker patient overweight obes : systemat review meta \u2010 analys . crit rev food sci nutr . 2021 ; 61 ( 8 ) :1293 \u2013304 . 6. gu l , fu r , hong j , ni h , yu k , lou h. effect intermitt fast human compar non \u2010intervent diet calor restrict : meta \u2010analysi random control trial . front nutr . 2022 ; 9:871682 . 7. horn bd , muhlestein jb , anderson jl . health effect intermitt fast : hormesi harm ? systemat review . amj clin nutr . 2015 ; 102 ( 2 ) :464 \u201370 . 8. habi mm , chapman e , clark r , barreto j , reveiz l , lavi jn . best methodolog rapid review researchevid evid \u2010inform decis make health polici practic : rapid review . health re polici syst . 2016 ; 14 ( 1 ) :83 . 9. aromatari e , fernandez r , godfrey cm , holli c , khalil h , tungpunkom p. summar systemat review : methodologicaldevelop , conduct report umbrella review approach . int j evid base healthcar . 2015 ; 13 ( 3 ) :132 \u201340 . 10. adaf r , messaadi w , meddahi , patey , haderbach , bayen , et al . food time , circadian rhythm chrononutri- tion : systemat review time \u2010restrict eat 's effect human health . nutrient . 2020 ; 12 ( 12 ) :3770 . 11. allaf , elghazali h , moham og , fareen mfk , zaman , salmasi , et al . intermitt fast prevent cardiovascular diseas . cochr datab syst rev . 2021 ; 1 ( 1 ) :013496 . 12. ashtari \u2010larki , bagheri r , tinsley gm , asbaghi , paoli , moro t. effect intermitt fast combin resist train bodi composit : systemat review meta \u2010 analysi . physiol behav . 2021 ; 237:113453 . 13. bonnet jp , cardel mi , cellini j , hu fb , guasch \u2010ferr\u00e9 m. breakfast skip , bodi composit , cardiometabol risk : systemat review meta \u2010analysi random trial . obes . 2020 ; 28 ( 6 ) :1098 \u2013109 . 14. borgundvaag e , mak j , kramer ck . metabol impact intermitt fast patient type 2 diabet mellitu : systemat review meta \u2010analysi intervent studi . j clin endocrinol metabol . 2021 ; 106 ( 3 ) :902 \u201311 . 15. chen jh , lu lw , ge q , feng , yu j , liu b , et al . miss puzzl piec time \u2010restrict \u2010eat ( tre ) long \u2010term weight \u2010loss strategi overweight obes peopl ? systemat review meta \u2010analysi random control trial . crit rev food sci nutr . 2021 ; 63:2331 \u201347 . 16. cho , hong n , kim k , cho , lee , lee , et al . effect intermitt fast reduc bodi mass index andglucos metabol : systemat review meta \u2010analysi . j clin med . 2019 ; 8 ( 10 ) :1645 . 17. cui , cai , zhou z , mu , lu , gao z , et al . health effect altern \u2010day fast adult : systemat review meta \u2010 analysi . front nutr . 2020 ; 7:586036 . 18. harri l , hamilton , azevedo lb , olajid j , de br\u00fan c , waller g , et al . intermitt fast intervent treatment ofoverweight obes adult : systemat review meta \u2010 analysi . jbi datab syst rev implement report . 2018 ; 16 ( 2 ) : 507\u201347 . 19. headland , clifton p , carter , keogh j. weight \u2010loss outcom : systemat review meta \u2010analysi intermitt energi restrict trial last minimum 6 month . nutrients.2016 ; 8 ( 6 ) :354.20. kang j , ratamess na , faigenbaum ad , bush ja , beller n , varga , et al . effect time \u2010restrict feed anthropomet- ric , metabol , \ufb01tness paramet : systemat review . j coll nutr . 2021 ; 41:810 \u201325 . 21. liu l , chen w , wu , hu f. metabol ef \ufb01caci time \u2010restrict eat adult : systemat review meta \u2010analysi random control trial . j clin endocrinol metab . 2022 ; 107 ( 12 ) :3428 \u201341 . 22. moon , kang j , kim sh , chung hs , kim yj , yu jm , et al . bene \ufb01cial effect time \u2010restrict eat metabol diseas : system review meta \u2010analysi . nutrient . 2020 ; 12 ( 5 ) :1267 . 23. park j , seo yg , paek yj , song hj , park kh , noh hm . effect altern \u2010day fast obes cardiometabol risk : systemat review meta \u2010analysi . metabol . 2020 ; 111:154336 . 24. pellegrini , ciof \ufb01i , evangelista , ponzo v , goitr , ciccon g , et al . effect time \u2010restrict feed bodi weight metabol . systemat review meta \u2010analysi . rev endocrin metabol disord . 2020 ; 21 ( 1 ) :17 \u201333 . 25. seimon rv , roeken ja , zibellini j , zhu b , gibson aa , hill ap , et al . intermitt diet provid physiolog bene \ufb01t continu diet weight loss ? systemat review clinic trial . mol cell endocrinol . 2015 ; 418 ( pt 2 ) :153 \u201372 . 26. wei x , cooper , lee , cernoch ca , huntoon g , hodek b , et al . intermitt energi restrict weight loss : systematicreview cardiometabol , \ufb02ammatori appetit outcom . biol re nur . 2022 ; 24 ( 3 ) :410 \u201328 . 27. welton , minti r , o'driscol , willm h , poirier , madden , et al . intermitt fast weight loss : systemat review . fam physician . 2020 ; 66 ( 2 ) :117 \u201325 . 28. xie z , z , ye , mao y. effect time \u2010restrict feed differ feed window metabol health : systemat review human studi . nutrit . 2022 ; 102:111764 . 29. yang f , liu c , liu x , pan x , li x , tian l , et al . effect epidem intermitt fast cardiometabol risk factor : systemat review meta \u2010analysi random control trial . front nutr . 2021 ; 8:669325 . 30. yuan x , wang j , yang , gao , cao l , li x , et al . effect intermitt fast diet glucos lipid metabol insulin resist patient impair glucos lipid metabol : systemat review meta \u2010analysi . int j endocrinol . 2022 ; 2022:1 \u2013 9 . 31. alhamdan ba , garcia \u2010alvarez , alzahrnai ah , karanxha j , stretchberri dr , contrera kj , et al . altern \u2010day versu daili energi restrict diet : effect weight loss ? systemat review meta \u2010analysi : altern \u2010day fast versu daili energi restrict . obe sci pract . 2016 ; 2 ( 3 ) :293 \u2013302 . 32. choi jh , cho yj , kim hj , ko sh , chon , kang jh , et al . effect carbohydr \u2010restrict diet intermitt fast obes , type 2 diabet mellitu , hypertens manag : consensu statement korean societi studi obes , korean diabet associ , korean societi hypertens . diabet metab j . 2022 ; 46 ( 3 ) :355 \u201376 . 33. ciof \ufb01i , evangelista , ponzo v , ciccon g , soldati l , santarpia l , et al . intermitt versu continu energi restrict weight loss cardiometabol outcom : systemat review meta \u2010analysi random control trial . j transl med . 2018 ; 16 ( 1 ) :371 . 34. lima chr , oliveira ikf , frota kmg , carvalho cmrg , paiva aa , campelo v , et al . impact intermitt fast bodi weight overweight obes individu . rev assoc medbra . 2020 ; 66 ( 2 ) :222 \u20136 . 35. moral \u2010suarez \u2010varela , collado s\u00e1nchez e , peraita \u2010costa , llopi \u2010moral , soriano jm . intermitt fast possibl bene \ufb01t obes , diabet , multipl sclerosi : systemat review random clinic trial . nutrients.2021 ; 13 ( 9 ) :3179.12 | metabol chang follow intermitt fast 1365277x , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/jhn.13253 test , wiley onlin librari [ 18\/01\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens 36. roman ym , dominguez mc , easow tm , pasupuleti v , white cm , hernandez av . effect intermitt versu continu diet weight bodi composit obes overweight peopl : systemat review meta \u2010analysi random control trial . int j obe . 2019 ; 43 ( 10 ) :2017 \u201327 . 37. vital r , kim y. effect intermitt fast glycem control bodi composit adult obes type 2 diabet : systemat review . metab syndr relat disord . 2020 ; 18 ( 10 ) :450 \u201361 . 38. wang x , li q , liu , jiang h , chen w. intermitt fast versu continu energi \u2010restrict diet patient type 2 diabet mellitu metabol syndrom glycem control : systemat review meta \u2010analysi random control trial . diabet re clin pract . 2021 ; 179:109003 . 39. zhang q , zhang c , wang h , z , liu , guan x , et al . intermitt fast versu continu calori restrict : isbett weight loss ? nutrient . 2022 ; 14 ( 9 ) :1781 . 40. sandov c , santiba\u00f1ez , villagr\u00e1n f. effect intermit- tent fast potenti weight loss muscl gain humansyoung 60 year old : systemat review . int j food sci nutr . 2021 ; 72 ( 6 ) :734 \u201345 . 41. bitsani , giannak k , hadjimbei e , chrysostom s. effect earli time \u2010restrict feed glycem pro \ufb01le adult : systemat review intervent studi . rev diabeticstudi . 2022 ; 18 ( 1 ) :10 \u20139 . 42. pureza irom , macena ml , da silva junior ae , praxed dr , vasconcelo lgl , bueno nb . effect earli time \u2010restrict feed metabol pro \ufb01le adult excess weight : systemat review meta \u2010analysi . clin nutr . 2021 ; 40 ( 4 ) :1788 \u201399 . 43. thackrey e , chen j , martino cr , preda v. effect diet weight metabol outcom patient doubl diabet : systemat review . nutrit . 2022 ; 94:111536 . 44. meng h , zhu l , kord \u2010varkaneh h , santo h , tinsley gm , fu p. effect intermitt fast energi \u2010restrict diet lipid pro \ufb01le : systemat review meta \u2010analysi . nutrit . 2020 ; 77:110801 . 45. correia jm , santo , pezarat \u2010correia p , silva , mendonca gv . effect ramadan non \u2010ramadan intermitt fast bodi composit : systemat review meta \u2010analysi . front nutr . 2021 ; 7:625240 . 46. fernando h , zibellini j , harri r , seimon r , sainsburi a. effect ramadan fast weight bodi composit healthynon \u2010athlet adult : systemat review meta \u2010analysi . nutrient . 2019 ; 11 ( 2 ) :478 . 47. mazidi , rezai p , chaudhri , nemati m. effect ramadan fast cardiovascular risk factor anthropo- metric paramet : systemat review . pak j med sci.2015 ; 31 ( 5 ) :1250 \u20135 . 48. sadeghirad b , motaghipisheh , kolahdooz f , zahedi mj , haghdoost aa . islam fast weight loss : systemat review meta \u2010analysi . public health nutr . 2014 ; 17 ( 2 ) :396 \u2013406 . 49. jahrami h , trabelsi k , alhaj oa , saif z , pandi \u2010perum sr , bahammam . impact ramadan fast metabol syndrom sever relat ethnic sex : result systemat review meta \u2010analysi . nutr metab cardiovasc di . 2022 ; 32 ( 12 ) :2714 \u201329 . 50. mirmiran p , bahadoran z , gaeini z , moslehi n , azizi f. effect ramadan intermitt fast lipid lipoprotein paramet : updat meta \u2010analysi . nutr metab cardiovasc di . 2019 ; 29 ( 9 ) :906 \u201315 . 51. fari mai , jahrami h , bahammam , kalaji z , madkour , hassanein m. systemat review , meta \u2010analysi , meta \u2010 regress impact diurnal intermitt fast ramadan glucometabol marker healthi subject . diabet re clin pract . 2020 ; 165:108226.52. arciero pj , poe , mohr ae , ive sj , arciero , sweazea kl , et al . intermitt fast protein pace superior calor restrict weight viscer fat loss . obes . 2023 ; 31 ( suppl 1 ) :139 \u201349 . 53. patterson , laughlin ga , lacroix az , hartman sj , natarajan l , senger cm , et al . intermitt fast humanmetabol health . j acad nutr diet . 2015 ; 115 ( 8 ) :1203 \u201312 . 54. jahrami ha , alsibai j , clark cct , fari maie . systemat review , meta \u2010analysi , meta \u2010regress impact diurnal intermitt fast ramadan bodi weight healthi subject age 16 year . eur j nutr . 2020 ; 59 ( 6 ) :2291 \u2013316 . 55. jahrami ha , fari , janahi ai , janahi mi , abdelrahim dn , madkour mi , et al . four \u2010week consecut , dawn \u2010to\u2010sunset intermitt fast ram adan affect cardiometabol risk factor healthi adult ? systemat review , meta \u2010analysi , meta \u2010regress . nutr metab cardiovasc di . 2021 ; 31 ( 8 ) :2273 \u2013301 . author biographi maria g. lang , mbchb , mrcp , intern medic traine nihr fund academ clinic fellow . research interest obesityaetiolog span epidemiolog risk factor genet . alic a. coffey phd student univers warwick , research sustain diet childhood . research interest includ child nutrit , environ-ment sustain diet public health . paul c. coleman senior specialist registrar public health medicin honorari lectur collabor role univers york leed teach hospit nh trust . thoma m. barber associ professor consult endocrinologist obes specialist , 25 year clinic experi , emphasi clinic research obes , metabol diabet . publish 143 paper ( h \u2010index 37 ) . thij van ren , phd princeton , professor univers warwick , macroeconomi st studi unemploy food system . recent research focus price polici deter minant diet . oyinlola oyebod professor public health lead centr public health polici qmul , research interest includ social andenvironment driver sustain healthi dietari behaviour . salli abbott ( phd , rd ) clinic academ dietitian coventri univers univers hospit coventri warwickshir nh trust , lang et al . |13 1365277x , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/jhn.13253 test , wiley onlin librari [ 18\/01\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens research interest nutrit , behaviour psychosoci implic obes . petra hanson nihr clinic lectur train diabet , endocrinolog intern medicin . herresearch interest includ metabol , type 2 diabet , digit healthcar applic mind medit medicine.how cite articl : lang mg , coffey aa , coleman pc , barber tm , van ren , oyebod , et al . metabol chang intermitt fast . j hum nutr diet . 2023 ; 1 \u201314.http : \/\/doi.org\/10.1111\/jhn.1325314 | metabol chang follow intermitt fast 1365277x , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/jhn.13253 test , wiley onlin librari [ 18\/01\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens",
  "roux\u2010en\u2010i gastric bypass , gastric band , sleev gastrectomi sever obes : baselin data by\u2010band\u2010sleev random control trial by\u2010band\u2010sleev collabor group publish pdf deposit coventri univers \u2019 repositori origin citat : by\u2010band\u2010sleev collabor group , 2023 , 'roux\u2010en\u2010i gastric bypass , gastric band , sl eev gastrectomi sever obes : baselin data by\u2010band\u2010 sleev random control trial ' , obes , vol . 31 , . 5 , pp . 1290 -1299. http : \/\/dx.doi.org\/ 10.1002\/oby.23746 doi 10.1002\/oby.23746 issn 1930 -7381 essn 1930 -739x publish : wiley open access articl term creativ common attribut licens , permit use , distribut reproduct medium , provid origin work properli cite . origin articl clinic trial investig roux-en-i gastric bypass , gastric band , sleev gastrectomi sever obes : baselin data fromth by-band-sleev random control trial by-band-sleev collabor group * correspond richard welbourn , depart upper gi bariatr surgeri , musgrov park hospit , somerset nh foundat trust , taunton , uk.email : richard.welbourn @ somersetft.nhs.uk fund inform health technolog assess programm , grant\/award number : hta 09\/127\/53abstract object : paper report studi design , particip characterist , recruit result by-band-sleev , investig clinic cost-effec- tive gastric bypass , gastric band , sleev gastrectomi adult sever obes uk . method : pragmat open adapt noninferior trial 3-year follow-up conduct . particip randomli assign bypass band initi sleev adapt . co-primari end point weight loss health-rel qualiti life assess use eq-5d util index.result : decemb 2012 august 2015 , studi recruit two group , adapt , three group septemb 2019. studi screen 6960 patient ; 4732 ( 68 % ) elig 1351 ( 29 % ) random ; 5 subsequ withdrew consent use data , leav 462 , 464 , 420 assign bypass , band , sleev , respect . baselin data show high level obes ( mean bmi =46.4 kg\/m 2 ; sd : 6.9 ) comorbid ( e.g. , 31 % diabet ) , low score health-rel qualiti life , high level anxieti depress ( e.g. , 25 % abnorm score ) . nutrit paramet poor , averag equiv household incom low ( \u00a316,667 ) . conclus : by-band-sleev fulli recruit . particip characterist consis- tent contemporari patient bariatr surgeri , therefor result generaliz . introduct obes increas worldwid . major risk factor type 2 dia- bete mellitu , cardiovascular diseas , cancer , poor health-rel qualiti life ( hrqol ) , mortal . bariatr surgeri provid sustain weight loss improv obesity-rel diseas , guidelin recommend offer select patient [ 1 ] . sever type bariatr surgeri exist , includ roux-en-i gas- tric bypass ( bypass ) , adjust gastric band ( band ) , sleev gas-trectomi ( sleev ) . recent , techniqu emerg ( e.g. , one anastomosi gastric bypass ) . mani surgic proce- dure , literatur support effect surgic interven-t limit . compar studi often random andrandom control trial ( rct ) studi often singl center , risk bia , limit follow-up . issu * by-band-sleev collabor group consist write committe ( trial manag group list end manuscript ) investig ( list onlin supportinginform ) .receiv : 25 novemb 2022 revis : 1 januari 2023 accept : 22 januari 2023 doi : 10.1002\/oby.23746 open access articl term creativ common attribut licens , permit use , distribut reproduct medium , provid origin work properli cited.\u00a9 2023 author . obes publish wiley period llc behalf obes societi . 1290 obes ( silver spring ) . 2023 ; 31:1290 \u20131299 . www.obesityjournal.org highlight 2009 , two systemat review highlight need better qualiti bariatr surgic trial long-term follow- assess hrqol [ 2,3 ] . pauciti evid led call research compar differ procedur , led design by-band trial . initi intend compar bypass band ( two surgic procedur predomin time ) .howev , increas popular sleev year follow , becam relev adapt studi includ type surgeri [ 4 ] . 2015 , by-band becam by-band-sleev , sampl size increas provid adequ power the3 two-way comparison [ 5 ] . , summar demograph , dis- eas preval , baselin hrqol score , dietari bing eat characterist , incom benefit random partici-p by-band-sleev . method trial design particip full detail design publish previous [ 5 , 6 ] . briefli , rct design pragmat , elig base nation guid-anc ( support inform tabl s1 ) . by-band began inter-n pilot phase decemb 2012 two center establish feasibl recruit , support quintet recruit inter- vention ( qri ) [ 7 ] . by-band expand four center ( phase two ) , twelv center involv 40 surgeon ( phase three ) , becam by-band-sleev adapt includ sleev ( august 2015 ) . sampl size increas from724 1341. surgic intervent qualiti assur center requir commit least two surgeon particip , undertak minimum 50 bariatr oper per year , tohav prior experi 200 gastric band , 250 gastric bypass , 200 sleev gastrectomi procedur . mandatori prohibit com- ponent oper identifi monitor casereport form . prohibit compon undertaken , mandat compon omit , chief investig ( ci ) discuss instanc relev center . recruit recruit process establish qri work close ci , trial center , clinic team phase one two continu phase three [ 8 ] . recruit issu understood use interview nurs dietitian , audio record recruit discuss , scrutini recruit log . activ optim present studi inform andrecruit includ train session individu feedback recruit , avoid develop treatment prefer , andsit visit . random mask by-band , particip random 1:1 ratio . adapt- trial includ sleev , alloc ratio 1:1:1 newstudi import alreadi known ? \u2022the uk by-band-sleev random control trial pragmat open adapt noninferior trial , dual pri- mari end point weight loss qualiti life , with3-year follow-up , investig clinic cost- effect gastric bypass , gastric band , sleev gastrectomi particip sever obes inth uk . \u2022between decemb 2012 august 2015 , recruit two group , adapt add sleevegastrectomi , three group . studi add ? \u2022by-band-sleev fulli recruit decemb 2019 , ran- domli assign 1351 particip opera-t 12 hospit uk . \u2022we describ particip baselin characterist show high level obes ( mean bmi =46.4 kg\/m 2 ) comorbid , high level anxieti depress , poor physic mental health , poor qualiti life , poor averag equiv household incom , similar tothos undergo routin care uk . might result chang direct research focu clinic practic ? \u2022we shown possibl recruit larg pragmat random control trial compre- hensiv collect particip characterist , includingemploy , incom , benefit , dietari macro- micro-nutri intak measur , bing eat . \u2022futur bariatr surgeri random control trial consid collect addit characteris-t evalu differ procedur . \u2022the trial result generaliz surgeri sever obes uk.baselin data uk by-band-sleev rct 1291 1930739x , 2023 , 5 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1002\/oby.23746 test , wiley onlin librari [ 10\/05\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens center . exist center , center-specif alloc ratio set ( lower probabl bypass band higher probabil- iti sleev ) , aim maintain alloc conceal achiev a1:1:1 final ratio . random perform center use secur , internet-bas system ( seal envelop ltd. ) . alloc computer-gener use cohort minim , incorporatingdiabet ( yes\/no ) bodi mass index ( bmi ) 50 kg\/m 2 ( yes\/no ) , stratif center . outcom data storag co-primari end point weight loss hrqol 3 year afterrandom [ 5,6 ] chosen ensur three procedur compar fairli , differ weight-loss trajectori time . weight-loss metric percentag excess bmi lost . thehrqol metric eq-5d-5l health state ( util ) score [ 9,10 ] . sec- ondari outcom includ gener disease-specif aspect hrqol ( support inform tabl s2 ) , obesity-rel diseas , dietari outcom , advers event , resourc use . baselin data collect prerandom clinic , record case report form , store studi databas ( custom-design , built , maintain bristol trial centr ) . statist analysi sampl size calcul describ protocol [ 5 , 6 ] . mean standard deviat ( sd ) calcul symmetricallydistribut measur median interquartil rang ( iqr ) asymmetr distribut . categor ordin measur express frequenc percentag . particip groupedbi random alloc . summari statist gener use sa softwar version 9.4 ( sa institut inc. ) . eq-5d-5l score calcul map onto eq-5d-3l valu set [ 9 ] . sf-12 version 2 score calcul use optum pro core soft- ware . dietari recal analyz nutrient analysi pro- gram dietplan7 ( forestfield softwar limit , version 7.00.47 ) [ 11 ] . benefit receiv categor three group thatwer consid potenti modifi bariatr surgeri : , disability-rel , child-rel benefit . baselin gross house- hold incom total benefit receiv combin obtainth gross household incom includ benefit adjust ( equiv ) number adult children household . studi manag leadership by-band-sleev led ci ( jmb ) support multidisci-plinari trial manag group inc lude methodologist , statisti- cian , qualit quantit research , patient publicmemb , trial manag , clinician ( dietitian , surgeon endocrinologist ) . particip site princip investiga- tor ( bariatr surgeon\/physician ) dedic research nurses\/dietitian . studi over een steer committe data monitor safeti commi ttee ( onlin support infor- mation ) . car eg full access baselin data , octjan 2013aprjuloctjan 2014aprjuloctjan 2015aprjuloc tjan 2016aprjuloctjan 201 7aprjuloctjan 2018aprjuloctjan 2019aprjuloct trial month010020030040050060070080090010001100120013001400numb patient randomis 010020030040050060070080090010001100120013001400 recruit target figur 1 recruit random trial target [ color figur view wileyonlinelibrary.com ] 1292 baselin data uk by-band-sleev rct 1930739x , 2023 , 5 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1002\/oby.23746 test , wiley onlin librari [ 10\/05\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens jmb , final respons decis submit public . result recruit decemb 2012 septemb 2019 , 6960 patient screen , 4728 ( 68 % ) confirm elig approached.of , 1351 ( 28.6 % ) consent random . target recruit- ment achiev first 4 ear , fall behind thereaft ( figur 1 ) . opportun taken improv present trial inform make clearer bal anc patient . train session surgeon , research nurs , dietitian undertaken annual investig meet regular visit center . among 6960 patient screen elig , reason inelig relat unspecifi clinic psycholog factor , histori gastric abdomin surgeri , concern commit- ment long-term follow-up ( support inform tabl s3 ) .among elig patient approach take part , main reason record noncons patient prefer one surgic method ( support inform tabl s4 ) . numbersalloc differ procedur , exclud particip with- drew consent use data ( n=5 ) , 462 bypass , 464 band , 420 sleev ( figur 2 ) . june 2022 , median follow-up random 3 year ( iqr : 2.05 \u20133.09 year ) . overal , 1153 par- ticip reach 3 year co-primari outcom weight eq-5d-5l questionnair data complet 993\/1153 ( 86.1 % ) 929\/1153 ( 80.6 % ) particip , respect . balanc baselin data random group data complet baselin data random group overal shown tabl 1\u2013 3and support inform tabl s5 \u2013s9 . random work well : baselin characterist balanc group . base- line data complet shown support informationt s10 \u2013s15 . data complet excel ( > 90 % ) clinic sociodemograph variabl . complet rate hrqol questionnair 93 % . complet rate hospi- tal anxieti depress questionnair lower , still above91 % . blood measur complet > 91 % particip . complet dietari macronutri intak detail bing eat- ing questionnair 78 % 85 % , respectively.figur 2 consort diagrambaselin data uk by-band-sleev rct 1293 1930739x , 2023 , 5 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1002\/oby.23746 test , wiley onlin librari [ 10\/05\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens baselin sociodemograph employ incom benefit particip predominantli femal ( 1020\/1344 , 75.9 % ) white ethnic ( 1140\/1344 , 84.8 % ) , mean age 47.3 year ( sd : 10.6 ; tabl 1 ) . baselin bmi mean bodi weight 46.4 ( sd : 6.9 ) 129.7 kg ( sd : 23.6 ) , respect ( tabl 2 ) . mean baselin eq-5d-5l util score 0.61 ( sd : 0.28 ) . overal , 778\/1343 ( 57.8 % ) particip full- part-tim employ , 91\/1343 ( 6.8 % ) unemploy , 155\/1343 ( 11.5 % ) unabl work , 129\/1343 ( 9.6 % ) homemak ( tabl 1 ) . median gross household incom \u00a326,870 , reduc \u00a316,667 adjust house- hold composit . total , 326\/1344 ( 24.3 % ) recruit pop-ul receiv disability-rel benefit , includ statutori sickpay ( tabl 1 ) . baselin clinic characterist number particip comorbid high ; 407\/1344 ( 30.2 % ) type 2 diabet mellitu mediant 1 particip sociodemograph , employ , incom , benefit random group overal gastric bypass ( n=462 ) gastric band ( n=464 ) sleev gastrectomi ( n=420 ) overal ( n=1346 ) sex , n ( % ) femal 345 ( 74.8 ) 354 ( 76.3 ) 321 ( 76.6 ) 1020 ( 75.9 ) age , mean ( sd ) ( ) 47.4 ( 10.3 ) 46.8 ( 10.4 ) 47.8 ( 11.0 ) 47.3 ( 10.6 ) ethnic , n ( % ) white 401 ( 87.0 ) 394 ( 84.9 ) 345 ( 82.3 ) 1140 ( 84.8 ) mixed\/multipl ethnic groups11 ( 2.4 ) 11 ( 2.4 ) 11 ( 2.6 ) 33 ( 2.5 ) asian\/asian british 10 ( 2.2 ) 21 ( 4.5 ) 15 ( 3.6 ) 46 ( 3.4 ) black\/african\/ caribbean\/black british30 ( 6.5 ) 26 ( 5.6 ) 36 ( 8.6 ) 92 ( 6.8 ) ethnic group 9 ( 2.0 ) 12 ( 2.6 ) 12 ( 2.9 ) 33 ( 2.5 ) employ , n ( % ) full time 191 ( 41.5 ) 188 ( 40.5 ) 182 ( 43.4 ) 561 ( 41.8 ) part time 81 ( 17.6 ) 67 ( 14.4 ) 69 ( 16.5 ) 217 ( 16.2 ) self-employ 25 ( 5.4 ) 27 ( 5.8 ) 16 ( 3.8 ) 68 ( 5.1 ) homemak 39 ( 8.5 ) 50 ( 10.8 ) 40 ( 9.5 ) 129 ( 9.6 ) student 5 ( 1.1 ) 5 ( 1.1 ) 4 ( 1.0 ) 14 ( 1.0 ) retir 44 ( 9.6 ) 33 ( 7.1 ) 31 ( 7.4 ) 108 ( 8.0 ) unabl work 43 ( 9.3 ) 62 ( 13.4 ) 50 ( 11.9 ) 155 ( 11.5 ) unemploy 32 ( 7.0 ) 32 ( 6.9 ) 27 ( 6.4 ) 91 ( 6.8 ) gross household incom includ benefit median ( iqr ) \u00a328,000 ( \u00a319,404 \u2013\u00a345,000 ) \u00a326,400 ( \u00a317,285 \u2013\u00a345,000 ) \u00a326,774 ( \u00a317,847 \u2013\u00a345,000 ) \u00a326,870 ( \u00a318,259 \u2013\u00a345,000 ) unknown\/unwil say , n ( % ) 93 ( 20.1 ) 101 ( 21.8 ) 78 ( 18.6 ) 272 ( 20.2 ) equiv gross household incomeinclud benefit median ( iqr ) \u00a316,667 ( \u00a311,387 \u2013\u00a323,939 ) \u00a316,434 ( \u00a310,202 \u2013 \u00a323,664 ) \u00a316,093 ( \u00a311,220 \u2013\u00a325,000 ) \u00a316,667 ( \u00a310,924 \u2013\u00a324,430 ) unknown\/unwil say , n ( % ) 93 ( 20.1 ) 102 ( 22.0 ) 79 ( 18.8 ) 274 ( 20.4 ) benefit , n ( % ) benefit 179 ( 38.8 ) 204 ( 44.0 ) 165 ( 39.4 ) 548 ( 40.8 ) disabl benefit 106 ( 23.0 ) 123 ( 26.5 ) 97 ( 23.2 ) 326 ( 24.3 ) child benefit 46 ( 10.0 ) 48 ( 10.3 ) 37 ( 8.8 ) 131 ( 9.7 ) 1294 baselin data uk by-band-sleev rct 1930739x , 2023 , 5 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1002\/oby.23746 test , wiley onlin librari [ 10\/05\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens durat 4.7 year ( iqr : 2.1 \u20139.8 ; tabl 2 ) , 6 particip type 1 diabet . particip diabet , averag , 5 year older without diabet , although similar bmi ( support informationt s9 ) . rate obes -relat diseas show ill- ness sever particip , 1062\/1339 ( 79.3 % ) classifi american societi anesthesiologist grade ii higher , and772\/1340 ( 57.6 % ) impair function statu . additionalt 2 baselin co-primari outcom , particip characterist , obesity-rel diseas random group overal gastric bypass ( n=462 ) gastric band ( n=464 ) sleev gastrectomi ( n=420 ) overal ( n=1346 ) bmi , mean ( sd ) ( kg\/m2 ) 46.9 ( 7.1 ) 46.2 ( 6.6 ) 46.1 ( 6.9 ) 46.4 ( 6.9 ) weight , mean ( sd ) ( kg ) 131.4 ( 23.8 ) 129.0 ( 23.1 ) 128.8 ( 23.8 ) 129.7 ( 23.6 ) euroqol-5d-5l util score , mean ( sd ) 0.61 ( 0.29 ) 0.60 ( 0.28 ) 0.61 ( 0.28 ) 0.61 ( 0.28 ) euroqol-5d-5l va score , mean ( sd ) 61.5 ( 21.2 ) 61.4 ( 20.1 ) 61.2 ( 21.9 ) 61.4 ( 21.0 ) asa class , n ( % ) : healthi , medic problem 93 ( 20.3 ) 93 ( 20.1 ) 91 ( 21.8 ) 277 ( 20.7 ) ii : mild system diseas 229 ( 50.0 ) 222 ( 47.9 ) 211 ( 50.5 ) 662 ( 49.4 ) iii : sever system diseas , incapacit 128 ( 27.9 ) 140 ( 30.2 ) 113 ( 27.0 ) 381 ( 28.5 ) iv : sever system diseas constant threat life8 ( 1.7 ) 8 ( 1.7 ) 3 ( 0.7 ) 19 ( 1.4 ) diabet statu , n ( % ) type 1 1 ( 0.2 ) 3 ( 0.6 ) 2 ( 0.5 ) 6 ( 0.4 ) type 2 \u2013prediabet 8 ( 1.7 ) 5 ( 1.1 ) 1 ( 0.2 ) 14 ( 1.0 ) type 2 - diet control 9 ( 1.9 ) 14 ( 3.0 ) 15 ( 3.6 ) 38 ( 2.8 ) type 2 - oral hypoglycem 103 ( 22.3 ) 90 ( 19.4 ) 72 ( 17.1 ) 265 ( 19.7 ) type 2 - glp-1 agonist 11 ( 2.4 ) 10 ( 2.2 ) 6 ( 1.4 ) 27 ( 2.0 ) type 2 - insulin 20 ( 4.3 ) 22 ( 4.7 ) 21 ( 5.0 ) 63 ( 4.7 ) diabet medic , n ( % ) ye 137 ( 90.1 ) 125 ( 86.8 ) 103 ( 88.0 ) 365 ( 88.4 ) durat diabet median ( iqr ) ( ) 3.6 ( 1.8 \u20139.0 ) 5.0 ( 2.4 \u20139.8 ) 4.8 ( 2.2 \u201310.5 ) 4.7 ( 2.1 \u20139.8 ) number antidiabet medic taken median ( iqr ) 1.0 ( 1.0 \u20132.0 ) 2.0 ( 1.0 \u20132.5 ) 1.0 ( 1.0 \u20132.0 ) 1.0 ( 1.0 \u20132.0 ) hypertens medic , n ( % ) ye 210 ( 45.5 ) 178 ( 38.4 ) 176 ( 41.9 ) 564 ( 41.9 ) depress medic , n ( % ) ye 165 ( 35.7 ) 190 ( 40.9 ) 153 ( 36.4 ) 508 ( 37.7 ) obstruct sleep apnea , n ( % ) ye 127 ( 27.6 ) 135 ( 29.1 ) 94 ( 22.5 ) 356 ( 26.5 ) asthma , n ( % ) ye 127 ( 27.6 ) 150 ( 32.3 ) 137 ( 32.7 ) 414 ( 30.8 ) gord\/hiatu hernia , n ( % ) ye 209 ( 45.4 ) 229 ( 49.4 ) 212 ( 50.6 ) 650 ( 48.4 ) back leg pain arthriti , n ( % ) ye 251 ( 54.6 ) 247 ( 53.2 ) 226 ( 53.9 ) 724 ( 53.9 ) function statu , n ( % ) climb 3 flight stair without rest 194 ( 42.4 ) 197 ( 42.5 ) 177 ( 42.2 ) 568 ( 42.4 ) climb 1 flight stair without rest 187 ( 40.8 ) 179 ( 38.7 ) 156 ( 37.2 ) 522 ( 39.0 ) climb half flight stair without rest 61 ( 13.3 ) 74 ( 16.0 ) 71 ( 16.9 ) 206 ( 15.4 ) requir wheelchair housebound 16 ( 3.5 ) 13 ( 2.8 ) 15 ( 3.6 ) 44 ( 3.3 ) abbrevi : asa , american societi anesthesiologist ; glp-1 , glucagon-lik peptide-1 ; gord , gastroesophag reflux diseas ; va , visual analogu scale.baselin data uk by-band-sleev rct 1295 1930739x , 2023 , 5 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1002\/oby.23746 test , wiley onlin librari [ 10\/05\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens characterist , includ blood micronutri measure- ment , shown tabl 2and 3and support inform tabl s5 s6 . baselin hrqol profil score gener disease-speci fic aspect hrqol gener low , indic poor hrqol across measur ( support inform tabl s7 ) . exampl , mean physic health score assess short form 12 ( sf12 ) , impact weight qual iti life-lit , gastrointes- tinal qualiti life index 38.7 ( sd : 10.7 ) , 42.8 ( sd : 24.2 ) , 9.5 ( sd : 5.6 ) , respect . mean sf12 mental health overal score 43.1 ( sd : 11.1 ) , mean score self-esteem ( impact weight qualiti life-lit ) emot health ( gastrointestin qualiti lifeindex ) low , 31.2 ( sd : 26.4 ) 8.6 ( sd : 3.6 ) , respect ( 50 rep- resent \u201c normal \u201d sf12 ) . overal , 273\/1231 particip ( 22.2 % ) report possibl anxieti , 318\/123 5 ( 25.7 % ) possibl depress , 313\/1231 ( 25.4 % ) 304\/1235 ( 24.6 % ) report higher score indic manifest anxieti de pression , respect , assess use hospit anxieti depress questionnaire.baselin dietari bing eat characterist intak macronutri bing eat score shown support- ing inform tabl s8 . self-report total energi intak low . intak fat , satur fat , percentag total energi fatwer averag uk recommend , wherea intak energi , pro- tein , carbohydr , fiber lower recommend . addit , 25-hydroxyvitamin level low low 229\/1303 ( 17.6 % ) 562\/1303 ( 43.1 % ) particip , respect ( tabl 3 ) . propor- tion particip report mild moder sever bing eat disord 314\/1145 ( 27.4 % ) 134\/1145 ( 11.7 % ) , respect ( support inform tabl s8 ) . discuss by-band-sleev trial recruit random 1351 partici-p sever complex obes 12 uk center . baselineassess detail , comprehens , well complet . breadth inform collect extens collect previou bariatr surgic studi . baselin characterist oftabl 3 particip baselin blood measur random group overal gastric bypass ( n=462 ) gastric band ( n=464 ) sleev gastrectomi ( n=420 ) overal ( n=1346 ) hemoglobin 1c , median ( iqr ) ( mmol\/mol ) diabet 37.0 ( 35 \u201340 ) 38.0 ( 35 \u201341 ) 38.0 ( 35 \u201341 ) 38.0 ( 35 \u201341 ) prediabet 41.0 ( 39 \u201344 ) 43.0 ( 43 \u201345 ) 38.0 ( 38 \u201338 ) 42.5 ( 39 \u201345 ) diabet 54.0 ( 45 \u201364 ) 53.0 ( 45 \u201365 ) 51.0 ( 45 \u201363 ) 52.5 ( 45 \u201364 ) fast glucos , median ( iqr ) ( mmol\/l ) diabet 5.0 ( 5 \u20135 ) 5.0 ( 5 \u20135 ) 5.0 ( 5 \u20135 ) 5.0 ( 5 \u20135 ) prediabet 5.9 ( 5 \u20136 ) 4.9 ( 4 \u20136 ) 4.9 ( 5 \u20135 ) 5.6 ( 5 \u20136 ) diabet 6.7 ( 6 \u20139 ) 6.6 ( 6 \u20139 ) 6.9 ( 5 \u20139 ) 6.7 ( 6 \u20139 ) 25-hydroxyvitamin low ( < 25 nmol\/l ) , n ( % ) 82 ( 18.5 ) 76 ( 17.0 ) 71 ( 17.2 ) 229 ( 17.6 ) low ( 25 \u201350 nmol\/l ) , n ( % ) 188 ( 42.4 ) 195 ( 43.5 ) 179 ( 43.4 ) 562 ( 43.1 ) suffici ( > 50 nmol\/l ) , n ( % ) 173 ( 39.1 ) 177 ( 39.5 ) 162 ( 39.3 ) 512 ( 39.3 ) particip , median ( iqr ) ( nmol\/l ) 42.6 ( 28.0 \u201359.0 ) 44.0 ( 30.4 \u201361.0 ) 42.8 ( 29.5 \u201361.1 ) 43.0 ( 29.1 \u201360.2 ) elf , n ( % ) none\/mild ( ishak 0 \u20132 ) 39 ( 14.1 ) 36 ( 12.9 ) 29 ( 12.6 ) 104 ( 13.2 ) moder ( ishak 3 \u20134 ) 215 ( 77.6 ) 210 ( 75.3 % ) 180 ( 78.3 ) 605 ( 77.0 ) severe\/cirrhosi ( ishak 5 \u20136 ) 23 ( 8.3 ) 33 ( 11.8 % ) 21 ( 9.1 ) 77 ( 9.8 ) total cholesterol , mean ( sd ) ( mmol\/l ) 4.8 ( 1.2 ) 4.8 ( 1.0 ) 4.9 ( 1.0 ) 4.8 ( 1.1 ) triglycerid , median ( iqr ) ( mmol\/l ) 1.4 ( 1.1 \u20132.0 ) 1.4 ( 1.1 \u20131.9 ) 1.4 ( 1.1 \u20131.9 ) 1.4 ( 1.1 \u20131.9 ) hemoglobin , median ( iqr ) ( g\/l ) 139.0 ( 130.0 \u2013147.0 ) 139.0 ( 130.0 \u2013146.0 ) 138.0 ( 131.0 \u2013146.0 ) 139.0 ( 130.0 \u2013147.0 ) platelet , mean ( sd ) ( 109\/l ) 275.7 ( 67.5 ) 279.2 ( 72.3 ) 284.9 ( 66.0 ) 279.8 ( 68.8 ) white blood cell , median ( iqr ) ( 109\/l ) 7.5 ( 6.2 \u20139.1 ) 7.6 ( 6.6 \u20139.0 ) 7.6 ( 6.3 \u20139.0 ) 7.6 ( 6.4 \u20139.0 ) abbrevi : elf , enhanc liver fibrosis.1296 baselin data uk by-band-sleev rct 1930739x , 2023 , 5 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1002\/oby.23746 test , wiley onlin librari [ 10\/05\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens particip similar group aspect representa- tive popul patient undergo bariatr surgeri uk [ 12,13 ] . high level comorbid , poor overal mental physic health , high level anxieti depress , high level unemploy . highlight need patient live obes put forward consideredsuit bariatr surgeri nh clinic team . understand three surgeri impact outcom critic health care decision-mak allow inform patient choic . trial mani strength . recruit 1351 particip pragmat , well-design well-conduct rct provid data add evid base . recruit success despit con- cern outset would prevent strong clinician andpati prefer among member 12 multidisciplinari team . use qri optim recruit collabor trial center clinic team shown effect differ set-t , includ surgeri [ 14 ] . rct studi bariatr surgeri recruit fewer 250 particip , method could relev futur trial area , especi trial surgeri ver-su best medic therapi [ 15 ] . random particip similar patient select undergo bariatr surgeri within nh , although differ patient undergo surgeri countri [ 16 ] . differ proport men women undergo surgeri seenworldwid like reflect differ peopl ask help weight . particip patient sweden netherland younger , lower initi mean bmi thatobserv by-band-sleev [ 17 ] . also keep registri data unit state [ 18 ] . uk patient may sever diseas undergo surgeri patient countriesbecaus surgeri difficult access uk elsewher patient reluct ask surgic intervent [ 19 ] . patient surgeri sever obes possibl thattheir outcom may less favor surgeri undertakenat lower bmi . preplan subgroup analys by-band-sleev examin issu . data generaliz , includ ethnic minor group uk . except asian represent islow ( 3.4 % trial vs. 7.5 % uk ) , black represent high ( 6.8 % trial vs. 3.4 % uk popul ) . success addit sleev 3 year recruit show surgic rct effici use exist infrastructur maintain clinic relev research question . addit , by-band-sleev trial chose drop band group , despiteit popular declin dramat uk worldwid trial open 2012 [ 16 ] . decis support throughout independ oversight group . inform becom availableabout longer-term advers event bariatr surgeri risk ofweight regain procedur , trial provid unbias descrip- tion live three procedur . uniqu among bariatr rct studi , knowledg , by- band-sleev design co-primari end point weight loss hrqol measur 3 year random . previou rct studi typic power singl primari outcom , usual measur weight loss . by-band-sleev design 2011 , weight loss commonli defin proport par- ticip achiev weight loss greater 50 % excess bmi.weight-loss trial usual report percentag total weight loss ( % twl ) [ 20,21 ] , less influenc baselin bmi com- pare percentag excess bmi . trial team discuss changingth primari outcom metric % twl ; howev , potenti could introduc bia need agre new noninferior threshold , decid retain existingmetr . by-band-sleev report % twl data secondari out-com , result use futur data synthes meta-analys . choic 3 year co-primari end point compro- mise desir character experi proce- dure long possibl realiti finit resourc patienc particip . weight loss band slow progres-s 3 year , wherea nadir weight loss bypass sleev typic much sooner ( 12 month ) , weight regain year 3 [ 22 ] . although initi earli weight loss may appeal , sustain weight loss link health ben- efit improv hrqol . by-band-sleev trial aim includ comprehens clinic , sociodemograph , hrqol , nutrient , dietari intake\/bing eatingdata . inform incom receipt specif benefit well prospect inform dietari intak , bing eat disord , nutrit statu report bariatr surgeri rctstudi . similar peopl live obes gener uk popula- tion , trial particip tend receiv benefit , lower household incom , like live area higher dep-riv [ 23 ] . particip also unemploy rate approxi- mate doubl observ gener popul , mani receiv disability-rel benefit [ 23 , 24 ] . baselin macronutri energi intak similar previous report , although individualswith obes like underreport total energi intak without [ 25 ] . knowledg , trial captur informa- tion bariatr surgeri rct , scale data collec-t compar breadth inform record swedish obes subject studi 1980 [ 26 ] . by-band-sleev therefor provid repres , generaliz inform onth impact bariatr surgeri comprehens rang clinic relev socioeconom variabl random popul . slightli imbalanc number random group ( ratio bypass : band : sleev ; 0.99:1.0:0.9 ) aros fewer particip recruit six center initi open \u201c by-band \u201d continu \u201c by-band-sleev . \u201d adapt implement , revis alloc ratio center setbas anticip recruit rate go forward . imbal reduc power comparison involv sleev introduc bia undermin methodolog qualiti trial ( random alloc conceal , creat three compar group particip ) . by-band-sleev largest rct three procedur world . obaselin data uk by-band-sleev rct 1297 1930739x , 2023 , 5 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1002\/oby.23746 test , wiley onlin librari [ 10\/05\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens by-band-sleev trial manag group by-band-sleev trial manag group respons design , gain fund , conduct trial , review finalmanuscript . robert c andrew , phd , univers exet medic school , uk ; john bessent , patient repres ; jane m. blazebi , md ( chief investig ) , cowrot manuscript , bristol medicalschool : popul health scienc , univers bristol , uk ; jame p. byrn , md , univers hospit southampton nh foundat trust , uk ; nichola carter , msc , portsmouth hospit universitynh trust , uk ; carolin clay ( deceas ) , patient repres ; jenni l. donovan , phd , bristol medic school , univers bristol , uk ; eleanor gidman , phd , prepar studi tabl figur , cow- rote manuscript , bristol trial centr , bristol medic school , uni-vers bristol , uk ; graziella mazza , phd , bristol trial centr , bristol medic school , univers bristol , uk ; mari \u2019 kane , msc , phd , dietet depart , leed teach hospit nh trust , uk ; barnabi c. reev , phd , bristol trial centr , bristol medic school , univers bristol , uk ; chri a. roger , phd ( lead methodologist ) , co-wrot manuscript , bristol trial centr , bristol medic school , univers bristol , uk ; nicki salter , diph , somerset nh founda- tion trust , uk ; janic l. thompson , phd , school sport , exercis & rehabilit scienc , univers birmingham , uk ; richardwelbourn md , cowrot manuscript , somerset nh foundationtrust , uk ; sarah wordsworth , health econom research centr , nuffield depart popul health , univers oxford , uk . see full list by-band-sleev investig onlin supportinginform . acknowledg acknowledg support by-band-sleev contributor , includ investig , research dietitian , nurs ; inde- pendent trial steer committe ; data monitor safetycommitte . full detail onlin support inform . wear grate patient particip trial . by-band- sleev follow-up phase . acknowledg contribut carolin clay , patient repre- sent trial manag group , die prepara- tion manuscript . fund inform trial fund nation institut health care research ( nihr ) health technolog assess programm ( hta09\/127\/53 ) . also acknowledg fund mrc conduct- ii hub trial methodolog research nihr biomed research centr univers bristol . trial designedand deliv collabor bristol trial centr , uk clin-ic research collabor regist clinic trial unit , receipt nihr clinic trial unit support fund . chri a. roger fund british heart foundat 2016. funderhad role design conduct trial ; collect , manage- ment , analysi , interpret data ; prepar , review , approv report . view opinion express thereinar author necessarili uk nationalhealth servic , nihr , depart health social care . jane m. blazebi jenni l. donovan nihr senior investig . conflict interest statement jame byrn medic advisori board compani oxfordmed product . author declar conflict interest . conflict interest statement investig oversight committe provid onlin support inform . clinic trial registr clinicaltrials.gov identifi nct02841527 . data avail statement follow public main trial result , anonym individu patient data made avail upon request chief investi-g secondari research , condit assur sec- ondari research propos use data compliant medic research council polici data share regard scien-tif qualiti , ethic requir , valu money compli- ant nation institut health care research polici data share . minimum requir respect scientif qualitywil publicli avail prespecifi protocol describ pur-pos , method , analysi secondari research ( e.g. , protocol cochran systemat review ) , approv uk research ethic committe similar , approv ethic review bodi . participantidentifi pass third parti . orcid by-band-sleev collabor group http : \/\/orcid.org\/0000-0002- 8228-526x refer 1. stegenga h , hain , jone k , wild j ; guidelin develop group . identif assess , manag overweightand obes : summari updat nice guidanc . bmj . 2014 ; 349 : g6608 . doi : 10.1136\/bmj.g6608 2. picot j , jone j , colquitt jl , et al . clinic effect cost- effect bariatr ( weight loss ) surgeri obes : system- atic review econom evalu . health technol ass . 2009 ; 13 ( 41 ) . doi : 10.3310\/hta13410 3. colquitt jl , picot j , loveman e , clegg aj . surgeri obes . cochran databas syst rev . 2009 ; ( 2 ) : cd003641 . doi : 10.1002\/ 14651858.cd003641.pub3 4. colquitt jl , pickett k , loveman e , frampton gk . surgeri weight loss adult . cochran databas syst rev . 2014 ; ( 8 ) : cd003641 . doi : 10.1002\/14651858.cd003641.pub4 5. roger ca , reev bc , byrn j , et al . adapt by-band ran- domiz clinic trial by-band-sleev includ new interven-t maintain relev studi practic . br j surg . 2017 ; 104 ( 9 ) :1207-1214 . 6. roger ca , welbourn r , byrn j , et al . by-band studi : gastric bypass adjust gastric band surgeri treat morbid obes : studi protocol multi-centr randomis control trial anintern pilot phase . trial . 2014 ; 15:53. doi : 10.1186\/1745-6215-15-53 7. donovan jl , rooshena l , jepson , et al . optimis recruit inform consent randomis control trial : the1298 baselin data uk by-band-sleev rct 1930739x , 2023 , 5 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1002\/oby.23746 test , wiley onlin librari [ 10\/05\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens develop implement quintet recruit inter- vention ( qri ) . trial . 2016 ; 17:283. doi : 10.1186\/s13063-016-1391-4 8. paramasivan , roger ca , welbourn r , et al . enabl recruit success bariatr surgic trial : pilot phase by-band-sleevestudi . int j obe . 2017 ; 41 ( 11 ) :1654-1661 . 9. van hout b , janssen mf , feng ys , et al . interim score eq- 5d-5l : map eq-5d-5l eq-5d-3l valu set . valu health . 2012 ; 15 ( 5 ) :708-715 . 10. fermont jm , blazebi jm , roger ca , wordsworth ; by-band- sleev studi manag group . eq-5d-5l valid approach measur health relat qualiti life patient undergo bar- iatric surgeri . plo one . 2017 ; 12 ( 12 ) : e0189190 . doi : 10.1371\/ journal.pone.0189190 11. thompson fe , subar af . dietari assess methodolog . : coulston , bc j , ferruzzi , delahanti l , ed . nutrit pre- vention treatment diseas . 4th ed . academ press ; 2017 : 5-48 . 12. mackenzi rm , greenlaw n , ali , et al ; scot investig . surgi- cal obes treatment studi ( scot ) : prospect , observationalcohort studi health socioeconom burden treatment- seek individu sever obes scotland , uk . bmj open . 2021 ; 11 ( 8 ) : e046441 . doi : 10.1136\/bmjopen-2020-046441 13. welbourn r , small p , finlay , et al . unit kingdom nation bariatr surgeri registri . second registri report . publish 2014. http : \/\/ www.wlsinfo.org.uk\/assets\/documents\/extract-from-the-nbsr-2014- report.pdf 14. lim e , batchelor tjp , dun j , et al . video-assist thoracoscop open lobectomi early-stag lung cancer . nejm evid . 2022 ; 1 ( 3 ) . doi:10.1056\/evidoa2100016 15. sharpl aj , mahawar k. systemat review meta-analysi randomis control trial compar long-term outcom roux-en-i gastric bypass sleev gastrectomi . obe surg . 2020 ; 30 ( 2 ) : 664-672 . 16. welbourn r , hollyman , kinsman r , et al . bariatr surgeri world- wide : baselin demograph descript one-year outcom fourth ifso global registri report 2018. obe surg . 2019 ; 29 ( 3 ) : 782-795 . 17. poelemeij yqm , liem rsl , vage v , et al . periop outcom primari bariatr surgeri north-western europ : pool mul- tinat registri analysi . obe surg . 2018 ; 28 ( 12 ) :3916-3922 . 18. tewksburi c , crowley n , parrott jm , et al . weight loss prior bar- iatric surgeri 30-day mortal , readmiss , reoper , andintervent : mbsaqip analysi 349,016 case . obe surg . 2019 ; 29 ( 11 ) :3622-3628 . 19. sogg , grupski , dixon jb . bad word : languag count work bariatr patient . surg obe relat di . 2018 ; 14 ( 5 ) :682-692.20. van de laar aw , emou , hazebroek ej , boerma ej , faneyt , nienhuij sw. report weight loss 2021 : posit statement dutch societi metabol bariatr surgeri ( dsmb ) . obe surg . 2021 ; 31 ( 10 ) :4607-4611 . 21. van rijswijk , van olst n , schat w , van der peet dl , van de laar aw . weight loss bariatr surgeri express percentag total weight loss ( % twl ) ? systemat review . obe surg . 2021 ; 31 ( 8 ) :3833-3847 . 22. \u2019 brien pe , hindl , brennan l , et al . long-term outcom bariatr surgeri : systemat review meta-analysi weight loss 10 year bariatr procedur single- centr review 20-year outcom adjust gastric banding.ob surg . 2019 ; 29 ( 1 ) :3-14 . 23. offic nation statist . unemploy rate ( age 16 , season adjust ) : % . updat march 14 , 2023. access may 13 , 2022. http : \/\/www.ons.gov.uk\/employmentandlabourmarket\/peopl notinwork\/unemployment\/timeseries\/mgsx\/lm 24. gov.uk . famili resourc survey : financi year 2019 2020. publish march 25 , 2021. access may 13 , 2022. http : \/\/www . gov.uk\/government\/statistics\/family-resources-survey-financial-year- 2019-to-2020 25. janmohammadi p , sajadi f , alizadeh , daneshzad e. comparison energi food intak gastric bypass sleev gastrec-tomi : meta-analysi systemat review . obe surg . 2019 ; 29 ( 3 ) : 1040-1048 . 26. sj\u00f6str\u00f6m l. review key result swedish obes subject ( so ) trial - prospect control intervent studi bariatr sur-geri . j intern med . 2013 mar ; 273 ( 3 ) :219-234. doi : 10.1111\/joim.12012 support inform addit support inform found onlin support- ing inform section end articl . [ correct ad 19 decemb 2023 , first onlin public : supportinginform correct includ four author made sig- nific contribut research project . ] cite articl : by-band-sleev collabor group . roux-en-i gastric bypass , gastric band , sleev gastrectomi sever obes : baselin data by-band-sleev random control trial . obes ( silver spring ) . 2023 ; 31 ( 5 ) :1290 \u20101299 . doi : 10.1002\/oby.23746baselin data uk by-band-sleev rct 1299 1930739x , 2023 , 5 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1002\/oby.23746 test , wiley onlin librari [ 10\/05\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens",
  "societi endocrinolog ( sfe ) guidelin diagnosi manag post bariatr hypoglycaemia hazlehurst , j. , khoo , b. , lobato , c. b. , ilesanmi , i. , abbott , s. , chan , t. , pillai , s. , maslin , k. , purkayastha , s. , mcgowan , b. , andrew , r. , nicholson , e. , mccullough , k. , albon , l. , batterham , r. , dimitriaidi , g. k. , forb , s. , bewick , g. & tan , t. m. publish pdf deposit coventri univers \u2019 repositori origin citat : hazlehurst , j , khoo , b , lobato , cb , ilesanmi , , abbott , , chan , , pillai , , maslin , k , purkayastha , , mcgowan , b , andrew , r , nicholson , e , mccullough , k , albon , l , batterham , r , dimitriaidi , gk , forb , , bewick , g & tan , tm 2024 , 'societi endocrinolog ( sfe ) guidelin diagnosi manag post bariatr hypoglycaemia ' , endocrin connect , vol . 13 , . 5 , e230285 . http : \/\/doi.org\/10.1530\/ec -23-0285 doi 10.1530\/ec -23-0285 issn 2049 -3614 publish : societi endocrinolog \u00a9 author ( ) 2024 open access articl distribut term creativ common attribut licens ( http : \/\/creativecommons.org\/licenses\/by\/4.0\/ ) , permit unrestrict use , distribut , reproduct medium , provid origin work properli cite . . publish bioscientifica ltd. http : \/\/ec.bioscientifica.com \u00a9 2024 author ( ) guidelin guidanc societi endocrinolog guidelin diagnosi manag post-bariatr hypoglycaemia jonathan hazlehurst1 , * , bernard khoo2 , * , carolina brito lobato3,4 , * , ibiyemi ilesanmi5 , * , salli abbott6 , * , tin chan7 , * , sanesh pillai8 , * , kate maslin9 , * , sanjay purkayastha10,11 , * , barbara mcgowan12 , * , rob andrews13 , * , eveleigh nicholson14 , \u2020 , katherin mccullough15 , \u2020 , lorrain albon16 , \u2020 , rachel batterham2 , \u2020 , georgio k dimitriaidis17 , \u2020 , shareen forbes18 , \u2021 , gavin bewick19 , \u2021 tricia m-m tan5 , * 1depart diabet endocrinolog , univers hospit birmingham nh foundat trust , birmingham , uk 2endocrinolog , divis medicin , univers colleg london , london , uk 3depart biomed scienc , faculti health medic scienc , univers copenhagen , copenhagen , denmark 4depart medicin , copenhagen univers hospit \u2013 amag hvidovr , hvidovr , denmark 5section endocrinolog investig medicin , depart metabol , digest reproduct , faculti medicin , imperi colleg london , london , uk 6depart dietet , univers hospit coventri warwickshir nh trust , coventri , uk 7faculti medicin , chines univers hong kong , hong kong 8centr endocrinolog , diabet metabol , birmingham health partner , birmingham , uk 9school nurs midwiferi , univers plymouth , plymouth , uk 10brunel univers , london , uk 11imperi colleg healthcar nh trust , st mari \u2019 hospit , london , uk 12endocrinolog , guy \u2019 st thoma \u2019 nh foundat trust , london , uk 13univers exet medic school , exet , uk 14portsmouth hospit univers nh trust , portsmouth , uk 15royal surrey counti hospit , guildford , uk 16univers hospit sussex nh foundat trust , worth , uk 17king 's colleg hospit nh foundat trust , london , uk 18bhf centr cardiovascular scienc , queen \u2019 medic research institut , univers edinburgh , edinburgh , uk 19school life cours scienc , faculti life scienc medicin , king 's colleg london , london , uk correspond address m-m tan : t.tan @ imperial.ac.uk * ( j hazlehurst , b khoo , c b lobato , ilesanmi , abbott , chan , pillai , k maslin , purkayastha , b mcgowan , r andrew m-m tan steer group author ) \u2020 ( e nicholson , k mccullough , l albon , r batterham g k dimitriaidi steer group editor member ) \u2021 ( forb clinic chair , g bewick non-clin chair ) abstract post-bariatr hypoglycaemia ( pbh ) typic post-prandi hypoglycaemia occur 2\u20134 h eat individu undergon bariatr surgeri . pbh develop rel late surgeri often discharg post-surg follow-up bariatr team , lead variabl diagnosi manag non-specialist centres.5 13 23-0285230285 receiv 13 juli 2023 accept 7 march 2024 avail onlin 7 march 2024 version record publish 1 april 2024endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 work licens creativ common attribut 4.0 intern license.download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 aim : overal aim improv standardis clinic practic diagnosi manag pbh . object : ( 1 ) undertak up-to-d review current literatur ; ( 2 ) formul practic evidence- base guidanc regard diagnosi treatment pbh ; ( 3 ) recommend futur avenu research condit . method : scope review undertaken extens literatur search . consensu guidanc confid recommend reach steer group author prior review key stakehold . outcom : make pragmat recommend practic diagnosi manag pbh , includ criteria diagnosi recognit , well recommend research area explor . plain english summari post-bariatr hypoglycaemia ( pbh ) condit commonli affect peopl undergon weight loss surgeri . condit , peopl develop low blood sugar occur 2\u20134 h meal , lead debilit symptom hunger , sweat , anxieti , palpit even blackout faint . pbh becom common weight loss surgeri taken peopl help weight help diabet . condit often develop patient discharg follow-up surgeri , lead inconsist diagnosi treatment non-specialist healthcar centr . lack clear inform evid exist scientif literatur contribut variat care . address problem , societi endocrinolog creat new guidelin help healthcar profession accur diagnos manag condit . guidelin develop input dietitian , surgeon doctor specialis weight loss , hormon specialist . keyword : obes ; bariatr surgeri ; post-bariatr hypoglycaemia ; late dump introduct bariatr surgeri , roux-en-i gastric bypass , gastric band , sleev gastrectomi , carri signific metabol benefit , includ weight loss , diabet remiss , reduct macrovascular microvascular event . result clinic evid , bariatr surgeri often consid option treatment obes diabet , well metabol complic non-alcohol fatti liver diseas ( 1 ) . given increas preval bariatr surgeri , clinician increasingli encount complic surgeri ( 2 ) . one complic post-bariatr hypoglycaemia ( pbh ) ( 3 ) . pbh usual defin post-prandi hyperinsulinaem hypoglycaemia , occur typic 2\u20134 h ingest food , present document low glucos valu hypoglycaem symptomatolog , subsid euglycaemia restor \u2013 i.e . whippl \u2019 triad . pbh associ lower qualiti life , improv treatment ( 4 ) . hypoglycaemia lead psycholog consequ , prolong disrupt work leisur activ , possibl road traffic accid limit type work taken ( 5 ) . moreov , recurr hypoglycaemia lead impair awar hypoglycaemia , impair cognit function , cardiac arrhythmia mortal ( 6 ) . result , import identifi , diagnos , adequ treat pbh peopl undergon bariatr surgeri . aim object aim guidelin improv standardis clinic practic diagnosi manag pbh . end , object : ( 1 ) undertak up-to-d review current literatur ; ( 2 ) formul practic evidence-bas guidanc regard diagnosi treatment pbh ( 3 ) recommend futur avenu research condit . materi method societi endocrinolog \u2019 clinic committe commiss guidelin appoint tt jh lead guidelin committe . tt jh nomin initi work group ( jh , tt , ii , sp , tc bk ) . meet held virtual assign specif area guidelin group produc report base narr review synthesi wider literatur jh tc task provid . initi work group subsequ wider expert download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 j hazlehurst et al . panel group provid peer review report recommend . jh tc undertook detail search synthesis relev clinic literatur well identifi prior guidanc recommend diagnosi manag pbh . took form broad scope exercis identifi relev literatur . initi work group contribut search term search run ovid platform medlin embas well separ search cochran databas . scope exercis pre-regist osf open scienc platform ( http : \/\/osf.io\/ ) discuss nation obes updat meet well metabol endocrinolog network within societi endocrinolog . exampl search term includ ( appendix 1 , see section supplementari materi given end articl ) . search initi run 17 novemb 2020 updat 31 januari 2022. abstract review includ relev clinic human literatur exclus singl case report . confer abstract includ broaden identif relev literatur . synthesis literatur check assembl core write team bk , jh tt . co-chair wider group abl reach consensu underpin guidelin . confid recommend assess grade use grade criteria ( 7 ) . advanc draft guidelin review societi endocrinolog clinic committe submiss public . inform clarif ad assist bk , tt cbl peer review . pathophysiolog pbh exact pathophysiolog pbh unknown , dynam interact food absorpt , incretin , insulin secret thought play role . follow type bariatr surgeri , except gastric band , rapid transit nutrient jejunum ileum absorpt rapid peak glucos , provok insulin secret . exposur l cell distal jejunum proxim ileum nutrient also provok secret glp-1 incretin , amplifi hyperglycaemia-depend secret insulin insulin-depend dispos glucos ( 8 ) . lead theori peopl suffer exagger version incretin insulinotrop respons , lead \u2018 oversw \u2019 hypoglycaemia , i.e . pbh ( 9 ) . support theori , glp-1 receptor antagonist ( exendin 9\u201339 ) abolish hypoglycaemia peopl pbh ( also discuss ) . possibl mechan includ impair suppress basal insulin secret respons hypoglycaemia excess meal-stimul insulin secret , defect alpha- cell secret glucagon ( 10 , 11 , 12 , 13 ) , alter bile acid kinet ( 14 ) may turn trigger excess fgf-19 secret ( 15 ) , inflammatori cytokin il-1beta ( 16 ) . pbh also known \u2018 late dump syndrom \u2019 . phenomenon first describ peopl upper gastrointestin surgeri oesophagectomi , nissen fundopl ( 17 ) , gastrectomi cancer ( 18 ) . contrast \u2018 earli dump syndrom \u2019 , occur within minut food ingest . earli dump characteris combin gastrointestin symptom ( pain , bloat , nausea , diarrhoea borborygmi ) vasomotor symptom ( fatigu , flush , palpit , sweat , tachycardia , hypotens syncop ) without hypoglycaemia . earli dump syndrom thought mediat arriv hyperosmolar meal small intestin , turn lead shift fluid intravascular fluid compart intestin lumen , caus distens intestin , reduct intravascular fluid volum stimul autonom entero-neuro-endocrin system ( 19 ) . howev , distinct \u2018 earli dump \u2019 \u2018 late dump \u2019 \/pbh may clear definit suggest . two class dump may co-exist may aetiolog interrel . preval pbh true preval pbh follow bariatr surgeri remain unknown confound differ diagnost methods\/criteria ( see ) . estim 25 % 75 % base continu glucos monitor studi , 19\u201330 % follow provoc test use hypoglycaemia-rel event . registry- base studi report far lower preval 0.1\u20130.9 % follow bariatr surgeri ( 20 , 21 , 22 , 23 ) . risk factor pbh current , contrast report regard risk factor pbh . observ studi suggest peopl develop pbh non-diabet pre-op lower pre-op hba1c . phenomenon possibl relat higher pre-op \u03b2-cell function , insulin secret sensit ( 24 ) . inde , presenc pre-op hypoglycaemia oral glucos toler test ( ogtt ) associ pbh ( 25 ) . possibl risk factor younger age , lower bmi , femal gender , higher weight loss post- surgeri ( 26 , 27 ) . howev , studi found associ hypoglycaemia abovement risk factor , magnitud weight loss , age gender , although latter studi reli self-report hypoglycaemia . type bariatr surgeri suggest risk factor . peopl undergon laparoscop adjust gastric band ( lagb ) low risk pbh ; howev , type surgeri less perform download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 present due possibl lower efficaci rygb sg ( 28 ) . risk pbh appear similar rygb sg , although higher rate sever pbh hospitalis rygb ( 29 ) . studi compar occurr hypoglycaemia ogtt age , sex preoper bmi-match peopl undergon rygb , sg , biliopancreat divers ( bpd ) singl anastomosi duodenal-il bypass sleev gastrectomi ( sadi- ) show lower rate post-ogtt hypoglycaemia sadi- bpd group ( 30 ) . roslin et al . report peopl rygb report hypoglycaem symptom duoden switch ( ds , often combin bpd ) sg ( 31 ) . preval hypoglycaemia single-anastomosi gastric bypass ( sagb , also known one-anastomosi \u2018 mini \u2019 gastric bypass ) studi systemat conflict data . two surgic seri report hypoglycaemia , wherea anoth seri report rygb sagb equal respect pbh quantifi statement ( 32 ) . anoth seri pbh peopl includ undergon sagb , one studi show increas time hypoglycaemia continu glucos monitor rygb sagb ( 33 ) . therefor , like sagb also associ pbh , present clear whether surgeri carri benefit pbh rel rygb . suggest work done one group cholecystectomi may increas risk pbh , perhap alter kinet bile acid absorpt eat , observ yet confirm group . diagnosi thorough histori , includ onset symptom surgeri time hypoglycaemia food intak , taken ( fig . 1 ; recommend 1.1 , tabl 1 ) . investig proceed compon whippl \u2019 triad present : \u2022 symptom hypoglycaemia , sympathet nervou system activ lead tremor , palpit , sweat , anxieti , neuroglycopen symptom mood swing , irrat behaviour , confus , weak , seizur , decreas consciou level , syncop . \u2022 biochem confirm low blood glucos < 3.0 mmol\/l ( < 54 mg\/dl ) , prefer utilis venou plasma sampl assay valid low glucos concentr . cut-off recommend line ada easd recommend , blood glucos threshold associ impair hypoglycaemia awar , impair cognit function , cardiac arrhythmia , mortal ( 6 ) .\u2022 relief symptom hypoglycaemia correct . characterist , pbh appear 1 3 year surgeri 2\u20134 h eat . physic activ may trigger hypoglycaem symptom . differenti diagnos pbh includ use diabet drug insulin sulphonylurea , drug quinin hydroxychloroquin , caus endogen hyperinsulinaemia insulin- proinsulin-secret tumour , anti-insulin antibodi syndrom non-hyperinsulinaem caus hypoglycaemia hypoadren , malnutrit , liver kidney diseas sepsi . workup differenti diagnos outsid scope guidanc , intern accept guidanc avail ( 34 ) . pbh also distinguish idiopath postprandi syndrom , occurr symptom hypoglycaemia without actual hypoglycaemia , earli dump syndrom ( see ) ; howev , note , earli late dump syndrom co-exist . oral glucos toler test diagnost test wide studi pbh , though number uncertainti relat cut- off , durat test , symptomatolog test , clinic util remain ( tabl 2 ) . ogtt reli pure carbohydr load , liquid form , ingest peopl within 5\u201310 min . amount glucos given vari , studi administ 75 g. glucos , avail , insulin c-peptid , assess baselin 4 h administr glucos . length test variabl , last 4 h. definit hypoglycaemia vari studi . high preval induc hypoglycaemia asymptomat post-surg cohort screen , suggest like high fals posit rate use injudici . also limit correl report symptom subject hypoglycaemia biochem confirm hypoglycaemia follow ogtt . mix meal test mix meal test ( mmt ) typic consist variabl mix carbohydr , fat protein administ commonli oral ingest liquid sampl glucos 120\u2013300 min . larg unselect cohort , high rate hypoglycaemia seen , whilst even asymptomat peopl , hypoglycaemia common ( 12 ) . meta-analysi studi possibl variabl term stimulu also cut-off hypoglycaemia ( tabl 3 ) . also limit correl induc hypoglycaemia symptom . fals posit , side effect lack definit meal composit glycaem cut-off prevent routin clinic applic . download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 j hazlehurst et al . continu glucos monitor continu glucos monitor ( cgm ) , whether use real-tim system dexcom g-seri sensor system medtron guardian system , intermitt scan system abbott freestyl libr system , allow continu measur interstiti glucos concentr via easili painlessli insert subcutan sensor . technolog purchas peopl figur 1 framework diagnosi post-bariatr hypoglycaemia alli condit . download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 tabl 1 summari tabl recommend . confid guidanc recommend classifi use grade ( 7 ) . 1. diagnosisgrad certainti 1.1 peopl potenti present pbh undergo care initi evalu includ consider altern caus hypoglycaemia.n\/a 1.2 pbh defin pragmat patient bariatr surgeri biochem confirm hypoglycaemia < 3.0 mmol\/l ( 54 mg\/dl ) , typic hypoglycaem symptom , fulfil whippl \u2019 triad , investig exclus altern caus hypoglycaemia.moder 1.3 hypoglycaemia prefer confirm venou plasma sampl util assay valid low glucos concentrations.high 1.4 dynam provoc test ogtt mmt recommend diagnosi pbh . moder 1.5 cgm present recommend diagnosi pbh . moder 1.6 venou plasma glucos measur avail practic , capillari blood glucos measur also accept diagnosi taken use test system conform iso 15197 standard , multipl confirmatori read histori strongli consist pbh.low 2. behaviour , dietari lifestyl manag 2.1 peopl pbh undergo evalu dietari habit , dietari trigger eat behaviour regist dietitian , prefer specialist interest bariatr surgeri , enabl individualis guidanc healthi post-bariatr eat strategy.moder 2.2 peopl pbh also screen treat nutrit defici accord accept guidance.high 2.3 dietari advic pbh includ eat control portion carbohydr , togeth reinforc post-bariatr eat strategi . suggest strategi includ : - small frequent meal ( 6\u00d7 per day ) . - reduc carbohydr content ( start < 30 g\/meal ) . - emphasi choos low gi high gi carbohydr . - consider may given lower carbohydr target ( e.g . 25 g\/meal , 20 g\/meal ) supervis initi 30 g\/meal target effective.moder 2.4 recommend modifi type carbohydr ( e.g . fructose-contain food ) , use cornstarch supplement , use food addit modifi glycaem index.low 2.5 cgm , avail fund , may consid tool educ , reinforc document relationship dietari chang amelior pbh , improv adher dietari advic earli recognit treatment hypos.low 2.6 peopl pbh taught procedur treat emerg hypoglycaemia . suggest approach follow : - advis alway carri fast act carbohydr treat hypoglycaemia . - upon receiv warn confirm hypoglycaemia , advis consum small amount fast act carbohydr ( e.g . 10\u201315 g dextros ) . - advis test blood glucos 15 min consumpt confirm resolut hypoglycaemia . necessari , small dose carbohydr use blood glucos still low . - follow-on low gi carbohydrate-contain snack may consid initi resolut hypoglycaemia.low 2.7 sucros treatment hypoglycaemia avoid acarbose-tr pbh . high 2.8 peopl encourag exercis bariatr surgeri . suggest approach exercis pbh follow : - advis take exercis risk pbh low ( e.g . fast least 3 hr meal ) . - advis avoid carbohydr load prior exercis . - advis measur blood glucos feel unwel . - advis carri fast-act carbohydr use manag hypoglycaemia . - follow-on low gi carbohydrate-contain snack may consid exercise.low 2.9 peopl pbh encourag reduc ceas alcohol intak . low 2.10 modif dietari macronutri content increas consumpt protein meal encourag . individualis target protein consumpt set . minim 60 g\/day higher target may required.moder 2.11 peopl pbh encourag avoid fluid meal . ideal , avoid drink 30 min prior continu 30 min meal , minim avoid drink meal least 30 min meal.low 2.12 gastrostomi feed tube placement remnant stomach may consid sever pbh respond dietari pharmacolog treatment.low ( continu ) download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 j hazlehurst et al . prescrib nh diabet mellitu monitor , although present prescrib peopl pbh . current research , summaris tabl 4 , suggest cgm potenti detect pbh . cgm studi , pbh relat elev glycaem variat ( gv ) utilis variou metric percentag coeffici variat ( % cv ) , mean absolut glucos ( mag ) mean absolut glucos excurs ( mage ) . cgm , measur day-to-day glucos concentr reaction particular person \u2019 diet , may reflect experi hypoglycaemia standardis dynam test . howev , studi use cgm system obsolet collect data rel short period time , limit interpret . consider recommend diagnosi recommend pragmat definit pbh patient bariatr surgeri typic hypoglycaem symptom well record biochem confirm hypoglycaemia < 3.0 mmol\/l ( 54 mg\/dl ) prefer utilis venou plasma sampl assay valid low glucos concentr , resolut symptom revers hypoglycaemia , thu fulfil whippl \u2019 triad . altern caus hypoglycaemia consid , investig exclud ( recommend 1.1 , 1.2 , 1.3 , tabl 1 ) . dynam provoc test recommend diagnosi pbh ( recommend 1.4 , tabl 1 ) follow reason : ( 1 ) ogtt non- physiolog stimulu provok post-prandi hypoglycaemia 5.5 % peopl diabet well high proport peopl postop may otherwis well ; ( 2 ) although mmt attempt reproduc mixtur carbohydr , fat protein meal , stimuli standardis , arguabl whether liquid dietari supplement reflect true mix meal due differ gastric empti digest . cut-off hypoglycaemia provoc test non-standardis rang 2.8 3.3 mmol\/l ( 50\u201360 mg\/dl ) . given often-delay 3. pharmacolog manag 3.1 acarbos consid first-lin pharmacolog treatment pbh . moder 3.2 second-lin option , acarbos effect toler , includ short-act sc pasireotid octreotid ( given three time day meal ) long-act im pasireotid lar.moder 3.3 diazoxid may consid third-lin option somatostatin analogu toler . low 3.4 peopl frequent , sever pbh , consid prescrib glucagon inject ( glucagen\u00ae , ogluo\u00ae ) rescu treatment , appropri train helpers.moder 3.5 avexitid ( exendin 9\u201339 ) may consid part investig trial pbh , avail . moder 3.6 current recommend long-term treatment pbh type long-act somatostatin analogu im octreotid lar lanreotid , sglt inhibitor , glp-1 analogu , il-1beta antagonist , dpp-iv inhibitor calcium channel antagonists.low 4. surgic endoscop manag 4.1 decis regard revers surgeri discuss multidisciplinari set , prefer bariatr surgeon experienc techniqu , full disclosur likelihood post-op complic weight regain.n\/a 4.2 partial pancreatectomi may indic case evid coincid insulinoma\/ pancreat mass evid localis excess insulin secret ( e.g . intraarteri calcium stimul hepat vein sampl insulin ) . case refer experienc hepato- pancreato-biliari multidisciplinari teams.low 5. drive peopl diagnos pbh uk 5.1 peopl diagnos pbh advis contact dvla advic . 5.2 advis stop drive contact dvla experi episod sever hypoglycaemia ( defin requir assist anoth person ) , evid impair awar hypoglycaemia . 5.3 peopl pbh drive group 1 vehicl ( car , motorcycl ) utilis glucos monitor sensor system must carri back-up capillari blood glucos system vehicl . 5.4 peopl pbh drive group 2 vehicl ( truck , buse ) must use back-up capillari blood glucos system . 6. research area recommend 6.1 diagnost perform cost-effect cgm capillari blood glucos diagnosi pbh . 6.2 relationship low interstiti glucos read cgm symptom pbh . 6.3 clinic efficaci cost-effect utilis cgm manag pbh . 6.4 optim method treatment hypoglycaemia peopl pbh . 6.5 control trial potenti treatment current standard-of-car ( e.g . best dietari practic ) . 6.6 efficaci long-term effect altern approach endoscop revis gastro-jejun anastomos ( tore ) . cgm , continu glucos monitor ; gi , glycaem index ; mmt , mix meal test ; ogtt , oral glucos toler test ; pbh , post-bariatr hypoglycaemia .. tabl 1 continu . download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 hypoglycaemia post-prandi , measur post provoc may need continu 3 h 4 hour peopl report particularli delay clinic featur hypoglycaemia , increas cost diagnosi . present recommend cgm diagnosi pbh ( recommend 1.5 , tabl 1 ) follow reason : ( 1 ) accuraci devic hypoglycaem rang insuffici ( 61 ) ; ( 2 ) present clear expect \u2018 normal \u2019 respons glycaemia bariatr surgeri ( 62 ) ; ( 3 ) cgm may over-sensit , detect interstiti hypoglycaemia without appar symptom peopl bariatr surgeri ( 13 ) \u2013 present unknown clinic implic phenomenon ; ( 4 ) healthi peopl exhibit hypoglycaemia < 3.9 mmol\/l ( 70 mg\/dl ) cgm ( 63 ) ; ( 5 ) defin agreed-upon metric identifi pbh cgm current exist . recommend research need conduct defin diagnost perform cost-effect cgm diagnosi pbh ( recommend 6.1 , tabl 1 ) , relationship low interstiti glucos read cgm symptom pbh ( recommend 6.2 , tabl 1 ) . regard use capillari blood glucos measur , mani current ce-mark capillari blood glucos measur system still exhibit rel larg bias hypoglycaem level excess iso 15197 standard make diagnosi hypoglycaemia problemat ( 64 ) . notwithstand caveat note may practic difficult captur venou plasma glucos time hypoglycaemia , pragmat recommend capillari blood glucos read < 3.0 mmol\/l ( 54 mg\/dl ) accept taken use test system conform iso 15197 standard , multipl confirmatori read , histori strongli consist pbh ( recommend 1.6 , tabl 1 ) . spirit , peopl suspect pbh biochem proven hypoglycaemia , captur venou plasma glucos practic possibl , issu capillari blood glucos meter pragmat strategi diagnosi . also recommend research need tabl 2 summari tabl studi ogtt pbh . studi populationtyp ogtt test donedefinit hypoglycaemiapreval hypoglycaemia roslin , 2011 ( 35 ) rygb , n=36 symptom stated75 g ogtt 4 h least 6 month post-op\u226460 mg\/dl ( 3.3 mmol\/l ) drop \u2265100 mg\/dl ( 5.6 mmol\/l ) 1 h72 % rygb chen , 2013 ( 36 ) sg , n=33 rygb , n=96 pre-exist t2dm symptom statedogtt stimulu state , length state pre-op , 12 week 12 month post-opnot state 36.4 % sg 12.5 % rygb itariu , 2014 ( 37 ) rygb , n=30 sg , n=3 lagb , n=3 symptom stated75 g ogtt 2 h pre-op approxim 12 month post-op < 60 mg\/dl ( 3.3 mmol\/l ) 50 % overal , rygb group 53 % rygb none sg lagb capristo , 2018 ( 29 ) rygb , n=59 ( 4 symptomat ) sg , n=60 ( asymptomat ) 75 g ogtt 3 h 12 month post-op < 55.8 mg\/dl ( 3.1 mmol\/l ) 29 % rygb 14 % sg pigeyr , 2015 ( 38 ) rygb , n=222 , ( includ symptomat dump hypoglycaemia ) lagb , n=129 ( asymptomat ) 75 g ogtt 2 h 12 month post-op < 50 mg\/dl ( 2.8 mmol\/l ) 10 % rygb none lagb brix , 2019 ( 39 ) rygb , n=175 sg , n=62 lagb , n=44 asymptomatic75 g ogtt 2 h 24 month post-op < 2.8 mmol\/l 32.6 % rygb 22.6 % sg 2.3 % lagb guarino , 2019 ( 40 ) rygb , n=35 pre-exist t2dm ( 11 mod-sever symptomat hypoglycaemia ) 75 g ogtt 3 h pre-op 24 month post-op\u226460 mg\/dl ( 3.3 mmol\/l ) 31 % rygb papamargar , 2019 ( 41 ) sg , n=18 ( symptom categoris though score includ ) 75 g ogtt 2 h pre-op 6 month post-op < 60 mg\/dl ( 3.3 mmol\/l ) 44 % sg raverdi , 2016 ( 24 ) rygb , n=957 ( prospect unselect cohort ) 75 g ogtt 2 h , pre- 1 5 year post surgeri < 50 mg\/dl ( 2.8 mmol\/l ) plasma insulin > 3 mu\/l 120 min \u22120.5 % baselin , 9.1 % 7.9 % 12 month 60 month lagb , laparoscop adjust gastric band ; ogtt , oral glucos toler test ; rygb , roux-en-i gastric bypass ; sg , sleev gastrectomi ; t2dm , type 2 diabet mellitu . download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 j hazlehurst et al . tabl 3 summari tabl studi mmt pbh . studi popul type mmt test donedefinit hypoglycaemia preval hypoglycaemia gasser , 2019 ( 42 ) rygb , n = 113 , symptom statedcarbohydr rich mmt ( 201 kcal ) low-carbohydr mmt ( 195 kcal ) pbh subset ( n = 13 ) 12 month post-op , 150 min < 54 mg\/dl ( 3.0 mmol\/l ) 13.2 % rygb carbohydrate-rich mmt ; none identifi pbh hypo low- carbohydr mmt roslin , 2014 ( 31 ) rygb , n = 12 vsg , n = 12 ds , n = 12 symptom statedmixed-m form muffin contain 100 g glucos , post-op interv 9 month , 120 minnot state averag 2 h glucos rygb= 85.3 \u00b1 41 mg\/dl ( 4.7 \u00b1 2.3 mmol\/l ) ; vsg = 89.3 \u00b1 39 mg\/dl ( 5 \u00b1 2.2 mmol\/l ) ; ds = 83.3 \u00b1 23 mg\/dl ( 4.6 \u00b1 1.3 mmol\/l ) faro , 2018 ( 43 ) symptomat rygb , n = 5 mmt stimulu : 500 kcal , 20 % protein , 20 % fat 60 % carbohydr ) , post-op interv 1.5\u201310 year , 120 minnot state nadir glucos 120 min 45 ; 34 ; 52 ; 26 ; 43 mg\/dl ( respect 2.5 ; 1.9 ; 2.9 ; 1.4 ; 2.4 mmol\/l ) goldfin , 2007 ( 9 ) symptomat rygb , n = 12 asymptomat rygb , n = 9 non-rygb similar bmi pre-op , n = 5 non rygb similar bmi post-op , n = 10ensur , 9 g protein , 40 g carbohydr , 6 g fat , 240 ml , post-op interv 0.8\u20133.8 symptomat group , 2\u20134 year asymptomat group , 120 min < 60 mg\/dl ( < 3.33 mmol\/l ) 3\/9 asymptomat peopl develop asymptomat hypoglycaemia honka , 2019 ( 44 ) symptomat rygb , n = 43 asymptomat rygb , n = 52 separ cohort symptomat rygb , n = 31 asymptomat rygb , n = 18350 kcal mtt ( ensur plus\u00ae , 51 g carbohydr ) isovolem 250 kcal liquid mtt ( ensure\u00ae , 40 g carbohydr ) post-op interv state sampl durat statednot state nadir blood glucos cut-off 53 mg\/dl ( 2.9 mmol\/l ) produc highest sum sensit ( 65 % ) specif ( 88 % ) detect hypoglycaemia jacobsen , 2012 ( 45 ) eight peopl pre 2 week rygb200 ml liquid mix meal test ( nutridrink , nutricia , netherland ) contain 300 kcal ( 1260 kj ) 49 % carbohydr , 35 % fat 16 % protein . also compar 25 50 g ogtt , 210 minnot state chang pre- post-op kefurt , 2015 ( 46 ) symptom state , rygb , n = 51200 ml liquid ( in\u00ae complet kaffe , allin , vienna ) contain 7.2 g fat , 28.4 g carbohydr 16 g protein , post-op interv mean 7.2 year , 180 min < 55 mg\/dl ( 3.1 mmol\/l ) 29 % lee , 2022 ( 47 ) symptomat sg , n = 12 asymptomat sg , n = 11 symptomat rygb , n = 7 asymptomat rygb , n = 138-ounc ensur plu drink ( abbott laboratori ; 350 kcal , 50 g carbohydr , 13 g protein , 11 g fat ) , post-op interv averag 5 year , 240 min < 60 mg\/dl ( 3.3 mmol\/l ) sg 39 % , rygb 40 % lobato , 2020 ( 12 ) symptomat rygb , n = 14 asymptomat rygb , n = 9liquid mix meal ( fresubin energi drink , 200 ml , 300 kcal ( 50e % carbohydr , 15e % protein 35e % fat ) ; freseniu kabi deutschland , bad homburg , germani ) , post-op interv ~3\u20135 year , 120 min < 55 mg\/dl ( 3.1 mmol\/l ) 50 % symptomat , 44.4 % asymptomat mulla , 2019 ( 15 ) symptomat rygb , n = 11 asymptomat rygb , n = 7 overweight non oper , n = 3 obes non oper , n = 4 ( ensur , 40 g carbohydr , 9 g protein , 6 g fat , 240 ml ; abbott laboratori , abbott park , il ) post-op interv state , 120 minnot defin nadir glucos ( mmol\/l ) ( rygb symptomat : 4.3 \u00b1 0.2 ; rygb asymptomat : 3.9 \u00b1 0.1 ; overweight non oper : 5.5 \u00b1 0.2 ; obes non oper : 5.3 \u00b1 0.3 ( continu ) download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 conduct diagnost perform cost- effect capillari blood glucos measur diagnosi pbh ( recommend 6.1 , tabl 1 ) . suggest framework diagnosi present fig . 1 . treatment option pbh dietari behaviour modif previous publish guidelin posit statement typic contain minim dietari guidanc despit acknowledg mainstay treatment ( 19 , 65 ) . small publish seri includ confer abstract suggest > 90 % peopl respond dietari intervent whilst unpublish systemat review suggest modest respons dietari intervent ( 66 ) . recommend peopl diagnos pbh undergo evalu regist dietitian , prefer specialist interest bariatr surgeri , aim provid individualis guidanc healthi sustain post-bariatr eat strategi ( recommend 2.1 , tabl 1 ) . note high preval malnutrit bariatr surgeri , peopl also screen treat nutrit defici follow accept guidanc british obes metabol studi popul type mmt test donedefinit hypoglycaemia preval hypoglycaemia patti , 2015 ( 48 ) symptomat rygb , n = 17 asymptomat rygb , n = 6 ( ensur , 40 g carbohydr , 9 g protein , 6 g fat , 240 ml ) post-op interv ~3\u20135 year , 120 min < 60 mg\/dl ( 3.33 mmol\/l ) hypo detect 7\/17 ( 41 % ) symptomat group 0\/9 asymptomat group hypo preskil , 2015 ( 49 ) symptomat rygb , n = 31 asymptomat rygb , n = reportedmmt contain carbohydr , fat , protein ( solid form ) , post-op interv report , 300 min < 55 mg\/dl ( < 3.1 mmol\/l ) 2\/31 symptomat group asymptomat report raverdi , 2017 ( 50 ) rygb , n = 89 agb , n = 20 unselect prospect cohort studymmt specifi , pre-surgeri , 12 60 month post surgeri , 180 minnot specifi 2 h post-prandi lower rygb agb salehi , 2010 ( 51 ) symptomat rygb , n = 20 cbg < 50 mg\/dl asymptomat rygb , n = 21mmt 350 kcal specifi , post-op interv sampl durat reportednot specifi nadir glucos < 50 mg\/dl ( < 2.8 mmol\/l ) 9\/20 symptomat 5\/21 asymptomat smaji , 2016 ( 52 ) symptomat rygb ( gb ) , n = 10 symptomat hypoglycaemia surgeri ( con ) , n = 5solid mmt ( one meal consist 40 g whole wheat bread , 15 g butter , 20 g honey 100 g banana ( total kcal : 360 ; 4 g protein , 13 g fat , 57 g carbohydr ) , post-op interv report , 240 min < 55 mg\/dl ( 3.1 mmol\/l ) asymptomat hypoglycaemia detect gb = 2\/10 con = 2\/5 emou , 2019 ( 53 ) rygb , n = 44 200 ml liquid nutrit supplement ( abbott ensur plu ) contain 300 kcal , 12.5 g protein , 40.4 g carbohydr ( 13.8 g sugar ) , 9.84 g fat 154.9 g water mmt , 4 year post-op , 210 min < 60 mg\/dl ( 3.3 mmol\/l ) hypo 48 % , asymptomat tharakan , 2017 ( 54 ) symptomat rygb , n = 18 asymptomat rygb , n = 10 non-rygb control , n = 9ensur plu food supplement ( 13.8 g protein , 10.8 g fat , 44.4 g carbohydr , 330 kcal , 220 ml , abbott ) < 3.0 mmol\/ll hypo 7\/18 symptomat peopl johannson , 2010 ( 55 ) bpd-d , n = 10 normal weight control , n = 12mix meal includ hamburg , jam sandwich margarin oat bread , 2400 kj ( 570 kcal ) , consist : carbohydr 68.2 g , fat 22.3 g , protein 24.6 g fibr 6.4 g. 2 year post-op , 180 minnot prespecifi report hypoglycaemia bpd-d , biliopancreat divers duoden switch ; ds , duoden switch ; ( l ) agb , ( laparoscop ) adjust gastric band ; mmt , mix meal test ; rygb , roux-en-i gastric bypass ; sg , sleev gastrectomi ; vsg , vertic sleev gastrectomy.t 3 continu . download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 j hazlehurst et al . surgeri societi \u2019 guidanc ( 67 ) ( recommend 2.2 , tabl 1 ) . although major focu dietari intervent restrict carbohydr , role protein adequaci , fat , meal time space , caffein , alcohol eat behaviour consid detail part pragmat review suhl et al . , includ 10-point nutrit plan emphasi import detail personalis assess ( 68 ) . evid tabl 4 summari tabl studi cgm pbh . studi popul investigationdefinit hypoglycaemia outcom rett , 2013 ( 56 ) symptomat rygb , n = 27dexcom seven+ cgm 7 day < 70 mg\/dl ( < 3.9 mmol\/l ) hypoglycaemia detect 93 % . rais gv measur mag . nielsen , 2015 ( 57 ) symptomat rygb , n = 12 asymptomat rygb , n = 12not specifi cgm 6 day set peopl subject 5-h mmt , low-carbohydr diet 1 day , ordinari diet rest monitor periodnot specifi cgm glucos level overestim plasma glucos mmt 1.0 mmol\/l . rais gv measur mage low carbohydr diet lower ordinari diet . ritz , 2016 ( 58 ) symptomat non- specifi bariatr surgeri , n = 142 asymptomat non- specifi bariatr surgeri , n = 25not specifi cgm system < 60 mg\/dl ( < 3.33 mmol\/l ) cohort divid hypo withouthypo peopl time hypo < 60 mg\/dl gv . differ symptom hypo peopl hypo without . sigstad dump syndrom score higher hypo peopl . halperin , 2011 ( 59 ) asymptomat rygb , n = 6 symptomat rygb , n = 10medtron minim ipro cgm 72\u2013120 h peopl also subject mmt ( ensur , 9 g protein , 40 g carbohydr , 6 g fat , 240 ml ; abbott ) < 70 mg\/dl ( < 3.9 mmol\/l ) 9\/10 symptomat peopl hypo cgm 3\/9 mmt . 3\/6 asymptomat peopl hypo cgm 3\/5 mmt . sensit cgm clinic signific hypo 90 % specif 50 % ( 33 % , 40 % mmt ) . kefurt , 2015 ( 46 ) symptom state rygb , n = 51medtron ipro-2 cgm 5 day < 55 mg\/dl ( < 3.1 mmol\/l ) 75 % hypo episod mean durat 71 min . capristo , 2018 ( 29 ) randomli select rygb , n = 25 randomli select sg , n = 25 ( cohort 120 peopl assign 1:1 rygb vs sg ) medtron enlit 5 day < 55 mg\/dl ( < 3.1 mmol\/l ) differ averag daili glycaem valu \u22643.1 mmol\/l daili averag number hypo episod rygb vs sg . lobato , 2020 ( 60 ) symptomat rygb , n = 13abbott freestyl libr 14 day , first 48 h exclud < 70 mg\/dl ( < 3.9 mmol\/l ) concurr hypoglycaem symptom < 54 mg\/ dl ( < 3.0 mmol\/l ) signific hypoglycemia ( time rang < 54 mg\/dl\/ < 3.0 mmol\/l \u22651 % ) 8\/13 . ilesanmi , 2021 ( 13 ) asymptomat rygb , n = 10dexcom g4 g6 cgm 10 day assess surgeri , 1 month , 1 year 2 year surgeri mmt ensur compact ( 13 g protein , 11.6 g fat , 36 g carbohydr , 330 kcal , 137.5 ml ; abbott ) surgeri , 1 month , 1 year < 3.0 < 3.9 mmol\/l signific hypoglycaemia ( time rang < 3.0 mmol\/l > 1 % ) 5\/10 . gv similar baselin pre-surgeri 1 month , increas 1 year 2 year surgeri . preval asymptomat hypo roux-en-i gastric bypass 50 % . cgm , continu glucos monitor ; gv , glycaem variat ; ( l ) agb , ( laparoscop ) adjust gastric band ; mag , mean absolut glucos ; mage , mean absolut glucos excurs ; mmt , mix meal test ; rygb , roux-en-i gastric bypass ; sg , sleev gastrectomi . download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 synthesi associ summari evid base best employ dietitian particular interest expertis bariatr surgeri though also intend use less expert set may resource-limit . avail data identifi scope review summaris reliant combin small experiment feed studi includ uncontrol crossov design studi well retrospect uncontrol studi intervent deliv real-world set . carbohydr restrict control portion carbohydr , emphasis low glycaem index ( gi ) carbohydr avoid rapidli absorb carbohydr , central dietari treatment ( 68 ) . go hand-in-hand posit reinforc healthi post-bariatr eat strategi . unfortun , adher strategi often inadequ pbh control , group exceed recommend ad sugar . much data relat effect carbohydr restrict small uncontrol feed studi ( 69 , 70 , 71 ) . exampl , test meal carbohydr load 30 g result hypoglycaemia 14 peopl pbh ( 70 ) . retrospect studi 41 peopl pbh includ patient interview well medic record review found guidanc eat 6 small meal day < 30 g carbohydrates\/m associ reduct hypoglycaem frequenc , nocturn symptom , increas nadir glucos well improv qualiti life ( 72 ) . therefor , advis start dietari advic includ small frequent meal , reduc carbohydr consumpt < 30 g\/meal emphasi choos low gi high gi carbohydr . consider may given lower target ( e.g . 25 g\/ meal , 20 g\/meal ) supervis initi 30 g\/meal target effect , need supervis ( recommend 2.3 , tabl 1 ) . modif carbohydr type glycaem index carbohydr modifi carbohydr type also make impact . small , randomis crossov studi demonstr fructose-contain meal modest effect insulin glucos variabl glucose-contain meal peopl pbh ( 73 ) . howev , increas fructos intak fulli recommend given potenti role foster metabol dysfunction- associ fatti liver diseas increas cardiovascular risk ( 74 ) . whilst cornstarch supplement propos , scope review identifi one studi cornstarch use two peopl unrespons prior dietari intervent , result improv hypoglycaem frequenc cgm ( 75 ) . variou food addit pectin , guar gum glucomannan studi method slow gastric empti nutrient absorpt mainli context late dump syndrom , evid efficaci reduc post-prandi hypoglycaemia ( 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 ) . howev , publish evid applic addit pbh exist , mani peopl unabl toler addit chang textur palat food . present , recommend dietari manoeuvr ( recommend 2.4 , tabl 1 ) . use cgm manag hypoglycaemia cgm may role educ peopl , reinforc document relationship dietari chang amelior pbh ( 60 , 86 , 87 ) , therefor improv adher dietari advic . cgm technolog enabl user set alarm alert incipi hypoglycaemia , may allow take prevent action , especi hypoglycaem unawar . small studi suggest unblind cgm associ improv time rang ( 3.9\u201310 mmol\/l , 70\u2013180 mg\/dl ) compar blind cgm , reduct time rang ( < 3.9 mmol\/l , 70 mg\/dl ) rang ( > 10 mmol\/l , 180 mg\/dl ) ( 88 ) . summari , earli evid cgm may help improv manag pbh ( recommend 2.5 , tabl 1 ) . present , nice recommend includ use cgm purpos , thu make access technolog difficult peopl otherwis afford acquir sensor . stronger evid efficaci cost-effect approach need develop enabl fund technolog ( recommend 6.3 , tabl 1 ) . emerg treatment hypoglycaemia hypoglycaemia treatment follow gener principl manag diabet addit note sucros avoid treatment peopl treat acarbos ( 68 , 89 ) . unit recommend strategi stage treatment hypoglycaemia avoid precipit pbh . involv take small quantiti fast-act carbohydr ( e.g . 10\u201315 g dextros ) obviat re-precipit pbh , check blood glucos everi 15 min decid dose . hypoglycaemia resolv , low glycaem index carbohydr contain snack may consid ( recommend 2.6 , 2.7 , tabl 1 ) . howev , research requir optim method\/strategi download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 j hazlehurst et al . treat hypoglycaemia pbh ( recommend 6.4 , tabl 1 ) . manag exercis although exercis precipit symptom pbh peopl , gener consid safe least 3 month surgeri , exercise-associ hypoglycaemia uncommon . small studi nine peopl suggest moder intens exercis whilst fast peopl report pbh associ hypoglycaemia ( 90 ) . practic , peopl pbh advis exercis regularli assist weight mainten bariatr surgeri , exercis time low risk pbh ( e.g . fast , least 3 hour eat ) . avoid carbohydr load prior exercis , measur glucos level feel unwel , treat emerg hypoglycaemia exercis consid low gi carbohydrate- contain snack exercis ( recommend 2.8 , tabl 1 ) . caffein guidanc suggest trial reduc caffein intak help ( 68 ) . theoret , caffein exacerb initi rapid rise glucos insulin eat . howev , current specif evid directli demonstr reduc caffein intak help pbh . reduct alcohol consumpt alcohol consumpt reduc glucos level , least part mediat reduct hepat gluconeogenesi . effect bariatr surgeri like dose depend modest amount alcohol consum without food similar effect post-surgeri compar pre-surgeri , despit mark effect surgeri blood alcohol concentr post ingest ( 91 ) . alcohol drink contain vari level non-fer high gi carbohydr , , even without effect alcohol , drink trigger pbh . lastli , higher risk alcohol use disord bariatr surgeri ( 92 ) . therefor , avoid alcohol good practic peopl pbh bariatr surgeri gener ( recommend 2.9 , tabl 1 ) . high dietari protein intak protein adequaci import post-bariatr surgeri protein malnutrit seriou complic . current guidanc nutrit manag bariatr surgeri emphasis role enhanc protein intak , minim 60 g\/day , although higher individualis target may requir ( recommend 2.10 , tabl 1 ) ( 93 ) . protein consumpt also like relev manag pbh given role protein glp-1 , glucagon insulin secret alter gastric emptying\/intestin motil consum time carbohydr . ten peopl post rygb hypoglycaemia , randomis cross-ov experiment meal studi examin differ convent recommend ( cr ) carbohydrate-reduc high-protein diet ( crhp ) found less glycaem variabl crhp diet hypoglycaemia follow crhp test meal . crhp 30\/30\/40 percentag energi suppli , respect , carbohydrate\/protein\/fat , whilst cr diet 55\/15\/30 . 15 % total energi expenditur given breakfast test meal 20 % lunch test meal ( 94 ) . import protein adequaci support studi 17 peopl prior rygb half symptomat pbh . studi incorpor cgm , food symptom diari demonstr meal prior hypoglycaemia like lower protein higher sugar ( 95 ) . modif meal volum fluid intak although specif studi peopl pbh , feed studi peopl rygb demonstr physiolog basi reduct meal volum well trial supin postur peopl pbh ( 96 ) . care control feed studi peopl pre post rygb , solid rather liquid meal associ lower frequenc hypoglycaemia reduct peak glp-1 respons feed . effect small , regular rather larg , singl meal less certain , though anticip , small regular meal associ reduct insulin respons feed ( 97 ) . studi provid clear evid import solid rather liquid meal well smaller volum regular meal . basi commonli deliv guidanc peopl pbh avoid fluid meal ( 68 ) . ideal , peopl avoid drink 30 min prior continu 30 min meal , minim avoid drink meal least 30 min meal ( recommend 2.11 , tabl 1 ) . gastrostomi feed tube gastrostomi feed tube placement remnant stomach propos possibl treatment option peopl resist pbh post rygb asmb , practic experi one author ( ra ) shown may use option sever case pbh . howev , avail data limit small case seri , includ studi four download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 six peopl identifi treatment-resist post- bariatr surgeri hypoglycaemia nadir glucos < 2.8 mmol\/l ogtt , experiment studi six peopl await rygb revers shown much less mark glp-1 , insulin hypoglycaem respons liquid mmt given via tube compar oral feed , recent seri detail outcom treatment respons failur pbh ( 98 ) . nevertheless , recommend may option sever pbh respond dietari pharmacolog treatment ( recommend 2.12 , tabl 1 ) . pharmacotherapi glucosidas inhibitor acarbos competit inhibitor pancreat \u03b1-amylas intestin brush border \u03b1-glucosidas , caus delay hydrolysi ingest polysaccharid , oligosaccharid disaccharid monosaccharid . acarbos , administ peopl symptomat pbh , result blunt postprandi rise plasma glucos , turn reduc insulin secret mix meal studi . effect acarbos postprandi level glp-1 controversi , studi show chang other report reduct peak glp-1 . real-lif condit use cgm , acarbos significantli reduc time hyperglycaemia time hypoglycaemia ( 99 ) . retrospect seri de heid et al . , 107 120 peopl pbh treat acarbos median dose 150 mg daili , 21 % report complet resolut hypo event , 35 % 50\u2013 100 % resolut , 20 % 20\u201350 % resolut 24 % 0\u201320 % resolut ( minim resolut ) . patient 's perspect , major ( 61 % ) peopl treat acarbos report either hypo , almost hypo , accept frequenc hypo . although effect treat pbh , gastrointestin side effect abdomin pain , flatul , bloat , diarrhoea , lead long-term attrit adher ( 100 ) . despit limit , acarbos use treat peopl pbh long 120 month ( 100 , 101 ) . simethicon may also consid mean eas flatul acarbos treatment ( 102 ) . summari ( tabl 5 ) , suffici clinic experi acarbos suggest moder efficaci pbh . consid rel low cost side effect profil , suggest consid first-lin pharmacotherapi pbh ( recommend 3.1 , tabl 1 ) . glp-1 analogu small case seri peopl pbh , treatment glp-1 analogu liraglutid improv symptom hypoglycaemia , fast post-prandi glucos concentr , lower insulin level ogtt one case reduc time hypoglycaemia cgm . case seri report de heid co-work , 13 peopl pbh treat liraglutid semaglutid 60 month complet respons ( 100 % reduct hypo episod ) 1 13 , 50\u2013100 % reduct hypo episod 8 13 , 20\u201350 % reduct hypo episod 1 13 0\u201320 % reduct hypo episod 2 13 , suggest partial efficaci ( 100 ) . mechan glp-1 agonist amelior hypoglycaemia case seri unclear . short-term studi peopl undergon rygb ( albeit without histori pbh ) , exenatid shown influenc counter-regulatori hormon secret ( glucagon , catecholamin , growth hormon , cortisol ) hypoglycaem hyperinsulinem clamp , suggest effect glp-1 analogu , mediat mechan ( 104 ) . contrari abovement studi , cross-ov studi examin effect 3 week \u2019 treatment liraglutid 11 women document pbh show evid signific chang time hypoglycaemia , although glucos variat reduc cgm . summari ( tabl 6 ) , insuffici evid current exist recommend use glp-1 analogu pbh ( recommend 3.6 , tabl 1 ) . glp-1 receptor antagon discuss earlier , lead hypothesi pathogenesi pbh involv excess secret glp-1 l-cell reaction ingest absorpt nutrient , excess hyperinsulinaemia consequ \u2018 overshoot \u2019 correct blood glucos . blockad glp-1 receptor antagonist exendin 9\u201339 ( also known recommend intern non-proprietari name avexitid ) lead correct hypoglycaemia reduc hyperinsulinaemia respons mmt ogtt reduc hypoglycaem symptom peopl pbh ( 10 , 107 , 108 , 109 ) . phase ii placebo-control crossov trial subcutan avexitid two dose ( 30 mg twice day 60 mg day ) 28 day 18 peopl pbh show improv nadir glucos peak insulin ogtt , reduct hypoglycaemia without relev increas hyperglycaemia cgm , improv rate hypoglycaemia defin self-measur blood glucos ( smbg ) < 70 mg\/dl ( 3.9 mmol\/l ) , < 54 mg\/dl ( 3.0 mmol\/l ) sever hypoglycaem event alter mental and\/or physic function requir assist ( 110 ) . summari , avexitid ( exendin 9\u201339 ) appear effect treat pbh ( tabl 7 ) current avail outsid phase iii clinic trial , download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 j hazlehurst et al . write . referr trial , avail , may reason step will particip ( recommend 3.5 , tabl 1 ) . glucagon glucagon analogu rygb associ reduc counter-regulatori respons post-prandi hypoglycaemia , includ glucagon secret ( 111 , 112 ) . evid pbh hypoglycaemia mix meal test continu glucos monitor associ alter glucagon secret ( 12 , 13 ) . glucagon current licenc treatment sever hypoglycaemia peopl diabet , uk , exist powder solvent formul ( glucagen\u00ae , novo nordisk ) stabilis liquid formul ( ogluo\u00ae , tetri pharma\/xeri ) . dasiglucagon glucagon analogu liquid formul ( zegalogue\u00ae , novo nordisk ) current licenc usa uk.in case studi , halperin et al . describ use iv glucagon infus one patient pbh rygb demonstr elimin hypoglycaemia experienc mix meal test , albeit much- enhanc insulin secret respons eat ( 113 ) . exploratori clinic studi , mulla et al . utilis liquid glucagon deliv via subcutan infus pump coupl cgm predict algorithm hypoglycaem episod 12 peopl pbh . comparison vehicl control , glucagon deliveri system , utilis bolu dose 150\u2013300 \u00b5g , abl prevent post-prandi hypoglycaemia mix meal test ( 112 ) . howev , write , pump system present gener avail clinic set . dasiglucagon studi cross-ov trial : singl dose 80 200 \u00b5g prior mmt stimulu , shown effect increas nadir glucos reduc time hypoglycaemia < 3.9 mmol\/l . summari , glucagon use treat hypoglycaemia ( tabl 8 ) may consid rescu therapi tabl 5 summari tabl studi acarbos pbh . studi popul intervent compar outcom valdera , 2012 ( 103 ) rygb symptomat pbh , n = 8acarbos 100 mg singl dose 15 min mmtno acarbos mmt ( unblind ) episod hypoglycaemia < 50 mg\/dl ( 2.8 mmol\/l ) mmt acarbos . reduct insulin auc reduct peak glp-1 mmt . cadegiani , 2016 ( 102 ) rygb symptomat earli late dump syndrom , refractori dietari intervent , n = 25acarbos 50 mg , four five time day 6 month , simethicon 120 mg twice day peopl flatul ( attenu side effect acarbos ) compar 85.8 % reduct episod earli dump 95.7 % reduct episod late dump ( pbh ) per week . improv symptom earli dump assess sigstad score . frankhous , 2013 ( 101 ) rygb symptomat pbh , n = 5acarbos , 5 48 monthsno compar symptomat hypoglycaemia resolv four peopl . one patient discontinu due rash . ohrstrom , 2019 ( 99 ) rygb ; symptomat pbh , n = 11acarbos 50 mg four six time day 7 dayscompar no-treat baselin ( part cross-ov studi sitagliptin , verapamil , pasireotid , liraglutid ) reduc peak increas nadir glucos mmt compar treatment pre-treat . reduc insulin c-peptid level mmt . differ peak glp-1 mmt . reduc time hyperglycemia glycaem variabl cgm treatment compar pre-treat . signific differ time hypoglycaemia ( < 3.9 3.0 mmol\/l ) . de heid , 2023 ( 100 ) n = 120 case pbh , 82\/120 rygb , 34\/120 sagb , 3\/120 sg 1 sadiacarbos , median dose 150 mg daili , 107 peopl , 120 monthsno specif compar ( case seri ) 21 % 100 % reduct hypo , 35 % 50\u2013100 % reduct , 20 % 20\u201350 % reduct , 24 % 0\u201320 % reduct . mmt , mix meal test ; rygb , roux-en-i gastric bypass ; sg , sleev gastrectomi ; sadi , single-anastomosi duodenal-il bypass ; sagb , single-anastomosi gastric bypass , also known one-anastomosi gastric bypass . download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 tabl 6 summari tabl studi glp-1 analogu pbh . studi popul intervent compar outcom abrahamsson , 2013 ( 105 ) symptomat rygb , n = 5liraglutid 1.2 mg daynon symptom peopl treatment . cgm record one patient show signific hypoglycaem dip prior treatment time hypoglycaemia treatment . stier , 2015 ( 106 ) symptomat rygb , n = 7liraglutid 0.6 mg 1.2 mg daynon improv glycaem symptom report resolut symptom 6\/7 . fast ogtt insulin level report reduc . ohrstrom , 2019 ( 99 ) symptomat rygb , n = 11liraglutid 1.2 mg day 3 weekscompar no-treat baselin ( part cross-ov studi sitagliptin , verapamil , pasireotid , acarbos ) signific effect nadir glucos mmt . differ time hypoglycaemia ; reduc glycaem variat cgm . de heid , 2023 ( 100 ) n = 120 case pbh , 82\/120 rygb , 34\/120 sagb , 3\/120 sg 1 sadiliraglutid ( median dose 1.8 mg\/day ) semaglutid ( median dose 1 mg\/week ) , 13 peopl 60 monthsno specif compar ( case seri ) 1\/13 100 % reduct hypo , 8\/13 50\u2013100 % reduct , 1\/13 20\u201350 % reduct , 2\/13 0\u201320 % reduct . cgm , continu glucos monitor ; mmt , mix meal test ; ogtt , oral glucos toler test ; rygb , roux-en-i gastric bypass ; sg , sleev gastrectomi ; sadi , single-anastomosi duodenal-il bypass ; sagb , single-anastomosi gastric bypass , also known one-anastomosi gastric bypass . tabl 7 summari tabl studi glp-1 receptor antagon pbh . studi popul intervent compar outcom salehi , 2014 ( 10 ) symptomat rygb ( h-gb ) , n=9 asymptomat rygb ( a-gb ) , n = 7 healthi control , n = 8exendin 9\u201339 iv infus salin infus exendin 9\u201339 correct post-prandi hypoglycaemia h-gb group . craig , 2017 ( 107 ) symptomat rygb , n = 10 exendin 9\u201339 iv infus cross-ov studyplacebo 75 g ogtt , exendin 9\u201339 reduc peak increas nadir glucos ( prevent develop hypoglycaemia ) . craig , 2018 ( 108 ) symptomat rygb , n = 9 ascend sc dose exendin 9\u201339none 75 g ogtt , exendin 9\u201339 increas nadir glucos decreas peak insulin . tan , 2020 ( 109 ) symptomat rygb , n = 19 lyophilis n = 5 liquid formulationascend sc dose exendin 9\u201339 ( avexitid ) lyophilis liquid formulationsnon 75 g ogtt , avexitid improv glucos nadir , insulin peak symptom score dose-depend manner . dose \u226520 mg twice day obviat need rescu glucos treatment initi glucos < 2.8 mmol\/l . craig , 2021 ( 110 ) symptomat rygb , women diet-refractori , n = 18avexitid 30 mg sc bd 60 mg sc od 2 week cross-ov studyplacebo mixed-m test , avexitid increas nadir glucos 21\u201326 % reduc peak insulin 21\u201323 % . signific reduct frequenc hypoglycaem episod . bd , twice day ; iv , intraven ; od , day ; ogtt , oral glucos toler test ; rygb , roux-en-i gastric bypass ; sc , subcutan . download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 j hazlehurst et al . case frequent sever pbh ( recommend 3.4 , tabl 1 ) . somatostatin analogu somatostatin analogu octreotid , lanreotid pasireotid use individu \u2018 dump syndrom \u2019 follow upper gastrointestin surgeri , gastrectomi peptic ulcer surgeri , mani year . found effect earli late dump syndrom , late dump syndrom analog condit pbh individu undergo upper gi surgeri oesophagectomi gastrectomi ( 115 , 116 , 117 , 118 ) . thought work activ somatostatin receptor ( particularli subtyp 2 5 ) inhibit releas variou gut metabol hormon gastrin , pancreat polypeptid , glucagon , neurotensin , secretin , glp-1 , insulin , implic pathophysiolog dump syndrom . rel differ activ present avail somatostatin analogu octreotid , lanreotid pasireotid . octreotid lanreotid exhibit greater activ subtyp 2 subtyp 5 , wherea pasireotid activ subtyp 2 5. mark hyperglycaem effect pasireotid rel octreotid non-bariatr surgeri individu due rel ratio subtyp 5:2 activ . pasireotid octreotid abl suppress insulin secret , pasireotid less abl suppress glucagon secret octreotid , explain fact inhibit insulin secret human pancreat islet mediat subtyp 2 5 , inhibit glucagon secret mainli via subtyp 2 ( 119 ) . long-term safeti somatostatin analogu establish widespread use treatment acromegali , neuroendocrin tumour indic , common side effect steatorrhoea due rel pancreat exocrin defici increas risk gallston development.with regard pbh ( tabl 9 ) , short-act sc octreotid pasireotid ( 99 , 120 ) appear effect prevent hypoglycaemia follow ogtt mmt . im long-act pasireotid also effect , although sc pasireotid three time day may effect long-act im pasireotid ( 117 ) . regard lanreotid , publish experi medic pbh , although experi analogu dump syndrom suggest differ late dump symptom score ( 118 ) . summari , evid suggest short-act sc octreotid pasireotid prevent pbh given three time day meal ( recommend 3.2 , tabl 1 ) . im pasireotid lar also effect ( recommend 3.2 , tabl 1 ) . howev , less evid efficaci exist long-act prepar , present recommend ( recommend 3.6 , tabl 1 ) . sglt inhibitor human , sodium\u2013glucos link transport sglt-1 sglt-2 play import role sodium glucos transport across basal brush membran gut kidney cell . sglt-1 express enterocyt enteroendocrin cell ( l cell k cell ) , respect , produc incretin glp-1 gip . sglt-1 respons glucos absorpt small intestin reabsorpt approxim 10 % filter glucos load segment 3 renal proxim tubul . sglt-2 primarili express kidney respons reabsorpt approxim 90 % filter glucos load proxim tubul segment 1 2. addit sglt-1 receptor , glut-2 receptor essenti transport glucos across basolater membran small intestin . rygb , upregul sglt-1 glut-2 express ( 122 ) . sglt-1 present enteroendocrin cell , plausibl intestin inhibit sglt-1 tabl 8 summari tabl studi glucagon glucagon analogu pbh . studi popul intervent compar outcom halperin , 2010 ( 113 ) symptomat rygb , n = 1glucagon iv infus cross-ov studyvehicl mmt , glucagon elimin post-prandi hypoglycaemia evid vehicl infus . mulla , 2020 ( 112 ) symptomat rygb , n = 12autom glucagon sc bolus 150 300 \u00b5g cross-ov studyvehicl mmt , algorithm predict hypoglycaemia administ glucagon bolus , obviat need rescu glucos treatment , increas nadir post-prandi plasma glucos comparison vehicl . nielsen , 2022 ( 114 ) rygb hypoglycaemia cgm , n = 10singl dose 80 \u00b5g 200 \u00b5g dasiglucagon three-way cross-ov trialplacebo increas nadir glucos reduc time hypoglycaemia < 3.9 mmol\/l mmt compar placebo , dose dasiglucagon . cgm , continu glucos monitor ; iv , intraven ; mmt , mix meal test ; rygb , roux-en-i gastric bypass ; sc , subcutan . download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 tabl 9 summari tabl studi somatostatin analogu late dump syndrom pbh . studi popul intervent compar outcom art , 2009 ( 116 ) upper gi surgeri includ partial gastrectomi , rygb , nissen fundopl , partial oesophagectomi ; post-op hypoglycaemia ( < 3.3 mmol\/l ) ogtt , n = 30 n = 10 rygbsc octreotid 50 \u00b5g three time day 3 day ( cross-ov studi ) im octreotid lar 20 mg monthli 3 monthssc octreotid improv nadir glucos ogtt although 7\/30 still experienc signific hypoglycaemia . im octreotid lar ( 3 month \u2019 treatment ) improv nadir glucos ogtt although 11\/30 still experienc signific hypoglycaemia . improv late dump sever score sc octreotid im octreotid lar . tack , 2018 ( 117 ) upper gi surgeri includ rygb , gastrectomi , oesophagectomi ; symptomat hypoglycaemia ( late dump symptom ) , n = 43 sc dose escal phase ( 38 rygb ) . n = 33 ( 28 rygb ) went im phase3-month dose escal phase sc pasireotid ( 50\u2212200 \u00b5g three time day ) follow 3-month im phase ( 10 20 mg monthli ) , option 6-month extens phase im pasireotidenon ( single-arm trial ) 60.5 % peopl hypoglycaemia end sc phase . 36.4 % peopl hypoglycaemia end im phase . wauter , 2019 ( 118 ) upper gi surgeri : gastrectomy\/bypass , oesophagectomi , non-resect oesophag surgeri ; meet criteria earli dump syndrom , late dump syndrom ( hypoglycaemia < 60 mg\/ dl 3.3 mmol\/l ) ogtt , histori hypoglycaemia < 60 mg\/dl 3.3 mmol\/l ; n = 24 ( 2 arm 12 ) sc lanreotid autogel 90 mg monthli 3 month double-blind , randomis , placebo-control crossov studi peopl underw 3 month lanreotid 3 month placebosalin inject monthli 3 monthslanreotid improv earli dump symptom score late dump symptom score ( hypoglycaemia ) . whyte , 2010 ( 121 ) symptomat rygb , n = 4 singl dose sc octreotid 100 \u00b5gno treatment symptomat hypoglycaemia extend ogtt said prevent pre-treat octreotid . de heid , 2014 ( 120 ) symptomat rygb , n = 1 singl dose sc octreotid 100 \u00b5gsingl dose sc pasireotid 300 \u00b5goctreotid given prior mmt result hypoglycaemia ( 2.0 mmol\/l ) mmt wherea pasireotid ( 3.5 mmol\/l ) . sc pasireotid 300 \u00b5g twice day result amelior hypoglycaem episod . ohrstrom , 2019 ( 99 ) symptomat rygb , n = 11 singl dose sc pasireotid 300 \u00b5g prior mmtcompar no-treat baselin ( part cross-ov studi sitagliptin , verapamil , liraglutid , acarbos ) signific increas nadir glucos mmt . cgm , continu glucos monitor ; im , intramuscular ; iv , intraven ; lar , long-act releas ; mmt , mix meal test ; ogtt , oral glucos toler test ; rygb , roux-en-i gastric bypass ; sc , subcutan . download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 j hazlehurst et al . may reduc exagger incretin rise seen surgeri . consequ could lower peak glucos theoret reduc risk subsequ hypoglycaemia . canagliflozin competit inhibit sglt-1 sglt-2 higher select sglt-2 ( 123 ) . canagliflozin , given individu undergon rygb , led delay glucos absorpt reduc peak glucos respons 50 g ogtt . signific reduct nadir glucos , albeit evid pbh group . accompani reduct peak glp-1 concentr later glucagon level ( 124 ) . pilot studi involv 21 peopl pbh rygb , pre-treat canagliflozin 300 mg reduc peak glucos increas nadir glucos respons 100 g ogtt ( 125 ) . case report , one patient pbh given canagliflozin 100 mg day 9 month , symptomat improv reduct hypoglycaemia document intermitt scan glucos monitor continu glucos monitor ( 126 ) . formal clinic trial progress , evalu effect canagliflozin pbh ( 127 ) . sotagliflozin similarli inhibit sglt-1 sglt-2 higher select latter , present , record studi trial medic pbh . one trial conduct small number peopl symptomat pbh , empagliflozin ( select sglt-2 inhibitor ) reduc peak postprandi glucos , reduc insulin level reduc episod hypoglycaemia mmt ( 16 ) . subsequ , randomis double-blind control trial empagliflozin 22 peopl , given 25 mg daili ( placebo ) 20 day , show post-prandi glucos excurs reduc , time rang ( < 3.0 mmol\/l ) cgm differ placebo treatment group ( 128 ) . summari , anecdot evid support use canagliflozin evid use empagliflozin pbh ( tabl 10 ) . overal , present insuffici evid recommend routin clinic use sglt inhibitor pbh ( recommend 3.6 , tabl 1 ) . treatment diazoxid potassium channel activ , lead hyperpolar inhibit beta-cel secret insulin . describ treatment pbh case studi ( 129 , 130 , 131 ) . case seri de heid et al. , 14 peopl treat diazoxid : 3\/14 100 % reduct hypo , 4\/14 50\u2013100 % reduct , 3\/14 20\u201350 % reduct hypo 5\/14 0\u201320 % reduct hypo ( 100 ) . therefor , diazoxid recommend possibl third-lin treatment ( recommend 3.3 , tabl 1 ) . howev , toler diazoxid limit side effect hypotens , palpit peripher oedema , lead discontinu peopl within rel short time . post-prandi insulin secret stimul il-1beta , turn stimul post-prandi rise glucos . inhibit il-1beta , exampl , il-1 receptor antagonist anakinra , may inhibit post-prandi insulin secret . double-blind , placebo control , randomis studi , hepprich et al . administ anakinra ( il-1beta receptor antagonist ) placebo 12 peopl symptomat pbh , follow liquid mmt . show anakinra reduc postprandi insulin secret subsequ hypoglycaem event tabl 10 summari tabl studi sglt inhibitor pbh . studi popul intervent compar outcom abouglila , 2017 ( 126 ) symptomat rygb , n = 1canagliflozin 100 mg day 9 month symptomat improv reduct hypoglycaemia document glucos monitor . ciudin , 2021 ( 125 ) rygb , symptomat 83 % , n = 21canagliflozin 300 mg singl dose prior 100 g ogtt signific reduct peak nadir glucos ogtt.20\/21 peopl nadir glucos < 50 mg\/ dl ( 2.8 mmol\/l ) baselin , 2\/21 canagliflozin . ferreira , 2023 ( 128 ) rygb , n = 22 empagliflozin 25 mg daili 20 day differ quantiti qualiti symptom , reduc glucos excurs meal , differ time < 3.0 mmol\/l cgm . hepprich , 2020 ( 16 ) symptomat rygb , n = 12empagliflozin 10 mg prior mmt reduc hypoglycaemia episod mmt follow empagliflozin compar placebo . martinussen , 2020 ( 124 ) asymptomat rygb , n = 10canagliflozin 600 mg singl dose prior 50 g ogttnon no-treat baselin 100 g ogtt placebo anakinra ( il-1beta antagonist ) placebo placebo canagliflozin led delay glucos absorpt reduc peak glucos nadir glucos . mmt , mix meal test ; ogtt , oral glucos toler test ; rygb , roux-en-i gastric bypass . download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 j hazlehurst et al . mmt , howev chang glp-1 glucagon ( 16 ) . xoma 358 ( also known rz358 ) monoclon antibodi neg alloster modul insulin receptor , select insulin receptor bind igf-1 receptor . xoma 358 administ 13 peopl pbh ascend dose ( 3 mg\/kg , 6 mg\/kg 9 mg\/kg ) . individu fit cgm 22 day ; underw meal test oral boost ( mix meal drink ) day 3 , 1 , 5 11. author report improv time hypoglycaemia meal test , reduc daili period hypoglycaemia correct night-tim hypoglycaemia ( 9 mg\/kg group ) cgm ( 132 ) . medic present develop congenit hyperinsulin current avail gener use . treatment pbh peopl studi ohrstrom et al . dpp-iv inhibitor sitagliptin advers effect nadir glucos mm , calcium channel antagonist verapamil appear benefici effect hypoglycaemia ( 99 ) . summari , insuffici evid support treatment pbh il-1beta antagonist , dpp-iv inhibitor , calcium channel antagonist ( recommend 3.6 , tabl 1 ) . call research pharmacotherapeut option forego paragraph show dearth rigor clinic evid effect treatment peopl pbh refractori dietari treatment . evid necessari open treatment option also allow reimburs fund treatment . henc , call control trial potenti treatment pbh current standard-of-car treatment expand rang pharmacotherapeut option peopl pbh ( recommend 6.5 , tabl 1 ) . surgic endoscop option laparoscop endoscop revers convers surgeri revers convers surgeri variou kind describ solut obviat pbh , describ mostli retrospect patient seri . seri five individua ls ( three pbh alon , one hypocalcaemia one pbh hypocalcaemia ) undergo revers surgeri normal anatomi sleev gastrectom , three suffer post-op complic ( bleed , gallston pancreat trocar site infect ) . mean follow-up 12 month , pbh , reduct document hypoglycaem episod obviat neuroglycopen episod . two five gain weight , wherea three fi lost weight ( 133 ) . seri 16 pbh individu undergo revers surgeri normal atomi \u00b1 sleev gastrectomi roux-en-i gastric bypass , gastrojejunostomi , singl anastomosi duodenojejun gastric bypass sleev gastrectomi combin vertic band gastroplasti distal gastric bypass , post-op complic ( coliti , leak , intra-abdomin haemorrhag , mesenter vein thrombosi ) describ 5 16 case . although individu experienc amelior pbh , 3 16 continu present mild hypoglycaemia ( 2.8\u20133.9 mmol\/l , 50\u201370 mg\/dl ) . long- term complic includ gastro-oesophag reflux 4 16 , function stenosi requir endoscop dilat 1 16 , anorexia 2 16 weight regain 7 16 ( 134 ) . anoth small seri eight roux-en-i gastric bypass revers ( one describ pbh ; other recurr anastomot ulcer , recurr nausea vomit hypocalcaemia ) , 3 8 requir readmiss abdomin pain , nausea vomit . one patient pbh , hypoglycaemia describ resolv revers . mean follow-up 14 month , weight stabil seen 2 7 individu , partial weight regain seen 4 7 individu one regain weight baselin ( 135 ) . kantharia et al . describ case studi one patient pbh underw revers surgeri lead resolut pbh , accompani partial weight regain ( 136 ) . wood et al . describ two case sever pbh underw surgic revers convers sleev gastrectomi , resolut pbh describ follow-up ascertain tendenc weight regain ( 137 ) . davi et al . describ seri seven individu receiv revers rygb sleev gastrectomi ( n=4 ) \u2018 normal \u2019 anatomi , relief pbh variabl weight gain surgeri ( mean 16 kg , one subject weight gain 58 kg despit revis sleev gastrectomi ) ( 138 ) . mehta et al . describ seri eight individu sever pbh roux-en-i gastric bypass underw convers roux jejuno-duodenostomi , lead resolut pbh 2 8 , amelior 4 8 minimal\/no respons 2 8 , associ variabl post-op weight chang rang \u221229.5 +18.2 kg mean follow-up 35 months.on post-op anastomot bleed manag withtransfus ( 139 ) . carter et al . describ seri 12 individu undergo laparoscop convers roux-en-i gastric bypass sg 2 12 pbh and1 dump ( indic includ refractorymargin ulcer , strictur , dump , gastrogastricfistula failur lose weight ) . seri , 4 outof 12 encount post-op complic asthromboembol , haemorrhag requir transfus , pancreat leak requir re-oper , wound seromaand anastomot leak . six 12 requir re-admissionwithin 30 day discharg , mainli poor oral intakeand nausea , one shown stenosisat gastro-gastr anastomosi . averag , 15month follow-up , post-operativedecreas bmi 2.2 kg\/m 2 ( \u221213.9 +12.0 ) . state pbh dump syndrom resolv , download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 j hazlehurst et al . detail ( 140 ) . anoth case report suggest laparoscop roux-en-i gastric bypass revers plu concomit sg effect resolv pbh one patient . post-op weight chang report ( 141 ) . vilarrasa et al . describ four individu underw revision surgeri pbh , one underw \u2018 kiss oper \u2019 re-anastamosi alimentari limb antral remnant ( later revis re-anastamos gastric pouch gastric remnant ) , two underw convers normal anatomi one resect \u2018 candi cane \u2019 roux limb gastric pouch restrict . first patient continu pbh manag medic treatment , other describ resolut pbh ( 131 ) . final , de heid et al . case seri 120 individu pbh , five underw roux-en-i gastric bypass revers , 4 5 full resolut symptom 1 5 minimal\/ resolut although weight regain 24 55 kg report ( 100 ) . summari , variou case report case seri utilis differ techniqu reversal\/convers roux-en-i gastric bypass may offer solut sever pbh . howev , depend type procedur , procedur may associ high rate earli post-op complic . weight regain report appear variabl natur . recommend procedur discuss patient multidisciplinari set involv surgeon experienc procedur . full disclosur likelihood post-op complic weight regain requir ( recommend 4.1 , tabl 1 ) . gastric band silast ring placement small case seri 12 individu , z \u2019 graggen colleagu describ placement silast ring adjust gastric band around gastric pouch roux-en-i gastric bypass report effect resolv pbh 11 12 particip ( 142 ) . case seri de heid et al . also describ 13 individu \u2018 band bypass \u2019 utilis adjust band gastric ring , 9 13 report complet resolut ( 100 % reduct hypo event ) , 3 13 experienc 50\u2013100 % reduct hypo 1 13 experienc 0\u201320 % reduct hypo minim weight regain report ( 100 ) . summari , limit clinic experi suggest restrict gastric pouch efficaci treat pbh rel complic report . howev , insuffici evid recommend approach . endoscop approach endoscop revis dilat gastro-jejun anastomosi transor outlet reduct ( sometim abbrevi tore ) option excess weight regain dump syndrom gastric bypass . retrospect review 107 individu , 26 report dump syndrom ( explicit pbh ) , procedur effect resolv dump syndrom 90\u2013100 % ( 143 ) . case report suggest procedur effect resolv pbh patient roux-en-i gastric bypass ( 144 ) . case seri 11 individu pbh report confer , procedur effect resolv pbh 10 11 , 10 11 experienc weight regain ( averag 5.6 kg ) rel short follow-up period 145 day ( 145 ) . seri four individu undergo endoscop approach use lumen-appos metal stent creat gastro- gastrostomi revers roux-en-i gastric bypass , author describ resolut pbh four descript weight regain post procedur given ( 146 ) . summari , endoscop approach tore show promis resolv pbh may associ weight regain , evid long-term efficaci avail . call research efficaci procedur pbh ( recommend 6.6 , tabl 1 ) . pancreatectomi initi report servic et al . suggest roux- en-i gastric bypass pbh associ pancreat nesidioblastosi ( diffus hyperplasia hypertrophi islet cell ) seri six individu , treat distal pancreatectomi . report 5 6 individu , resolut hypoglycaemia ( 147 ) . z \u2019 graggen et al. , addit describ silast ring restrict mention , also subject three individu distal pancreatectomi addit gastric restrict ( 142 ) . vilarasa et al . describ three individu underw partial pancreatectomi pbh report symptom-fre follow-up 1\u20132 year surgeri ( 131 ) . faro et al . describ singl case patient pbh pancreat tail tumour cure distal pancreatectomi togeth diazoxid hydrochlorothiazid therapi ( 43 ) . howev , partial pancreatectomi associ multipl complic , includ pancreat fistula , collect develop , post-op haemorrhag , pancreat , thrombosi portal vein superior mesenter vein , resect spleen hyposplen , pancreatogen diabet pancreat exocrin defici . summari , case report show efficaci partial pancreatectomi select case . recommend consid case evid coincid insulinoma\/pancreat mass evid localis excess insulin secret . case refer experienc hepato-pancreato- biliari multidisciplinari team ( recommend 4.2 , tabl 1 ) . download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 drive pbh pbh neg impact drive perform ( 148 ) . current dvla regul ( http : \/\/www.gov.uk\/ guidance\/diabetes-mellitus-assessing-fitness-to- drive # hypoglycaemia-due-to-other-caus , revis jun 2022 ) suggest group 1 driver ( car motorcycl ) , follow criteria met prior licenc : \u2022 adequ awar hypoglycaemia ; \u2022 practic appropri glucos monitor : glucos test 2 h start first journey everi 2 h drive start , maximum 2 hour pre-driv glucos test first test perform drive start ; \u2022 demonstr understand risk hypoglycaemia ; \u2022 regard like risk public drive ; \u2022 remain regular clinic review manag underli medic condit . group 2 driver ( bu lorri ) , follow criteria need met prior licenc : \u2022 full awar hypoglycaemia ; \u2022 episod sever hypoglycaemia preced 12 month ; \u2022 practic appropri glucos monitor ( see ) ; \u2022 demonstr understand risk hypoglycaemia ; \u2022 regard like risk public drive ; \u2022 remain regular clinic review manag underli medic condit . regard technolog glucos monitor , accept use intermitt scan glucos monitor sensor ( e.g . freestyl libr system ) cgm ( e.g . medtron dexcom system ) drive group 1 vehicl , although back-up capillari blood glucos monitor equip kept vehicl use confirm sensor read occas sensor glucos \u22644.0 mmol\/l , hypoglycaemia symptom , sensor read consist symptom . group 2 driver , sensor system allow , driver must use capillari blood glucos monitor . sever hypoglycaemia ( defin episod hypoglycaemia requir assist anoth person ) occur due pbh , evid unawar hypoglycaemia , drive must stop , patient notifi dvla ( recommend 5.1\u2013 5.4 summaris advic ( tabl 1 ) ) .supplementari materi link onlin version paper http : \/\/doi.org\/10.1530\/ ec-23-0285 . declar interest t.m-m.t . declar sharehold consult zihipp ltd . b.k. , c.b.l. , g.a.b. , r.a. , s.p . k.m . declar conflict interest . s.a. declar consult fee educ event johnson & johnson . j.h . k.mcc . declar honoraria speak engag advisori work novo nordisk . b.mcg . declar sharehold reset health , research grant novo nordisk , honoraria advisori work novo nordisk , pfizer , johnson & johnson , boehring ingleheim , consult fee educ event novo nordisk , lilli , amgen , astra zeneca , sanofi johnson & johnson . s.f . collabor receiv fund novo nordisk ( cell therapi programm ) . g.k.d . receiv research grant novo nordisk ddm , well honoraria lectur , present , speaker \u2019 bureau , manuscript write educ event novo nordisk , johnson & johnson\/ethicon medtron . r.l.b . report honoraria novo nordisk , eli lilli , medscap , viiv healthcar ltd. , advisori board consult work novo nordisk , eli lilli , pfizer , gila therapeut ltd. , epitome medic ltd. viiv healthcar ltd. , may 2023 employe sharehold eli lilli compani . fund fund requir develop guidanc . refer 1 cusi k , isaac , barb , basu r , caprio , garvey wt , kashyap , mechanick ji , mouzaki , nadolski k , et al . american associ clinic endocrinolog clinic practic guidelin diagnosi manag nonalcohol fatti liver diseas primari care endocrinolog clinic set : co-sponsor american associ studi liver diseas ( aasld ) . endocrin practic 2022 28 528\u2013562 . ( http : \/\/doi.org\/10.1016\/j . eprac.2022.03.010 ) 2 bramant c , wise e & chaudhri z. care patient metabol bariatr surgeri . annal intern medicin 2022 175 itc65\u2013itc80 . ( http : \/\/doi.org\/10.7326\/aitc202205170 ) 3 salehi , vella , mclaughlin & patti . hypoglycemia gastric bypass surgeri : current concept controversi . journal clinic endocrinolog metabol 2018 103 2815\u20132826 . ( http : \/\/doi.org\/10.1210\/jc.2018-00528 ) 4 vanderveen ka , grant cs , thompson gb , farley dr , richard ml , vella , vollrath b & servic fj . outcom qualiti life partial pancreatectomi noninsulinoma pancreatogen hypoglycemia diffus islet cell diseas . surgeri 2010 148 1237\u20131245 . ( http : \/\/doi.org\/10.1016\/j.surg.2010.09.027 ) 5 domgaard , bagger , rhee na , burton cm & thorsteinsson b. individu societ consequ hypoglycemia : cross- section survey . postgradu medicin 2015 127 438\u2013445 . ( http : \/\/ doi.org\/10.1080\/00325481.2015.1045815 ) 6 intern hypoglycaemia studi group . hypoglycaemia , cardiovascular diseas , mortal diabet : epidemiolog , pathogenesi , manag . lancet diabet endocrinolog 2019 7 385\u2013396 . ( http : \/\/doi.org\/10.1016\/s2213- 8587 ( 18 ) 30315-2 ) 7 guyatt gh , oxman ad , kunz r , vist ge , falck-ytt , schunemann hj & grade work group . `` qualiti download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 j hazlehurst et al . evid '' import clinician ? bmj 2008 336 995\u2013998 . ( http : \/\/doi.org\/10.1136\/bmj.39490.551019.b ) 8 falken , hellstrom pm , holst jj & naslund e. chang glucos homeostasi roux-en-i gastric bypass surgeri obes day three , two month , one year surgeri : role gut peptid . journal clinic endocrinolog metabol 2011 96 2227\u20132235 . ( http : \/\/doi.org\/10.1210\/jc.2010-2876 ) 9 goldfin ab , mun ec , devin e , bernier r , baz-hecht , jone db , schneider , holst jj & patti . patient neuroglycopenia gastric bypass surgeri exagger incretin insulin secretori respons mix meal . journal clinic endocrinolog metabol 2007 92 4678\u20134685 . ( http : \/\/doi . org\/10.1210\/jc.2007-0918 ) 10 salehi , gastaldelli & d'alessio da . blockad glucagon-lik peptid 1 receptor correct postprandi hypoglycemia gastric bypass . gastroenterolog 2014 146 669\u2013680.e2 . ( http : \/\/doi . org\/10.1053\/j.gastro.2013.11.044 ) 11 salehi , wood sc & d'alessio da . gastric bypass alter glucose-depend glucose-independ regul islet hormon secret . obes 2015 23 2046\u20132052 . ( http : \/\/doi . org\/10.1002\/oby.21186 ) 12 lobato cb , pereira ss , guimara , hartmann b , wewer albrechtsen nj , hilst l , holst jj , nora & monteiro mp . potenti role endogen glucagon prevent post- bariatr hypoglycemia . frontier endocrinolog 2020 11 608248 . ( http : \/\/doi.org\/10.3389\/fendo.2020.608248 ) 13 ilesanmi , tharakan g , alexiad k , behari p , alessimii h , bovill- taylor c , kenkr j , choudhuri , doyl c , purkayastha , et al . roux-en-i gastric bypass increas glycem variabl time hypoglycemia patient obes prediabet type 2 diabet : prospect cohort studi . diabet care 2021 44 614\u2013617 . ( http : \/\/doi.org\/10.2337\/dc20-1609 ) 14 van den broek , de heid ljm , sip flp , koehorst , van zutphen , emou , van faassen , groen ak , van riel naw , de boer jf , et al . alter bile acid kinet contribut postprandi hypoglycaemia roux-en-i gastric bypass surgeri . intern journal obes 2021 45 619\u2013630 . ( http : \/\/doi . org\/10.1038\/s41366-020-00726-w ) 15 mulla cm , goldfin ab , dreyfuss jm , houten , pan h , pober dm , wewer albrechtsen nj , svane ms , schmidt jb , holst jj , et al . plasma fgf-19 level increas patient post-bariatr hypoglycemia . obes surgeri 2019 29 2092\u20132099 . ( http : \/\/doi . org\/10.1007\/s11695-019-03845-0 ) 16 hepprich , wiedemann sj , schelker bl , trinh b , starkl , geigg , lolig j , boni-schnetzl , rudofski g & donath . postprandi hypoglycemia patient gastric bypass surgeri mediat glucose-induc il-1beta . cell metabol 2020 31 699\u2013709.e5 . ( http : \/\/doi.org\/10.1016\/j . cmet.2020.02.013 ) 17 zaloga gp & chernow b. postprandi hypoglycemia nissen fundopl reflux esophag . gastroenterolog 1983 84 840\u2013842 . ( http : \/\/doi.org\/10.1016\/0016-5085 ( 83 ) 90155-5 ) 18 mine , sano , tsutsumi k , murakami , ehara k , saka , hara k , fukagawa , udagawa h & katai h. large-scal investig dump syndrom gastrectomi gastric cancer . journal american colleg surgeon 2010 211 628\u2013636 . ( http : \/\/doi . org\/10.1016\/j.jamcollsurg.2010.07.003 ) 19 scarpellini e , art j , karamanoli g , laureniu , siquini w , suzuki h , ukleja , van beek , vanuytsel , bor , et al . intern consensu diagnosi manag dump syndrom . natur review . endocrinolog 2020 16 448\u2013466 . ( http : \/\/doi.org\/10.1038\/s41574-020-0357-5 ) 20 goldfin ab & patti . common hypoglycemia gastric bypass ? obes 2016 24 1210\u20131211 . ( http : \/\/doi . org\/10.1002\/oby.21520 ) 21 marsk r , jona e , rasmussen f & naslund e. nationwid cohort studi post-gastr bypass hypoglycaemia includ 5,040 patient undergo surgeri obes 1986\u20132006 sweden . diabetologia 2010 53 2307\u20132311 . ( http : \/\/doi.org\/10.1007\/s00125- 010-1798-5 ) 22 lee cj , brown tt , schweitzer , magnuson & clark jm . incid risk factor associ develop symptom hypoglycemia bariatr surgeri . surgeri obes relat diseas 2018 14 797\u2013802 . ( http : \/\/doi.org\/10.1016\/j . soard.2018.01.028 ) 23 sarwar h , chapman wh , 3rd , pender jr , ivanescu , drake aj , 3rd , pori wj & dar ms. hypoglycemia roux-en-i gastric bypass : bold experi . obes surgeri 2014 24 1120\u20131124 . ( http : \/\/ doi.org\/10.1007\/s11695-014-1260-8 ) 24 raverdi v , baud g , pigeyr , verkindt h , torr f , preda c , thuillier , gele p , vantyghem mc , caiazzo r , et al . incid predict factor postprandi hyperinsulinem hypoglycemia roux-en-i gastric bypass : five year longitudin studi . annal surgeri 2016 264 878\u2013885 . ( http : \/\/doi.org\/10.1097\/ sla.0000000000001915 ) 25 rebelo e , moriconi , scales , denoth f , molinaro , siciliano v , anselmino , taddei , ferrannini e & nannipieri m. impact postprandi hypoglycemia weight loss bariatr surgeri . obes surgeri 2020 30 2266\u20132273 . ( http : \/\/doi.org\/10.1007\/ s11695-020-04465-9 ) 26 nielsen jb , pedersen , gribsholt sb , svensson e & richelsen b. preval , sever , predictor symptom dump hypoglycemia roux-en-i gastric bypass . surgeri obes relat diseas 2016 12 1562\u20131568 . ( http : \/\/doi.org\/10.1016\/j . soard.2016.04.017 ) 27 zweck e , hepprich & donath . predictor postprandi hypoglycemia gastric bypass surgeri : retrospect case- control studi . obes surgeri 2021 31 2497\u20132502 . ( http : \/\/doi . org\/10.1007\/s11695-021-05277-1 ) 28 sjostrom l. review key result swedish obes subject ( so ) trial - prospect control intervent studi bariatr surgeri . journal intern medicin 2013 273 219\u2013234 . ( http : \/\/doi.org\/10.1111\/joim.12012 ) 29 capristo e , panunzi , de gaetano , spuntarelli v , bellanton r , giustacchini p , birkenfeld al , amiel , bornstein sr , raffaelli , et al . incid hypoglycemia gastric bypass vs sleev gastrectomi : random trial . journal clinic endocrinolog metabol 2018 103 2136\u20132146 . ( http : \/\/doi.org\/10.1210\/ jc.2017-01695 ) 30 sessa l , guidon c , gallucci p , capristo e , mingron g & raffaelli m. effect singl anastomosi duodenal-il bypass sleev gastrectomi glucos toler test : comparison bariatr procedur . surgeri obes relat diseas 2019 15 1091\u20131097 . ( http : \/\/doi.org\/10.1016\/j.soard.2019.04.013 ) 31 roslin ms , dudiy , brownle , weiskopf j & shah p . respons glucos toler test solid high carbohydr challeng : comparison roux-en-i gastric bypass , vertic sleev gastrectomi , duoden switch . surgic endoscopi 2014 28 91\u201399 . ( http : \/\/doi.org\/10.1007\/s00464-013-3176-0 ) 32 rheinwalt kp , plamper , ruckbeil mv , kroh , neumann & ulmer tf . one anastomosi gastric bypass-mini-gastr bypass ( oagb-mgb ) versu roux-en gastric bypass ( rygb ) -a mid-term cohort studi 612 patient . obes surgeri 2020 30 1230\u20131240 . ( http : \/\/doi.org\/10.1007\/s11695-019-04250-3 ) download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 33 ashrafi ra , ahola aj , rosengard-barlund , saarinen , heinonen , juuti , marttinen p & pietilainen kh . comput model self-report dietari carbohydr intak glucos concentr patient undergo roux-en-i gastric bypass versu one-anastomosi gastric bypass . annal medicin 2021 53 1885\u20131895 . ( http : \/\/doi.org\/10.1080\/07853890.2021.1964035 ) 34 cryer pe , axelrod l , grossman ab , heller sr , montori vm , seaquist er , servic fj & endocrin societi . evalu manag adult hypoglycem disord : endocrin societi clinic practic guidelin . journal clinic endocrinolog metabol 2009 94 709\u2013728 . ( http : \/\/doi.org\/10.1210\/jc.2008- 1410 ) 35 roslin , damani , oren j , andrew r , yatco e & shah p . abnorm glucos toler test follow gastric bypass demonstr reactiv hypoglycemia . surgic endoscopi 2011 25 1926\u20131932 . ( http : \/\/doi.org\/10.1007\/s00464-010-1489-9 ) 36 chen sc . incid hypoglycemia diabet surgeri . ifso-asia pacif chapter ( apc ) meet . kaohsiung , taiwan : ifso , 2013 . 37 itariu bk , zeyda , prager g & stulnig tm . insulin-lik growth factor 1 predict post-load hypoglycemia follow bariatr surgeri : prospect cohort studi . plo one 2014 9 e94613 . ( http : \/\/doi.org\/10.1371\/journal.pone.0094613 ) 38 pigeyr , vaur c , raverdi v , hanair h , ritz p & pattou f. increas risk ogtt-induc hypoglycemia gastric bypass sever obes patient normal glucos toler . surgeri obes relat diseas 2015 11 573\u2013577 . ( http : \/\/doi . org\/10.1016\/j.soard.2014.12.004 ) 39 brix jm , kopp hp , hollerl f , schernthan gh , ludvik b & schernthan g. frequenc hypoglycaemia differ bariatr surgic procedur . obes fact 2019 12 397\u2013406 . ( http : \/\/doi.org\/10.1159\/000493735 ) 40 guarino , moriconi , mari , rebelo e , colligiani , baldi , anselmino , ferrannini e & nannipieri m. postprandi hypoglycaemia roux-en-i gastric bypass individu type 2 diabet . diabetologia 2019 62 178\u2013186 . ( http : \/\/doi . org\/10.1007\/s00125-018-4737-5 ) 41 papamargar , zacharouli , sioka e , zachari e , bargiota , koukouli g & tzovara g. differ anthropometr metabol paramet subject hypoglycaemia subject euglycaemia oral glucos toler test six month laparoscop sleev gastrectomi . obes surgeri 2016 26 2747\u20132755 . ( http : \/\/doi.org\/10.1007\/s11695-016-2187-z ) 42 gasser , meier c , herren , aubri e , steffen r & stanga z. test postprandi hyperinsulinem hypoglycemia gastric bypass necessari ? clinic nutrit 2019 38 444\u2013449 . ( http : \/\/doi.org\/10.1016\/j.clnu.2017.11.013 ) 43 faro fn , bussular tc , bezerra amlb , asato mt , pereira mv , parent eb , sall jen , de aguiar medeiro , chang cv , scalissi nm , et al . mix meal toler test util diagnosi hyperinsulinem hypoglycemia bariatr surgeri . journal diabetolog & metabol syndrom 2018 10 ( supp 1 ) a269 . ( http : \/\/ doi.org\/10.1186\/s13098-018-0315-8 ) 44 honka h , defronzo ra , patti & salehi m. accuraci meal test diagnos hypoglycemia gastric bypass . diabet 2019 68 ( supplement_1 ) 2098-p . ( http : \/\/doi.org\/10.2337\/db19-2098-p ) 45 jacobsen sh , olesen sc , dirksen c , jorgensen nb , bojsen- moller kn , kielgast u , worm , almdal , naver ls , hvolri le , et al . chang gastrointestin hormon respons , insulin sensit , beta-cel function within 2 week gastric bypass non-diabet subject . obes surgeri 2012 22 1084\u20131096 . ( http : \/\/doi.org\/10.1007\/s11695-012-0621-4 ) 46 kefurt r , langer fb , schindler k , shakeri-leidenmuhl , ludvik b & prager g. hypoglycemia roux-en-i gastric bypass : detect rate continu glucos monitor ( cgm ) versu mix meal test . surgeri obes relat diseas 2015 11 564\u2013569 . ( http : \/\/doi.org\/10.1016\/j.soard.2014.11.003 ) 47 lee cj , clark jm , egan jm , carlson od , schweitzer , langan & brown t. comparison hormon respons mixed-m challeng hypoglycemia sleev gastrectomi vs gastric bypass . journal clinic endocrinolog metabol 2022 107 e4159\u2013e4166 . ( http : \/\/doi.org\/10.1210\/clinem\/dgac455 ) 48 patti , li p & goldfin ab . insulin respons oral stimuli glucos effect increas neuroglycopenia follow gastric bypass . obes 2015 23 798\u2013807 . ( http : \/\/doi.org\/10.1002\/ oby.21043 ) 49 preskil c , shah p & vella a. abnorm postprandi glucagon respons roux-en-i gastric bypass patient symptom postprandi hypoglycemia . 97th annual meet expo endocrin societi , endo 2015 , san diego , ca , usa . endocrin societi , 2015 . 50 raverdi v , verkindt h , caiazzo r & pattou f. decreas glucos intestin absorpt lower 2 hour postprandi glycaemia gastric bypass . abstract # 729. easd meet . lisbon , portug : easd , 2017 . ( avail : http : \/\/www.easd.org\/media-centre\/ home.html % 20 # ! resources\/decreased-glucose-intestinal- absorption-lowers-2-hour-postprandial-glycaemia-after-gastric- bypass ) 51 salehi , prigeon rl & d'alessio da . postprandi insulin secret clearanc patient hyperinsulinem hypoglycem syndrom follow gastric bypass surgeri . 70th scientif session american diabet associ , orlando , fl , usa . american diabet associ , 2010 . 52 smaji , hofer , schindler k , langer f , prager g , luger & kreb m. standard evalu suspect postprandi hypoglycemia gastric bypass . d\u00b7a\u00b7ch-tagung der dge , \u00f6ge und sged . munich , germani : deutschen gesellschaft f\u00fcr endokrinologi , \u00f6sterreichischen gesellschaft f\u00fcr endokrinologi und stoffwechsel , schweizerischen gesellschaft f\u00fcr endokrinologi und diabetologi , 2016 . 53 emou , van den broek , wijma rb , de heid ljm , van dijk g , laskewitz , tott e , wolffenbuttel bhr & van beek ap . preval hypoglycaemia random popul roux-en-i gastric bypass meal test . endocrin connect 2019 8 969\u2013978 . ( http : \/\/doi.org\/10.1530\/ec-19-0268 ) 54 tharakan g , behari p , wewer albrechtsen nj , chahal h , kenkr j , mira ad , ahm ar , holst jj , bloom sr & tan t. role increas glycaem variabl , glp-1 glucagon hypoglycaemia roux-en-i gastric bypass . european journal endocrinolog 2017 177 455\u2013464 . ( http : \/\/doi.org\/10.1530\/eje-17-0446 ) 55 johansson , haenni , karlsson fa , eden-engstrom b , ohrval , sundbom & zetheliu b. bileopancreat divers duoden switch lower earli late phase glucos , insulin proinsulin respons meal . obes surgeri 2010 20 549\u2013558 . ( http : \/\/doi.org\/10.1007\/s11695-010-0102-6 ) 56 rett k , wagenknecht , fischer e , krieger k , weitz e , chandra r & stier c. continu glucos monitor ( cgm ) disclos high glycaem variabl patient `` late dump '' rygb . easd meet . epost # 672. barcelona , spain : easd , 2013 . ( avail : http : \/\/w.easd.org\/media-centre\/hom . html # ! resources\/continuous-glucose-monitoring-cgm-discloses- high-glycaemic-variability-in-patients-with-late-dumping-after- rygb -- 2 ) 57 nielsen jb , abild cb & richelsen b. continu glucos monitor evalu glycem excurs hypoglycemia download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 j hazlehurst et al . roux-en-i gastric bypass . 22nd congress european congress obes . pragu , czechia : eco , easo , 2015 . 58 ritz p , vaur c & hanair h. continu glucos monitor screen tool hypoglycaemia bariatr surgeri . european obes summit ( eo ) : 1st joint congress easo ifso-ec . gothenburg , sweden : easo , 2016 . 59 halperin f , patti , skow , bajwa & goldfin ab . continu glucos monitor evalu glycem excurs gastric bypass . journal obes 2011 2011 869536 . ( http : \/\/doi . org\/10.1155\/2011\/869536 ) 60 lobato cb , pereira ss , guimara , morai , oliveira p , de carvalho jpm , nora & monteiro mp . use flash glucos monitor post-bariatr hypoglycaemia diagnosi manag . scientif report 2020 10 11061 . ( http : \/\/doi . org\/10.1038\/s41598-020-68029-8 ) 61 lindner n , kuwabara & holt t. non-invas minim invas glucos monitor devic : systemat review meta-analysi diagnost accuraci hypoglycaemia detect . systemat review 2021 10 145 . ( http : \/\/doi.org\/10.1186\/s13643- 021-01644-2 ) 62 balli l , khoo b , knop f , madsbad , patti & tan t. call prospect studi continu glucos monitor defin glycaem respons bariatr surgeri . lancet diabet endocrinolog 2023 11 712\u2013714 . ( http : \/\/doi.org\/10.1016\/s2213- 8587 ( 23 ) 00228-0 ) 63 shah vn , dubos sn , li z , beck rw , peter al , weinstock rs , kruger , tansey , sparl , woerner , et al . continu glucos monitor profil healthi nondiabet particip : multicent prospect studi . journal clinic endocrinolog metabol 2019 104 4356\u20134364 . ( http : \/\/doi.org\/10.1210\/jc.2018- 02763 ) 64 pleu , baumstark , jendrik n , mend j , link , zschornack e , haug c & freckmann g. system accuraci evalu 18 ce-mark current-gener blood glucos monitor system base en iso 15197:2015. bmj open diabet research care 2020 8 . ( http : \/\/doi.org\/10.1136\/bmjdrc-2019-001067 ) 65 eisenberg , azaguri de , ghiassi , grover bt & kim jj . asmb posit statement postprandi hyperinsulinem hypoglycemia bariatr surgeri . surgeri obes relat diseas 2017 13 371\u2013378 . ( http : \/\/doi.org\/10.1016\/j . soard.2016.12.005 ) 66 carswel k , belgaumkar & patel a. systemat review post- prandial hypoglycaemia gastric bypass . ifso 2009 14th world congress , pari , franc : ifso , 2009 . 67 o'kan , parretti hm , pinkney j , welbourn r , hugh ca , mok j , walker n , thoma , devin j , coulman kd , et al . british obes metabol surgeri societi guidelin periop postop biochem monitor micronutri replac patient undergo bariatr surgery-2020 updat . obes review 2020 21 e13087 . ( http : \/\/doi.org\/10.1111\/ obr .13087 ) 68 suhl e , anderson-hayn se , mulla c & patti . medic nutrit therapi post-bariatr hypoglycemia : practic insight . surgeri obes relat diseas 2017 13 888\u2013896 . ( http : \/\/doi . org\/10.1016\/j.soard.2017.01.025 ) 69 bantl jp , ikramuddin , kellogg ta & buchwald h. hyperinsulinem hypoglycemia develop late gastric bypass . obes surgeri 2007 17 592\u2013594 . ( http : \/\/doi.org\/10.1007\/ s11695-007-9102-6 ) 70 botro n , rijnaart , brandt h , bleumink g , janssen & de boer h. effect carbohydr restrict patient hyperinsulinem hypoglycemia roux-en-i gastric bypass . obes surgeri 2014 24 1850\u20131855 . ( http : \/\/doi.org\/10.1007\/ s11695-014-1319-6 ) 71 kellogg ta , bantl jp , lesli db , redmond jb , slusarek b , swan , buchwald h & ikramuddin s. postgastr bypass hyperinsulinem hypoglycemia syndrom : character respons modifi diet . surgeri obes relat diseas 2008 4 492\u2013499 . ( http : \/\/doi.org\/10.1016\/j.soard.2008.05.005 ) 72 van meijeren jl , timmer , brandt h , janssen & de boer h. evalu carbohydr restrict primari treatment post-gastr bypass hypoglycemia nutrit bariatr surgeri . 22nd world congress intern feder surgeri obes metabol disord , ifso 2017 . london , uk : ifso , 2017 . 73 bantl ae , wang q & bantl jp . post-gastr bypass hyperinsulinem hypoglycemia : fructos carbohydr safe consum . journal clinic endocrinolog metabol 2015 100 3097\u20133102 . ( http : \/\/doi.org\/10.1210\/jc.2015- 1283 ) 74 mirtschink p , jang c , arani z & krek w. fructos metabol , cardiometabol risk , epidem coronari arteri diseas . european heart journal 2018 39 2497\u20132505 . ( http : \/\/doi . org\/10.1093\/eurheartj\/ehx518 ) 75 lembo e , lupoli r , ciciola p , creanza , silvestri e , saldalamacchia g & capaldo b. implement low glycem index diet togeth cornstarch post-gastr bypass hypoglycemia : two case report . nutrient 2018 10 670 . ( http : \/\/doi . org\/10.3390\/nu10060670 ) 76 jenkin dj , gassul , leed ar , metz g , dilawari jb , slavin b & blendi lm . effect dietari fiber complic gastric surgeri : prevent postprandi hypoglycemia pectin . gastroenterolog 1977 73 215\u2013217 . ( http : \/\/doi.org\/10.1016\/s0016- 5085 ( 19 ) 32189-4 ) 77 jenkin dj , bloom sr , albuquerqu rh , leed ar , sarson dl , metz gl & alberti kg . pectin complic gastric surgeri : normalis postprandi glucos endocrin respons . gut 1980 21 574\u2013579 . ( http : \/\/doi.org\/10.1136\/ gut.21.7.574 ) 78 leed ar , ralph dn , ebi f , metz g & dilawari jb . pectin dump syndrom : reduct symptom plasma volum chang . lancet 1981 1 1075\u20131078 . ( http : \/\/doi.org\/10.1016\/s0140- 6736 ( 81 ) 92242-x ) 79 lawaetz , blackburn , bloom sr , arita & ralph dn . effect pectin gastric empti gut hormon releas dump syndrom . scandinavian journal gastroenterolog 1983 18 327\u2013336 . ( http : \/\/doi.org\/10.3109\/00365528309181602 ) 80 speth pa , jansen jb & lamer cb . effect acarbos , pectin , combin acarbos pectin , placebo postprandi reactiv hypoglycaemia gastric surgeri . gut 1983 24 798\u2013802 . ( http : \/\/doi.org\/10.1136\/gut.24.9.798 ) 81 harju e & larmi tk . efficaci guar gum prevent dump syndrom . journal parenter enter nutrit 1983 7 470\u2013472 . ( http : \/\/doi.org\/10.1177\/0148607183007005470 ) 82 harju e , heikkila j & larmi tk . effect guar gum gastric empti gastric resect . journal parenter enter nutrit 1984 8 18\u201320 . ( http : \/\/doi . org\/10.1177\/014860718400800118 ) 83 harju e & makela j. reduct symptom proxim select vagotomi increas dietari viscos . american journal gastroenterolog 1984 79 861\u2013863 . 84 kneepken cm , fernand j & vonk rj . dump syndrom children . diagnosi effect glucomannan glucos download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 toler absorpt . acta paediatrica scandinavica 1988 77 279\u2013286 . ( http : \/\/doi.org\/10.1111\/j.1651-2227.1988.tb10643.x ) 85 andersen jr , holtug k & uhrenholt a. trial pectin-enrich muffin patient sever dump syndrom gastric resect . observ symptom gastric empti pattern . acta chirurgica scandinavica 1989 155 39\u201341 . 86 nielsen jb , abild cb , pedersen , pedersen sb & richelsen b. continu glucos monitor gastric bypass evalu glucos variabl low-carbohydr diet determin hypoglycemia . obes surgeri 2016 26 2111\u20132118 . ( http : \/\/doi.org\/10.1007\/s11695-016-2058-7 ) 87 rett kg , weiner r , schreiwei h , skudelni , fischer e , krieger k & weitz e. resolut inadequ eat behavior acceler glucos appear sensor-aug nutrit train ( sant ) patient noninsulinoma pancreatogen hypoglycaemia syndrom ( niph ) rygb . 10th intern diabet federation-western pacif region congress 6th aasd scientif meet . singapor : idf , 2014 . 88 cum c , jiang , sheehan , ferraz-bannitz r , puleio , simonson dc , dreyfuss jm & patti . continu glucos monitor patient post-bariatr hypoglycaemia reduc hypoglycaemia glycaem variabl . diabet , obes metabol 2023 25 2191\u20132202 . ( http : \/\/doi.org\/10.1111\/ dom.15096 ) 89 richard jl , rodier , monnier l , orsetti & mirouz j. effect acarbos glucos insulin respons sucros load reactiv hypoglycemia . diabet metabolism 1988 14 114\u2013118 . 90 lannoo , pattyn n , mathieu c , schuit f , merten & van der schueren b. effect exercis patient suffer symptom suggest hypoglycemia bariatr surgeri . surgeri obes relat diseas 2017 13 s182 . ( http : \/\/doi . org\/10.1016\/j.soard.2017.09.403 ) 91 acevedo mb , ferrando r , patterson bw , eagon jc , klein & pepino . effect alcohol ingest plasma glucos kinet roux-en-i gastric bypass surgeri . surgeri obes relat diseas 2019 15 36\u201342 . ( http : \/\/doi.org\/10.1016\/j . soard.2018.10.021 ) 92 azam h , shahrestani & phan k. alcohol use disord bariatr surgeri : systemat review meta-analysi . annal translat medicin 2018 6 148 . ( http : \/\/doi . org\/10.21037\/atm.2018.03.16 ) 93 mechanick ji , apovian c , brethauer , timothi garvey w , joff , kim j , kushner rf , lindquist r , pessah-pollack r , seger j , et al . clinic practic guidelin periop nutrit , metabol , nonsurg support patient undergo bariatr procedur - 2019 updat , cosponsor american associ clinic endocrinologists\/american colleg endocrinolog , obes societi , american societi metabol bariatr surgeri , obes medicin associ , american societi anesthesiologist . obes 2020 28 o1\u2013o58 . ( http : \/\/doi . org\/10.1002\/oby.22719 ) 94 kandel , bojsen-mol kn , svane ms , samkani , astrup , holst jj , madsbad & krarup t. mechan action carbohydrate-reduc , high-protein diet reduc risk postprandi hypoglycemia roux-en-i gastric bypass surgeri . american journal clinic nutrit 2019 110 296\u2013304 . ( http : \/\/doi . org\/10.1093\/ajcn\/nqy310 ) 95 marqu ar , lobato cb , pereira ss , guimara , faria , nora & monteiro mp . insight impact meal composit glucos profil toward post-bariatr hypoglycemia manag . obes surgeri 2020 30 249\u2013255 . ( http : \/\/doi.org\/10.1007\/s11695- 019-04147-1 ) 96 nguyen nq , debreceni tl , burgstad cm , wishart jm , bellon , rayner ck , wittert ga & horowitz m. effect postur meal volum gastric empti , intestin transit , oral glucos toler , blood pressur gastrointestin symptom roux-en-i gastric bypass . obes surgeri 2015 25 1392\u20131400 . ( http : \/\/doi.org\/10.1007\/s11695-014-1531-4 ) 97 stano , alam f , wu l , dutia r , ng sn , sala , mcginti j & laferrer b. effect meal size textur gastric pouch empti glucagon-lik peptid 1 gastric bypass surgeri . surgeri obes relat diseas 2017 13 1975\u20131983 . ( http : \/\/doi.org\/10.1016\/j.soard.2017.09.004 ) 98 zanley e , shah nd , craig c , lau jn , riva h & mclaughlin t. guidelin gastrostomi tube placement enter nutrit patient sever , refractori hypoglycemia gastric bypass . surgeri obes relat diseas 2021 17 456\u2013465 . ( http : \/\/doi.org\/10.1016\/j.soard.2020.09.026 ) 99 ohrstrom cc , worm , hojag , andersen , holst jj , kielgast ul & hansen dl . postprandi hypoglycaemia roux- en-i gastric bypass effect acarbos , sitagliptin , verapamil , liraglutid pasireotid . diabet , obes metabol 2019 21 2142\u20132151 . ( http : \/\/doi.org\/10.1111\/ dom.13796 ) 100 de heid ljm , wouda sht , peter vjt , oosterwerff-suik , gerd va , emou & van beek ap . medic surgic treatment postbariatr hypoglycaemia : retrospect data daili practic . diabet , obes metabol 2023 25 735\u2013747 . ( http : \/\/doi.org\/10.1111\/dom.14920 ) 101 frankhous sy , ahmad , perilli ga , quintana bj & vengrov . post-gastric-bypass hypoglycemia success treat alpha-glucosidas inhibitor therapi . endocrin practic 2013 19 511\u2013514 . ( http : \/\/doi.org\/10.4158\/ep12281.ra ) 102 cadegiani fa & silva os . acarbos promot remiss earli late dump syndrom post-bariatr patient . diabet , metabol syndrom obes 2016 9 443\u2013446 . ( http : \/\/ doi.org\/10.2147\/dmso.s123244 ) 103 valdera jp , ahuad j , rubio l , escalona , pollak f & maiz a. acarbos improv hypoglycaemia follow gastric bypass surgeri without increas glucagon-lik peptid 1 level . obes surgeri 2012 22 582\u2013586 . ( http : \/\/doi.org\/10.1007\/s11695-011- 0581-0 ) 104 almbi ke , abrahamsson n , lundqvist mh , hammar u , thombar k , panagiot , karlsson fa , sundbom , wiklund u & eriksson jw . effect glp-1 counter-regulatori respons hypoglycemia gbp surgeri . european journal endocrinolog 2019 181 161\u2013171 . ( http : \/\/doi.org\/10.1530\/eje-19- 0171 ) 105 abrahamsson n , engstrom , sundbom & karlsson fa . glp1 analog treatment postprandi hypoglycemia follow gastric bypass surgeri : potenti new indic ? european journal endocrinolog 2013 169 885\u2013889 . ( http : \/\/doi . org\/10.1530\/eje-13-0504 ) 106 stier c , malo n , el-say & weiner r. new therapeut option patient post-surg late dump syndrom - glp-1 previous unreport effect . 20th intern feder surgeri obes metabol disord world congress . vienna , austria : ifso , 2015 . 107 craig cm , liu lf , deacon cf , holst jj & mclaughlin tl . critic role glp-1 symptomat post-bariatr hypoglycaemia . diabetologia 2017 60 531\u2013540 . ( http : \/\/doi.org\/10.1007\/s00125-016- 4179-x ) 108 craig cm , liu lf , nguyen , price c , bingham j & mclaughlin tl . efficaci pharmacokinet subcutan exendin ( 9\u201339 ) download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 j hazlehurst et al . patient post-bariatr hypoglycaemia . diabet , obes metabol 2018 20 352\u2013361 . ( http : \/\/doi.org\/10.1111\/dom.13078 ) 109 tan , lamendola c , luong r , mclaughlin & craig c. safeti , efficaci pharmacokinet repeat subcutan dose avexitid ( exendin 9\u201339 ) treatment post-bariatr hypoglycaemia . diabet , obes metabol 2020 22 1406\u20131416 . ( http : \/\/doi.org\/10.1111\/dom.14048 ) 110 craig cm , lawler hm , lee cje , tan , davi db , tong j , glodowski , rogowitz e , karaman r , mclaughlin tl , et al . prevent : random , placebo-control crossov trial avexitid treatment postbariatr hypoglycemia . journal clinic endocrinolog metabol 2021 106 e3235\u2013e3248 . ( http : \/\/doi.org\/10.1210\/clinem\/dgab103 ) 111 abrahamsson n , borjesson jl , sundbom , wiklund u , karlsson fa & eriksson jw . gastric bypass reduc symptom hormon respons hypoglycemia . diabet 2016 65 2667\u20132675 . ( http : \/\/ doi.org\/10.2337\/db16-0341 ) 112 mulla cm , zavitsan , laguna sanz aj , pober , richardson l , walcott p , arora , newswang b , cummin mj , prestrelski sj , et al . random , placebo-control double-blind trial closed- loop glucagon system postbariatr hypoglycemia . journal clinic endocrinolog metabol 2020 105 e1260\u2013e1271 . ( http : \/\/doi.org\/10.1210\/clinem\/dgz197 ) 113 halperin f , patti & goldfin ab . glucagon treatment post- gastric bypass hypoglycemia . obes 2010 18 1858\u20131860 . ( http : \/\/ doi.org\/10.1038\/oby.2010.15 ) 114 nielsen ck , ohrstrom cc , kielgast ul , hansen dl , hartmann b , holst jj , lund , vilsbol & knop fk . dasiglucagon effect mitig postbariatr postprandi hypoglycemia : random , double-blind , placebo-control , crossov trial . diabet care 2022 45 1476\u20131481 . ( http : \/\/doi.org\/10.2337\/dc21-2252 ) 115 hopman wp , wolberink rg , lamer cb & van tongeren jh . treatment dump syndrom somatostatin analogu sm 201\u2013995 . annal surgeri 1988 207 155\u2013159 . ( http : \/\/doi.org\/10.1097\/00000658-198802000-00007 ) 116 art j , caenepeel p , bisschop r , dewulf , holvoet l , piessevaux h , bourgeoi , sifrim , janssen j & tack j. efficaci long-act repeat formul somatostatin analogu octreotid postop dump . clinic gastroenterolog hepatolog 2009 7 432\u2013437 . ( http : \/\/doi . org\/10.1016\/j.cgh.2008.11.025 ) 117 tack j , aberl j , art j , lavil , oppert jm , bender g , bhoyrul , mclaughlin , yoshikawa , vella , et al . safeti efficaci pasireotid dump syndrome-result phase 2 , multicentr studi . alimentari pharmacolog therapeut 2018 47 1661\u20131672 . ( http : \/\/doi.org\/10.1111\/apt.14664 ) 118 wauter l , art j , caenepeel p , holvoet l , tack j , bisschop r & vanuytsel t. efficaci safeti lanreotid postop dump syndrom : phase ii randomis placebo-control studi . unit european gastroenterolog journal 2019 7 1064\u20131072 . ( http : \/\/doi.org\/10.1177\/2050640619862166 ) 119 schmid ha & brueggen j. effect somatostatin analog glucos homeostasi rat . journal endocrinolog 2012 212 49\u201360 . ( http : \/\/doi.org\/10.1530\/joe-11-0224 ) 120 de heid lj , laskewitz aj & aper ja . treatment sever postrygb hyperinsulinem hypoglycemia pasireotid : comparison octreotid insulin , glucagon , glp-1 . surgeri obes relat diseas 2014 10 e31\u2013e33 . ( http : \/\/ doi.org\/10.1016\/j.soard.2013.11.006 ) 121 whyte mb , grove g , le roux cw , patel ag & aylwin sjb . octreotid administr prevent hyperinsulinaem hypoglycaemia may complic roux-en-i gastric bypass . 11th intern congress obes , ico 2010 . stockholm , sweden : world obes feder , 2010 . 122 nguyen nq , debreceni tl , bambrick je , chia b , dean , wittert g , rayner ck , horowitz & young rl . upregul intestin glucos transport roux-en-i gastric bypass prevent carbohydr malabsorpt . obes 2014 22 2164\u20132171 . ( http : \/\/doi.org\/10.1002\/oby.20829 ) 123 ohgaki r , wei l , yamada k , hara , kuriyama c , okuda , ueta k , shiotani , nagamori & kanai y. interact sodium\/ glucos cotransport ( sglt ) 2 inhibitor canagliflozin sglt1 sglt2 . journal pharmacolog experiment therapeut 2016 358 94\u2013102 . ( http : \/\/doi.org\/10.1124\/jpet.116.232025 ) 124 martinussen c , veedfald , dirksen c , bojsen-mol kn , svane ms , wewer albrechtsen nj , van hall g , kristiansen vb , fenger , holst jj , et al . effect acut dual sglt1\/sglt2 inhibit incretin releas glucos metabol gastric bypass surgeri . american journal physiolog . endocrinolog metabol 2020 318 e956\u2013e964 . ( http : \/\/doi.org\/10.1152\/ ajpendo.00023.2020 ) 125 ciudin , sanchez , hernandez , cordero e , fidilio e , coma , gonzalez c , lopez n , vilallonga r , giralt , et al . canagliflozin : new therapeut option patient present postprandi hyperinsulinem hypoglycemia roux-en-i gastric bypass : pilot studi . obes fact 2021 14 291\u2013297 . ( http : \/\/doi . org\/10.1159\/000515598 ) 126 abouglila k & devin k. success use canagliflozin treatment post-bariatr surgeri hypoglycaemia unrespons therapi . endocrin abstract 2017 50 ep090 . ( http : \/\/doi . org\/10.1530\/endoabs.50.ep090 ) 127 cochran central regist control trial . effect canagliflozin 300mg glucos level peopl without diabet weight loss surgeri . ( avail : http : \/\/www . cochranelibrary.com\/central\/doi\/10.1002\/central\/cn-02169492\/ful ) 128 ferreira , schonenberg ka , potoczna n , vogt , gerber pa , zehetn j , giachino , nett p , gawinecka j , cossu l , et al . random , double-blind , placebo-control crossov trial daili empagliflozin 25 mg treatment postprandi hypoglycemia roux-en-i gastric bypass . diabet technolog therapeut 2023 25 467\u2013475 . ( http : \/\/doi.org\/10.1089\/dia.2023.0036 ) 129 spanaki e & gragnoli c. success medic manag statu post-roux-en-y-gastric-bypass hyperinsulinem hypoglycemia . obes surgeri 2009 19 1333\u20131334 . ( http : \/\/doi . org\/10.1007\/s11695-009-9888-5 ) 130 gonzalez-gonzalez , delgado & fraga-fuent md . use diazoxid manag sever postprandi hypoglycemia patient roux-en-i gastric bypass . surgeri obes relat diseas 2013 9 e18\u2013e19 . ( http : \/\/doi.org\/10.1016\/j . soard.2011.05.010 ) 131 vilarrasa n , goday , rubio , caixa , pellitero , ciudin , calana , botella ji , breton , moral mj , et al . hyperinsulinem hypoglycemia bariatr surgeri : diagnosi manag experi spanish multicent registri . obes fact 2016 9 41\u201351 . ( http : \/\/doi.org\/10.1159\/000442764 ) 132 johnson kw , gordon , neal ac , vella , lee cje , goldfin ab , lawler hm , millstein r , costante-hamm , bezwada p , et al . singl administr xoma 358 , insulin receptor attenu , improv post-meal nighttim hypoglycemia profil post gastric bypass hypoglycemia ( pgbh ) patient . 99th annual meet endocrin societi , endo 2017 . orlando , fl , usa : endocrin societi , 2017 . 133 campo gm , ziem , paparodi r , ahm & davi db . laparoscop revers roux-en-i gastric bypass : techniqu download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/ endocrin connect ( 2024 ) 13 e230285 http : \/\/doi.org\/10.1530\/ec-23-0285 util treatment endocrin complic . surgeri obes relat diseas 2014 10 36\u201343 . ( http : \/\/doi.org\/10.1016\/j . soard.2013.05.012 ) 134 vilallonga r , rodriguez-luna mr , roriz-silva r , caubet e , gonzalez , ruiz de gordejuela , ciudin , armengol & fort jm . revers normal anatomi ( sleev gastrectomi ) sever hypoglycemia . surgic innov 2021 28 536\u2013543 . ( http : \/\/doi . org\/10.1177\/1553350620984647 ) 135 moon rc , frommelt , teixeira af & jawad . indic outcom revers roux-en-i gastric bypass . surgeri obes relat diseas 2015 11 821\u2013826 . ( http : \/\/doi . org\/10.1016\/j.soard.2014.11.026 ) 136 kantharia n , lakdawala & govil a. laparoscop revers roux-en-i gastric bypass intract hypoglycaemia post- oper complic . ifso 2017 22nd world congress . london , uk : ifso , 2017 . 137 wood c , breen c , connel jo , aziz , connel ro , khattak , geoghegan j & shea . hyperinsulinaem hypoglycaemia common follow roux en gastric bypass surgeri resolut sever recurr hypoglycaemia achiev surgic revers convers sleev gastrectomi . aso confer diabet obes 2011 . london , uk : aso , 2012 . 138 davi db , khoraki j , ziem , sirinvaravong , han jy & campo gm . roux en gastric bypass hypoglycemia resolv gastric feed revers : confirm non-pancreat etiolog . molecular metabol 2018 9 15\u201327 . ( http : \/\/doi.org\/10.1016\/j . molmet.2017.12.011 ) 139 mehta k , sarr mg , kellogg ta , kendrick ml & mckenzi tj . efficaci convers roux-en-i gastric bypass roux jejuno- duodenostomi sever medic refractori postprandi hypoglycemia . obes surgeri 2020 30 4141\u20134144 . ( http : \/\/doi . org\/10.1007\/s11695-020-04694-i ) 140 carter co , fernandez az , mcnatt ss & powel ms. convers gastric bypass sleev gastrectomi complic gastric bypass . surgeri obes relat diseas 2016 12 572\u2013576 . ( http : \/\/doi.org\/10.1016\/j.soard.2015.07.001 ) 141 tayar c , nasser ha , lawand & ghazal a. laparoscop gastric bypass revers concomit sleev gastrectomi ( sg ) refractori hypoglycemia : unusu procedur . obes surgeri 2021 31 467\u2013468 . ( http : \/\/doi.org\/10.1007\/s11695-020-05090-2 ) 142 z'graggen k , guweidhi , steffen r , potoczna n , biral r , walther f , komminoth p & horber f. sever recurr hypoglycemia gastric bypass surgeri . obes surgeri 2008 18 981\u2013988 . ( http : \/\/ doi.org\/10.1007\/s11695-008-9480-4 ) 143 tsai c , steffen r , kessler u , merki h & zehetn j. endoscop gastrojejun revis follow gastric bypass : lesson learn 100 consecut patient . journal gastrointestin surgeri 2019 23 58\u201366 . ( http : \/\/doi.org\/10.1007\/s11605-018-3961-0 ) 144 conati ea , novak , avitia r , su b , linn jg & ujiki mb . endoscop gastrojejun revis ( transor outlet reduct ) persist hypoglycemia gastric bypass . obes surgeri 2019 29 3773\u20133775 . ( http : \/\/doi.org\/10.1007\/s11695-019-04113-x ) 145 dunn sh , tejani , almandoz j , messiah se , schelling jn , marroquin em , mathew ms , horton jd & tavakkoli a. transor gastric outlet reduct post-prandi hypoglycemia roux- en-i gastric bypass . gastrointestin endoscopi 2022 95 ab22\u2013ab23 . 146 kerdsirichairat , arain , freeman ml , lesli db , ikramuddin & amateau sk . endoscop revers roux-en-i gastric bypass use lumen appos metal stent : seri single-cent experi . digest diseas week 2016 asg . san diego , ca , usa : american societi gastrointestin endoscopi , 2016 . 147 servic gj , thompson gb , servic fj , andrew jc , collazo- clavel ml & lloyd rv . hyperinsulinem hypoglycemia nesidioblastosi gastric-bypass surgeri . new england journal medicin 2005 353 249\u2013254 . ( http : \/\/doi.org\/10.1056\/ nejmoa043690 ) 148 lehmann v , tripyla , herzig , meier j , banholz n , maritsch , zehetn j , giachino , nett p , feuerriegel , et al . impact postbariatr hypoglycaemia drive perform : random , single-blind , two-period , crossov studi drive simul . diabet , obes metabol 2021 23 2189\u20132193 . ( http : \/\/doi.org\/10.1111\/dom.14456 ) download bioscientifica.com 04\/09\/2024 11:13:41am via open access . work licens creativ common attribut 4.0 intern licens . http : \/\/creativecommons.org\/licenses\/by\/4.0\/",
  "researchresearch introduct increas focu role gp primari care commun healthcar profession ( hcp ) health promotion,1,2 includ address childhood obes . howev , evid gp concern initi convers parent child \u2019 weight.3 two systemat review qualit studi conduct hcp high-incom countries4,5 report barrier hcp convers , includ lack knowledg compet , time clear referr pathway , concern hcp\u2013patient relationship , social cultur factor , limit abil address child weight without support agenc . less research directli inform strategi lack guidanc support requir facilit hcp convers child weight parent . 2018 meta-synthesi 13 studi , factor hcp found help discuss child weight identifi . factor mainli relat approach interact famili tool assess child weight.4 england , programm routin assess child weight : nation child measur programm ( ncmp ) ,6 90 % coverag provid bodi mass index ( bmi ) data children age 4\u20135 year 10\u201311 years.7 current , data routin access primari care,3 aspir provid access futur ( commun public health england ; offic health improv dispar , novemb 2019 ) part nh digit child health programme,8 could assist support hcp convers child weight . studi explor gp \u2019 , primari care nurs \u2019 ( pn \u2019 ) , school nurs \u2019 ( sn \u2019 ) experi consult parent address overweight and\/or obes children primari school age ( 4\u201311 year ) . studi aim gain deeper understand barrier support healthcar profession address child weight parent : qualit studi miranda pallan , franc mason , helen parretti , peyman\u00e9 adab , salli abbott kate jolli abstract background primari care commun healthcar profession ( hcp ) well place discuss child excess weight parent support make chang . howev , hcp concern address issu . need understand factor influenc hcp initi convers inform strategi support . aim explor hcp , work primari care commun set , experi convers child weight parent , factor creat barrier facilit convers . design set qualit studi gp , primari care nurs ( pn ) , school nurs ( sn ) england.method gp pn recruit particip semi-structur interview . sn commun healthcar nh trust recruit particip focu group . vignett use stimul discuss . data analys guid framework approach . result thirteen gp , seven pn , 20 sn particip . follow three theme identifi regard barrier hcp convers child excess weight : structur organis ; hcp relat ; parent famili relat . theme identifi factor facilit convers : structur chang ( exampl , dedic appoint , access weight assess data , joined-up work across agenc ) ; hcp approach ( exampl , provid appropri dietari physic activ advic ) ; hcp knowledg skill ( exampl , enhanc hcp \u2019 gener weight management-rel skill knowledg child weight manag servic ) . conclus rang barrier exist hcp address child excess weight parent primari care commun set . action effect structur chang support hcp develop relev knowledg skill requir overcom barrier . keyword child ; gener practic ; paediatr obes ; primari health care ; qualit research ; school nurs . e417 | research british journal gener practic , june 2024 researchbritish journal gener practic , januari 2024 research | 473 research british journal gener practic , june 2024 research | e418 facilit convers inform potenti futur strategi provid support hcp . role routin collect data support hcp activ also explor . method studi design qualit studi conduct hcp novemb 2019 march 2020. gp pn invit particip interview , sn invit particip focu group . particip recruit particip work popul high ethnic divers socioeconom depriv purpos sampled.9 advertis gp pn took place primari care network social media . monetari compens provid time . sn invit particip school health advisori servic birmingham ( larg , superdivers citi england high depriv ) .10 sn receiv continu profession develop certif particip . particip provid written consent complet questionnair provid demograph profession detail . gp pn , practic postcod map index multipl depriv ( imd ) deciles.11 data collect one author conduct interview gp pn , either face face telephon , enabl in-depth explor particip \u2019 experiences.12 two author conduct focu group sn team work base , enabl group interact share experi among team members.13 author posit within health care public health . interview focu group discuss guid develop draw publish literatur , clinic experi research team , advic studi steer group ( compris gp , pn , sn , paediatrician , public health repres ) , addit address issu specifi public health organis fund studi ( public health england ; offic health improv dispar ) . follow two approach incorpor : 1 ) narr hcp experi ; supplement 2 ) clinic vignettes,14 develop consult hcp advisori group ( box 1 supplementari inform s1\u2013s4 ) encourag deeper reflect particip would approach sensit issu . particip group , three vignett develop . vignett discuss way particip . inform vignett develop use provid supplementari inform s4 . interview focu group audio-record transcrib . throughout data collect , transcript review ( two author ) suffici inform power15 judg reach 20 interview three focu group . one author kept research journal data collect inform analysi . data analysi analysi conduct use nvivo ( version 12 ) softwar guid framework method.16 initi high- level framework defin . transcript code use induct themat analysis17 situat within high- level framework . two transcript code independ two author discuss develop initi code . transcript code one author . data chart develop framework matrix , enabl identif theme subthem . review research team . result thirteen gp seven pn seven differ local author area west east midland region england particip interview ( averag durat 50 min ) . twenti sn particip three focu group ( averag durat 62 min ) . particip characterist present tabl 1. follow three theme identifi relat barrier hcp convers parent child weight : structur organis ; hcp relat ; parent famili relat . three theme identifi relat facilit convers , : structur chang ; hcp approach ; hcp knowledg skill . theme relat subthem present figur 1 addit quot correspond subthem present supplementari inform s5 . barrier hcp convers parent child weight structur organis . limit time capac commonli cite barrier , hcp identifi deal primari present issu left littl time opportunist intervent . although particip hcp felt well place address child fit healthcar profession ( hcp ) work primari care commun set known experi barrier discuss child excess weight parent . qualit studi conduct gp , primari care nurs , school nurs explor barrier identifi facilit factor inform recommend action support hcp address child weight parent . structur chang within primari commun care , joined-up system data share across agenc , develop hcp knowledg skill , core train continu profession develop , enabl hcp discuss child weight provid advic parents.m pallan ( orcid : 0000-0002-2868-4892 ) , mbchb , mph , phd , ffph , professor child adolesc public health ; f mason ( orcid : 0000-0002-2796-3945 ) , bsc , phd , research fellow ; p adab ( orcid : 0000-0001-9087- 3945 ) , mbchb , md , mph , ffph , fhkccm , professor chronic diseas epidemiolog public health ; k jolli ( orcid : 0000-0002- 6224-2115 ) , mbchb , msc , phd , ffph , professor public health primari care , institut appli health research , colleg medic dental scienc , univers birmingham , birmingham . hm parretti ( orcid : 0000- 0002-7184-269x ) , , msc , phd , mrcgp , consult clinic associ professor , norwich medic school , faculti medicin health , univers east anglia , norwich . abbott ( orcid : 0000-0002-1895-1942 ) , bsc , mre , pgcert , pgdip , assist professor , research centr healthcar commun , institut health wellb , coventri univers , coventri ; depart dietet , univers hospit coventri warwickshir nh trust , coventri . correspond miranda pallan institut appli health research , murray learn centr , univers birmingham , edgbaston , birmingham b15 2tt , uk . email : m.j.pallan @ bham.ac.uk submit : 10 may 2023 ; editor \u2019 respons : 20 juli 2023 ; final accept : 6 octob 2023 . \u00a9the author full-length articl ( publish onlin 3 apr 2024 ) abridg version publish print . cite version : br j gen pract 2024 ; doi : http : \/\/doi.org\/10.3399\/bjgp.2023.0238researchresearch e419 | research british journal gener practic , june 2024 overweight parent , felt proactiv child weight manag intervent beyond remit role . sn express health promot , address child overweight , longer role descript expect focu prioriti . gp felt address child weight margin part role : \u2018 time , usual come someth els . , got worri weight , often , basic \u2019 time. \u2019 ( gp , 06 ) \u2018 \u2019 commiss . us feel \u2019 work lies. \u2019 ( sn , focu group [ fg ] 01 ) although hcp recognis role provid child weight manag advic , felt limit could offer , lack referr opportun deter initi convers parent : \u2018 unfortun , \u2019 got access specif dietician children obes . refer , tend rejected. \u2019 ( pn , 06 ) ask access exist inform child weight statu , gp pn discuss access data sourc ( exampl , ncmp ) , box 1. summari interview focu group discuss guid vignett object interview guid gp primari care nurs focu group discuss guid school nurs explor experi address overweight obes children parent talk experi convers parent carer child \u2019 excess weight gener ? tell consult parent brought issu child \u2019 excess weight ? tell consult initi convers parent address child \u2019 excess weight ? feel convers parent ? share group experi convers parent carer child \u2019 excess weight gener ? tell discuss parent carer main reason meet child \u2019 excess weight ? tell time initi convers parent carer address child \u2019 excess weight ? feel convers parent ? explor hcp use would use weight statu data nation child measur programm ( ncmp ) data within consult address child \u2019 weight recognis child excess weight ? inform child \u2019 weight statu avail ? recognis child excess weight ? use nation child measur programm ( ncmp ) data ? explor hcp \u2019 engag , perceiv access , valu , relev train opportunitieshav train support convers ? ( ) train awar would help support convers parent children healthier weight ? train support convers ? ( ) train awar would help support convers parent children healthier weight ? explor hcp best support consult healthier weight scenariosdo idea might help convers parent ? identifi inform would like support healthier weight convers parent ? skill think need order convers parent support chang child \u2019 famili eat physic activ behaviour ? [ discuss vignett ] idea might help convers parent ? identifi inform would like support healthier weight convers parent ? skill think need order convers parent support chang child \u2019 s\/famili eat physic activ behaviour ? [ discuss vignett ] identifi barrier facilit consult potenti recommend action [ data aris question state relat prompt ] [ discuss vignett ] [ data aris question state relat prompt ] [ discuss vignett ] vignett 1 child parent consult non-acut health problem child ; healthcar profession notic child overweightpar make contact respons ncmp feedback letter say child excess weight . parent happi agre child overweight 2 parent consult health issu healthcar profession notic accompani child overweightchild parent attend manag long-term condit ( exampl , asthma ) ; healthcar profession notic child excess weight 3 parent child consult health problem child . healthcar profession notic child overweight ; social and\/or cultur context need consideredchild parent carer attend safeguard health assess . child assess excess weight hcp = healthcar professional.researchbritish journal gener practic , june 2024 research | e420 research readi access tool assist overweight and\/or obes assess , could easili address issu famili . mani particip discuss need integr data differ sourc weight could longitudin track primari care , acknowledg current capabl data integr : \u2018 think [ ncmp data ] would help \u2026 \u2019 [ ] sole reli upon visual recognit whether child littl overweight , actual \u2019 got someth , would actual help convers parents. \u2019 ( gp , 01 ) gp pn discuss time cost barrier attend train need help convers parent ( see hcp- relat barrier ) : \u2018 \u2026 train core work hour . \u2019 away put somebodi [ place ] . \u2019 go cost arm leg that. \u2019 ( gp , 04 ) hcp relat . gp pn fear rais issu child weight would damag relationship parent , especi parent attend consult differ agenda . felt parent unprepar convers child weight could defens . hcp feel confid rais issu , sometim relat hcp live overweight . anoth factor relat hcp confid perceiv low awar differ cultur , term understand childhood overweight may view provid cultur appropri advic : \u2018 [ parent ] quit standoffish alreadi \u2026 \u2019 quit hard start bring child \u2019 weight. \u2019 ( gp , 05 ) \u2018 \u2026 sometim feel famili might bit \u2026 \u2019 come differ thing agenda today . radar. \u2019 ( gp , 09 ) \u2018 \u2019 [ cultur belief relat child weight ] one thing \u2019 struggl \u2019 brutal honest \u2026 \u2019 cultur belief \u2019 got handl yet. \u2019 ( gp , 03 ) use bmi centil hcp assess overweight identifi issu . sn good understand bmi centil chart , express mistrust , prefer use height weight centil chart assess overweight . gp pn less familiar bmi centil , also perceiv bmi good measur younger children : \u2018 \u2026 use use [ height weight ] centil chart actual bmi put tabl 1. particip characterist ( n = 40 ) gp ( n = 13 ) primari care nurs ( n = 7 ) school nurs ( n = 20 ) sex , n ( % ) femal 36 ( 90.0 ) 9 ( 69.2 ) 7 ( 100 ) 20 ( 100 ) age , year , n ( % ) 20\u201339 15 ( 37.5 ) 6 ( 46.2 ) 1 ( 14.3 ) 8 ( 40.0 ) 40\u201359 23 ( 57.5 ) 7 ( 53.8 ) 5 ( 71.4 ) 11 ( 55.0 ) \u226560 1 ( 2.5 ) 0 ( 0.0 ) 0 ( 0.0 ) 1 ( 5.0 ) miss data 1 ( 2.5 ) 0 ( 0.0 ) 1 ( 14.3 ) 0 ( 0.0 ) ethnic group , n ( % ) white\/british 24 ( 60.0 ) 6 ( 46.2 ) 7 ( 100.0 ) 11 ( 55.0 ) pakistani 3 ( 7.5 ) 2 ( 15.4 ) 0 ( 0.0 ) 1 ( 5.0 ) indian 8 ( 20.0 ) 5 ( 38.5 ) 0 ( 0.0 ) 3 ( 15.0 ) black caribbean 3 ( 7.5 ) 0 ( 0.0 ) 0 ( 0.0 ) 3 ( 15.0 ) white\/black caribbean 1 ( 2.5 ) 0 ( 0.0 ) 0 ( 0.0 ) 1 ( 5.0 ) miss data 1 ( 2.5 ) 0 ( 0.0 ) 0 ( 0.0 ) 1 ( 5.0 ) number year post , n ( % ) < 3 13 ( 32.5 ) 3 ( 23.1 ) 4 ( 57.1 ) 6 ( 30.0 ) 4\u201310 17 ( 42.5 ) 4 ( 30.7 ) 2 ( 28.6 ) 11 ( 55.0 ) \u226511 9 ( 22.5 ) 6 ( 46.2 ) 0 ( 0.0 ) 3 ( 15.0 ) miss data 1 ( 2.5 ) 0 ( 0.0 ) 1 ( 14.3 ) 0 ( 0.0 ) depriv decil ( imd 2019 ) practic district , n ( % ) 1 ( depriv ) 18 ( 45.0 ) 6 ( 46.2 ) 2 ( 28.6 ) 10 ( 50.0 ) 2 7 ( 17.5 ) 1 ( 7.7 ) 0 ( 0.0 ) 6 ( 30.0 ) 3 5 ( 12.5 ) 1 ( 7.7 ) 0 ( 0.0 ) 4 ( 20.0 ) 4 4 ( 10.0 ) 2 ( 15.4 ) 2 ( 28.6 ) 0 ( 0.0 ) 5 4 ( 10.0 ) 2 ( 15.4 ) 2 ( 28.6 ) 0 ( 0.0 ) 6 1 ( 2.5 ) 1 ( 7.7 ) 0 ( 0.0 ) 0 ( 0.0 ) 7\u201310 ( least depriv ) 1 ( 2.5 ) 0 ( 0.0 ) 1 ( 14.3 ) 0 ( 0.0 ) proport patient minor ethnic practic popul compar nation averag , n ( % ) higher 9 ( 45.0 ) 8 ( 61.5 ) 1 ( 14.3 ) n\/a similar 4 ( 20.0 ) 2 ( 15.4 ) 2 ( 28.6 ) n\/a lower 6 ( 30.0 ) 3 ( 23.1 ) 3 ( 42.9 ) n\/a miss data 1 ( 5.0 ) 0 ( 0.0 ) 1 ( 14.3 ) imd = index multipl deprivation.researchresearch e421 | research british journal gener practic , june 2024 lot children overweight categori centil chart will. \u2019 ( sn , fg01 ) ask skill train need , particip often highlight limit train hcp receiv childhood obes nutrit , contribut reluct initi convers child weight : \u2018 think \u2019 problem lot peopl would like tackl \u2019 realli know start \u2026 \u2019 much way train childhood nutrition. \u2019 ( gp , 07 ) parent famili relat . hcp identifi parent often perceiv children ( ) excess weight , could barrier . case , hcp discuss context ethnic cultur factor : \u2018 think , popul issu certain minor , ideal healthi weight , \u2019 true reflect medic think good weight. \u2019 ( gp , 02 ) discuss vignett , sever hcp acknowledg challeng famili circumst ( exampl , low incom , mental health challeng , parent separ ) may make reluct address child overweight : \u2018 think \u2019 quit difficult talk weight \u2019 [ famili ] got much go on. \u2019 ( sn , fg01 ; discuss vignett 3 ) sn particularli saw feedback letter parent children overweight and\/or obes receiv follow ncmp measur issu . sn role respond queri rais parent follow receipt feedback letter discuss word problemat , often caus anger distress : \u2018 \u2019 quit parent upset receiv [ ncmp feedback ] letter . think \u2019 way letter worded. \u2019 ( sn , fg03 ) facilit hcp convers parent child weight structur chang . one strategi identifi address lack time make dedic appoint discuss child excess weight . sens also gave parent time prepar convers : \u2018 [ discuss child weight ] requir extra thirti second end ten-minut consult . sometim get say , \u201c think need discuss child \u2019 gener health , pleas book separ appoint that. \u201d \u2019 ( gp , 02 ) perceiv need cross-ag work . relat integr data system enabl hcp access share health inform measur children healthcar organis , joined-up work school agenc . ask inform would use , hcp identifi recommendationsincreas access child weight data primari care \u2014 access ncmp data data healthcar servic ; link feedback ncmp data parent support enhanc core hcp train \u2014 emb skill knowledg train core hcp programm , exampl , childhood obes assess ment manag , cultur awar , nutrit manag develop continu profession develop ( cpd ) opportun \u2014 profession bodi develop cpd opportun encourag cross-disciplinari peer learningsupport hcp provid dietari physic activ advic \u2014 increas awar exist resourc ; develop resourc pack consid cultur divers support signpost referr servic \u2014 develop process ensur hcp awar local children \u2019 weight manag servic care pathwaysclearli defin respons hcp \u2014 ensur child weight manag respons defin commiss structur dedic time resourc allocatedhcp knowledg skill hcp approach structur chang commun skillslink child weight present health issu discuss health consequ parent involv whole familyprovid appropri dietari physic activ adviceincreas hcp knowledg referr pathway servicesincreas access interpret signpost provid dietari physic activ resourcesfacilitatorsded appoint discuss child weightaccess data identifi track child weight statu joined-up system cross-ag workinglearn child weight manag approach peersincentivis exist primari care structur ( qualiti outcom framework ) aspecif skill support weight managementstructur organis hcp relat parent famili relat lack hcp time capac limit referr pathway servicesfear damag parent\u2013 profession relationshipbeyond remit rolelimit awar differ culturesparent percept overweightchalleng social circumst lack confid conversationsno readi access routin collect data tool aid child weight assessmenta limit knowledg mistrust bmi centilesparent anger feedback child \u2019 weight routin nation child measur programm ( ncmp ) limit train weight manag dietari physic activ advic lack time budget attend relev trainingbarri figur 1. barrier facilit healthcar profession convers parent child weight : theme subthem , propos recommend action . box present subthem relat barrier facilit colour-cod correspond recommend inform . agp primari care nurs . bmi = bodi mass index . hcp = healthcar professional.researchbritish journal gener practic , june 2024 research | e422 research access integr routin collect data health servic ncmp would enabl easili track children \u2019 weight statu alert children rapidli gain weight : \u2018 \u2026 \u2019 collabor work \u2019 ? \u2019 stop work twice \u2026 also \u2019 page well parent may come us say , \u201c \u2019 know problem \u201d , say , \u201c well actual , let \u2019 look school nurs measured. \u201d \u2019 ( pn , 03 ) discuss vignett , access interpret parent limit english identifi facilit convers child excess weight famili . ask directli incent , gp identifi incent qualiti outcom framework ( remuner gener practic specifi healthcar activ ) proactiv address childhood excess weight could use approach . howev , hcp felt may result \u2018 tick-box \u2019 approach : \u2018 patient spoke limit english abl understand \u2019 say , would probabl address main symptom \u2026 invit return interpret follow-up appointment. \u2019 ( gp , 10 ; discuss vignett 1 ) \u2018 \u2026 want done [ gp convers parent child excess weight ] , attach kind incent gp take serious , unfortun . time think run risk becom tick-box exercis , get payment. \u2019 ( gp , 02 ) hcp approach . hcp identifi sever use approach convers parent child excess weight . describ link weight problem child present give common-sens advic relat food provis , diet , physic activ . train skill discuss , highlight train give advic would facilit convers ( see hcp knowledg skill ) . mani hcp recognis need involv whole famili provid advic : \u2018 would relat problem present , \u201c one thing might factor might child carri weight . \u2019 someth might want tackle. \u201d \u2019 ( gp , 07 ) \u2018 one mum child overweight , young parent actual \u2019 know cook dinner , yeah \u2026 spent lot time give worksheet , cook , make potato bean rather go fish chip shop. \u2019 ( sn , fg03 ) '\u2026 \u2019 kind address sens , thing famili togeth term diet , chang chapati white flour brown flour , simpl thing like . chang rice brown rice . mayb everyon go walk togeth go park togeth . ' ( gp , 05 ; discuss vignett 1 ) 'we obvious want work famili feel \u2019 someth benefici , children whole famili . ' ( pn , 02 ) particip discuss signpost provid lifestyl weight manag resourc famili , often highlight free onlin materi change4lif ( nation campaign improv famili dietari intak physic activ ) . particip felt bespok resourc pack contain specif weight manag advic famili would assist opportunist address child excess weight : \u2018 think inform packag abl give parent would great \u2026 think healthcar profession point view , give someth put hand , sit look \u2019 got five minutes. \u2019 ( pn , 07 ) hcp knowledg skill . need increas hcp knowledg child weight manag servic requir develop certain skill identifi facilit . hcp primari care perceiv exist servic local area could refer , alway known : \u2018 \u2026 offer peopl servic avail , know servic , make convers lot easier. \u2019 ( gp , 01 ) ask skill train , particip identifi gener hcp skill help convers parent child \u2019 weight , includ commun skill train difficult convers . particip also identifi use specif skill , includ skill relat help patient chang behaviour ( motiv interview ) , provid child weight manag healthi eat advic . mani particip felt train provid advic would help address child weight . also comment need consid differ cultur context provid healthi eat weight manag advic : \u2018 think \u2014 \u2019 term ? \u2014 motiv interview . \u2019 done lot past . think \u2019 use , look motiv change. \u2019 ( pn , 02 ) \u2018 \u2019 never realli formal train deal obes children \u2026 think practic train [ need ] actual offer proven work effectively. \u2019 ( gp , 02 ) 'you need awar differ type food differ type peopl [ refer differ cultur ] . ' ( sn , fg02 ) sever pn sn discuss valu learn skill approach convers provid weight manag advic peer : \u2018 actual believ well share experi well ; like , say , \u201c one. \u201d \u2019 ( sn , fg02 ) discuss summari gp , pn , sn recognis import convers parent child excess weight experienc sever barrier . relat famili factor , mani structur relat hcp . studi abl identifi facilit factor hcp convers , inform potenti strategi author propos ( see implic practic ) would address hcp-relat structur barrier within primari commun care . studi provid valuabl new insight facilit factor hcp , particularli around structur aspect health care support develop hcp \u2019 knowledg skill , previou research focus facilit relat hcp\u2013parent interactions.4 structur chang would support hcp convers researchresearch e423 | research british journal gener practic , june 2024 parent child weight relat organis aspect within primari commun care ( exampl , system dedic appoint , better access interpret , financi incentivis ) . howev , need joined-up approach across healthcar organis school , cross-ag work share inform weight- assess data ( includ ncmp ) highlight . sever approach hcp alreadi use identifi good strategi convers parent child weight , particip clearli articul need develop knowledg skill . includ knowledg local child weight manag provis , skill weight manag advic support behaviour chang . awar cultur context abil provid cultur appropri advic seen import . strength limit studi address knowledg gap relat strategi support hcp convers parent child weight . main primari commun care hcp group well place address weight primari school-ag children includ . particip serv socioeconom disadvantag ethnic divers popul recruit , enabl studi explor challeng face within commun . data collect approach includ use vignett , identifi valuabl method explor depth challeng face hcps.14 strengthen involv multidisciplinari hcp group , advis develop discuss guid vignett . limit includ focu english healthcar context . clear whether find would transferr wider uk intern context ; howev , given reson find intern literatur barrier hcp conversations,4,5 like would applic find context . recruit approach primari care profession depend advertis studi like recruit particip interest childhood overweight . differ perspect hcp may miss , interest particip topic area help term explor potenti strategi facilit hcp address child weight . sn particip one healthcar organis , sn experi may influenc local organis context , limit generalis . howev , recruit method allow focu group methodolog use , enabl develop particip \u2019 view discuss peers.18 discuss guid develop ensur specif area request funder cover , may influenc data collect ; howev , highlight result data obtain respons specif question . comparison exist literatur mani barrier hcp convers parent child weight identifi present studi report studi hcps,4,5 commun high deprivation.19,20 line present studi \u2019 find , barrier identifi latter studi includ lack confid initi discuss , inadequ time , fear undermin parent trust , lack recognit overweight cultur percept weight parent , difficulti avoid give nutrit advic , lack collabor work organis . hcp \u2019 fear damag parent trust relationship , common , may unfound . adult obes mostli welcom health profession initi convers weight,21 parent young children gener recept hcp discuss child weight.22,23 howev , insight studi \u2019 particip barrier , limit cultur awar lack train skill give weight manag advic , reinforc previous identifi hcp train gap . need better address cultur compet safeti gp nurs train highlighted,24,25 need better skill develop medic nurs profession nutrit , obes assess management.26\u201329 develop skill resourc support hcp child weight manag activ promin facilit theme present studi . line , studi english primari care nurs identifi train support obes manag factor legitimis role undertak weight manag activities.30 anoth factor highlight import clariti around role hcp provid weight manag advic , reson find present studi . qualit studi parent children excess weight also shown parent want practic well-inform advic resourc hcp help manag child \u2019 weight.23,31 present studi highlight need awar children \u2019 weight manag servic joined-up approach across agenc , includ data share . uk-bas studi explor adult weight manag servic relationship primari care identifi need servic develop better commun relationship primari care professionals.32 present find lack hcp \u2019 knowledg children \u2019 weight manag servic would suggest even greater need improv commun primari care fund project fund public health england . kate jolli part- fund nation institut health care research ( nihr ) appli research collabor west midland . view express articl author necessarili author \u2019 employ univers , public health england , nh , nihr , depart health social care . ethic approv ethic approv provid scienc , technolog , engin mathemat ethic review committe , univers birmingham , birmingham , unit kingdom ( ern_19-1724 , rg_19-273 ) . hra health care research wale also provid approv research ( ira project id 277128 ) . data data ( anonymis transcript ) could made avail reason request author . researchbritish journal gener practic , june 2024 research | e424 research servic . england , children bmi record primari care health record33 evid hcp good identifi children excess weight use observ alone.34 ncmp provid object data high nation coverage,7,35 therefor integr data primari care record repres key opportun support hcp address child weight parent . present find also suggest , addit ncmp data , share inform primari care health servic would enabl comprehens engag child weight manag . implic practic studi identifi sever recommend action address identifi barrier . recommend inform identifi facilit support primari care commun hcp initi convers parent provid weight manag advic support famili . figur 1 present recommend , colour- code show subthem inform recommend . clariti around respons hcp need . achiev clariti , respons need defin within primari commun care commiss arrang , adequ time resourc alloc enabl respons fulfil . assist identif track child excess weight , share weight assess data ncmp health servic primari care requir . access ncmp data primari care may also enabl support feedback process ncmp data parent . readi access weight manag resourc could given famili would support hcp initi manag child excess weight would import address cultur divers develop new resourc . addit , need systemat approach enabl hcp signpost refer exist weight manag servic better commun process servic primari commun care . final , identifi train gap need address . done enhanc core hcp train inclus gener skill train , cultur awar compet , well specif train relat nutrit , childhood overweight assess manag . addit train could provid part continu profession develop programm incorpor peer cross-disciplinari learn . conclus , action could taken address structur hcp-relat barrier address child excess weight primari commun care . requir nation local action implement success . refer 1. nation institut health care excel . obes : identif , assess manag . cg189 . london : nice , 2014. http : \/\/www.nice.org . uk\/guidance\/cg189 ( access 18 mar 2024 ) . 2. boyc , peckham , hann , trenholm s. pro-act approach . health promot ill-health prevent . 2010. http : \/\/www . kingsfund.org.uk\/sites\/default\/files\/field\/ field_document\/health-promotion-ill-health- prevention-gp-inquiry-research-paper-mar11 . pdf ( access 18 mar 2024 ) . 3. viner rm , stiglic n , william z , et al . understand improv gener practition ( gp ) use childhood bmi surveil data nation child measur programm ( ncmp ) . public health england , 2017 . 4. bradburi , chisholm , watson pm , et al . barrier facilit health care profession discuss child weight parent : meta-synthesi qualit studi . br j health psychol 2018 ; 23 ( 3 ) : 701\u2013722 . 5. abdin , heath g , welch rk . health profession \u2019 view experi discuss weight children famili : systemat review qualit research . child care health dev 2021 ; 47 ( 4 ) : 562\u2013574 . 6. nh digit . nation child measur programm . 2023. http : \/\/digital.nhs.uk\/ services\/national-child-measurement- programm ( access 18 mar 2024 ) . 7. nh digit . nation child measur programm , england , 2021\/22 school year . 2022. http : \/\/digital.nhs.uk\/ data-and-information\/publications\/ statistical\/national-child-measurement- programme\/2021-22-school-year ( access 18 mar 2024 ) . 8. nh digit . digit child health . 2023. http : \/\/digital.nhs.uk\/services\/digital-child- health ( access 18 mar 2024 ) . 9. green j , thorogood n. qualit method health research . london : sage public , 2018 . 10. offic nation statist . life chang birmingham : censu 2021 . 2023. http : \/\/www.ons.gov.uk\/visualisations\/ censusareachanges\/e08000025\/ ( access 18 mar 2024 ) . 11. ministri hous , commun local govern . english indic depriv 2019 . 2019. http : \/\/www.gov.uk\/ government\/statistics\/english-indices-of- deprivation-2019 ( access 18 mar 2024 ) . 12. taylor mc . interview . : holloway , ed . qualit research health care . maidenhead : open univers press , 2005 : 39\u201355 . 13. kitzing j. focu group research : use group dynam explor percept , experi understand . : holloway , ed . qualit research health proven freeli submit ; extern peer review . compet interest helen parretti council member british obes metabol surgeri societi , co-opt steer committe member obes empower network member nation institut health care excel weight manag guidelin updat committe . receiv honoraria educ event healthcar profession johnson & johnson honoraria particip develop dissemin algorithm manag adult obes primari care support arm \u2019 length sponsorship novo nordisk . co-author public uk data studi fund novo nordisk ( honorarium ) . author compet interest declar . acknowledg would like thank gp , practic nurs , school nurs took part interview focu group . thank clinic lead school health advisori servic birmingham support recruit school nurs . thank local expert healthcar profession group input develop discuss guid vignett , final thank public health england-l studi steer group input throughout studi . open access articl open access : cc 4.0 licenc ( http : \/\/creativecommons.org\/ licences\/by\/4.0\/ ) . discuss articl : bjgp.org\/ lettersresearchresearch e425 | research british journal gener practic , june 2024 care . maidenhead : open univers press , 2005 : 56\u201370 . 14. tremblay , turcott , touati n , et al . develop use research vignett collect qualit data healthcar profession : scope review . bmj open 2022 ; 12 ( 1 ) : e057095 . 15. malterud k , siersma vd , guassora ad . sampl size qualit interview studi : guid inform power . qual health re 2016 ; 26 ( 13 ) : 1753\u20131760 . 16. gale nk , heath g , cameron e , et al . use framework method analysi qualit data multi-disciplinari health research . bmc med re methodol 2013 ; 13 : 117 . 17. clark v , braun v , hayfield n. themat analysi . : smith ja , ed . qualit psycholog : practic guid research method . london : sage public , 2015 : 222\u2013248 . 18. jayasekara rs . focu group nurs research : methodolog perspect . nur outlook 2012 ; 60 ( 6 ) : 411\u2013416 . 19. sastr lr , matson , gruber kj , haldeman l. qualit studi examin medic provid advic , barrier , perceiv effect address childhood obes patient famili low- incom commun health clinic . sage open med 2019 ; 7 : 2050312119834117 . 20. sjunnestrand , nordin k , eli k , et al . plant seed \u2014 child health care nurs \u2019 percept speak parent overweight obes : qualit studi within stop project . bmc public health 2019 ; 19 ( 1 ) : 1494.21. caterson id , alfadda aa , auerbach p , et al . gap bridg : misalign percept , realiti action obes . diabet obe metab 2019 ; 21 ( 8 ) : 1914\u2013 1924 . 22. bentley f , swift ja , cook r , redsel sa . \u2018 would rather told know \u2019 \u2014 qualit studi explor parent view identifi futur risk childhood overweight obes infanc . bmc public health 2017 ; 17 ( 1 ) : 684 . 23. uy mja , pereira , berg jm , loth ka . approach discuss children \u2019 weight parent ? qualit analysi recommend parent preschool-ag children physician . clin pediatr ( phila ) 2019 ; 58 ( 2 ) : 226\u2013237 . 24. watt k , abbott p , reath j. develop cultur compet gener practition : integr review literatur . bmc fam pract 2016 ; 17 ( 1 ) : 158 . 25. gradellini c , g\u00f3mez-cantarino , dominguez-isabel p , et al . cultur compet cultur sensit educ univers nurs cours . scope review . front psychol 2021 ; 12 : 682920 . 26. mazur , matusik p , revert k , et al . childhood obes : knowledg , attitud , practic european pediatr care provid . pediatr 2013 ; 132 ( 1 ) : e100\u2013 e108 . 27. macanich e , buckner l , amin p , et al . time nutrit medic educ . bmj nutr prev health 2020 ; 3 ( 1 ) : 40\u201348 . 28. mastrocola mr , roqu ss , ben lv , stanford fc . obes educ medic school , resid , fellowship throughout world : systemat review . int j obe ( lond ) 2020 ; 44 ( 2 ) : 269\u2013279 . 29. dimaria-ghalili ra , mirtallo jm , tobin bw , et al . challeng opportun nutrit educ train health care profess : intraprofession interprofession call action . j clin nutr 2014 ; 99 ( 5 suppl ) : 1184s\u20131193 . 30. nolan c , deehan , wyli , jone r. practic nurs obes : profession practice-bas factor affect role adequaci role legitimaci . prim health care re dev 2012 ; 13 ( 4 ) : 353\u2013363 . 31. lupi jl , haddad mb , gazmararian ja , rask kj . parent percept famili pediatrician role childhood weight manag . j pediatr 2014 ; 165 ( 1 ) : 99\u2013103.e2 . 32. blane dn , macdonald , morrison , \u2019 donnel ca . role primari care adult weight manag : qualit interview key stakehold weight manag servic . bmc health serv re 2017 ; 17 ( 1 ) : 764 . 33. firman n , robson j , ahm z , et al . complet repres bodi mass index children \u2019 electron gener practic record : link cross- section studi ethnically-divers urban popul unit kingdom . pediatr obe 2021 ; 16 ( 8 ) : e12772 . 34. smith sm , gate p , rudolf m. recognis obes clinic ? arch di child 2008 ; 93 ( 12 ) : 1065\u20131066 . 35. townsend n , rutter h , foster c. improv data qualiti nation bmi measur programm . int j obe ( lond ) 2015 ; 39 ( 9 ) : 1429\u20131431 .",
  "influenc religios food choic among british muslim : qualit studi owai , u. , pat el , r. & abbott , s. publish pdf deposit coventri univers \u2019 repositori origin citat : owai , u , patel , r & abb ott , 2024 , 'the influenc religios food choic among british muslim : qualit studi ' , nutrit health , vol . ( -press ) , pp . ( in-press ) . http : \/\/dx.doi.org\/ 10.1177\/02601060241244883 doi 10.1177\/02601 060241244883 issn 0260 -1060 essn 2047 -945x publish : sage public articl distribut term creativ common attribut 4.0 licens ( http : \/\/creat ivecommons.org\/licenses\/by\/4.0\/ ) permit use , reproduct distribut work without permiss provid origin wor k attribut specifi sage open access page ( http : \/\/us.sagepub.co m\/en -us\/nam\/open -access -at-sag ) \ufb02uenc religios food choic among british muslim : qualit studi umama owais1 , riya patel2and salli abbott2 abstract background : religios known socio-cultur \ufb02uenc food choic . howev , date , research explor- ing \ufb02uenc islam food select almost exclus focus fast ramadan explor \ufb02uenc islam everyday food choic among muslim peopl . aim : qualit studi explor \ufb02uenc islam religios everyday food choic among muslim peopl . method : thirty-two adult partici- pant resid unit kingdom ( n=16 faith leader n=16 lay muslim peopl ) recruit three sunni mosqu , data collect use semi-structur interview . data analys use \ufb02exiv themat analysi constant comparison method appli draw similar differ faith leader lay muslim peopl . result : result reveal islam religios \ufb02uenc food choic two main overarch theme 1 ) demonstr religi obedi food choic , 2 ) sphere \ufb02uenc food choic ; \ufb01ve sub-them 1a ) rust familiar food provid , 1b ) veri \ufb01cation halal authent , 1c ) seek puriti within food , 2a ) prophet muham ( peac upon ) role model food choic , 2b ) islam juris- prudenc . conclus : \ufb01nding provid import insight \ufb02uenc islam food choic could use support design faith-inform dietari intervent among muslim peopl . research requir examin role faith-inform dietari intervent muslim commun . keyword islam , muslim , food choic , religios , qualit introduct health belief valu vari cultur reli-gion healthcar profession abl provid cultur respons care . cultur responsivecar tailor need individu patient consid uniqu cultur , spiritu religi factor \ufb02uenc health ( \ufb01ce health improv dispar , 2021 ) . healthcar profes- sional must learn cultur \ufb02uenc food nutrit provid dietari educ speci \ufb01ct patient deliv cultur sensit manner ( ring et al. , 2023 ) . understand role food religi practic assist healthcar profession wider societi respect respond need peopl religi communi-ti ( chouraqui et al. , 2021 ) . religion de \ufb01ne food prac- tice variou rule symbol religi teach . result , certain food choic symbolicact part ritual demonstr faith enhanc feel- ing belonging ( monterrosa et al. , 2020 ) . muslim , peopl follow islam \u2019 teach , com- prise second-largest religi commun world , nearli quarter ( 24.9 % ) world popul iden- tifi muslim 2020 ( pew research center , 2022 ) .islam also second-largest practic religion unit kingdom , popul 3.87 million muslim peopl live england wale , comprising6.5 % popul ( \ufb01ce nation statist , 2023 ) . religios socio-cultur \ufb02uenc food choic , religi teach may use power deliv- eri channel promot health dietari behaviour . understand islam perspect diet assisthealthcar profession deliv appropri nutrit care cultur sensit manner ( ring et al. , 2023 ) . religion islam place great emphasi food 1school health life scienc , coventri univers , coventri , uk 2research centr healthcar commun , institut health wellb , coventri , uk correspond author : salli abbott , research centr healthcar commun , institut health wellb , coventri , cv1 5rw , uk . email : sally.abbott2023 @ gmail.comorigin articl nutrit health 1\u20138 \u00a9 author ( ) 2024 articl reus guidelin : sagepub.com\/journals-permiss doi : 10.1177\/02601060241244883 journals.sagepub.com\/home\/nah consumpt , dietari habit food etiquett . holi quran , promin islam scriptur , contain 250 vers nutrit concept , includ avoiding drink haram ( unlaw ) food ( e.g . pork deriv alcohol ) , halal ( permiss ) tayyib ( pure ) food encourag ( tarighat-esfanjaniand namazi , 2016 ) . despit central food islam scriptur , research religion food habit islam cultur islack ( norman , 2012 ) . publish qualit research nutrit behaviour muslim popul , date , focus practic fast ramadan ( algha \ufb02i et al . 2019 ; hasan et al. , 2021 ) , popula- tion speci \ufb01c health condit , type 2 diabet ( bouchareb et al. , 2022 ; lee et al. , 2017 ) chronickidney diseas ( adanan et al. , 2021 ) . howev , absenc qualit research undertaken uk \ufb02uenc islam everyday dietari behaviour , literatur compar faith leader lay muslim perspect . therefor , aim studi explor \ufb02uenc islam religios food choic among british muslim peopl . materi method studi report accord \u2018 consolid criteria report qualit research \u2019 checklist ( tong et al. , 2007 ) . studi design author conduct exploratori qualit studi toexplor \ufb02uenc islam religios experi food choic , seek perspect faith leader lay muslim . sinc literatur topic limit well establish , qualit approachprovid freedom \ufb02exibl requir investig phenomenon ( leedi ormrod , 2015 ) . research position studi , \ufb02uenc lead author \u2019 ( uo ) reli- giou af \ufb01liation islam experi muslim pakistani ethnic acknowledg throughout research process , includ role aninterview , exercis \ufb02exiv . position co-author ( sa dietitian white ethnic atheist ; rp qualit research british indian ethni-c practic christian ) also consid , regard involv data analysi interpret \ufb01nding . particip practic muslim age 18 , \ufb02uent english lan- guag speaker , either faith leader ( e.g . imam , islam theologist etc . ) practic lay muslim wereelig take part studi . purpos sampl faith leader lay muslim recruit via \ufb02yer three sunni mosqu ( west midland n =1 ; west sussex n=2 ) ensur equal number faith leader lay muslim studi . recruit took place juli 2021 octob 2022. particip encouragedto share studi advertis elig poten- tial particip via snowbal sampl method . data collect point consent , 34 particip provid demograph detail , includ age , gender , ethnic vocat . two particip respons invita- tion arrang interview . semi-structur interview ( durat rang 24 min 90 min ) con- duct one interview ( uo ) zoom microsoft team use interview topic guid . topic guidewa inform studi object pilot one muslim person , lead minor modi \ufb01ca- tion word question . individualsinvolv studi gave written inform consent arrang interview . interview audio- record transcrib verbatim lead research ( uo ) ensur authent ( lingard , 2019 ) . transcript particip anonymis ensur con\ufb01denti . data analysi transcript read re-read facilit research- er \u2019 immers data . \ufb02exiv themat analysi ( braun clark , 2006 ) use analys data.transcript \ufb01rst code individu , theme relat food choic develop . follow , constant compar method perform similar- differ two particip group ( faith leader lay muslim ) identi \ufb01ed ( maykut morehous , 2005 ) . iter process , discuss within research team \ufb01ned develop theme . overarch theme sub- theme captur similar differenceswer develop \ufb01nal analysi . uo , sa rp engag peer review data interpret stage , enhanc credibl . ethic approv ethic approv grant coventri universityeth committe ( p121546 ) . result particip characterist thirty-two sunni muslim particip ( n =16 faith leader n=16 lay muslim ) interview four regions2 nutrit health 0 ( 0 ) within uk : west midland ( n =13 ) , london ( n =10 ) , west sussex ( n =8 ) greater manchest ( n =1 ) . particip ( 28\/32 ; 87.5 % ) identi \ufb01ed south asian ethni- citi . lay muslim younger ( n =13 age 20 \u201329 year old ) faith leader ( n =3 age 20 \u201329 year old ) . see tabl 1 detail demograph particip level . theme sub-them two overarch theme total \ufb01ve sub-them develop present , accompany- illustr particip quotat . theme 1 : demonstr religi obedi food choic . particip state purpos life pleas god consum food permiss islam , demonstr devot god , thequr \u2019 anic teach sunnah prophet muhammad , peac upon ( pbuh ) .particip spoke \u2018 wisdom \u2019 ( hikmah ) ordain abid . dietari rule halal haram islam perceiv \u2018 bene\ufb01t \u2019 thu food select actual perceiv food \u2018 choic \u2019 , requir act obedi- enc god . particip clear understand food haram halal . share qur \u2019 anic vers spoke god promis guarante \u2018 ajar \u2019 ( reward ) life hereaft make food choic line islam dietari rule . physic environ pose challeng muslim peopl abl identifi , therefor consum , food truli halal . \ufb02ect sub-them \u2018 trust familiar food provid \u2019 , \u2018 veri\ufb01c halal authent \u2019 \u2018 seek puriti within food \u2019 ; illus- trate islam teach \ufb02uenc decision-mak process surround food select . sub-them : trust familiar food provid . cautious around authent food claim tobe \u2018 halal \u2019 , especi came meat anim deriv product . decis around sourc , purchasingt 1. particip characterist . particip gender age faith leader congreg ethnic 1 male 23 \u2713 pakistani 2 male 53 \u2713 british-indian 3 femal 23 \u2713 british-indian 4 femal 40 \u2713 british-indian 5 femal 29 \u2713 british-indian 6 male 28 \u2713 british-pakistani 7 male 39 \u2713 british-pakistani 8 male 34 \u2713 sri lankan 9 femal 23 \u2713 british-pakistani 10 femal 36 \u2713 british-pakistani 11 femal 20 \u2713 british-bangladeshi 12 femal 20 \u2713 british-bangladeshi 13 femal 27 \u2713 british-bangladeshi 14 femal nr \u2713 arab 15 femal 47 \u2713 british- pakistani 16 femal 21 \u2713 arab 17 male 42 \u2713 british-pakistani 18 male 27 \u2713 british-pakistani 19 male 39 \u2713 indonesian 20 male 41 \u2713 indonesian 21 femal 26 \u2713 indian mauritian 22 male 22 \u2713 british-pakistani 23 femal 39 \u2713 british-indian 24 femal 23 \u2713 british-afghan 25 male 30 \u2713 british-indian 26 male 40 \u2713 british-bangladeshi 27 male 47 \u2713 british-indian 28 femal 34 \u2713 british-indian 29 femal 44 \u2713 british-bangladeshi 30 male 20 \u2713 british-sri lankan 31 femal 20 \u2713 british-sri lankan 32 femal 25 \u2713 british asian note : nr : recorded.owai et al . 3and consum meat base familiar , trust , reput individu ( ) and\/or small busi within commun . credibl \u2018 word \u2019 individu ( ) suppli food lay muslim mosqu within local , someon othersfrom islam commun endors : \u2018 \u2026if know person seen worshipp good person , \u2019 lie matter . cours , consum say halal , \u2019 know person , go certi \ufb01cate , evid \u2019 ( particip 17 , faith leader ) . trust familiar demonstr particip discuss uk supermarket chain ( e.g . asda , sainsburi \u2019 ) . particip less trust food authent halal unabl identifi inform meat way would known independ halal butcher . supermarketwork perceiv intim knowledg meat suppli chain , comparison local halal butcher , result doubt buy meat fromuk supermarket chain : \u2018 know peopl , know certi \ufb01cate , even ask get meat , \u2019 cut meat front . brand big groceri store halal food bit question \u2019 ( particip 22 , lay muslim ) . greater trust food prepar familiar set also demonstr muslim peopl prefer homefood \u2018 trust sourc \u2019 due \u2018 conveni \u2019 \u2018 tast \u2019 ; would gener elect choos home-cook tradit meal takeaway : \u2018 tend eat lot food home , \u2019 easier food better anyway . gener , also take food home place like work \u2019 ( particip 22 , lay muslim ) ; \u2018 \u2026the way consum food , come , particularli choos play vital role come spiritu connect allah . \u2019 sm reason strongli pick home cook food trust sourc \u2019 ( particip 6 , faith leader ) . reassur sought muslim peopl ensur food consum contamin impermiss ingredi ( ) and\/or product . particip share believ food consumedultim \ufb02uenc spiritu connect god , consumpt food haram would neg impact ibadah ( worship ) . \u2018 \u2019 vigil know neglect consum [ food ] unlaw impact worship . everyth eat drink ibadah kind ofworship . therefor , prerequisit accept pure khaali [ pure ] food without contamin unlaw thing \u2019 ( particip 20 , lay muslim ) . feel insecur around consump- tion food travel outsid local commu- niti , extent muslim peopl may avoid eatingmeat product altogeth : \u2018 local , activ refrain eat anyth . \u2019 go someth vegetarian \u2019 con \ufb01dent place serv halal \u2019 ( particip 26 , faith leader ) . particip \ufb02ect prefer travel muslim countri vacat , perceiv meat anim deriv muslim countri wouldb univers halal , provid air conveni comfort came food select : \u2018 whenev go new town , alway make sure \u2019 halal food option . go abroad muslim countri , everyth halal \u2019 ( particip 12 , lay muslim ) ; \u2018 enjoy go countri everyth halal . \u2026 [ ] sometim [ uk ] actual ques- tion whether halal even though \u2019 got sign , dif\ufb01cult , especi \u2019 go town area \u2019 familiar . , \u2019 lot research beforehand , abl see place suit diet \u2019 ( particip 5 , lay muslim ) . sub-them : veri \ufb01cation halal authent . decid- ing whether food \u2018 worthi \u2019 consumpt , muslim peopl sought reassur recognis certi \ufb01cation . faith leader sought veri \ufb01cation trust accept halal monitor committe ( hmc ) certi- \ufb01ed food : \u2018 hmc give peac mind ( meat ) slaughter correct manner . \u2019 ( particip 28 , faith leader ) . hmc certi \ufb01ed meat consid particip \u2018 gold standard \u2019 halal certi \ufb01cation , wherea emblem cater venu sole denot \u2018 halal \u2019 perceiv less valid . faith leader show stronger sens determin authent halal food due knowledg respons learn individu within commun . faith leader , absenc hmc certi \ufb01cation \u2018 warn sign \u2019 venu truli halal , appli proactiv approach sought valid claim \u2018 halal \u2019 food : \u2018 \u2026 told peopl , place reput- abl , still tend sceptic , go ask owner peopl work insid . wouldalso help \ufb02uenc decis eat . [ ] know got meat \u2026and understand stun meat un-stun meat , \u2018 ye \u2019 , would eat \u2019 ( particip 25 , faith leader ) . \u2018 warn sign \u2019 includ venu serv halal food drink alongsid haram food and\/or drink ( e.g . cateringvenu also serv alcohol ) . instanc , faith leader sceptic , ask question cross contamin , request proof certi \ufb01cate and\/or name meat supplier . hand , lay muslim particip alway seek valid unconvincedov authent food claim \u2018 halal \u2019 .i n situat , lay muslim would take reactiv approach default choos vegetarian , vegan or\ufb01sh option absenc halal certi \ufb01ed option avail : \u2018 go choic limit . you4 nutrit health 0 ( 0 ) either go vegetarian dish , \ufb01sh option \u2019 ( particip 14 , lay muslim ) . sub-them : seek puriti within food . faith leader , permiss food judg way anim sacri \ufb01ced also pure ( tayyib ) food . term \u2018 halal \u2019 \u2018 tayyib \u2019 use inter- changeabl \u2018 organ \u2019 \u2018 wholesom \u2019 food pre- fer : \u2018 islam teach us eat good wholesom food , \u201c qulubuna tayyibaat \u201d [ vers qur \u2019 ] good wholesom food . also driver engag good food rather eat junk . think , \u2019 halal , \u2019 s\ufb01ne . \u2019 much , wholesom ? pure ? everyth halal \u2019 necessarili good \u2019 ( particip 26 , faith leader ) . muslim peopl express intent nourish one \u2019 bodi \u2018 pure \u2019 ( tayyib ) food seen act \u2018 worship \u2019 ( ibadah ) mean \u2018 feed \u2019 spir- itual connect god : \u2018 \u2026eat pure state , \u2019 , affect spiritu , certain degre even call supplicationit answer . [ ] eat food organ , pure ; eat best thing possibl . believ muslim food one core thing thatnot affect physic , even affect spiritu- aliti . vital us believ care eat \u2019 ( particip 10 , faith leader ) . faith leader deem puriti food mean physic nourish worship , lay muslim parti- cipant assess puriti food focusedsol cleanli meat drain \u2018 impur \u2019 blood anim sacri \ufb01ced : \u2018 strict make sure eat halal foodsand stay away food prohibit eat muslim exampl , anim slaughter islam way , say \u2018 bsimillah , allahu akbar \u2019 , slaughter make sure meat clean . done respect manner \u2026the process slaughter meat clean \u2026 make dirti blood leav meat . \u2019 ( particip 1 , lay muslim ) theme 2 : sphere \ufb02uenc food choic . muslim peopl \u2019 food choic \ufb02uenc \ufb01gure islam famili set . two sub-them describ extent food choic guid \ufb02uential \ufb01gure live , includ \u2018 prophet muham ( pbuh ) role model food choic \u2019 \u2018 islam jurisprud \u2019 . sub-them : prophet muham ( pbuh ) role model food choic . teach islam \ufb02uential \ufb01gure , speci \ufb01calli prophet muhmmad ( pbuh ) , \ufb02u- enc particip \u2019 food choic . food prefer guid sunnah tradit prophet muhammad ( pbuh ) follow : \u2018 like date prefer oliv diet . thing some- time fact holi prophet use it.ther level affect well involv sentiment way. \u2019 ( particip 7 , faith leader ) .there desir adher prophet muhammad ( pbuh ) ate ( e.g.milk , oliv , \ufb01g , watermelon , grape , pomegran , vinegar , lamb shoulder , nigella seed , gourd pumpkin ) , \u2018 emul \u2019 feel closer : \u2018 prophet saw ( sallallahu \u2018 alayhi wa sallam ) use like gourd . \u2019 alway enjoy gourd pumpkin . elat think could close prophet , enjoy food . \u2019 whole select thing eaten , want eat \u2019 someth tradit . everyth actuallyrais conscious around pleas god \u2019 ( particip 27 , faith leader ) . food recommend sunnah prophet muhammad ( pbuh ) eaten consid health bene \ufb01t could treat ill ; includ honey heal properti : \u2018 even \u2019 ill mom make concoct thing like , turmer . know \u2019 cultur , also come like sunnah food like honey \u2026the bene \ufb01t also like ingrain think \u2019 sometim cultur islam belief come togeth \u2019 ( particip 3 , lay muslim ) desir imit prophet \u2019 diet also dis- cuss relat meat . particip express prefer- enc eat lamb shoulder , well make consciou effort follow lifestyl ( e.g . \u2018 semi- vegetarian \u2019 ) , consum non-meat-bas meal : \u2018 islam taught much meat eat . exampl , prophet muhammad saw love meat spe- ci\ufb01cal shoulder part , hardli ate . , see semi vegetarian . , islam also encourag us eat veget less meat , eat less pure \u2019 ( particip 23 , faith leader ) . sub-them : islam jurisprud . particip express clear enact \u2018 black white \u2019 rule food drink halal haram islam . howev , element \u2018 grey \u2019 islam jurisprud , led differ opinion amongst sunni muslim . especi illustr vari- anc perspect islam jurisprud surround- prawn : \u2018 \u2026there \u2019 idea makru \u0304h still [ prawn ] \u2019 ( particip 22 , lay muslim ) . muslim peopl exercis virtu person agenc \ufb02uenc whether prawn consid makru \u0304h ( dislik ) per- missibl ( halal ) , consequ , avoid con- sume base independ reason : \u2018 school thought follow , \u2019 undesir . mean , \u2019 unlaw . actual prawn , \ufb02avour \u2019 ( particip 4 , faith leader ) . even within nuclear famili , differ interpret hana \ufb01 school thought surround consumpt prawn : \u2018 husband eat prawn . eat whenev mom cook , \u2019 bring hous \u2019 ( particip 23 , faith leader ) . howev , faith leader feltowai et al . 5 \u2018 indebt \u2019 teacher follow teacher \u2019 pos- ition consumpt prawn , regardless interpret : \u2018 teacher \u2019 prawn , \u2019 \u2019 ( particip 7 , faith leader ) . discuss research \ufb01rst publish qualit studi explor \ufb02uenc islam religios food choic among faith leader lay muslim , allowinginsight islam teach \ufb02uenc nutrit . lay muslim peopl faith leader share clear under- stand food haram ( impermiss ) andhal ( permiss ) . choos consum food halal perceiv requir act obedi god , rather \u2018 food choic \u2019 make . halal certi \ufb01cation , form visual logo emblem , serv inform reassur consum product halal compliant ( ambali bakar,2014 ) . present studi , muslim peopl determin whether food \u2018 authent \u2019 halal , particip look halal logo , deem hmc logo trustedin context uk . qualit studi muslim peopl resid pakistan also found halal logo allow particip con \ufb01dent food halal reliabl indic whether food \ufb01t con- sumption islam law ( bukhari et al. , 2019 ) . absenc convinc veri \ufb01cation statu food halal , muslim peopl studi would opt vegetarian option instead , report literatur . studi found muslim peopl trust halal butch- er halal cater venu within local commun distrust supermarket chain . similarli , consumersurvey research found point purchas , major uk muslim trust supermarket chain trust local shop run muslim ownersand staff , \ufb02ect respond ( 96 % ) purchas halal meat local butcher ( ahm , 2008 ) . studi also report muslim peopl pre-fer travel muslim major countri vacat , ensur islam dietari requir cater . similarli , qualit studi undertaken theunit arab emir found avail halal food affect travel \u2019 intent revisit travel destin- ation , length stay ( mannaa , 2019 ) . muslim peopl \u2019 food choic ultim role mod- ell food choic prophet muhammad ( pbuh ) ; action refer \u2018 follow sunnah \u2019 . henc , particip favour eat \u2018 wholesom \u2019 food mention islam scriptur . likewis , quali- tativ studi undertaken iran among univers academicsfound food \ufb01g , oliv , date , honey , milk oliv oil note emphasis qur \u2019 particularli valu particip , believedthes posit \ufb02uenc social physic health ( salarvand pournia , 2014 ) .there , howev , diverg food choic faith leader lay muslim , suggest muslim peopl undertaken educ ofth religion islam differenti interpret qur \u2019 compar lay muslim peopl . notabl , permiss food judg faith leader beyondfood halal , instead favour tayyib ( pure ) food ( e.g . organ food ) , seen intent act ibadah ( worship ) \u2018 fed \u2019 spiritu connect god . concept tayyib relat food report previou empir research . addit , diverg sphere in\ufb02uenc faith leader lay muslim term food consid makru \u0304h ( dislik ) e.g . prawn . hana \ufb01school islam jurisprud forbid con- sumption seafood \u2018 \ufb01sh \u2019 ; howev , dis- agreement among scholar whether prawns\/shrimp consid \u2018 \ufb01sh \u2019 ( rind siddiqui , 2023 ) . famili member main sourc \ufb02uenc eat practic lay muslim . howev , islam teacher \ufb02uential eat practic faith leader . differ sourc \ufb02uenc report literatur . suggest religi interpret pass oral hierarchyof faith leader given preced , may explain islam jurisprud seen around food consid makru \u0304h . strength limit studi sever methodolog strength . peer-review perform facilit develop theme , enhanc credibl \ufb01nding , data satur reach sampl 32 parti- cipant , ensu transfer ( lincoln guba , 1986 ) . purpos sampl method ensur recruit ofequ number faith leader lay muslim , reason- abli homogen sampl , allow constant compari- son analysi method employ solid basi fortransfer ( boeij , 2002 ) . howev , also limit . studi primarili consist sunni muslim identifi south asian . therefor , the\ufb01nd current studi may transferr muslim belong differ ethnic resid outsid uk . addit , particip were\ufb02u english speaker henc experi non-english muslim speaker includ studi . implic health promot the\ufb01nd studi provid novel insight similar differ food choic islam faith leader lay muslim , leverag public health initi co-develop commu-n evidence-bas faith-inform behaviour dietari intervent prevent ill health ( world health6 nutrit health 0 ( 0 ) organ , 2022 ) . islam faith leader trust wield great deal \ufb02uenc within commun . consequenti , promot willing takepart advoc lifestyl behaviour allay concern relat faith appropri ( padela et al. , 2011 ) . way , faith leader act \u2018 boundari spanner \u2019 healthcar local commun ( long et al. , 2013 ) . henc , involv faith leader faith-inform intervent could potenti strategi increaseengag healthi eat behaviour muslim com- muniti . intervent , howev , area requir- ing research . conclus studi found islam belief \ufb02uential muslim peopl \u2019 decision-mak around choic food . prophet muham ( pbuh ) seen signi \ufb01cant role model muslim peopl opt eat food outlin islam scriptur emul . muslim peopl clear food halal haram would makefood choic line . howev , lay muslim peopl lack con \ufb01denc determin whether meat pro- vide food outlet authent halal , comparisonto faith leader felt could determin authenti- citi food claim halal . , howev , diver- genc interpret islam scriptur . faith leadersview food tayyib ( pure ) provid health bene\ufb01t , lay muslim peopl perceiv puriti clean- liness . also jurisprud amongst laymuslim peopl faith leader around whether con- sumption prawn makru \u0304h halal , demonstr degre person virtu . \ufb01nding offer opportun healthcar pro- fession promot facilit dietari educ inform islam , \ufb02uenc posit faith-inform health behaviour . qualit research requir examin role faith-inform dietari intervent muslim commun prevent treat long-termhealth condit , explor potenti role faith leader endors heal th promot nutrit advic . author \u2019 contribut salli abbott umama owai contribut studi concep- tion design . data collect perform umama owais.data analysi perform umama owai , salli abbottand riya patel . \ufb01rst draft manuscript written umama owai author read , comment approvedthe\ufb01n manuscript . avail data materi data shareabl maintain particip anonym . declar con \ufb02ict interest author declar potenti con \ufb02ict interest respect research , authorship , and\/or public article.eth approv ethic approv grant coventri univers ethicscommitte ( p121546 ) . fund author receiv \ufb01nancial support research , author- ship , and\/or public articl . orcid id salli abbott http : \/\/orcid.org\/0000-0002-1895-1942 supplement materi supplement materi articl avail onlin . refer adanan n , adnan w , khosla p , et al . ( 2021 ) explor experi- enc percept haemodialysi patient observ ramadan fast : qualit studi . bmc nephrolog 22 ( 1 ) : 1 \u201311 . ahm ( 2008 ) market halal meat unit kingdom : supermarket versu local shop . british food journal 110 ( 7 ) : 655 \u2013670 . algha \ufb02i z , hatch , rose , et al . ( 2019 ) qualit studi ramadan : month fast , famili , faith . religion 10 ( 2 ) : 123. ambali bakar ( 2014 ) peopl \u2019 awar halal food product : potenti issu policy-mak . procedia - social behavior scienc 121 : 3 \u201325 . boeij h ( 2002 ) purpos approach constant compara- tive method analysi qualit interview . qualiti quantiti 36 ( 4 ) : 391 \u2013409 . bouchareb , chrifou r , bourik z , et al . ( 2022 ) \u2018 ia mm yo w n doctor \u2019 : qualit studi perspect decision- make process muslim diabet ramadan fast . plo one 17 ( 3 ) : e0263088 . braun v clark v ( 2006 ) use themat analysi psych- olog . qualit research psycholog 3 ( 2 ) : 77 \u2013101 . bukhari , woodsid f , hassan r , et al . ( 2019 ) religios import consider muslim consum behavior : exploratori studi context western import food pakistan . journal islam market 10 ( 4 ) : 1288 \u20131307 . chouraqui j , turck , briend , et al . ( 2021 ) religi dietari rule potenti nutrit health consequ . intern journal epidemiolog 50 ( 1 ) : 12 \u201326 . hasan f , latzer , diedrich p , et al . ( 2021 ) qualit explor- ation motiv fast impact ramadan eat behavior bodi imag among young adult muslim women unit kingdom . eat behavior 42 : 101545. lee j , wong c , tan c , et al . ( 2017 ) type 2 diabet patient \u2019 per- spectiv ramadan fast : qualit studi . bmj open diabet research care 5 ( 1 ) : e000365 . leedi p ormrod j ( 2015 ) practic research : plan design . harlow : pearson . lincoln guba e ( 1986 ) rigor ? trustworthi authent naturalist evalu . new direct program evalu 1986 ( 30 ) : 73 \u201384 . lingard l ( 2019 ) beyond default colon : effect use quot qualit research . perspect medic educ 8 ( 6 ) : 360 \u2013364.owai et al . 7long j , cunningham f braithwait j ( 2013 ) bridg , broker boundari spanner collabor network : systemat review . bmc health servic research 13 ( 1 ) : 1 \u201313 . mannaa ( 2019 ) halal food tourist destin import muslim travel . current issu tourism 23 ( 17 ) : 2195 \u20132206 . maykut p morehous r ( 2005 ) qualit data analysi : use constant compar method . : begin qualit research : philosoph practic guid . london : falmer press , 116 \u2013137 . monterrosa e , frongillo e , drewnow ki , et al . ( 2020 ) sociocultur in\ufb02uenc food choic implic sustain healthi diet . food nutrit bulletin 41 ( 2 ) : 59 \u201373 . norman c ( 2012 ) food religion . : pilcher j ( ed ) oxford handbook food histori . new york : oxford univers press , 409 \u2013427 . of\ufb01c health improv dispar ( 2021 ) cultur , spiritu religion : migrant health guid . avail : http : \/\/www.gov.uk\/guidance\/culture-spirituality-and-religion ( access 14 march 2024 ) . of\ufb01c nation statist ( 2023 ) religion age sex , england wale : censu 2021. avail : http : \/\/www . ons.gov.uk\/peoplepopulationandcommunity\/culturalidentity\/ religion\/articles\/religionbyageandsexenglandandwales\/censu 2021 # : \u223c : text=download % 20the % 20data , -.xlsx & text =it % 20i % 20import % 20to % 20note , ( 3.9 % 20million ) % 20in % 202021 ( access 16 june 2023 ) . padela , killawi , heisler , et al . ( 2011 ) role imam american muslim health : perspect muslim communitylead southeast michigan . journal religion health 50 ( 2 ) : 359 \u2013373 . pew research center ( 2022 ) religi composit countri , 2010-2050 estim religi composit 198 countri territori 2010 2050. avail : http : \/\/www . pewresearch.org\/religion\/intera ctives\/religio us-composition- by-country-2010-2050\/ ( access 16 june 2023 ) . rind n siddiqui ( 2023 ) compar analysi jurispru- denc : common , muslim , jewish civil law . ssrn electron journal . epub ahead print 28 april 2023. doi : 10.2139\/ssrn.4432136 . ring , ai , maker-clark g , et al . ( 2023 ) cook chang : deib principl key ingredi nutrit culinari medicin educ . nutrient 15 ( 19 ) : 4257. salarvand pournia ( 2014 ) percept medic univer- siti member nutrit health quran . iranian red crescent medic journal 16 ( 4 ) : e10846 . tarighat-esfanjani namazi n ( 2016 ) nutrit concept frequenc foodstuff mention holi quran . journal religion health 55 ( 3 ) : 812 \u2013819 . tong , sainsburi p craig j ( 2007 ) consolid criteria report qualit research ( coreq ) : 32-item checklist interview focu group . intern journal qualiti health care 19 ( 6 ) : 349 \u2013357 . world health organ ( 2022 ) engag faith partner health emerg : interim implement tool . avail : http : \/\/www.who . int\/europe\/publications\/i\/ item\/who-euro-2022-6281-46046-66590 ( access 21 june 2023 ) .8 nutrit health 0 ( 0 )",
  "uk cost -effect analysi endoscop sleev gastroplasti versu lifestyl modif alon adult class ii obes kelli , j . , menon , v. , o'neil , f. , elliot , l. , comb , e. , drinkwat , w. , abbott , s. & haye , b. publish pdf deposit coventri univers \u2019 repositori origin citat : kelli , j , menon , v , o'neil , f , elliot , l , comb , e , drinkwat , w , abbott , & haye , b 2023 , 'uk cost -effect analysi endoscop sleev gastroplasti versu lifestyl modif alon adult class ii obes ' , intern journal obes , vol . ( -press ) , pp . ( -press ) . http : \/\/dx.doi.org\/ 10.1038\/s41366 -023-01374 -6 doi 10.1038\/s41366 -023-01374 -6 issn 0307 -0565 essn 1476 -5497 publish : springer natur articl licens creativ common attribut 4.0 intern licens , permit use , share , adapt , distribut reproduct medium format , long give appropri credit origin author ( ) sourc , provid link creativ common licens , indic chang made . imag third parti materi articl includ articl \u2019 creativ common licens , unless indic otherwis credit line materi . materi includ articl \u2019 creativ common licens intend use permit statutori regul exce permit use , need obtain permiss directli copyright holder . view co py licens , visit http : \/\/creat ivecommons.org\/licenses\/by\/4.0\/ articl open health econom uk cost-effect analysi endoscop sleev gastroplasti versu lifestyl modi \ufb01cation alon adult class ii obes jami kelly1\u2709 , vinod menon2,3 , frank \u2019 neill4 , laura elliot5 , emili combe5 , drinkwater5 , salli abbott2,6and buhussain hayee7 \u00a9 crown 2023 background : endoscop sleev gastroplasti ( esg ) minim invas procedur demonstr merit randomis , control trial result substanti durabl addit weight loss adult obes compar lifestyl modi \ufb01cation ( lm ) alon . sought conduct \ufb01rst cost-effect analysi esg versu lm alon adult class ii obes ( bmi 35.0 \u201339.9 kg\/m2 ) nation healthcar system perspect england base result studi . method : 6-state markov model develop compris 5 bmi-bas health state absorb death state . baselin characterist , util , transit probabl inform patient-level data subset patient class ii obes merit . advers event ( ae ) base merit safeti popul . mortal estim appli bmi- speci \ufb01c hazard ratio publish literatur uk gener popul mortal rate . util healthi weight overweight health state inform literatur ; disutil associ increas bmi class i-iii obes health state estim use merit util data . disutil due ae preval obesity-rel comorbid base literatur . cost includ intervent cost , ae cost , comorbid costs.result : e gr e u l e di nh g h e ro v e r l lc st h nl l n eb u tl e dt oa ni n creas quality-adjust life year ( qali ) . increment cost-effect ratio ( icer ) esg vs lm alon \u00a32453\/qali ga ine . esg consist cost effect across wide rang sensit analys , icer estim exceed \u00a310,000\/qali ga ine . probabilist sensit analysi , mean icer \u00a32502\/ qali gain esg remain cost effect ive 98.25 % iter willingn ess-to-pay threshold \u00a320,000\/qali . conclus : studi indic esg highli cost effect versu lm alon treatment adult class ii obes england . intern journal obes ; http : \/\/doi.org\/10.1038\/s41366-023-01374-6 background grow obes epidem lead caus death anddis europ , uk one highest reportedobes rate region [ 1 ] . data health survey england 2021 show one-quart ( 25.9 % ) adult england live obes [ 2 ] . obes major risk factor mani chronic diseas includ type 2 diabet cardiovasculardiseas , associ reduc qualiti life increas risk prematur death [ 3,4 ] . multi-compon manag lifestyl modi \ufb01cation ( lm ) compris diet , physic exercis , behaviour therapi ( \u00b1pharmacolog treatment ) standard \ufb01rst-line treatment adult obes [ 5,6 ] . howev , result weight loss typic modest usual maintain , bariatr surgeri often neededto achiev substanti sustain weight reduct necessari signi \ufb01cantli improv gener health [ 5,6 ] .contemporari guidelin american societi metabol bariatr surgery\/intern feder thesurgeri obes metabol disord broadli recommendbariatr intervent adult class ii obes ( bodi mass index [ bmi ] 35.0 \u201339.9 kg\/m 2 ) regardless presenc , absenc , sever obesity-rel comorbid [ 5 ] . notabl , non- surgic treatment describ guidelin \u2018 ineffect \u2019 achiev adequ weight loss peopl class ii obes . guidelin uk nation institut health care excel ( nice ) recommend consider ofbariatr intervent alongsid intens \u2018 tier 3 \u2019 weight manag programm deliv multidisciplinari team adult class ii obes [ 6 ] . elig , patient class ii obes requir least one obesity-relatedcomorbid non-surg weight manag measur achiev maintain clinic bene \ufb01cial weight loss . howev , receiv : 22 februari 2023 revis : 8 august 2023 accept : 23 august 2023 1univers hospit southampton nh foundat trust , southampton , uk.2univers hospit coventri & warwickshir nh foundat trust , coventri , uk.3univers warwick , coventri , uk.4apollo endosurgeri uk ltd , knaresborough , uk.5fiecon ltd , st alban , uk.6research centr healthcar commun , institut health wellb , coventri univers , coventri , uk.7k \u2019 colleg hospit nh foundat trust , london , uk.\u2709email : jamiekelli @ doctors.org.ukwww.nature.com\/ijo intern journal obesity1234567890 ( ) ; , :the guidelin recommend bariatr surgeri publish almost decad ago comprehens review\/ updat underway [ 7 ] . sever bariatr procedur avail use uk clinic practic ( includ roux-en-i gastricbypass , laparoscop sleev gastrectomi , gastric band ) [ 8 ] . howev , invas , associ risk post-op complic , hesit undergo surgeri perspect patient common [ 5,9,10 ] . , 20 % procedur record uk nation bariatr surgeri registrydur 2013-2018 perform day case , patient typic requir inpati admiss 2 3 day [ 8 ] . obes disproportion affect depriv commu- niti england [ 2,8 ] . desogu et al , estim 7.8 million peopl england would met nice \u2019 elig criteria bariatr surgeri 2014 [ 11 ] . howev , wide acknowledg access bariatr servic within nh heavili rationedbi clinic commiss group england fewer 5000 nhs-fund procedur record nation bariatr surgeri registri 2019 , suggest demand far outstripscapac [ 8,12,13 ] . endoscop sleev gastroplasti ( esg ) minim invas procedur use full-thick sutur reduc gastric capac delay empti [ 14 ] . multipl meta-analys demonstr esg effect safe method weightloss peopl obes [ 15,16 ] . merit randomis , control trial ( rct ) rct conduct date evalu effect safeti esg , wasperform studi use \ufb01rst approv esg devic ( overstitch tm ; apollo endosurgeri , austin tx , us ) [ 14 ] . cohort 209 adult class class ii obes ( bmi30.0 \u201339.9 kg\/m2 ) histori unsuccess attempt weight loss conserv method , esg alongsid lm result rapid sustain addit excess weight loss versu lm alon , well improv obesity-rel comorbidities.us esg treatment obes subject anupcom review nice via intervent procedur apprais programm [ 17 ] . whilst numer cost-effect analys bariatr intervent obes beenprevi publish [ 18,19 ] , none evalu esg . aim provid \ufb01rst cost-effect analysi esg uk leverag data merit rct . \ufb01nding studyar expect relev futur clinic econom decis make uk , could potenti inform ongo nice obes guidelin updat . method cost-util analysi conduct uk ( england ) popul line nice refer case [ 20 ] . includ adopt nation health servic ( nh ) person social servic perspect cost , measuringhealth bene \ufb01t quality-adjust life year ( qali ) , use lifetim time horizon , appli 3.5 % annual discount rate cost health effect . increment cost-effect ratio ( icer ) estim cost effect evalu use lower bound ofth \u00a320,000 \u201330,000\/qali willingness-to-pay threshold rang adopt nice [ 21 ] . report align consolid health econom evalu report standard ( cheer ) checklist ( tabl s1 ) [ 22 ] . analysi consid cost effect esg alongsid lm versu lm alon base merit rct model popul limit patient class ii obes ( i.e. , could potenti beelig esg per current intern uk guidelin ) . meritsubgroup ( n=115 ) , mean age baselin 42 year ( rang 20 \u201364 ) , mean bmi 37.5 ( rang 34.33 \u201339.91 ) , 14.0 % particip male ; total 58.1 % hypertens , 33.0 % type 2 diabet , and20.0 % sleep apnoea [ 23 ] . comparison esg lm alon model relev merit rct conduct date evalu effect andsafeti esg repres robust sourc clinic evid onth procedur . model , lm \ufb02ect tier 3 weight manag servic recommend nice clinic guidelin [ 6 ] . typic administ 2-year durat compris specialist physician , dietician , specialist nurs , clinic psychologist access physic therapi [ 24 ] . esg procedur assum perform use devic ( i.e. , overstitch \u2122 ) outpati set merit studi . author jk , vm , sa bh provid expert clinic advic valid model structur , inputs\/assumpt , plausibl result . giventh technic model natur studi , patient group input solicit model develop , though result present obes uk . model de novo 6-state markov model develop microsoft \u00aeexcel includ 5 bmi-bas health state absorb death state ( fig . 1 ) . simul cohort 1000 patient enter model class ii obes healthi weight ( bmi 18.5-24.9 kg\/m2 ) overweight ( bmi 25.0-34.9 kg\/m2 ) obes ( bmi 30.0-34.9 kg\/m2 ) obes ii ( bmi 35.0-39.9 kg\/m2 ) obes iii ( bmi > 40.0 kg\/m2 ) deathpati enter model esglifestyl modif alon fig . 1 model schemat . patient enter model obes ii health state receiv either esg lifestyl modi \ufb01cation alon . base model transit probabl , model cycl patient either move adjac obes health state ( death state ) remainin obes health state . bmi bodi mass index , esg endoscop sleev gastroplasty.j . kelli et al . 2 intern journal obesityt 1. summari model clinic input . paramet paramet valu sourc baselin characterist age ( year ) , mean ( se ) 46 ( n\/a ) [ 23 ] male sex , % ( se ) a14 ( 3 ) incid sever advers eventb [ 9 ] abdomin abscess , % ( se ) esg 1.18 ( n\/a ) lm alon 0.00 ( n\/a ) upper gastrointestin bleed , % ( se ) esg 1.18 ( n\/a ) lm alon 0.00 ( n\/a ) malnutrit , % ( se ) esg 1.18 ( n\/a ) lm alon 0.00 ( n\/a ) bmi-speci \ufb01c mortal risk health statec healthi weight , hazard ratio ( se ) 1.00 ( refer ) [ 27 ] overweight , hazard ratio ( se ) 1.00 ( 0.03 ) obes , hazard ratio ( se ) 1.12 ( 0.01 ) obes ii , hazard ratio ( se ) 1.36 ( 0.01 ) obes iii , hazard ratio ( se ) 1.88 ( 0.03 ) comorbid preval health state type 2 diabet , % ( se ) healthi weight 2.30 ( 0.46 ) [ 59 ] overweight 6.20 ( 1.24 ) obes 13.20 ( 2.64 ) obes ii 18.60 ( 3.72 ) obes iii 25.70 ( 5.14 ) hypertens , % ( se ) healthi weight 45.00 ( 9.00 ) [ 30 ] overweight 67.00 ( 13.40 ) obes 79.00 ( 15.80 ) obes ii 79.00 ( 15.80 ) obes iii 87.00 ( 17.40 ) sleep apnoea , % ( se ) healthi weight 0.20 ( 0.04 ) [ 31 ] overweight 0.51 ( 0.10 ) obes 0.51 ( 0.10 ) obes ii 0.51 ( 0.10 ) obes iii 4.67 ( 0.93 ) gastro-oesophag \ufb02ux diseas , % ( se ) healthi weight 11.17 ( 2.23 ) [ 60 ] overweight 21.13 ( 4.23 ) obes 26.69 ( 5.34 ) obes ii 26.58 ( 5.32 ) obes iii 26.58 ( 5.32 ) non-alcohol fatti liver diseas healthi weight 0.09 ( 0.02 ) [ 61 ] overweight 0.34 ( 0.07 ) obes 0.72 ( 0.14 ) obes ii 0.72 ( 0.14 ) obes iii 0.72 ( 0.14 ) bmibodi mass index , esgendoscop sleev gastroplasti , lmlifestyl modi \ufb01cation . adata subset patient class ii obes enrol merit studi . bdata merit safeti popul compris patient underw esg . standard error applic estim incid indivi dual advers event , multipli separ cost disutil advers event determin total cost total disutil advers event treatment . total vari one-way sensit analysi assum standard error \u00b120 % . cbmi-speci \ufb01c all-caus mortal hazard ratio report bhaskaran et al. , [ 27 ] < 1.00 ( 0.94 ) overweight health state . would appropri use model hazard ratio appli gener popul mortal rate would therefor result lower mortal overweight health state gener popul . , hazard ratio overweight health state assum 1.00 match thehealthi weight health state ( refer group ) . dsee tabl s5 , s6 , s7 detail calcul comorbid preval rate model health state ; preval estim differ model health state sourc public report preval accord bmi group use de \ufb01ne model health state.j . kelli et al . 3 intern journal obesityst ; patient could transit model state depend chang weight risk death model time horizon ( 100year minu mean age model patient baselin ) . cycl length of6 month use \ufb01rst year order \ufb02ect immedi weight loss observ esg annual cycl use thereaft . ahalf-cycl correct appli account fact event andtransit could occur point cycl . clinic paramet model clinic input paramet valu summaris tabl 1and fig.2 . model baselin characterist ( age sex ) bmi group data requir calcul health state transit probabl 6 month , 1 year , 2 year base patient-level data subgroup ofpati class ii obes merit studi [ 23 ] . last observ carri forward approach use imput miss bmi data eachtimepoint , provid last observ \u226410 week timepoint ( patient last observ > 10 week timepoint exclud ) . \ufb01rst year 6-month cycl use , event miss data week 26 ( 6 month ) , valu taken order ofprefer observ week 24 , week 30 , week 16 , wereal monitor visit consid suf \ufb01cient captur weight loss associ esg . merit studi 2-year follow-up durat withavail data lm alon limit \ufb01rst year patient randomis lm permit cross receiv esg . consequ , assumpt requir extrapol transit probabl remaind model time horizon . weight losswa assum plateau 2 year ( bmi remain constant thereaft ) 80 % model patient receiv esg . account thepotenti weight regain follow esg , remain 20 % patientsreceiv esg assum gradual return baselin bmi 5 yearsbas recent systemat review meta-analysi studi assessingweight regain follow bariatr surgeri [ 25 ] . weight regain assum occur patient receiv lm 1 year bmi gradual return baselin bmi 5 year , consist approach taken nice \u2019 apprais liraglutid manag obes [ 26 ] . advers event ( ae ) includ model base incid sever ae occur merit safeti populationcompris studi particip [ 14 ] . result inclus abdomin abscess , upper gastrointestin bleed , malnutrit ae esg , ae lm . merit studi includ rel small sampl size , death observ 2-year follow-up period . mortal ( fig . s1 ) wastherefor estim appli bmi-speci \ufb01c mortal risk larg uk population-bas cohort studi identi \ufb01ed pragmat literatur search [ 27 ] age\/sex-match gener popul mortal rate 2021 \ufb01ce nation statist [ 28 ] . merit studi similarli provid suf \ufb01cient data inform model input preval obesity-rel comorbid . preval comorbid eachhealth state therefor estim use bmi-speci \ufb01c rate identi \ufb01ed pragmat literatur search . comorbid includ modelwer type 2 diabet [ 29 ] , hypertens [ 30 ] , sleep apnoea [ 31 ] , non- alcohol fatti liver diseas [ 32 ] , gastro-oesophag \ufb02ux diseas [ 33 ] . given limit sampl size merit studi , model subgroup analys conducted.01002003004005006007008009001000 1 3 5 7 9 1 11 31 51 71 92 12 32 52 72 93 13 33 53 73 94 14 34 54 74 95 15 3number patient cyclea 01002003004005006007008009001000 1 3 5 7 9 1 11 31 51 71 92 12 32 52 72 93 13 33 53 73 94 14 34 54 74 95 15 3number patient cycl overweight obes obes ii obes iii deadb fig . 2 health state transit esg lifestyl modi \ufb01cation alon model time horizon . proport model patient health state cycl model time horizon shown esg ( ) lifestyl modi \ufb01cation alon ( b ) . healthi weight health state includ patient project enter health state timepoint model time horizon . esg endoscop sleev gastroplasti , lm lifestyl modi \ufb01cation.j . kelli et al . 4 intern journal obesityutil eq-5d nice \u2019 prefer measur health-rel qualiti life inform cost-util analys [ 20 ] . sf-36 data collect merit directli map eq-5d use map algorithm thatfrom rowen et al . [ 34 ] . therefor conduct analysi patient-level sf-36 data class ii obes merit subgroup use algorithm toinform health state util valu ( tabl s2 ) . limit number patientstransit overweight health state ( n=28 ) patient transit healthi weight health state studi follow-up . , sf-36 data merit consid inadequ derivingutil estim health state ; model paramet valu ( tabl 2 ) instead inform larg uk population-bas cohort studi fromstephenson et al , 2021 identi \ufb01ed pragmat literatur search associ bmi qualiti life [ 35 ] . , directli map merit sf-36 data , result util estim higher report stephenson et al , ( tabl s2 ) , like due toth ceil effect [ 36 ] . therefor , line nice technic guidanc [ 37 ] , linear mixed-effect model use estim incrementaldisutil associ increas bmi obes i-iii health state ( tabl s3 ) . disutil appli overweight health stateutil valu taken stephenson et al , deriv health state util valu obes i-iii health state ( tabl 2and tabl s4 ) . disutil also appli esg-rel ae , valu abdomin abscess , upper gastrointestin bleed , malnutrit ( tabl 2 ) identi \ufb01ed pragmat literatur search [ 38\u201340 ] . given one-off natur procedur , disutil appli cycl 1 . avoid doubl count , comorbidity-associ disutil assum alreadi captur bmi-bas health state util valu . cost cost includ model \ufb02ect intervent cost esg lm , cost associ manag ae , cost associ treatment obesity-rel comorbid ( tabl 2 ) . base 2020\/21 unit cost possibl ; older cost \ufb02ate 2020\/21 valu use nh cost \ufb02ation index [ 41 ] . esg cost base cost devic hospit cost associ deliveri procedur . cost lm appli toboth treatment group base tier 3 weight manag , tabl 2. summari model cost util input . paramet paramet valu sourc cost input intervent cost esg devic procedur costsa\u00a34287.00 [ 62 ] lifestyl modi \ufb01cation costsb , c\u00a3224.85 [ 41,42 ] advers event cost ( per event ) abdomin abscess \u00a3821.91 [ 42 ] upper gastrointestin bleed \u00a31786.28 [ 42 ] malnutrit \u00a31988.00 [ 42 ] comorbid cost ( annual cost per patient ) type 2 diabet \u00a32129.00 [ 29 ] hypertensione\u00a336.19 [ 43\u201346 ] sleep apnoeaf , g\u00a31537.42 [ 31 ] gastro-oesophag \ufb02ux diseas \u00a3389.20 [ 33 ] non-alcohol fatti liver diseaseg\u00a3397.53 [ 32 ] util input health state util valu , mean ( se ) healthi weight 0.85 ( 0.001 ) [ 35 ] overweight 0.81 ( 0.002 ) [ 35 ] obes ih0.78 ( 0.030 ) [ 23,34,35 ] obes iih0.70 ( 0.030 ) [ 23,34,35 ] obes iiih0.61 ( 0.040 ) [ 23,34,35 ] advers event disutil valu , mean ( se ) abdomin abscess 0.13 ( n\/a ) [ 40 ] upper gastrointestin bleed 0.15 ( n\/a ) [ 38 ] malnutrit 0.08 ( n\/a ) [ 39 ] total advers event disutil valu , mean ( se ) esg 0.004 ( 0.001 ) [ 40 ] lifestyl modi \ufb01cation alon 0.000 ( 0.000 ) [ 40 ] cost 2020\/21 valu . esgendoscop sleev gastroplasti . ainclud devic cost , pre-op assess , surgeon\/assist time , anaesthet , post-op gastroscopi , post-discharg medic ation . bsee tabl s8 breakdown individu cost compon , calcul , sourc . cannual cost appli esg lifestyl modi \ufb01cation alon group durat model horizon . done-off esg procedure-rel advers event cost disutil appli cycl 1 . standard error applic individu advers e vent disutil , appli model total treatment-rel advers event disutil ; total vari one-way sensitiv iti analysi assum standard error \u00b120 % . ese tabl s9 breakdown cost compon , calcul , sourc . faverag ( mean ) report cost hrg code dz18d , dz18e , dz18f dz18g . gcost \ufb02ate 2019 valu ( sleep apnoea ) 2016 valu ( non-alcohol fatti liver diseas ) 2020\/21 valu . hhealth state util estim calcul appli disutil gener linear mixed-effect regress model overweight healt h state util valu ( 0.81 ) report stephenson et al . [ 35 ] .j . kelli et al . 5 intern journal obesityinclud healthcar profession visit , cost categori ( gp consulta- tion , nurs consult , dietician consult , specialist consult , consult , blood count ) frequenc visit taken nice \u2019 apprais liraglutid [ 26 ] . cost clinic psychologist visit also incorpor base feedback clinic expert author routin offer tier 3 weight manag servic . cost ofeach compon sourc person social servic research unit2021 unit cost nh england 2020\/21 refer cost applic [ 41,42 ] . model captur subsequ obes treatment cost ( e.g. , bariatr procedur elig patient treatment result adequ durabl weight loss ) , lm cost assum beincur treatment group durat model horizon.although expect proport patient compliantwith lm medic advic lifestyl dietari chang thedur intervent , 100 % complianc rate assum absenc robust data . cost manag obesity-rel comorbid base annual cost identi \ufb01ed pragmat literatur search [ 29,31\u201333,43\u201346 ] . annual cost combin previous describ comorbid preval rate estim total comorbiditycost treatment per health state per model cycl ( tabl s10 ) . costsfor manag sever ae appli one-off cost cycl 1 sourc nation cost collect 2020\/21 [ 42 ] . sensit scenario analys determinist one-way sensit analys ( owsa ) conduct model paramet across rang equal 95 % con \ufb01denc interv . mostli calcul use standard error \u00b120 % ofth mean valu paramet . except health state util valu sourc literatur ( healthi weight overweight health state ) calcul ( remaininghealth state ) , mortal hazard ratio standard errorwa calcul . result plot tornado diagram identifi keydriv cost effect . probabilist sensit analysi conduct use 10.000 iter characteris overal uncertainti cost-effect result , valu paramet simultan drawn individu uncertainti distribut . result plot increment cost-effect plane scatter plot visualis uncertainti cost-effect accept curv gener show probabl ofesg cost effect rang willingness-to-pay threshold ( \u00a30 \u201350,000\/qali ) . full list model paramet includ uncertainti distribut provid supplementari materi . scenario analys conduct explor structur uncertainti relat import model assumptions\/input includ use alter-n long-term bmi extrapol . addit scenario analys includedus gener popul mortal rate without adjust accountfor impact bmi mortal risk ( bmi-speci \ufb01c mortal hr set 1 ) , use altern map algorithm ara brazier , 2008 [ 47 ] , health state util estim base valu report stephenson et al . threshold analysi conduct estim high total esg device\/procedur cost would need icer exceed the\u00a320,000\/qali willingness-to-pay threshold . result base-cas analysi , esg associ \u00a33024 highercost lm alon result 0.31 addit life year and1.23 addit qali , lead icer \u00a32453\/qali gain ( tabl 3 ) fall well willingness-to-pay threshold \u00a320,000\/qali . rel low increment cost esg isattribut esg intervent ae cost partli offsetbi save comorbid cost . probabilist sensit analysi , increment cost qali 10,000 model iter shown theincrement cost-effect plane ( fig . s2 ) result mean icer \u00a32502\/qali gain , consist base-cas analysi . , esg remain cost effect 98.25 % ofiter willingness-to-pay threshold \u00a320,000\/qalygain . cost-effect accept curv ( fig . s3 ) showedthat base-cas model input , esg like cost effect willingness-to-pay threshold \u00a33000\/qalygain . result owsa ( fig . 3 ) demonstr base-cas analysi broadli insensit chang individu inputparamet result icer rang \u00a31540 \u00a35585\/qali gain . paramet greatest impact icer health state util valu preval type 2 diabet obes ii health state . theremain paramet , owsa show tight interv around base-cas estimate.t 3. determinist base-cas key scenario analysi result . cost ( \u00a3 ) life yearsqali icer ( \u00a3\/qali ) base-cas result esg 19,558 21.257 15.909 lm alon 16,534 20.943 14.676 increment ( esg vs lm ) 3024 0.314 1.233 2453 scenario 1 : altern bmi extrapol esg ( bmi plateau follow end trial observ period 100 % patient ) esg 19,321 21.324 16.140 lm alon 16,534 20.943 14.676 increment ( esg vs lm ) 2787 0.381 1.464 1903 scenario 2 : altern bmi extrapol esg ( 30 % patient return baselin bmi year 5 ) esg 19,681 21.222 15.789 lm alon 16,534 20.943 14.676increment ( esg vs lm ) 3147 0.279 1.113 2828 scenario 3 : altern bmi extrapol esg lm ( bmi plateau follow end trial observ period 100 % patient ) esg 19,321 21.324 16.140 lm alon 16,480 20.959 14.788 increment ( esg vs lm ) 2840 0.366 1.352 2101 scenario 4 : health state bmi mortal risk adjust appli gener popul mortal estim ( hr set 1 ) esg 19,977 21.772 16.279 lm alon 17,221 21.772 15.256 increment ( esg vs lm ) 2757 0.000 1.023 2696 scenario 5 : health state util valu stephenson et al , 2021 [ 35 ] esg 19,558 21.257 15.649 lm alon 16,534 20.943 15.318increment ( esg vs lm ) 3024 0.314 0.331 9134 scenario 6 : use altern sf-36 eq-5d map algorithm ara brazier , 2008 [ 47 ] esg 19,558 21.257 15.625 lm alon 16,534 20.943 14.259increment ( esg vs lm ) 3024 0.314 1.365 2215 bmibodi mass index , esgendoscop sleev gastroplasti , hrhazard ratio , icer increment cost-effect ratio , lmlifestyl modi \ufb01cation , qali quality-adjust life year.j . kelli et al . 6 intern journal obesityresult scenario analys ( tabl 3and tabl s14 ) also consist show esg cost effect versu lm alon . useof conserv long-term weight loss extrapol esg 30 % patient return baselin bmi 5 year result modest increas icer , even scenarioswith highli conserv weight regain assumpt esg ( withup 70 % patient return baselin bmi 5 year ) , result icer estim consist < \u00a36000\/qali gain . convers , use optimist extrapol esg lmalon ( bmi plateau 100 % patient weight regain occur gradual 10 year esg ) result modest chang icer . use gener popul mortalityr without adjust potenti impact bmi onmort ( bmi-speci \ufb01c mortal hr set 1 ) use altern map algorithm estim health state util valu obes i-iii health state similarli result modestchang icer . base health state util estim thevalu report stephenson et al , 2021 result increas icer \u00a39134\/qali gain highest icer estim across sensit scenario analysi , thoughthi remain well assum \u00a320,000\/qali threshold . threshold analysi cost associ esg device\/ procedur show cost would need \ufb01ve-tim higher base-cas analysi ( > \u00a325,926 ) icer exceed \u00a320,000\/qali willingness-to-pay threshold . discuss key\ufb01nd analysi suggest , perspect uk healthcar payer , esg highli cost effect compar lmalon treat adult class ii obes . base-cas icerwa \u00a32453\/qali gain , fall well lower bound nice \u2019 typic willingness-to-pay threshold rang ( \u00a320,000\/qali ) . sensit scenario analys broadli insensit tochang model input assumpt , consist demon- strate cost effect esg versu lm alon icer estim exceed \u00a310,000\/qali . use rct evid toinform key model input repres strength analysi , consist result across wide rang sensit andscenario analys conduct suggest overal \ufb01nding esg cost effect compar lm alon robust . util estim obes obes ii health state estim preval type 2 diabet health stateshad largest impact icer owsa . \ufb01nding model input among largest impact icer unsurpris patient project spend themodel time horizon health state ( esg , obes ; lm , obes ii ) type 2 diabet associ highest manag cost comorbid includ model.th merit rct demonstr esg result improv indiabet 93 % patient diabet baselin compar 15 % patient randomis lm alon [ 14 ] . long-term follow-up data sleevepass rct compar theoutcom weight loss remiss obesity-relatedcomorbid roux-en-i gastric bypass versu laparoscop sleev gastrectomi show approxim one-third ( 26 % 33 % ) patient diabet baselin achiev andmaintain diabet remiss 10 year follow theprocedur [ 48 ] . togeth , \ufb01nding suggest substanti addit weight loss observ esg like result reduc rate diabet associ cost savingscompar lm alon longer term , consist model project . merit rct conduct us lm base mayo clinic health programm includ low-caloriediet plan physic activ counsel customis individu [ 14 ] . given modest weight loss typic observ lm , weight loss outcom merit lm arm wereconsid generalis uk set tier 3 weightmanag use . addit , patient merit class ii obes subgroup least one obesity-rel comorbid baselin , consist nice \u2019 current elig criteria bariatr intervent [ 14 ] . , mean baselin age 42 year ( rang 20 \u201364 year ) high proport femal model popul ( 86 % ) broadli consist with0 1000 2000 3000 4000 5000 6000 util : obes ii ( 0.640 , 0.757 ) util : obes ( 0.719 , 0.836 ) type 2 diabet preval : obes ii ( 12 % , 26 % ) type 2 diabet preval : obes ( 8 % , 19 % ) annual cost type 2 diabet ( \u00a31377.78 , \u00a33041.07 ) gastro-oesophag reflux diseas preval : obes ii ( 17 % , 38 % ) gastro-oesophag reflux diseas preval : obes ( 17 % , 38 % ) hypertens preval : obes ii ( 41 % , 99 % ) hypertens preval : obes ( 41 % , 99 % ) type 2 diabet preval : overweight ( 4 % , 9 % ) gastro-oesophag reflux diseas preval : overweight ( 13 % , 30 % ) lifestyl modif alon mortal hr : obes ii ( 1.330 , 1.380 ) type 2 diabet preval : obes iii ( 16 % , 36 % ) sleep apnoea preval : obes ii ( 0 % , 1 % ) sleep apnoea preval : obes ( 0 % , 1 % ) esg mortal hr : obes ( 1.100 , 1.130 ) esg advers event total cost cycl 1 ( \u00a334.99 , \u00a377.24 ) util : obes iii ( 0.530 , 0.687 ) esg mortal hr : obes ii ( 1.330 , 1.380 ) hypertens preval : overweight ( 39 % , 90 % ) icer ( \u00a3\/qali gain ) esg versu lm alon lower bound ( \u00a3 ) upper bound ( \u00a3 ) fig . 3 determinist one-way sensit analysi result tornado plot . tornado plot gener one-way sensit analysi show impact icer chang individu model input paramet lower upper bound 95 % con \ufb01denc interv ( shown parenthes next paramet plot ) . given neglig impact paramet icer plot limit 20 impact model paramet breviti . esg endoscop sleev gastroplasti , hr hazard ratio , qali quality-adjust life year.j . kelli et al . 7 intern journal obesityuk clinic practic base data uk nation bariatr surgeri registri show 76 % peopl undergo bariatr surgeri obes england 2010 \u20132019 femal averag age time bariatr surgeri inengland approxim 46 year ( rang 18 \u201361 year ) [ 8 ] . per nice refer case [ 20 ] , direct cost consid analysi account substanti indirect cost obes patient societi , sucha wide report wage penalti disproportionatelyaffect women [ 49 ] . consist studi best knowledg \ufb01rst publish cost- effect analysi esg . \ufb01nding esg cost effect versu lm alon broadli consist publish uk-bas econom evalu bariatr procedur severeobes consist shown cost effect versu lm intervent cost partli offset longer-term cost save manag obesity-rel comorbid [ 19,50,51 ] . also adapt cost-effect analysi re\ufb02ect us healthcar set similar result ( manuscript develop ) [ 52 ] , suggest overal \ufb01nding broadli generalis develop countri . polici makersshould take account consist studi haveshown bariatr procedur includ esg repres cost- effect use healthcar resourc compar lm alon determin polici fund use bariatricintervent clinic practic . limit typic case rct-base cost-util analys , long-term health effect beyond durat merit studi extrapol , introduc uncertainti analysi . whilst durabl total bodi weight loss longer term esg hasbeen shown previou 5-year prospect cohort studi bysharaiha et al [ 53 ] , recidiv follow modest initi weight loss often observ lm alon [ 53\u201356 ] . inclus weight regain assumpt 20 % patient receiv esg basecas repres strength analysi . highlight byavenel et al [ 18 ] , previou econom evalu obes assum perman weight loss like overestim intervent \u2019 cost effect . notabl , scenario analys esg remain cost effect even conserv weight regain assumpt esg ( includ highli conserv scenario 70 % patient return baselin bmibi 5 year ) use shorter model time horizon . insuf \ufb01cient data merit studi bmi rang inform healthi weight overweight health state calcul health state util valu . , thehealth state util valu health state inform byvalu report stephenson et al [ 35 ] . remain health state ( obes i-iii ) , util estim appli disutil overweight health state gener mixed-effectsmodel . limit number merit observ remain health state util valu calcul repres anoth sourc uncertainti analysi . also insuf \ufb01cient data merit studi directli estim mortal rate obesity-rel comorbid . shown one-way sensit analysi scenario analysi use unadjust gener populationmort rate , impact bmi mortal risk akey driver cost effect model . comorbid rate sourc literatur limit comorbid includ model , preval rate werereport bmi rang span multipl model health state . approach also allow us explicitli model complex multifactori relationship bariatr proce-dur induc weight loss diseas remiss among peoplewith pre-exist comorbid baselin . addit , cardio- vascular diseas import obesity-rel comorbid , identifi suitabl data literatur compat model structur generalis toth uk set . mani condit also shown beindepend associ increas bmi [ 57,58 ] . inclus limit number obesity-rel comorbid model could potenti bias analysi esg owe toth failur account addit potenti comorbid costsav . lastli , given model popul alreadi restrict merit class ii obes subgroup ( n= 115 ) , includ 14 % male particip , consid methodolog appropriateto conduct model subgroup analys accord addit characterist sex age could potenti impact cost effect esg . futur research futur research could valid \ufb01nding reduc uncertainti estim includ longer-term randomisedstudi esg bmi-bas health state transit probabl , comorbid rate , potenti even mortal could estim use directli model validatevalu deriv literatur . randomis studi evaluatingth impact esg-induc weight loss health-rel qualiti life larger set observ captur merit cost\/resourc use studi could provid preciseestim long-term cost associ esg lm would also bring addit certainti \ufb01nding . distribut effect formal evalu model , though avail esg routin perform aday case procedur could potenti help improv ef \ufb01cienci nh servic deliveri reduc health inequ . well conduct studi provid evid compar effective-ness\/safeti ( includ risk post-procedur complic ) , impact health-rel qualiti life , costs\/resourc use ( e.g. , length inpati stay ) need inform robust econom evalu esg versu bariatr procedures.given common patient concern risks\/complicationsassoci surgeri , incorpor patient prefer econom evalu also import . conclus studi indic esg highli cost effect versu lmalon treatment adult class ii obes england . inth context ration access nhs-fund bariatr servic obes , avail effect safe intervent routin deliv day case procedur would repres avalu addit complement current routin practic . data avail except detail cost data esg commerci sensit includ , relev data gener studi areinclud publish articl supplementari inform \ufb01le . model \ufb01le publicli avail contain commerci sensit data , copi model commerci sensit data remov avail thecorrespond author reason request . formal health econom analysisplan avail none develop advanc studi . refer 1. world health organ . european region obes report 2022 . 2022. http : \/\/www.who.int\/europe\/publications\/i\/item\/9789289057738 . access 28 nov 2022 . 2. baker c obes statist . : hous common librari . research brie \ufb01ng . 2023. http : \/\/commonslibrary.parliament.uk\/research-bri \ufb01ngs\/sn03336\/ . access 15 feb 2023.j . kelli et al . 8 intern journal obesity3 . donini lm , rosano , di lazzaro l , lubrano c , carbonelli , pinto , et al . impact disabl , psycholog statu , comorbid health-relatedqu life perceiv subj ect obes . obe fact . 2020 ; 13:191 \u2013200 . 4. tobia dk , hu fb . associ bmi mortal : implic obes prevent . lancet diabet endocrinol . 2018 ; 6:916 \u20137 . 5. eisenberg , shikora sa , aart e , aminian , angrisani l , cohen rv , et al . american societi metabol bariatr surgeri ( asmb ) internationalfeder surgeri obes metabol disord ( ifso ) indicationsfor metabol bariatr surgeri . surg obe relat di . 2022 ; 18:1345 \u201356 . 6. nation institut health care excel . obes : identi \ufb01cation , assess- ment manag ( cg189 ) . 2022. http : \/\/www.nice.org.uk\/guidance\/cg189 . access 7 jan 2023 . 7. nation institut health care excel . final scope . : weight man- agement : prevent , assess manag overweight obes ( updat ) .in develop [ gid-ng10182 ] . 2021. http : \/\/www.nice.org.uk\/guidance\/ indevelopment\/gid-ng10182\/docu . access 18 nov 2022 . 8. nation bariatr surgeri registri . uk nation bariatr surgeri registri third registri report . 2020. http : \/\/www.e-dendrite.com\/nbsr2020 . access 18 nov 2022 . 9. beran , matar r , jaruvongvanich v , rapaka bb , alalwan , portela r , et al . compar effect safeti endoscop sleev gastroplastyand laparoscop sleev gastrectomi : meta-analysi 6775 individu obes . obe surg . 2022 ; 32:3504 \u201312 . 10. quealli , doherti e , finucan f , \u2019 neill c. prefer weight loss treatment amongst treatment-seek patient sever obes : discret choiceexperi . appl health econ health polici . 2020 ; 18:689 \u201398 . 11. desogu , menon v , singhal r , oyebod o. examin elig receiv bariatr surgeri england : secondari analysi health survey england dataset . obe surg . 2019 ; 29:3246 \u201351 . 12. pillutla v , maslen h , savulescu j. ration elect surgeri smoker obes patient : respons prognosi ? bmc med ethic . 2018 ; 19:28 . 13. owen-smith , coast j , donovan jl . self-respons , ration treatment decis make - manag moral narr alongsid \ufb01scal realiti obes surgeri clinic . health expect . 2018 ; 21:606 \u201314 . 14. abu dayyeh bk , bazerbachi f , varga ej , sharaiha rz , thompson cc , thaemert bc , et al . endoscop sleev gastroplasti treatment class 1 2 obes ( merit ) : prospect , multicentr , randomis trial . lancet . 2022 ; 400:441 \u201351 . 15. de miranda neto aa , de moura dth , ribeiro ib , khan , singh , da pont neto , et al . ef \ufb01caci safeti endoscop sleev gastroplasti mid term manag overweight obes patient : systemat review meta-analysi . obe surg . 2020 ; 30:1971 \u201387 . 16. hedjoudj , abu dayyeh bk , cheskin lj , adam , neto mg , badurdeen , et al . ef\ufb01caci safeti endoscop sleev gastroplasti : systemat review meta-analysi . clin gastroenterol hepatol . 2020 ; 18:1043 \u201353.e4 . 17. nation institut health care excel . endoscop sleev gastroplasti sever obes . develop [ gid-ipg10300 ] . 2022. http : \/\/ www.nice.org.uk\/guidance\/indevelopment\/gid-ipg10300 . 18. avenel , robertson c , skea z , jacobsen e , boyer , cooper , et al . bariatr surgeri , lifestyl intervent orlistat sever obes : rebal mixed-method systemat review econom evalu . health technolassess . 2018 ; 22:1 \u2013246 . 19. boyer , retat l , jacobsen e , avenel , aveyard p , corbould e , et al . cost- effect bariatr surgeri non-surg weight manag pro-gramm adult sever obes : decis analysi model . int j obe ( lond ) . 2021 ; 45:2179 \u201390 . 20. nation institut health care excel . nice health technolog eva- luation : manual . 2022. http : \/\/www.nice.org.uk\/process\/pmg36\/resources\/ . access 18 nov 2022 . 21. gandjour a. willing pay new medicin : step toward narrow gap nice iqwig . bmc health serv re . 2020 ; 20:343 . 22. husereau , drummond , augustovski f , de bekker-grob e , brigg ah , carswel c , et al . consolid health econom evalu report standard 2022 ( cheer 2022 ) statement : updat report guidanc health economicevalu . bmj . 2022 ; 376 : e067975 . 23. apollo endosurgeri inc. merit trial patient-level data . data file . 2022 . 24. alkharaiji , anyanwagu u , donnelli r , idri i. tier 3 specialist weight manage- ment servic pre-bariatr multicompon weight manag pro- gramm adult obes live uk : systemat review . endocrinol diabet metab . 2019 ; 2 : e00042 . 25. athanasiadi di , martin , kapsamp p , monfar , stefanidi d. factor associ weight regain post-bariatr surgeri : systemat review . surgendosc . 2021 ; 35:4069 \u201384 . 26. nation institut health care excel . committe paper . : liraglu- tide manag overweight obes . technolog apprais guidanc [ ta664 ] . 2020. http : \/\/www.nice.org.uk\/guidance\/ta664\/evid . access 18 nov 2022 . 27. bhaskaran k , dos-santos-silva , leon da , dougla ij , smeeth l. associ bmi overal cause-speci \ufb01c mortal : population-bas cohort studi 3.6 million adult uk . lancet diabet endocrinol . 2018 ; 6:944 \u201353 . 28. \ufb01ce nation statist . mortal rate ( qx ) , male femal , age 0 100 , uk , england , wale , scotland northern ireland , 1980-1982 2018-2020 . 2021.http : \/\/www.ons.gov.uk\/peoplepopul andcommunity\/birthsd eathsandmarriages\/ lifeexpect . access 18 nov 2022 . 29. wang hi , han l , jacob r , doran , holt rig , pradi sl , et al . healthcar resourc use cost peopl type 2 diabet mellitu without sever mental ill england : longitudin matched-cohort studi use clinicalpractic research datalink . br j psychiatri . 2022 ; 221:402 \u20139 . 30. landi f , calvani r , picca , tosato , marton , ortolani e , et al . bodi mass index strongli associ hypertens : result longevitycheck-up 7 +studi . nutrient . 2018 ; 10:1976 . 31. wall h , smith c , hubbard r. bodi mass index obstruct sleep apnoea uk : cross-sect studi over-50 . prim care respir j . 2012 ; 21:371 \u20136 . 32. younossi zm , blissett , blissett r , henri l , stepanova , younossi , et al . econom clinic burden nonalcohol fatti liver diseas unitedst europ . hepatolog . 2016 ; 64:1577 \u201386 . 33. epstein , bojk l , sculpher mj , group rt . laparoscop fundopl compar medic manag gastro-oesophag \ufb02ux diseas : cost effec- tive studi . bmj . 2009 ; 339 : b2576 . 34. rowen , brazier j , robert j. map sf-36 onto eq-5d index : reliabl relationship ? health qual life outcom . 2009 ; 7:27 . 35. stephenson j , smith cm , kearn b , haywood , bissel p. associ obes qualiti life : retrospect analysi large-scal population-bas cohort studi . bmc public health . 2021 ; 21:1990 . 36. hyland . brief guid select qualiti life instrument . health qual life outcom . 2003 ; 1:24 . 37. ara r , wailoo a. nice dsu technic support document 12 : use health state util valu decis model . 2011. http : \/\/www.shef \ufb01eld.ac.uk\/nice- dsu\/tsds\/util . access 12 dec 2022 . 38. miller jd , ye x , lenhart gm , farr , tran ov , kwong wj , et al . cost-effect edoxaban versu rivaroxaban stroke prevent patient non- valvular atrial \ufb01brillat ( nvaf ) us . clinicoecon outcom re . 2016 ; 8:215 \u201326 . 39. sullivan pw , slejko jf , sculpher mj , ghushchyan v. catalogu eq-5d score unit kingdom . med deci make . 2011 ; 31:800 \u20134 . 40. worbes-cerezo , nafe b , lloyd , gallop k , ladha , kerr c. disutil studi adult patient moder sever crohn \u2019 diseas . j health econ outcom re . 2019 ; 6:47 \u201360 . 41. jone k , burn a. unit cost health social care 2021 , person social servic research unit , univers kent , canterburi . 2021 . 42. nh england . 2020\/21 nation cost collect data public . 2022. http : \/\/ www.england.nhs.uk\/publication\/2020-21-national-cost-collection-data-publication\/ . 43. british nation formulari . enalapril maleat medicin form . 2022. http : \/\/ bnf.nice.org.uk\/drugs\/enalapril-maleate\/medicinal-forms\/ 44. british nation formulari . lisinopril medicin form . 2022. http : \/\/ bnf.nice.org.uk\/drugs\/lisinopril\/medicinal-forms\/ 45. british nation formulari . perindopril maleat medicin form . 2022. http : \/\/ bnf.nice.org.uk\/drugs\/perindopril-erbumine\/medicinal-forms\/ . 46. british nation formulari . ramipril medicin form . 2022. http : \/\/ bnf.nice.org.uk\/drugs\/ramipril\/medicinal-forms\/ . 47. ara r , brazier j. deriv algorithm convert eight mean sf-36 dimens score mean eq-5d preference-bas score publish studi ( wherepati level data avail ) . valu health . 2008 ; 11:1131 \u201343 . 48. salminen p , gronroo , helmio , hurm , juuti , juusela r , et al . effect laparoscop sleev gastrectomi vs roux-en-i gastric bypass weight loss , comorbid , \ufb02ux 10 year adult patient obes : slee- vepass random clinic trial . jama surg . 2022 ; 157:656 \u201366 . 49. kim tj , von dem knesebeck o. incom obes : direct relationship ? systemat review meta-analysi . bmj open . 2018 ; 8 : e019862 . 50. jordan k , fawsitt cg , carti pg , clyne b , teljeur c , harrington p , et al . cost- effect metabol surgeri treatment type 2 diabet andobes : systemat review econom evalu . eur j health econ . 2023 ; 24:575 \u201390 . 51. picot j , jone j , colquitt jl , gospodarevskaya e , loveman e , baxter l , et al . clinic effect cost-effect bariatr ( weight loss ) surgeri forobes : systemat review econom evalu . health technol assess.2009 ; 13:1 \u2013190 . 52. sharaiha r , wilson e , teixeira , thaemert b , chapman c , kumbhari v , et al . us commerci cost-effect analysi endoscop sleev gastroplasti ( esg ) j. kelli et al . 9 intern journal obesityversu lifestyl modi \ufb01cation ( lm ) alon adult class ii obes ( abstract ) . gastrointest endosc . 2023 ; 97 : ab4 . 53. sharaiha rz , hajifathalian k , kumar r , saunder k , mehta , ang b , et al . five-year outcom endoscop sleev gastroplasti treatment obes . clin gastroenterol hepatol . 2021 ; 19:1051 \u20137.e2 . 54. wadden ta , tronieri js , butryn ml . lifestyl modi \ufb01cation approach treatment obes adult . psychol . 2020 ; 75:235 \u201351 . 55. gibb bb , tudorascu , bryce cl , comer , fischer gs , hess r , et al . lifestyl habit associ weight regain intent loss primari carepati particip random trial . j gen intern med . 2020 ; 35:3227 \u201333 . 56. dombrowski su , knittl k , avenel , araujo-soar v , sniehotta ff . long term mainten weight loss non-surg intervent obes adult : systemat review meta-analys randomis control trial . bmj.2014 ; 348 : g2646 . 57. bhaskaran k , dougla , forb h , dos-santos-silva , leon da , smeeth l. body- mass index risk 22 speci \ufb01c cancer : population-bas cohort studi 5.24 million uk adult . lancet . 2014 ; 384:755 \u201365 . 58. raud b , gay c , guiguet-auclair c , bonnin , gerbaud l , pereira b , et al . level obes directli associ clinic function consequ ofkne osteoarthr . sci rep. 2020 ; 10:3601 . 59. nh england . nh diabet prevent programm weight manag ser- vice . elig criteria . nh england public gateway refer 05140 . 2016.http : \/\/www.england.nhs.uk\/wp-content\/uploads\/2016\/07\/dpp-wm-service.pdf . access 20 nov. 2022 . 60. jacobson bc , somer sc , fuch cs , kelli cp , camargo ca jr. body-mass index symptom gastroesophag \ufb02ux women . n engl j med . 2006 ; 354:2340 \u20138 . 61. vusirikala , thoma , bhala n , tahrani aa , thoma gn , nirantharakumar k. impact obes metabol health statu develop non-alcohol fatti liver diseas ( nafld ) : unit kingdom population-bas cohort studi use health improv network ( thin ) . bmc endocr disord . 2020 ; 20:96 . 62. apollo endosurgeri inc. data file . 2022. acknowledg thank lydia walder ( fiecon uk ltd ) contribut modeldevelop analysi , rori telfer ( apollo endosurgeri uk ltd ) providedclin cost inform esg procedur review manuscript , jame cann assist draft manuscript ( fund apollo endosurgeri ) . thank kenneth clare obes uk provid feedback draught manuscript ensur patient concern adequ captur thediscuss . author contribut jk , fon , le , wd , ec conceptualis econom model ; le , wd , ec builtth model ran analys . jk , vm , bh , sa review model providedinput clinic econom paramet . author critic review andrevis manuscript draught approv \ufb01nal manuscript ; jk fon guarantor cost effect data . correspond author jk atteststhat list author meet authorship criteria other meet criteriahav omit . fund studi fund apollo endosurgeri uk ltd. compet interest jk bh hold consult contract apollo endosurgeri uk ltd. vm no\ufb01nanci interest declar . fon employe apollo endosurgeri uk ltd fund studi . le , wd , ec employe fiecon uk ltd receiv payment apollo endosurgeri conduct studi . sa receiv speaker honorarium research grant fund johnson & johnson andsupport attend academ meet novo nordisk . addit inform supplementari inform onlin version contain supplementari materi avail http : \/\/doi.org\/10.1038\/s41366-023-01374-6 . correspond request materi address jami kelli . reprint permiss inform avail http : \/\/www.nature.com\/ reprint publish \u2019 note springer natur remain neutral regard jurisdict claim publish map institut af \ufb01liation . open access articl licens creativ common attribut 4.0 intern licens , permit use , share , adapt , distribut reproduct medium format , long give appropri credit origin author ( ) sourc , provid link creativecommon licens , indic chang made . imag third partymateri articl includ articl \u2019 creativ common licens , unless indic otherwis credit line materi . materi includ thearticl \u2019 creativ common licens intend use permit statutori regul exce permit use , need obtain permiss directli copyright holder . view copi licens , visit http : \/\/ creativecommons.org\/licenses\/by\/4.0\/ . \u00a9 crown 2023j . kelli et al . 10 intern journal obes",
  "variat ion commiss specialist weight manag servic bariatr surgeri across england : result freedom information\u2010 base map exercis across 42 integr care system england elhariri , m. , iyer , p. , isack , n. , sousa , b. , singh , p. , abbott , s. , wiggin , t. , nirantharakumar , k. , bellari , s. , flint , s. w. , pournara , d. j . & hazlehurst , j publish pdf deposit coventri univers \u2019 repositori origin citat : elhariri , , iyer , p , isack , n , sousa , b , singh , p , abbott , , wiggin , , nirantharak umar , k , bellari , , flint , sw , pournara , dj & hazlehurst , j 2025 , 'variat commiss specialist weight manag servic bariatr surgeri across england : result freedom information\u2010bas map exercis across 42 int grate care system england ' , clinic obes , vol . ( - press ) , e12731 , pp . ( -press ) . http : \/\/doi.org\/10.1111\/cob.12731 doi 10.1111\/cob.12731 issn 1758 -8103 essn 1758 -8111 publish : wiley associ studi obes \u00a9 2025 author ( ) . clinic obes publish john wiley & son ltd behalf world obes feder . open access articl term creativ common attribut licens , permit use , distribut reproduct medium , provid origin work properli cite . origin research variat commiss specialist weight manag servic bariatr surgeri across england : result freedom information-bas map exerciseacross 42 integr care system england maiar elhariry1| pranav iyer1| nadya isack2| bernado sousa3| pushpa singh4,5| salli abbott6,7| tom wiggins8| krishnarajah nirantharakumar4,9| srikanth bellary5,10| stuart w. flint11,12| dimitri j. pournaras13| jonathan m. hazlehurst4,5,14 1colleg medic dental scienc , univers birmingham , birmingham , uk 2obes empower network , uk 3patient repres , uk 4institut appli health research , univers birmingham , birmingham , uk 5depart diabet endocrinolog , univers hospit birmingham nh foundat trust , birmingham , uk 6specialist weight manag servic , univers hospit coventri warwickshir nh trustd , coventri , uk 7research centr intellig healthcar , coventri univers , coventri , uk 8depart upper gi surgeri , univers hospit birmingham , birmingham , uk 9midland health data research uk , birmingham , uk 10colleg health life scienc , aston univers , birmingham , uk 11school psycholog , univers leed , yorkshir , uk 12scale insight , nexu , univers leed , yorkshir , uk 13bristol weight manag bariatr servic , north bristol nh trust , southmead hospit , bristol , uk 14centr endocrinolog , diabet metabol , birmingham health partner , birmingham , uk correspond jonathan m. hazlehurst , depart endocrinolog , diabet metabol , heartland hospit , univers hospit birmingham , birmingham b9 5ss , uk . email : j.m.hazlehurst @ bham.ac.uk fund informationn institut health careresearchsummari specialist weight manag servic includ bariatr surgeri commiss within region england call integr care system ( icss ) elig treatment guidelin determin part nation institut health care excel ( nice ) guidanc . report variat commiss bariatr sur- geri elig criteria previous map . freedom inform ( foi ) request provid tool , support legisl , ask question public authori-ti includ icss must respond accur . foi sent 42 icss england ask 4 question aim establish whether variat commiss specialist weight manag servic elig maiar elhariri pranav iyer contribut equal work.receiv : 13 august 2024 revis : 22 octob 2024 accept : 29 novemb 2024 doi : 10.1111\/cob.12731 open access articl term creativ common attribut licens , permit use , distribut reproduct medium , provid origin work properli cite . \u00a9 2025 author ( ) . clinic obes publish john wiley & son ltd behalf world obes feder . clinic obes . 2025 ; e12731 . wileyonlinelibrary.com\/journal\/cob 1o f9 http : \/\/doi.org\/10.1111\/cob.12731 criteria bariatr surgeri across england . respons present descript map across england . respons receiv 41 42 icss , 34 report provid commiss medic weight manag pro- gramm 38 fund bariatr surgeri . thirteen report use criteria compliant nice guidanc . larg area countri centr around east england bariatr unit reduc access care . signifi- cant geograph variat avail bariatr specialist medic weight manag servic across england , larg portion countri with-out local access servic servic . servic avail , signific inconsist elig bariatr surgeri despit nation avail guidanc . keyword bariatr surgeri , commiss , obes , specialist weight manag , tier 3 , tier 4 alreadi known subject \u0081bariatr surgeri life-chang intervent peopl live obes associ signific health gain . \u0081within england , nation institut health care excel ( nice ) make recom- mendat patient like benefit bariatr surgeri . \u0081commiss decis relat servic provis treatment criteria made local within england geograph commiss area call integr care system ( icss ) . studi add \u0081mani icss appli addit non-evidence-bas criteria bariatr surgeri support nice restrict access treatment . \u0081part england medic weight manag servic . \u0081part england bariatr surgeri unit . \u0081taken togeth , lead signific geograph variat care . 1|introduct preval adult obes england , defin bodi mass index ( bmi ) \u226530 kg\/m2 , 26 % .1whilst prevent import part nation strategi , treatment peopl alreadi live withobes requir improv qualiti life health outcom . addit direct indirect effect obes health qualiti life , signific financi impact attributablenh ( nation health servic ) wider societ cost uk project rise \u00a39.7 billion \u00a349.9 billion , respect , 2050 . 2the nation institut health care excel ( nice ) provid clear guidanc provis specialist weight man- agement servic across uk,3howev , extent servic avail well defin . mani profession bodi oftenincorpor patient advocaci group well nh england haveproduc recommend guidanc includ commis- sion obes servic across last 10 year tri improv standardis servic avail deliveri . 4\u20136in uk , obe- siti treatment deliv four-tier system ; tier 1 repres public health intervent , tier 2 short-term diet behaviourintervent typic commiss local author , tier 3 multidisciplinari team-l specialist weight manag servicesand tier 4 bariatr surgeri . tier 3 tier 4 servic fall commiss respons integr care system ( icss ) . 7 prior bariatr surgeri , patient requir multidisci- plinari support assess specialist weight manag service.3th nice elig criteria bariatr surgeri bmi \u226540 kg\/m2 , 35 39.9 kg\/m2with signific health condit could improv weight loss ( e.g . type 2 diabe- te ) . criteria recent revis updat guid- anc publish juli 2023 wide-rang andinclud extend list health condit clarif list exhaust 3 : \u0081a bmi \u226540 kg\/m2 , 35 39.9 kg\/m2with signifi- cant health condit could improv lost weight ( exampl exhaust includ : cardiovascular diseas , hypertens , idiopath intracrani hypertens , non-alcoholicfatti liver diseas without steatohepat , obstruct sleep apnoea type 2 diabet ) 2o f9 elhariri et al . 17588111 , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/cob.12731 coventri univers , wiley onlin librari [ 10\/02\/2025 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens \u0081agre necessari long-term follow-up surgeri ( exampl , lifelong annual review ) . nice advis reduct bmi threshold 2.5 kg\/m2for peo- ple south asian , chines , asian , middl eastern , black afri-can african-caribbean famili background . nice also advis peopl bmi 30 \u201334.9 kg\/m 2and type 2 diabet diagnos within past 10 year also consid bariatr surgeryassess . latest iter nice guidelin remov prior emphasi patient review tier 3 servic instead use thephras specialist weight manag servic . practic term , thismean patient could potenti refer directli bariatr surgeri servic rather first seen tier 3 multidisciplinari team-l specialist weight manag servic . tier 3 servic aredefin multidisciplinari team typic encompass phy- sician , dietitian , psychologist often access physic therapi although definit vari outcom data often limit short-term weight loss . 8the increas avail medic obe- siti nice technolog apprais must deliv tier 3 ( liraglutid [ saxenda ] ) 9or within specialist weight manage- ment servic ( limit tier 3 4 ; semaglutid [ wegovi ] ) 10ha increas interest avail commiss specialist servic . previou work highlight challeng accur map- ping servic within england ; survey consult endocri- nologist estim area 60 % england provid tier 3 service.11thi reflect recent girft ( get right first time ) programm nation special report endocri- nolog , larg programm work tri identifi better understand variat weight manag servic . reportshow 44 % ( 55 ) 126 hospit trust visit tier 3 servic . 12there signific ongo nation work record better understand provis outcom spe-cialist weight manag servic across uk includ thenat bariatr surgeri regist ( nbsr ) , 13nh england nation obes audit14and societi endocrinolog nation obes audit.15th nbsr produc regular report focu outcom follow bariatr surgeri provid use data help guid polici . nh england nation obes audit aim collect data focu better understand treatment access cover-ag provis servic 14although number larg centr unabl engag due technic challeng hospital-bas electron system unabl provid data toth requir commun servic data set ( csd ) . thu , clear therefor accur pictur avail servic requir support polici develop commiss strategi . withinengland , decis health servic commiss made byicss . icss budgetari respons commis- sion decis specialis commiss respons held central nh england . icss make commiss decisionsfor health care deliv fund within ic . 2017 , bariatr surgeri specialist weight manag serviceshad commiss central 6when commiss responsibil- iti transfer clinic commiss group ( ccg ) , whichwer predecessor icss . freedom inform ( foi ) act ( foia ) 2000 foia increasingli recognis use tool social scienc research andthos work polici . due legal requir respond , use foi request result complet data set equival work survey enquiri . 16work map attention-deficit\/hyperact disord servic previous pub- lish highlight rel efficaci foi compar email survey 80 % 9 % respons , respectively.17 given commiss respons icss , primari aim ( 1 ) determin whether commiss bariatr surgeri specialist weight manag servic , ( 2 ) identifi criteria use elig bariatr surgeri servic across england , ( 3 ) determin whether criteria compliant nice recommend . 2|method author jmh , pi draft 4 question form basi foi request . question refin patient involve- ment guidanc author ni , review expert thefield , author sa dp . final word 4 question , whichwer sent integr care system ( icss ) via foi request 26.7.23 : 1. fund bariatr surgeri peopl live ic ? 2. pleas list current criteria use within ic fund decis regard bariatr surgeri . 3. commissioned\/design bariatr surgeri servic locat within ic catchment ? , peopl requir bariatr surgeri within ic typic refer ? 4. commiss tier 3 specialist weight manag ser- vice ? locat within ic catchment ? , peopl within ic requir tier 3 weight manag ser- vice typic refer ? 4 question sent foi offic individu ic . respons record . obtain requir infor-m follow iter process icss signpost alreadi avail inform , nice guidanc prior nation ser- vice specif . assess elig criteria provid beingnic compliant criteria either explicitli mention accord nice criteria state criteria con- sistent nice particular includ elig bm\u226540 kg\/m 2or\u226535 kg\/m2with relat health condit . foi request sent latest iter nice guidelin cg189 although bmi cut-off use assess bariatr surgeri chang across latest iter . respons rate complet well answer 4 question record . inform subsequentlyelhariri et al . 3o f9 17588111 , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/cob.12731 coventri univers , wiley onlin librari [ 10\/02\/2025 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens present use descript statist , map gener use softwar licenc purchas gb maps.18 3|result 42 icss england , 41 ( 98 % ) respond foi request . overal , ic repres respond major ofth question . number icss provid link respect websit respons question , indic data access public alreadi accord section 21of foia . 3.1 |do fund bariatr surgeri peopl live ic ? ( 90 % ; 38\/41 ) icss respond question pro- vide clear inform fund bariatr surgeri . one ic clearli state although bariatr surgeri cen- tre , fund bariatr surgeri patient cohort within othericss . 3 icss clearli answer ye question , one state patient could refer elsewher made comment fund , whilst two icss state ( incorrectli ) bariatricsurgeri commiss nh england suggest wecontact . five 38 ( 14 % ) icss confirm fund bariatr sur- geri , provid detail beyond ask responseto question . two report fund bariatr surgeri certain criteria met without expand criteria , one ic ad link criteria requir elig fund . icssstat weight manag servic , term tier , pro- vide fund recommend contact provid fur- ther inform . one ic ad fund bariatr surgeri \u201c via value-bas commiss polici \u201d . 3.2 |pleas list current criteria use within ic fund decis regard bariatr surgeri 38 icss report fund bariatr surgeri , 24 ( 63 % ) either directli quot follow nice clinic guide- line 189 cite criteria guidanc ( tabl 1 ; figur 1 ) . thirteen ( 34 % ) 38 icss report fund bariatr surgeri restrict criteria determin patient ' elig bar- iatric surgeri referr set nice . includ higherbmi threshold ( e.g . \u226550 kg\/m 2 ) restrict health-rel con- dition qualifi intervent ( e.g . lower bmi cut-ff 35 kg\/m2onli applic peopl type 2 diabet ) addi- tional requir set nice ( includ minim durat ofobes ) . one ic state elig criteria depend ic patient seek referr provid bariatr surgeryloc within ic . ic redirect question 1 nh england includ criteria met set nice guidelin includ analysi explicitli declarethey fund bariatr surgeri . 24 icss consist nice recommenda- tion , 21 either includ non-exhaust exampl comorbid phrase includ \u201c \u201d \u201c exampl \u201d \u201c signific comorbid \u201d simpli mirror nice guidanc . howev , three icss classifi nice compliant provid clear list requir comorbid elig bmi \u226535 kg\/m 2. ten icss expressli state need long-term follow-up . geo- graphic distribut icss across england report elig cri- teria bariatr surgeri present ( figur 1 ) . 38 icss provid clear confirm fund bariatr surgeri , 13 restrict elig criteria requir includ nice guidelin . 13 acknowledg criteria restrict . one ic thatdid bariatr unit report use elig criteria out-of-area icss patient could refer surgeri . four icss provid clear statement confirmingfund bariatr surgeri , one respond foi , one provid respons question , one signpost gener inform nh websit one incorrectli signpost tonh england . four icss classifi \u201c response\/ clear respons \u201d ( figur 1 ) . 13 icss restrict criteria , durat obes sever one restrict criterion withfour icss state patient refer bariatr surgeri must \u201c morbid\/sever obes least five year \u201d anoth ic man- date refer , patient must \u201c document record bmi 40 kg\/m 2or least 24 month \u201d . three icss mention higher bmi cut-off surgeri compar recommend bmi \u226540 kg\/m2bi nice guidelin \u2014with threetabl 1 breakdown provid bariatr surgeri elig criteria suppli icss compliant nice . icss purport nice compliant , n ( % total icss ) 24 ( 63 % ) age cut icss provid inform 6 age\u226518 year 6 bmi cut off icss provid inform 19bmi\u226535 kg\/m 2with comorbid 19 bmi\u226540 kg\/m219 comorbid : requir surgeri lower bmi cut \u226535 kg\/ m2 icss provid exampl comorbid 14 icss expand comorbid 7 need commit long-term follow-up icss provid inform 10 abbrevi : bmi , bodi mass index ; ic , integr care system ; nice , nation institut health care excellence.4o f9 elhariri et al . 17588111 , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/cob.12731 coventri univers , wiley onlin librari [ 10\/02\/2025 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens icss set minimum bmi 50 kg\/m2and one ic set mini- mum bmi 60 kg\/m2\u20137 icss includ minimum durat rang engag tier 3 weight manag servic othernon-surg option minimum set durat ( tabl 2 ) . restrict criteria includ : limit set comorbid bmi \u226535 kg\/m2 , mandatori preoper weight loss . 3.3 |i commissioned\/design bariatr surgeri servic locat within ic catchment ? , peopl requir bariatr surgerywithin ic typic refer ? 41 icss respond initi foi request , 30 41 ( 73 % ) state commissioned\/design bariat-r surgeri servic within ic catchment ( figur 2 ) . two icss report depend region patientswer also refer ic local provid . ten 41 ( 24 % ) state absenc servic within ic catchment area pro- vide altern site referr commissioned\/design bar-iatr surgeri . one ic respond state incorrectli , \u201c tier 4 weight manag bariatr surgeri specialis commiss therefor commiss respons nh england \u201d direct research team nh england . 3.4 |do commiss tier 3 specialist weight manag servic ? locat within ic catchment ? , peopl within youric requir tier 3 weight manag servicestyp refer ? thirty-four 41 ( 83 % ) icss provid level respons foi request state commiss tier 3 specialist weight manag servic ( figur 3 ) . howev , , two icss figur 1 map icss report elig bariatr surgeri concord nice guidance.elhariri et al . 5o f9 17588111 , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/cob.12731 coventri univers , wiley onlin librari [ 10\/02\/2025 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens report signific variat provis within ic area includ referr area patient one ic report notal patient within ic catchment access tier 3 scope provis one ic accept whilst servic commiss , provis limit consis-t recognis would expect nice guidanc specialist servic . one ic commiss servic entir deliv outsid ic catchment . one ic report servicethat jointli commiss local author includ analysi ic commiss . 34 report commiss servic , 29 ( 71 % ) provid servic entirelywithin ic catchment . five icss clearli respond \u201c \u201d question , one ic report ongo work scope pro- vision servic two icss comment patient could refer elsewher . one addit ic respond \u201c ye \u201d \u201c \u201d provid inform highlight local author commiss servic therefor answer \u201c \u201d provid inform jointli commiss , itdid howev report work set servic . onet 2 breakdown respons icss restrict elig criteria bariatr surgeri . restrict criterianumb ic restrict criteria total icss restrict criteria 13 minimum durat moderate\/sever obes bmi \u226540 kg\/m25 engag tier 3 weight manag servic non-surgicalopt minimum set duration12 month : 2 12\u201324 24 month : 4 restrict list comorbid lower bmi threshold4 mandatori pre-op weight loss 1 higher bmi cut-off bmi \u226550 kg\/m 2:3 bmi\u226560 kg\/m2:1 note : complianc nice guidance,3,29a bmi \u226530 kg\/m2with recent-onset type 2 diabet access tier 3 servic attemptedweight loss intervent consid surgeri consideredfor assess , one ic includ elig option.abbrevi : bmi , bodi mass index ; ic , integr care s. figur 2 map icss report locat bariatr surgeri centr relat geograph ic catchment.6o f9 elhariri et al . 17588111 , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/cob.12731 coventri univers , wiley onlin librari [ 10\/02\/2025 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens ic respond question within foi respons respond question . 4|discuss first publish studi use data gener foi request systemat map ic commiss bariatr sur-geri specialist weight manag servic across england . current studi find highlight whilst icss report fund bariatr surgeri , consider variat elig cri-teria patient must meet consid nh fund bar-iatr surgeri . 41 icss respond foi request , 38 confirm fund bariatr surgeri , , 24 report either compliant nice guidanc cg189 orpres criteria accord guidanc . one ic , without bariatr unit , report use criteria icsthat patient refer . thirteen icss appli restric- tive criteria access bariatr surgeri restrict bmi , dura-t comorbid obes requir preoper weight loss . concern highlight 31 % icss follow nice recommend thu , evidence-basedpractic . sinc 2017 , commiss bariatr surgeri devolv local , initi clinic commiss group , morerec , icss . 6within servic specif , criteria transfer fund respons local clear . one unintend find studi two icss reportedthat bariatr surgeri central commiss despit thecommiss respons transfer ccg ( icss ) sinc 2017 . 6bariatr surgeri effect treatment peopl liv- ing obes result improv qol,19reduct cardio- vascular mortality,20reduct all-caus mortality21a well improv outcom patient live type 2 diabetes.22 figur 3 map icss report whether commiss tier 3 weight manag centr relat geograph ic catchment.elhariri et al . 7o f9 17588111 , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/cob.12731 coventri univers , wiley onlin librari [ 10\/02\/2025 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens data show commiss specialist weight manage- ment servic across england limit 83 % icss report- commiss servic ; howev , 71 % commiss servic deliv within ic geograph catchment . data medic servic reflect data recent girft report 12 signific area countri without access servic . possibl identifi servic commiss local author rather icss . author readwith sad recent closur one local authority- commiss servic held high regard nation- alli local patient support . 23given advent increasingli effect intervent includ meal replac prod-uct medic augment lifestyl modif , find signific number icss across england commiss spe- cialist servic let peopl live obes . one unantic-ip find one ic commiss tier 3 servic report \u201c tier 3 servic typic consult led therefor patient \u201c right choos \u201d appli cir- cumstanc servic provid outsid ic oblig accept \u201d . import point provis fund care patient obes across differ icss accept shouldprompt icss ensur local servic commiss . current wait time across obes servic all-tim high signif- icant mismatch demand provis high-qualitymdt-l care , culmin 1 6 icss close liststo new weight manag referr . 24there ongo pilot studi roll commun includ digit deliv care and\/or increas avail medic obesity.25they welcom step give patient access treatment . howev , earli predict system place widen access even potenti exacerb health inequ given signific geo-graph variat servic provis . current studi gather data treatment offer within tier 3 servic need respons nice approv obes medic . studi highlight signific proport ( 31 % ) icss appli restrict criteria access bariatr surgeri . , nearli third icss non-compli nice guidanc evidence-bas practic . understand barrier impact oficss appli restrict criteria nice guidanc peopl live obes healthcar system need . find- ing studi import policymak highlight thene nation coordin strategi obes treatment provi- sion . policymak , nice icss non-compli nice guidanc consid region variat appli thecas obes long-term health outcom nation guidanc appli , avoid potenti inequ driven local decision-mak . region variat applic niceguid would accept long-term health condi-t . decis may reflect ingrain stigma toward obes consist highlight healthcar . 26,27 one key limit studi focus bariatr surgeri provis england extend work wale , scotland northern ireland intern . decis tofocu england current studi made pragmat assess respons icss creat 2022 move awayfrom prior ccg . 28we awar signific variat care servic avail across wider uk work design assess import point . work focus ic commis-s clinic servic unintend consequ may pick non-commiss specialist weight man- agement servic servic commiss local healthauthor . sinc respons commiss sit icss , like repres small proport servic . limit relianc respons qualiti foi request , although isa legal requir respons foi request accur . despitethes limit , potenti implic find present studi highlight need ensur accur pictur commiss bariatr surgeri weight manag servicesin england , thu , welcom collabor confirm commiss model employ across countri . current work highlight signific inequ access effect treatment , whether geograph local appli none-evidence-bas restrict criteria bariatr surgeri . centr issu peopl live obes , unabl toaccess care , mani progress obesity-associ medi- cal condit unabl access treatment includ ortho- paedic surgeri fertil treatment current let byth current lack effect avail local servic . author contribut jmh , dp tw conceiv studi input designbi , pi , ni , kn , ps sa . ni , bs , ps , sb , sa , kn , sb , dp sf provid critic input analysi present data . , pi jmh wrote initi manuscript analys data.al author involv write paper final approv submit publish version . fund inform work support wider nihr west mid clinic research network & award kn , sb jh well nihr west mid clinic research network research scholarship jh . conflict interest statement pi conflict interest . ni declar truste ofth obes empower network activ patient advoc . bs declar activ patient advoc . ps conflict interest . sa declar research support johnson & johnson aswel british dietet associ well consult fee astrazeneca johnson & johnson ice creat well sup- port attend educ meet novo nordisk thebritish dietet associ well committee-level membership ofbritish obes metabol surgeri societi british dietet associ obes specialist group obes manag col- labor , uk . tw conflict interest . kn declar grantsfrom nihr , ukri\/mrc , kennedi trust rheumatolog research , health data research uk , wellcom trust , european regional8o f9 elhariri et al . 17588111 , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/cob.12731 coventri univers , wiley onlin librari [ 10\/02\/2025 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens develop fund , institut global innov , boehring ingel- heim , action macular degener chariti , midland neuro-sci teach develop fund , south asian health foundat , vifor pharma , colleg polic , csl behr well consult fee bi , sanofi , cegedim msd leader-ship role within nicst , chariti openclin , social enter- prise . sb declar speaker fee astrazeneca , boehring ingelheim , novonordisk eli lilli receiv research fund fromastrazeneca bayer . swf declar grant nihr , offic health improv dispar , doncast council novo nordisk well support attend meet travel fromuk parliament , johnson johnson , novo nordisk , devon nhsintegr care servic safefood . djp declar consult fee johnson & johnson , novo nordisk , pfizer , gsk , medtron well honoraria johnson & johnson , medtron , sandoz novonordisk . jmh declar grant fund nihr previou advisori feed speak honoraria novo nordisk well support attend meet novo nordisk eli lilli well beinga committe member obes manag collabor uk . orcid jonathan m. hazlehurst http : \/\/orcid.org\/0000-0003-1036-103x refer 1. nh digit . health survey england . 2021. http : \/\/digital.nhs.uk\/ data-and-information\/publications\/statistical\/health-survey-for-england\/ 2021\/overweight-and-obesity-in-adult 2. public health england . health matter : obes food environ- ment . 2017 . 3. nice . obes : identif , assess manag clinic guidelin [ cg189 ] . 2023. http : \/\/www.nice.org.uk\/guidance\/cg189\/ resourc 4. british obes metabol surgeri sociey royal colleg surgeon partner organis . commiss guid : weightassess manag clinic ( tier 3 ) . 2014. http : \/\/www . rcseng.ac.uk\/library-and-publications\/rcs-publications\/docs\/weight- assessment-guide\/ 5. welbourn r , hopkin j , dixon jb , et al . commiss guidanc weight assess manag adult children withsever complex obes . obe rev . 2018 ; 19 ( 1 ) :14-27 . 6. nh england . guidanc commiss obes surgeri . 2016. http : \/\/www.england.nhs.uk\/wp-content\/uploads\/2016\/05\/appndx-7-obesity-surgery-guid.pdf 7. hazlehurst jm , logu j , parretti hm , et al . develop integr clin- ical pathway manag clinic sever adult obes : critiqu nh england polici . curr obe rep . 2020 ; 9 ( 4 ) :530-543 . 8. alkharaiji , anyanwagu u , donnelli r , idri i. tier 3 specialist weight manag servic pre-bariatr multicompon weightmanag programm adult obes live uk : systemat review . endocrinol diabet metab . 2019 ; 2 ( 1 ) : e00042 . 9. nice . liraglutid manag overweight obes ta664 . 2020. http : \/\/www.nice.org.uk\/guidance\/ta664 10. nice . semaglutid manag overweight obes nice ta875 . 2023. http : \/\/www.nice.org.uk\/guidance\/ta875 11. coulton v , dodhia , ell l , blackshaw j , tedston a. nation map weight manag servic : provis tier 2 tier 3 servic england . public health england ; 2015.12. wass j , landsdown m. girft programm nation specialti report endocrinolog . 2021 . 13. nbsr databas committe . uk nation bariatr surgeri regis- tri third registri report . 2020. http : \/\/e-dendrite.com\/publishing\/ reports\/bariatric\/nbsr2020.pdf 14. nh digit . weight manag servic , quarter 1 quarter 4 2022\/23 \u2014nation obes audit . 2023. http : \/\/digital.nhs.uk\/ data-and-information\/publications\/statistical\/national-obesity-audit\/ weight-management-services-quart r-1-to-quarter-4- 2022-23 -- -national- obesity-audit-management-inform 15. societi endocrinolog . nation obes databas . 2024. http : \/\/ www.endocrinology.org\/clinical-p ractice\/data-registries\/national- obesity-database\/ 16. uk data servic . freedom inform act . 2024. http : \/\/ ukdataservice.ac.uk\/learning-hub\/research-data-management\/data-protection\/data-protec tion-legislation\/freedom-of-information-act\/ 17. price , janssen , dunn-morua , et al . seven step map health servic provis : lesson learn map servic adult attention-deficit\/hyperact disord ( adhd ) uk.bmc health serv re . 2019 ; 19 ( 1 ) :468 . 18. gb map . map softwar . 2024. http : \/\/www.gbmaps.com\/ 19. lindekild n , gladston bp , l\u00fcbeck , et al . impact bariatr surgeri qualiti life : systemat review meta-analysi . obe rev . 2015 ; 16 ( 8 ) :639-651 . 20. vest ar , heneghan hm , agarw , schauer pr , young jb . bariatr surgeri cardiovascular outcom : systemat review . heart . 2012 ; 98 ( 24 ) :1763-1777 . 21. cardoso l , rodrigu , gome l , carrilho f. short- long-term mortal bariatr surgeri : systemat review meta-analy-sis.diabet obe metab . 2017 ; 19 ( 9 ) :1223-1232 . 2 2 . h e n gb , r u n gk , p l e rh , z h n gl , n gx , c h e nl .t h el n g - term effect bariatr surgeri type 2 diabet remiss , microvascular macrovascular c omplic , mortal : systemat review meta-analysi . obe surg . 2017 ; 27 ( 10 ) : 2724-2732 . 23. aso . respons loss pathway decommiss liverpool resi- dent . 2023 . 24. mahas e. obes : integr care board close list weight man- agement servic demand skyrocket . bmj . 2024 ; 385 : q1356 . 25. iacobucci g. wegovi : weight loss drug avail gp pilot scheme . bmj . 2023 ; 381:1308 . 26. brown , flint sw , batterham rl . pervas , impact implica- tion weight stigma . eclinicalmedicin . 2022 ; 47:101408 . 27. flint sw. time end weight stigma healthcar . eclinicalmedicin . 2021 ; 34:100810 . 28. nh england . find local integr care board ( icb ) . 2022. http : \/\/www.nhs.uk\/nhs-services\/fi nd-your-local-integrated-care- board\/ # : ~ : text =integr % 20care % 20board % 20 ( icb ) % 20replac , england % 20from % 201 % 20juli % 202022 29. nice . type 2 diabet adult : manag ( ng28 ) . 2022. http : \/\/ www.nice.org.uk\/guidance\/ng28 cite articl : elhariri , iyer p , isack n , et al . variat commiss specialist weightmanag servic bariatr surgeri across england : result freedom information-bas map exercis across 42 integr care system england . clinic obes . 2025 ; e12731 . doi : 10.1111\/cob.12731elhariri et al . 9o f9 17588111 , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/cob.12731 coventri univers , wiley onlin librari [ 10\/02\/2025 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens",
  "weight manag commun idiopath intracrani hypertens : challeng recommend patient \u2019 perspect . abbott , s. , denton , a. , wong , s. , mollan , s. & bul , k. publish pdf deposit coventri univers \u2019 repositori origin citat : abbott , , denton , , wong , , mollan , & bul , k 2023 , 'weight manag commun idiopath intracrani hypertens : challeng recommend patient \u2019 perspect . ' , bmj neurolog open , vol . 5 , . 2 , e000 527. http : \/\/dx.doi.org\/ 10.1136\/bmjno -2023 -000527 doi 10.1136\/bmjno -2023 -000527 issn 2632 -6140 publish : bmj publish group open access articl distribut accord creativ common attribut non commerci ( cc -nc 4.0 ) licens , permit other distribut , remix , adapt , build upon work non -commerci , licens deriv work differ term , provid origin work properli cite , appropri credit given , chang made indic , use non - commerci . se e : http : \/\/creativecommons.org\/licenses\/bi -nc\/4.0\/ 1 abbott , et al . bmj neurol open 2023 ; 5 : e000527 . doi:10.1136\/bmjno-2023-000527open access weight manag commun idiopath intracrani hypertens : challeng recommend patient \u2019 perspect salli abbott,1,2 amanda denton,3 sui h wong,4,5,6,7 susan p mollan,8,9 kim cm bul 10,11 cite : abbott , denton , wong sh , et al . weight manag commun idiopath intracrani hypertens : challeng recommend patient \u2019 perspect . bmj neurolog open 2023 ; 5 : e000527 . doi:10.1136\/bmjno-2023-000527 \u25baaddit supplement materi publish onlin . view , pleas visit journal onlin ( http : \/\/ dx . doi . org\/ 10 . 1136\/ bmjno- 2023- 000527 ) . receiv 15 septemb 2023accept 05 novemb 2023 number affili see end articl . correspond dr kim cm bul ; ac2658 @ coventri . ac . uk origin research \u00a9 author ( ) ( employ ( ) ) 2023. re- use permit cc - nc . commerci re- use . see right permiss . publish bmj . abstract background idiopa thic intracrani hypertens ( iih ) neurometabol condit sever impact qualiti life peopl live iih ( pwiih ) . pwiih overweight live obes , weight loss recommend healthcar profession ( hcp ) central diseas manag . current research evalu patient\u2013clinician interact discuss weight manag iih . aim studi evalu patient experi commun hcp regard weight manag perspect pwiih.method cross- section onlin sur vey develop distribut iih uk chariti via mail list social media network . elig particip adult iih recommend lose weight hcp . descript statist use summaris quantit respons content analysi use induct draw theme open- end free- text responses.result 625 respond . one- fifth pwiih ( n=127\/603 , 21 % ) felt hcp support empathet weight manag . five theme identifi experi regard weight manag iih improv , pwiih recommend hcp : ( 1 ) detail relationship iih weight , ( 2 ) individualis care , ( 3 ) give advic , ( 4 ) provid support ( 5 ) adapt communication.conclus major pwiih recal poor experi nega tive emot engag discuss regard weight manag hcp . research explor hcp perspect evalu intervent aim improv qualiti patient\u2013hcp commun iih . introduct idiopath intracrani hypertens ( iih ) characteris increas intracrani pressur lead report sign symp-tom headach , pulsatil tinnitu papilloedema , potenti risk perman visual loss . 1 2 although exact caus condit remain unknown occur often women childbear age compar men children well peopl overweight ( bodi mass index , bmi , 25\u201330 kg\/m2 ) live obes ( bmi\u226530 kg\/m2 ) .3 global annual alreadi known topic \u21d2discuss weight manag sen- sitiv topic patient evid show healthcar profession ( hcp ) lack confid discuss bodi weight patient . prioriti set-t research jame lind allianc highlight weight manag context idiopath- intracrani hypertens ( iih ) top research prioriti patient hcp . date , publish research evalu experi weight manag interact perspec-t peopl live iih ( pwiih ) . studi add \u21d2thi first studi evalu experi weight manag interact hcp perspect pwiih . result studi demonstr pwiih feel unsupport ex-peri neg emot weight manage- discuss initi hcp . studi also provid uniqu insight hcp could improv approach weight manage- ; explain relationship iih weight , provid personalis care , give tailor advic , provid support adapt communica-t style set commun . studi might affect research , practic polici \u21d2the result studi provid first time experi pwiih recollect weight manag discuss hcp of-fer suggest would make interact effect . research highlight need specif train hcp context weight manag iih support improv healthcar access , promot non- stigma tise practic improv patient clinician satisfact context.nurs & midwiferi librari . protect copyright . decemb 14 , 2023 mr guest , librarian http : \/\/neurologyopen.bmj.com\/ bmj neurol open : first publish 10.1136\/bmjno-2023-000527 9 decemb 2023. download 2 abbott , et al . bmj neurol open 2023 ; 5 : e000527 . doi:10.1136\/bmjno-2023-000527open access iih incid rate rang 0.03 2.36 per 100 000 posit associ country- specif obes rates.4 uk , stepwis increas incid preval iih increas number peopl admit hospit care.1 5\u20137 use specialis healthcar peopl live iih ( pwiih ) caus signific econom burden nation health servic ( nh ) estim direct healthcar resourc use cost \u00a3462 million per annum 2030.5 also demonstr usa.8 addit , research state pwiih experi low qualiti life mainli due headach symptom 9 ; howev , research factor contribut limit . stress import research effect accept weight manag inter - vention pwiih . strike associ increas bmi moder weight gain . 1 4 6 10 diseas modifi weight loss recent randomis control trial eval-u bariatr surgeri multicompon lifestyl intervent found weight loss mirror reduct intracrani pressur . 11 12 weight loss region 3 % 24 % shown reduc symptom lead remiss diseas wherea regain 6 % bodi weight shown associ recurr iih among pwiih demonstr one studi . 2 12 13 condit manag neurol- ogist , ophthalmologist , neurosurgeon recent intervent radiologist , none formal train weight manag . 14 recent qualit systemat literatur review high- light weight stigma within patient\u2013healthcar profession ( hcp ) interact neg impact healthcar access qualiti healthcar provi-s perspect peopl live obes . 15 peopl obes perceiv neg around weight statu base languag use hcp often feel asham , humili blame obes . time , due lack knowledg base , skill set guidelin , hcp experi mani challeng commun weight peopl obes . clear unmet clinic need educ specialis train among hcp commun bodi weight chang weight statu . import hcp interact weight manag nega-t affect futur weight trajectori dialogu peopl obes . 16 although hcp specialis neurolog medic train diagnos pwiih , like receiv train obes manage- . could potenti lead ineffect consulta-t import sustain weight reduct address manag effect . patient public involv engag research healthcar practic becom increas-ingli import gener meaning healthcar impact . 17 reflect recent research studi prioriti set exercis perform pwiih hcp accord jame lind allianc prioriti set partnership . 18 limit evid iih patient central conduct research , previou studi shown benefit close work relationship . 19 research role weight manag pwiih high-light research prioriti , includ approach provid sensit discuss weight address stigma associ obes . 2 18 despit , current publish research studi experi- pwiih hcp commun role bodi weight weight manag iih . henc , aim studi evalu experi pwiih interact hcp regard weight manag . method studi design participantsa cross- section studi undertaken collect data use sur veymonkey platform . survey open respons 26 april 2021 14 may 2021. elig particip peopl diagnosi iih , age age 18 year old , advis lose weight hcp . survey develop questionnair develop respons patient cite concern around patient\u2013hcp weight manag interact express pwiih across divers social media group . steer committe truste chariti iih uk , includ two pwiih , led questionnair develop . question within survey formul base patient expe-ri voic chariti iih uk pwiih , primarili via facebook twitter social media channel . survey pilot three pwiih led minor modif questionnair word aid use plain english languag readabl ( see onlin supple-ment file 1 ) . data collect survey distribut 395 member chariti iih uk via membership mail list . survey also distribut via social media channel , includ \u2018 iih uk nation chariti \u2019 facebook page @ iihuk twitter handl . respons anonym , question permit close open respons particip , give particip opportun expand given answer word . partic-ip abl answer question howev singl question mandat fill . addition- , particip could select one option certain question . ip address respons cross- check ensur respons submit pwiih resid uk . data analysi respons close question analys use frequenc descript statist ( n , % ) . open free- text nurs & midwiferi librari . protect copyright . decemb 14 , 2023 mr guest , librarian http : \/\/neurologyopen.bmj.com\/ bmj neurol open : first publish 10.1136\/bmjno-2023-000527 9 decemb 2023. download 3 abbott , et al . bmj neurol open 2023 ; 5 : e000527 . doi:10.1136\/bmjno-2023-000527open access respons analys use content analysi . content analysi provid subject interpret text data systemat process code categoris data theme 20 conveni method use health research analys textual type data , includ open- end sur vey questions.21 code frame devel- ope use induct approach determin theme data . quotat excerpt extract present illustr find enhanc credibl . result total 625 pwiih complet survey . iih uk chariti wide nation reach mail list social media network exact number mani peopl expos onlin survey unknown . frequent report hcp advis pwiih lose weight neurologist ( 526\/596 , 88 % ) , ophthalmologist ( 297\/596 , 50 % ) , gener practition ( 267\/596 , 44 % ) , nurs ( 129\/596 , 21 % ) neurosurgeon ( 100\/596 , 17 % ) ( figur 1 ) . weight manag interactionsmost pwiih ( 522\/603 , 87 % ) recal hcp made feel iih \u2018 fault \u2019 due weight . 7 % ( 42\/604 ) pwiih report ask hcp permiss discuss weight . one- fifth ( 121\/598 , 20 % ) pwiih \u2018 happi \u2019 weight discuss 21 % ( 127\/603 ) pwiih felt hcp empathet support weight manag ( figur 2 ) . pwiih ask told lose weight made feel , ten frequent respons neg emot : \u2018 fault \u2019 ( n=80 ) , \u2018 upset \u2019 ( n=42 ) , \u2018 embarrass \u2019 ( n=37 ) , \u2018 aw \u2019 ( n=37 ) , \u2018 asham \u2019 ( n=35 ) , \u2018 angri \u2019 ( n=32 ) \u2018 sad \u2019 ( n=30 ) , \u2018 depress \u2019 ( n=28 ) , \u2018 blame \u2019 ( n=24 ) , \u2018 worthless \u2019 ( n=23 ) \u2018 fat \u2019 ( n=19 ) ( figur 3 ) . weight manag supportonli 22 % ( 134\/603 ) pwiih report hcp offer weight manag support 16 % ( 73\/445 ) felt support \u2018 help appropri \u2019 . hcp offer varieti weight manag interven-t ( figur 4 ) , referr dietitian\/nutritionist ( n=76 ) offer frequent , follow nhs- fund weight manag programm ( n=30 ) , referr bariatr surger ( n=28 ) commerci slim group ( n=26 ) . weight loss target hcp provid weight loss target less third ( 177\/589 , 30 % ) pwiih . less quarter ( 97\/401 , 24 % ) pwiih felt weight loss target \u2018 realist \u2019 figur 1 \u2018 hcp ( ) ask lose weight ? \u2019 ( n=596 ) . hcp , healthcar e profession . figur 2 ( ) experi pwiih hcp rais topic weight , ( b ) experi pwiih hcp support weight manag , ( c ) experi pwiih hcp set weight loss tar get . hcp , healthcar profession ; pwiih , peopl live idiopath intracrani hypertens . figur 3 w ord cloud analysi respons question \u2018 advis lose weight make feel ? \u2019 ( n=602 ) . figur 4 w eight manag support offer pwiih hcp ( n=462 ) . hcp , healthcar profession ; pwiih , iih , idiopath intracrani hypertens ; pwiih , peopl live idiopath intracrani hypertension.nurs & midwiferi librari . protect copyright . decemb 14 , 2023 mr guest , librarian http : \/\/neurologyopen.bmj.com\/ bmj neurol open : first publish 10.1136\/bmjno-2023-000527 9 decemb 2023. download 4 abbott , et al . bmj neurol open 2023 ; 5 : e000527 . doi:10.1136\/bmjno-2023-000527open access ( figur 2 ) . tabl 1 show particip quotat excerpt illustr weight loss target advis hcp whether felt target realist . improv weight manag patient experi onlin supplement file 2 outlin 5 categori 18 subcategori deriv free- text respons question experi treat iih via weight manag could improv perspect pwiih , alongsid illustr quotat . rela tionship iih weight pwiih wish hcp explor relationship iih excess weight \u2018 provid expla-n \u2019 biolog mechan excess weight may caus exacerb symptom iih ; also \u2018 acknowledg weight risk factor , caus \u2019 iih . pwiih refer condit name idio-path ( mean \u2018 unknown caus \u2019 ) , thu perceiv iih caus excess weight alon . reason pwiih excess weight compar women childbear age obes popul iih , either . sens sceptic among pwiih around rela-tionship iih excess weight , therefor , want hcp \u2018 provid evid \u2019 \u2018 actual scientif proof \u2019 them.individualis care pwiih felt weight manag discuss individualis . hcp could \u2018 consid impact iih symptom \u2019 provid lifestyl advic weight manag ; cite symptom pain fatigu challeng adopt help physic activ eat behaviour . pwiih express hcp \u2018 investig comorbid \u2019 asid iih , barrier weight manag . pwiih also felt hcp \u2018 explor mental health \u2019 sinc felt symptom iih contribut mental ill vice versa mental ill present challeng weight manag . provid individualis care , pwiih express hcp \u2018 get know \u2018 person \u2019 without make assumpt express want \u2018 treat like number \u2019 . give advic given advic weight manag , pwiih felt hcp acknowledg iih \u2018 complex \u2019 self- manag hcp \u2018 avoid oversimplist advic \u2018 eat less , move \u2019 . pwiih want hcp \u2018 provid realist weight loss target \u2019 quantifi term amount weight loss specifi time frame . provid support pwiih wish improv weight manag support provid hcp . pwiih want hcp \u2018 discuss tabl 1 quotat excerpt fr om uniqu particip recal weight loss target set hcp whether feel realist realist weight loss goal unrealist weight loss goal \u2018 ask lose 5 % achiev 7 % . \u2019 \u2018 sound like big number . 13 % bodi weight sound huge. \u2019 \u2018 doctor told creat goal super goal unachiev short period . manag smaller goal one time. \u2019 \u2018 lowest end healthi bmi seem imposs bodi would ever small. \u2019 \u2018 approx 1 kg per week steadi loss . calori r educt approx 100\u2013200 per day. \u2019 \u2018 told lose least 10 % bodi weight within month . support help given help achiev that. \u2019 \u2018 5 % 10 % bodi weight year. \u2019 \u2018 10st huge , feel like mountain \u2019 climb. \u2019 \u2018 told 10 % origin weight often enough see improv . realiti , lose lot 10 % quit easi achieve. \u2019 \u2018 ye initi goal 10 % achiev made differ symptom told keep go work . goal end sight. \u2019 \u2018 kept move it\u2026 5 % , 6 % \u201310 % 12 % , n't lose fast enough. \u2019 \u2018 got told lose 15 stone good massiv goal like that. \u2019 \u2018 look said need lose lot weight . \u2019 even weighed. \u2019 \u2018 goal given realist weigh 20 year ago 15 year old adolescent. \u2019 \u2018 told 10 % bodi weight . lost quit bit mor e , yet doctor \u2019 still insist lost weight symptom would improve. \u2019 bmi , bodi mass index ; hcp , healthcar professional.nurs & midwiferi librari . protect copyright . decemb 14 , 2023 mr guest , librarian http : \/\/neurologyopen.bmj.com\/ bmj neurol open : first publish 10.1136\/bmjno-2023-000527 9 decemb 2023. download 5 abbott , et al . bmj neurol open 2023 ; 5 : e000527 . doi:10.1136\/bmjno-2023-000527open access avail option \u2019 , would contribut pwiih feel \u2018 control \u2019 care solu-t offer . pwiih expect hcp manag iih expect provid isol weight manag support want hcp \u2018 organis referr hcp \u2019 , particular weight manag servic hcp train life-styl manag ( eg , dietitian , exercis physiologist ) . pwiih express hcp could also \u2018 provid resourc self- manag \u2019 form leaflet offer \u2018 practic \u2019 support . commun pwiih felt hcp could adapt commun style approach discuss weight manag . pwiih felt hcp \u2018 ask permiss \u2019 discuss measur weight . pwiih felt hcp \u2018 show empathi \u2019 alter choic languag discuss weight manag ; includ \u2018 use people- first languag \u2019 use term \u2018 obes \u2019 \u2018 avoid use shame languag \u2019 could result pwiih feel \u2018 blame \u2019 ill . pwiih wish hcp \u2018 engag two- way dialogu \u2019 excess weight part share decision- make , rather \u2018 talk \u2019 . set weight manag - ment convers took place import pwiih . express hcp \u2018 ensur privaci \u2019 weight manag discuss privaci could maintain , inpati set , vocalis wait room investig call , weigh . discuss studi provid novel insight experi pwiih regard current , mostli neg , interact hcp bodi weight weight manag . offer suggest pwiih commun weight manag could improv context iih diseas manag . despit signific evid demonstr weight loss effect treatment iih 10\u201312 found fifth pwiih recal offer support weight manag 16 % pwiih found support \u2018 help appropri \u2019 . evid demonstr unmet clinic need provid train support regard approach weight manage- convers onward referr weight manag servic , appropri , hcp care pwiih . pwiih express import hcp first ask permiss discuss weight . howev , less 1 10 ( 7 % ) pwiih studi recal ask permiss first . ask question , rather issu statement , core principl moti-v interview shown facilit patient- driven behaviour change22 recommend field pain neurosci enhanc patient \u2019 recept advic educ . 23 way hcp commun weight manag invok neg emot respons among pwiih , report feel self- blame \u2018 fault \u2019 iih due weight . research shown provid biolog explan diseas process effect reduc disease- relat stigma24 shift focu person blame physiolog- mechan effect mean avoid use stigmatis languag incit blame . 25 set target goal consid import behaviour chang techniqu weight manag . studi , pwiih express found weight target help weight manag ; howev , pwiih recount target set unrealist attain . provid target weight loss iih yet determin , studi recommend level diseas remit , none yet assess primari aim . unrealist weight loss target cite literatur barrier weight manag gener obes popul , 26 \u2018 fals hope \u2019 hypothesi suggest ambiti target less like met lead disappoint , dissatisfac-t decreas effort . 27 contrari , systemat review data found realist specif goal set effect weight manag among peopl obes . 28 find also provid suggest improv clin- ical commun perspect pwiih . effect weight manag encount part treat-ment iih could enabl hcp explain evid relationship iih weight , individualis care , give advic , provid support adapt commun . could potenti contribut better treatment adher improv self- manag practic seen chronic condit , includ obesity.29 30 studi sever strength . embed activ patient public involv ensur research relev servic user user- friendli sur vey ques- tion.19 31 although unknown mani pwiih expos onlin survey , method survey distribut via iih uk chariti platform meant larg uk sampl pwiih complet survey . howev , studi also limit . due natur survey distribut , possibl calcu-l respons rate . futur occurr , onlin survey could post iih uk chariti webpag number view respons track calcu-l respons rate . although anonym survey may contribut higher respons rate , data particip characterist therefor certain repres studi sampl target popul . survey distribut onlin , peopl without access internet peopl lower level digit literaci like includ . 32 respons collect nurs & midwiferi librari . protect copyright . decemb 14 , 2023 mr guest , librarian http : \/\/neurologyopen.bmj.com\/ bmj neurol open : first publish 10.1136\/bmjno-2023-000527 9 decemb 2023. download 6 abbott , et al . bmj neurol open 2023 ; 5 : e000527 . doi:10.1136\/bmjno-2023-000527open access retrospect healthcar encount , result like suscept recal bia , question inquir time consult complet questionnair . rich qualit data limit respons provid written form therefor semistructur interview would recommend futur research . 33 research could focu examin experi perspect pwiih hcp affect patient\u2013hcp relationship , access ultim health outcom . increas knowl-edg base pwiih hcp regard role weight iih import seen prioriti . 18 - stand actual pathway pathogen role bodi weight weight gain iih help hcp discuss aspect diseas confid iih reduc hcp weight stigmatis . 10 effect commun challeng topic help make pwiih feel \u2018 heard \u2019 \u2018 accept \u2019 . conclus studi show mani pwiih experi neg emot hcp commun bodi weight , role iih manag weight reduct . call improv made weight manag experi context iih . research need understand hcp perspect bodi weight weight manag commun iih . target train readi access weight manag servic requir address weight stigma facilit effect communica-t hcp pwiih . author affili 1institut health wellb , centr healthcar commun , coventri univers , coventri , uk 2depart dietet , univers hospit coventri warwickshir nh trust , coventri , uk 3iih uk regist chariti , washington , uk 4depart neuro- ophthalmolog , moorfield eye hospit nh foundat trust , london , uk 5medic eye unit , guy 's st thoma ' hospit nh trust , london , uk 6faculti life scienc medicin , king \u2019 colleg london , london , uk 7institut neurolog , depart clinic movement neurosci , univers colleg london , london , uk 8birmingham neuro- ophthalmolog , univers hospit birmingham nh foundat trust , birmingham , uk 9institut metabol system research , translat brain scienc , univers birmingham , birmingham , uk 10institut health wellb , centr intellig healthcar , coventri univers , coventri , uk 11renal servic , univers hospit coventri warwickshir nh trust , coventri , uk acknowledg author would like thank chariti iih uk initia ting perform studi perspect pwiih support studi financi . author would also like thank pwiih willing complet onlin survey . contributor author contribut equal manuscript follo wing specif contribut : sa\u2014writ methodolog result section , data analysi , review final manuscript provid intellectu contribut ; ad\u2014conceptualis methodolog , review final manuscript provid intellectu contribut ; shw\u2014write , full manuscript review intellectu contribut ; spm\u2014write , full manuscript review intellectu contribut ; kcmb\u2014write introduct discuss section , review final manuscript provid intellectu contribut . sa act guarantor take full respons work conduct studi , access data control decis publish . author read approv final manuscript . fund stud fund iih uk chariti ( grant\/award number n\/a ) . compet interest author ha complet icmj uniform disclosur form declar compet interests.pati public involv wo pwiih involv develop onlin survey question formul base experi pwiih collect chariti iih uk . chariti iih uk repres voic pwiih distribut onlin survey mail list social media channel . three pwiih pilot onlin survey finalis . coauthor ad patient live experi iih review contribut current manuscript . patient consent public pplicabl . ethic approv pproval requir health research author ( hra ) nation health servic ( nh ) research ethic committe ( rec ) particip recruit nh site . particip survey made awar intend use data fill survey , therefor , gave consent fill survey . data collect anonymis . proven peer review commiss ; extern peer review . data av ailabl statement da ta avail . data shareabl due qualit natur data collect , order maintain particip anonym . supplement materi content suppli author ( ) . vet bmj publish group limit ( bmj ) may peer- review . opinion recommend discuss sole author ( ) endors bmj . bmj disclaim liabil respons aris relianc place content . content includ translat materi , bmj warrant accuraci reliabl translat ( includ limit local regul , clinic guidelin , terminolog , drug name drug dosag ) , respons error and\/or omiss aris translat adapt otherwis . open access open access artic le distribut accord creativ common attribut non commerci ( cc by- nc 4.0 ) licens , permit other distribut , remix , adapt , build upon work non- commerci , licens deriv work differ term , provid origin work properli cite , appropri credit given , chang made indic , use non- commerci . see : http : \/\/creativecommons.org\/licenses\/by-nc\/4.0\/ . orcid idkim cm bul http : \/\/orcid.org\/0000-0001-8984-9921 refer 1 miah l , straf ford h , fonferko- shadrach b , et al . incid , preval healthcar outcom idiopath intracrani hypertens : popul studi . neurolog 2021 ; 96 : e1251\u201361 . 2 mollan sp , grech , alimajstorov z , et al . new horizon idiopath intracrani hypertens : advanc challeng . br med bull 2020 ; 136:118\u201326 . 3 mollan sp , ali f , hassan- smith g , et al . evolv evid adult idiopath intracrani hypertens : pathophysiolog manag . j neurol neurosurg psychiatri 2016 ; 87:982\u201392 . 4 mccluskey g , doherty- allan r , mccarr p , et al . meta\u2010analysi systemat review population\u2010bas epidemiolog studi idiopath intracrani hypertens . eur j neurol 2018 ; 25:1218\u201327 . 5 mollan sp , aguiar , evison f , et al . expand burden idiopath intracrani hypertens . eye ( lond ) 2019 ; 33:478\u201385 . 6 adderley nj , subramanian , nirantharakumar k , et al . associ idiopath intracrani hypertens risk cardiovascular diseas women unit kingdom . jama neurol 2019 ; 76:1088\u201398 . 7 mollan sp , mytton j , tsermoula g , et al . idiopath intracrani hypertens : evalu admiss emerg readmiss nurs & midwiferi librari . protect copyright . decemb 14 , 2023 mr guest , librarian http : \/\/neurologyopen.bmj.com\/ bmj neurol open : first publish 10.1136\/bmjno-2023-000527 9 decemb 2023. download 7 abbott , et al . bmj neurol open 2023 ; 5 : e000527 . doi:10.1136\/bmjno-2023-000527open access hospit episod statist dataset 2002\u20132020 . life ( basel ) 2021 ; 11:417 . 8 friesner , rosenman r , lobb bm , et al . idiopath intracrani hypertens usa : role obes establish preval healthcar cost : preval healthcar cost iih . obe rev 2011 ; 12 : e372\u201380 . 9 mulla , markey ka , woolley rl , et al . headach determin qualiti life idiopath intracrani hypertens . j headach pain 2015 ; 16:45:521. : . 10 mollan sp , tahrani aa , sinclair aj . potenti modifi risk factor idiopath intracrani hypertens : bodi weight . neurol clin pract 2021 ; 11 : e504\u20137 . 11 mollan sp , mitchel jl , ottridg rs , et al . effect bariatr surgeri vs commun weight manag intervent treatment idiopath intracrani hypertens : random clinic trial . jama neurol 2021 ; 78:678\u201386 . 12 mollan sp , mitchel jl , yiangou , et al . associ amount weight lost bariatr surgeri intracrani pressur women idiopath intracrani hypertens . neurolog 2022 ; 99 : e1090\u20139 . 13 ko mw , chang sc , ridha , et al . weight gain recurr idiopath intracrani hypertens case- contr ol studi . neurolog 2011 ; 76:1564\u20137 . 14 mollan sp , sinclair aj , tsermoula g. letter : cerebrospin fluid shunt idiopath intracrani hypertens : systemat review , meta- analysi , implic moder n manag protocol . neurosurgeri 2023 ; 92 : e59\u201360 . 15 ryan l , coyn r , heari c , et al . weight stigma experienc patient obes healthcar set : qualit evid synthesi . obe rev 2023 ; 24 : e13606 . 16 auckbur , davi e , logu j. use ef fectiv languag commun manag obes : challeng healthcar profession . curr obe rep 2021 ; 10:274\u201381 . 17 cr ocker jc , boylan a- , bostock j , et al . worth ? patient public view impact involv health research assess : uk- base qualit interview studi . health expect 2017 ; 20:519\u201328 . 18 mollan , hem k , cp , et al . research prioriti idiopath intracrani hypertens ? prioriti set partnership patient healthcar profession . bmj open 2019 ; 9 : e026573 . 19 scotton wj , mollan sp , walter , et al . characteris patient experi diagnost lumbar punctur idiopath intracrani hypertens : cross- section onlin survey . bmj open 2018 ; 8 : e020445 . 20 hsieh h- f , shannon se . three approach qualit content analysi . qual health re 2005 ; 15:1277\u201388 . 21 kondracki nl , w ellman ns , amundson dr. content analysi : review method applic nutrit educ . j nutr educ behav 2002 ; 34:224\u201330 . 22 v , h p , , et al . n.d. minim intervent obes counsel primari care . 23 nij j , wijma aj , willaert w , et al . integr motiv interview pain neurosci educ peopl chronic pain : practic guid clinician . phi ther 2020 ; 100:846\u201359 . 24 doley jr , hart lm , stuka aa , et al . intervent reduc stigma eat disord : systemat review meta- analysi : doley et al . int j eat disord 2017 ; 50:210\u201330 . 25 fear n , sudlow , le roux cw , et al . say mean , mean say : import languag treatment obes . obes ( silver spring ) 2022 ; 30:1189\u201396 . 26 w amstek ew , geenen r , zelissen pmj , et al . unrealist weight- loss goal among obes patient ar e associ age causal attribut . j diet assoc 2009 ; 109:1903\u20138 . 27 polivi j , herman cp . false- hope syndr ome : unfulfil expect self- chang . curr dir psychol sci 2000 ; 9:128\u201331 . 28 pearson es . goal set health behavior chang strategi overweight obes adult : systemat literatur e review examin intervent compon . patient educ coun 2012 ; 87:32\u201342 . 29 iacobucci g. reat obes effort use reduc smoke , say lead psychologist . bmj 2019 : l5713 . 30 fer nand jb , teixeira f , godinho c. person care treatment complianc chronic condit . j per med 2022 ; 12:737 . 31 br ett j , staniszewska , mockford c , et al . map impact patient public involv health social care research : systemat review . health expect 2014 ; 17:637\u201350 . 32 datta , bhatia v , noll j , et al . bridg digit divid : challeng open digit world elderli , poor , digit illiter . ieee consum electron mag 2019 ; 8:78\u201381 . 33 reja u , manfr eda kl , hlebec v , et al . open- end vs. close- end question web questionnair es ; 2003.nurs & midwiferi librari . protect copyright . decemb 14 , 2023 mr guest , librarian http : \/\/neurologyopen.bmj.com\/ bmj neurol open : first publish 10.1136\/bmjno-2023-000527 9 decemb 2023. download",
  "weight manag intervent adult idiopath intracrani hypertens : systemat review practic recommend abbott , s. , chan , f. , tahrani , a. a. , wong , s. , campbel , f. e. , parmar , c. , pournara , d. , denton , a. , sinc lair , a. j . & mollan , s. p. publish pdf deposit coventri univers \u2019 repositori origin citat : abbott , , chan , f , tahrani , aa , wong , , c ampbel , fe , parmar , c , pournara , , denton , , sinclair , aj & mollan , sp 2023 , 'weight manag intervent adult idiopath intracrani hypertens : systemat review practic recommend ' , neurolog , vol . ( -press ) , pp . ( -press ) . http : \/\/dx.doi.org\/ 10.1212\/wnl.0000000000207866 doi 10.1212\/wnl.0000000000207866 issn 0028 -3878 essn 1526 -632x publish : lippincott , william & wilkin open access articl distribut term creativ common attribut -noncommerci -noderiv ativ licens 4.0 ( cc -by-nc-nd ) , permit download share work provid properli cite . work chang n way use commerci without permiss journal . copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . neurolog publish ahead print doi : 10.1212\/wnl.0000000000207866 weight manag intervent adult idiopath intracrani hypertens : systemat review practic recommend author ( ) : salli abbott1 ; fiona chan2 ; abd tahrani , phd3,4 ; sui h wong , mbb , md , frcp5,6,7,8 ; fiona e campbell9 ; chetan parmar10,11 ; dimitri pournaras12 ; amanda denton13 ; alexandra jean sinclair , phd14 ; susan p mollan , mbchb14,15 correspond author : susan p mollan , soozmollan @ doctors.org.uk affili inform author : 1. research centr healthcar commun , coventri univers ; 2. birmingham neuro-ophthalmolog , univers hospit birmingham ; 3. institut metabol system research , univers birmingham ; 4. novo nordisk , denmark ; 5. dept neuro- ophthalmolog , moorfield eye hospit ; 6. medic eye unit , guy 's st thoma ' nhsft ; 7. school life cours & popul scienc , king colleg london ; 8. dept clinic movement neurosci , univers colleg london ; 9. adult weight manag ( bariatr surgeri ) nh grampian ; 10. depart surgeri , univers colleg london hospit , ; 11. depart surgeri , bart health nh trust ; 12. upper gastrointestin , bariatr metabol surgeri , north bristol nh trust ; 13. iihuk ; 14. translat brain scienc , institut metabol system research , colleg medic dental scienc , univers birmingham , birmingham , uk ; 15. birmingham neuro-ophthalmolog , univers hospit birmingham nh trust , birmingham , uk open access articl distribut term creativ common attribution- noncommercial-noderiv licens 4.0 ( cc by- nc-nd ) , permit download share work provid properli cite . work chang way use commerci without permiss journal . neurolog \u00ae publish ahead print articl peer review accept public . manuscript publish final form copyedit , page composit , review proof . error could affect content may correct process . publish ahead print octob 9 , 2023 10.1212\/wnl.0000000000207866 copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . equal author contribut : contribut : salli abbott : drafting\/revis manuscript content , includ medic write content ; major role acquisit data ; studi concept design ; analysi interpret data fiona chan : drafting\/revis manuscript content , includ medic write content ; analysi interpret data abd tahrani : analysi interpret data sui hsien wong : analysi interpret ata fiona ej campbel : analysi interpret data chetan parmar : analysi interpret data dimitri pournara : analysi interpret data amanda denton : analysi interpret data alexandra jean sinclair : analysi interpret data susan p mollan : drafting\/revis manuscript content , includ medic write content ; major role acquisit data ; studi concept design ; analysi interpret data figur count : 1 tabl count : 5 search term : [ 104 ] idiopath intracrani hypertens , [ 14 ] clinic neurolog , [ 188 ] optic nerv , [ 186 ] neuro- ophthalmolog acknowledg : studi fund : iih uk chariti provid fund open access public cost . disclosur : sa consult fee johnson & johnson ; aat report grant novo nordisk sanofi ; person fee novo nordisk , janssen , az , eli lilli , bi , bm , napp , msd , nestl , gilead , sanofi well non-financi support novo nordisk , eli lilli , az , impeto medic , resm , aptiva , bi , bm , napp , msd . aat current employe novo nordisk . novo nordisk involv work ; djp fund royal colleg surgeon england . receiv consult fee johnson & johnson payment lectur , present , educ event johnson & johnson , medtron , novo nordisk ; report person fee invex therapeut role director stock hold , conduct studi , allergan , novarti , cheisi amgen outsid submit work ; sm report consult fee invex therapeut , velux foundat neurodiem , advisori board compens janssen , santhera , gensight biolog chugai-roch ltd ; speaker fee chiesi , heidelberg engin , allergan , chugai-roch ltd , santen , santhera , roch teva conflict interest outsid submit work ; author declar compet interest . preprint doi : receiv date : 2023- 05-11 accept date : 2023- 08-15 handl editor statement : submit extern peer review . handl editor associ editor rebecca burch , md . copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . abstract background object idiopath intracrani hypertens ( iih ) associ obes , howev lack clinic consensu manag weight iih . aim systemat review evalu weight loss intervent peopl iih determin intervent superior term weight loss , reduct intracrani pressur , benefit visual headach outcom , qualiti life , mental health . method systemat review carri accord prisma guidelin regist prospero ( crd42023339569 ) . medlin cinahl search relev literatur publish incept 15th decemb 2022. screen qualiti apprais conduct two independ review . recommend grade use scottish intercollegi guidelin network ( sign ) methodolog . result total 17 studi includ . bariatr surgeri result 27.2-27.8kg weight loss 24 month ( level 1- 1++ ) . lifestyl weight manag intervent result 1.4 15.7kg weight loss ( level 2+ 1++ ) . bariatr surgeri result greatest mean reduct icp ( -11.9cm h 2o ) 24 month ( level 1++ ) , follow multi-compon lifestyl intervent + acetazolamid ( -11.2cm h 2o ) 6 month ( level 1+ ) , low energi diet intervent ( -8.0cm h 2o ) 3 month ( level 2++ ) . least icp reduct shown 24 month complet 12-month multi-compon lifestyl intervent ( -3.5 cm h 2o ) ( level 1++ ) . reduct bodi weight shown highli correl reduct icp ( level 2++ 1++ ) . discuss bariatr surgeri consid women iih bmi \u226535kg\/m2 sinc robust evid sustain weight manag ( grade ) . multi- compon lifestyl intervent ( diet + physic activ + behaviour ) robust evid modest weight loss bmi < 35kg\/m2 ( grade b ) . longer term outcom weight manag intervent peopl iih requir , determin superior weight loss intervent iih . copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . introduct idiopath intracrani hypertens ( iih ) character rais intracrani pressur ( icp ) , puls -synchron tinnitu , headach papilloedema , potenti risk perman visual loss 1. peopl live iih also live obes 2. popul studi observ increas incid iih increas bodi mass index ( bmi ) 3 , elev bmi shown directli associ greater risk diagnosi iih 2. furthermor , relationship bm visual outcom establish . studi found patient bmi > 40kg\/m2 like sever papilloedema first neuro -ophthalmolog visit everi 10kg\/m2 increas bmi increas odd sever visual loss 1.4 time 4. iih emerg diseas neuro-ophthalm axi distinct metabol diseas , underli pathophysiolog may modifi weight loss 5\u2013 7. moreov , iih demonstr distinct pathophysiolog hinder weight loss promot weight gain 8. time , psychiatr disord sevenfold common peopl iih compar gener popul 9 , may result common biolog pathway relat hypot halamu -pituitari -adren cortex ( hpa ) -axi dysfunct 10 , may mean weight manag challeng peopl live iih . obes result interact innat biolog environment factor , strong genet compon underli interindividu variat bodi weight 11. result , human bodi biolog hard-wir prevent weight loss 12,13. challeng treatment iih sinc excess bodi weight impact iih develop improv . moder weight gain 5-15 % associ greater risk develop iih among peopl without obes 14. meanwhil , weight loss rang 3-24 % report lead remiss 5\u20137 weight re-gain found risk factor diseas recurr 15. copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . sustain weight loss therefor essenti long-term remiss diseas . howev , clinic practic vari deliv effect weight loss strategi iih . inde , sustain weight loss demonstr essenti long-term remiss diseas 15. optim weight loss method iih yet determin 16 , especi context chronic relaps natur obes . henc , aim studi identifi , evalu , summaris relev publish studi relat weight loss intervent iih term abil deliv sustain weight loss impact key outcom visi headach . second aim studi conven panel expert field iih weight manag review evid provid practic point help guid clinician may formal train weight manag . metho ds systemat review regist prospero intern prospect regist systemat review ( identifi crd42023339569 ) report accord prefer report item systemat review meta-analys ( prisma ) guidelin 17. search strategi databas medlin cinahl search incept 15th decemb 2022 via ebsco use comprehens search strategi ( eappendix 1 ) , test refin maximis sensit retriev relev studi . languag restrict . boolean oper \u201c \u201d use separ term within concept , concept concaten oper \u201c \u201d . possibl , medic subject head ( mesh ) term use expand search languag . search strategi ident databas , minor adapt code suit copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . individu databas set . refer import covid softwar de- duplic screen . inclus exclus criteria studi includ , studi popul criteria age \u226516 year old , diagnos iih baselin bmi \u226525kg\/m2 . studi includ weight manag intervent provid weight chang pre- post-intervent report . review , expert opinion , case report confer proceed exclud . paper select data extract two review ( sa spm ) independ duplic screen titl abstract screen full-text report identifi studi . review mask \u2019 respons screen stage complet , utilis covid . disagr resolv consensu review . data extract studi characterist document criteria particip diagnos iih record . primari outcom interest systemat review weight chang , measur either absolut weight ( kg % ) , excess weight ( % ) ( calcul absolut weight loss \/ ( baselin weight \u2013 ideal bodi weight ) x 100 ) absolut bmi ( kg\/m2 ) chang . secondari outcom chang icp , visual headach outcom , self-report qualiti life measur ( e.g. , short form 36 ( sf-36 ) health survey18 ) . specif visual outcom document visual acuiti , visual field type output , papilloedema whether subject grade quantifi optic coher tomographi ( oct ) imag . headach outcom includ headach symptom , headach phenotyp assess type , headach impact test ( hit ) -6 , headach frequenc , copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . sever score analges usag . data extract one review ( sa\/spm\/fch ) peer review anoth ( sa\/spm\/fch ) , use electron data extract form . data analysi sinc includ studi divers , heterogen studi term intervent , durat follow-up method outcom measur preclud pool result meta-analysi . instead , narr synthesi approach employ synthesis find includ studi . qualiti evid qualiti risk bia includ studi assess studi level studi assign evid level weight loss , icp , headach visual outcom , base scottish intercollegi guidelin network ( sign ) methodology19 ( eappendix 2 ) , two independ review ( sa spm ) . practic recommend process sign methodology19 ( eappendix 2 ) follow formul evidence- base clinic recommend . multi-disciplinari recommend panel form relev profession group experi expertis iih weight manag . recommend panel includ dietitian ( sa ) , clinic psychologist ( fca ) , endocrinologist ( aat ) , bariatr surgeon ( djp , cp ) , neurologist ( aj , fch ) , neuro- ophthalmologist ( spm , sw ) , patient repres ( ad ) . expert panel conven discuss evid base identifi systemat review formul draft recommend . draft recommend togeth grade circul within guidelin group iter process consensu achiev . evid base lack , good practic point ( gpp ) formul provid clinician short piec advic recommend panel deem essenti good clinic practic . copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . result remov duplic , databas search yield 328 studi . , 263 exclud base titl abstract . fo rty-seven public exclud full text review , due particip bmi < 25kg\/m2 ( n=2 ) , studi design ( n=25 ) , weight chang report ( n=12 ) absenc weight loss intervent ( n=8 ) . total 17 studi includ , 12 studi 5,6,20 \u201329 origin studi five studi 7,30\u201333 report includ studi . studi select process summaris figur 1. studi characterist studi characterist found tabl 1. six studies7,20,21,31 \u201333 randomis control trial ( rct ) , four prospect non-randomis intervent studies6,24,25,30 ; two prospective27,29 four retrospect observ studi 5,22,23,26,28. prescrib concomit iih pharmacotherapi note etabl 1. particip characterist total 496 patient includ review studi gener small sampl size , rang four 165 particip ( tabl 2 ) . studi ( n=10 ) includ femal inclus criteria . seven studi includ male participants5,21,26,29,31 \u201333 , minor studi popul ( rang 2.4 % 7.7 % ) , male receiv bariatr surgeri intervent . mean age particip rang 27 39 year old mean baselin bmi rang 36 47kg\/m2 . particip undergo bariatr surgeri also higher mean bmi ( rang 42.1 47.0kg\/m2 ) lifestyl intervent ( 30.6 40.0kg\/m2 ) . nine studi report ethnicity6,7,20 \u201322,25,30 \u201333 , particip white ( rang 65 94 % ) . nine studi 6,7,20,21,27,30 \u201333 record defin iih diseas durat , wide rang acut diseas within 6 week diagnosi establish diseas beyond 11 year . copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . weight loss intervent eight studi ( n=122 particip ) report bariatr surgeri intervent , includ gastric band 7,20,22\u2013 24,34 ( n=6 studi ) , sleev gastrectomi 7,20,22,27,28,34 ( n=6 studi ) gastric bypass7,20,22,24,34 ( n=5 studi ) . twelv studi report lifestyl weight manag intervent ( n=374 particip ) ; four studies6,25,29,30 dietari intervent alon , seven studi 20,21,26,31 \u201334 multi-compon intervent ( diet + physic activ + behaviour al intervent ) one study5 patient independ sourc weight manag intervent choos ( etabl 1 ) . weight loss outcom studi outcom pool across bariatr surgeri procedur ( gastric band , gastric bypass sleev gastrectomi ) , mean weight loss 27.2 27.8kg 24 month ( level 1- 1++ 20,34 ) ( tabl 3 ) . howev , weight loss outcom report procedur level , greatest weight loss seen gastric bypass procedur ( n= 37 particip ) signific weight reduct 42.5 45.0kg 12 24 month excess weight loss 69.9 71.0 % 24 month median 91 month ( level 2- 1- 7,22,24 ) . sleev gastrectomi ( n=42 particip ) result weight loss 32.2 39.0kg 12 24 month ( level 3 1- 7,28 ) . excess weight loss rang 75.2 87.4 % 12 month ( level 3 27,28 ) , 40.2 % excess weight loss median follow-up 68 month ( level 2- 22 ) ; statist signific report . weight loss outcom gastric band ( n=27 particip ) vari . one studi , mean 1.0kg weight gain observ 24 month post-gastr band procedur ( level 1- 7 ) . studi , excess weight loss 64.1 % mean 20 month lesser 27.1 % median 108 month ( level 3 2- 22,23 ) ; although statist signific report either studi . 24 month ( level 1- 7 ) , gastric bypass shown result greatest weight loss ( kg ) compar sleev gastrectomi gastric band ( p= < 0.001 ) 24 month . copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . longitudin follow- ( level 2- 22 ) , weight loss greater gastric bypass ( median follow-up 91 month ) compar gastric band ( median follow- 108 month ) ( p=0.007 ) , differ gastric bypass sleev gastrectomi ( median follow-up 68 month ) ( p=0.069 ) . greatest weight loss lifestyl intervent report use vled dietari intervent 15.7kg 3 month ( level 2+ 6 ) . short-term dietari intervent result modest reduct bmi 2.0 2.3kg\/m2 3 6 month ( level 2- 2+ 26,29 ) . median 10 11 month follow-up dietari intervent , weight loss signific howev addit 2.25g\/day metformin led mean weight loss 6.9 % 8.2 % patient hyperinsulinaemia pco , respect ( level 2+ 25 ) . 6-month multi- compon intervent result mean weight loss 3.5kg 7.5kg multi- compon intervent multi-compon intervent + acetazolamid , respect ( level 2+ 31\u201333 ) . 12-month multi-compon intervent result signific weight loss either 12- 24-month follow- ( level 1- 1++ 20,34 ) . intracrani pressur outcom ten studi record baselin icp measur lumbar punctur open pressure5,6,20,21,24,27 \u201329,33 ( tabl 4 ) , three studi 6,20,33 measur chang icp follow weight manag intervent . bariatr surgeri offer greatest mean reduct ( - 11.9cm h 2o ) icp 24 month ( level 1++ 20 ) , follow 6-month multi-compon lifestyl intervent + acetazolamid ( -11.2cm h 2o ) ( level 1+ 33 ) , 3-month vled ( diet ) intervent ( -8.0cm h 2o ) ( level 2++ 6 ) , 6-month multi-compon lifestyl intervent ( -5.2cm h 2o ) ( level 1+ 33 ) . least icp reduct shown 24 month complet 12-month multi-compon lifestyl intervent ( -3.5 cm h 2o ) ( level 1+ + 20 ) . reduct bodi weight also shown highli correl reduct icp ( level 2++ 1++ 6,20 ) . copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . visual outcom five studi report visual acuiti 6,20,26,29,33 ( etabl 2 ) . five studi gave brief descript visual field loss detail type visual field performed23\u201325,27,28 one studi report visual field outcomes20 . six studi report perimetr mean deviat ( pmd ) 24-2 humphrey visual field analys ( level 3 1+ 5,6,20,26,29,33 ) . five studi comment presenc absenc papilloedema ( level 4 23,24,27,28 ) , wherea formal fris\u00e9n grade , oct imag record six studi ( level 2- 1+ 6,20,26,29,31,33 ) . one study6 note signific improv visual acuiti , low contrast visual acuiti , hvf oct measur papilledema 15 % reduct weight ( level 2++ ) . gener , visual paramet improv time , howev direct comparison made group signific found studi ( etabl 2 ) . iihtt33 modest , statist signific , improv visual field md , conjunct signific differ weight loss placebo multicompon intervent acetazolamid multicompon intervent arm ( acetazolamid : \u22127.50 kg , 107.72 kg 100.22 kg ; placebo : \u22123.45 kg , 107.72 kg 104.27 kg ; treatment effect , \u22124.05 kg , 95 % ci , \u22126.27 \u22121.83 kg ; p < .001 ) ( level 1+ ) . mediat analysi primari outcom pmd perform determin degre effect acetazolamid pmd mediat effect weight , found signific ( p=0.64 ) . iihtt iihwt rct 3,33 therefor find visual paramet directli associ extent weight loss ( level 2+ 1+ ) studi report visual outcom directli compar chang visual outcom weight outcom ( level 4 level 2++ ) . headach outcom studi provid detail headach outcom ( l evel 2++ 2+ , etabl 3 ) . one study6 note signific reduct headach frequenc , sever , analges use hit- 6 copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . score vled also deliv 15 % reduct weight 3 month ( level 2++ 6 ) . two rct 20,31 support evid signific reduct headach follow weight loss ( level 2++ 2+ ) . notab ly iihtt studi 31 correl headach burden , assess hit-6 , bmi either baselin subsequ follow-up 6 month ( level 2+ ) . qualiti life outcom two studi 20,30 report quality- of-lif ; use short form 36 ( sf-36 ) health survey18 ( level 1++ ) . bariatr surgeri 20 , signific improv physic ( p= < 0.001 ) mental compon score 24 month ( level 1++ ) . immedi 3-month vled ( diet alon ) intervent 30 , signific improv physic ( p= < 0.001 ) mental ( p=0.020 ) compon score ( level 2+ ) . howev , improv sustain 3 month vled intervent end . mental health outcom one study20 report chang self-report anxieti depress , assess use hospit anxieti depress scale ( had ) 35. signific chang anxieti either multi-compon lifestyl intervent bariatr surgeri intervent group ; howev , signific ( p=0.002 ) reduct depress score ( -2.7 ; 95 % ci -1.0 -4.4 ) 24 month bariatr surgeri intervent group ( level 1++ ) . grade recommend clinic practic expert panel identifi consensus-bas recommend weight manag peopl iih base upon evid identifi within systemat review grade accord qualiti avail evid . evid avail iih popul , gpp formul base upon evid extrapol obes literatur . grade recommend shown tabl 5. copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . discuss recommend treat overweight obes peopl live iih weight loss reduc icp , also reduc mortal 36 reduc burden preval incid obes relat complic 36. weight loss recognis modifi factor treatment iih . studi sought determin optim weight loss intervent iih , identifi research prioriti jame lind allianc prioriti set partnership 16. panel made grade recommend base upon evid identifi systemat review , detail clinic guidanc good practic point obes literatur ( tabl 5 ) . one rct demonstr level 1++ evid direct use bariatr surgeri sustain weight loss reduct icp 24 month 19 , one cross studi ( level 2+ ) utilis vled 3 month demonstr efficaci term icp , visual headach outcom , two studi replic . result analysi therefor demonstr shortag high-qual evid , studi could directli compar due differ weight manag method use , lack standardis outcom measur . sustain long term weight loss consid tool improv health qualiti life patient iih . patient iih overweight obes counsel sensit role obes weight manag iih . weight measur bmi calcul assess weight manag option monitor intervent efficaci . although rct evalu measur overweight obes compar measur outcom , panel agre aspect iih patient care essenti . degre weight loss requir iih symptom improv less clear studi report amount weight lost varieti outcom measur . studi copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . evalu time minimum amount weight lost correl point diseas remiss . level 2+ evid demonstr reduct weight 15-24 % requir achiev diseas remiss . vled cross studi 15 % bodi weight loss correl reduct icp , resolut papilloedema favour headach outcom 6 iihwt diseas remiss defin icp return normal level 25 cmh 20 7. therefor import acknowledg lifestyl intervent deliv commun set may effect weight loss 37 may deliv magnitud weight loss requir induc remiss iih . panel consid evid recommend target weight loss 15 % iih diseas remiss . howev , panel acknowledg goal unlik achiev via lifestyl intervent alon , realist goal may 5-10 % weight loss 38 , may still offer improv iih symptom . studi evalu sole physic activ intervent iih . physic activ could recommend part weight control program may contribut mainten weight loss 39. behaviour therapi shown use adjunct incorpor treatment weight loss weight mainten 40. licens anti-obes medic ( aom ) featur studi , n studi primari aim use pharmacotherapi weight loss iih . noteworthi inadvert evid benefici effect acetazolamid weight reduct 31. carbon anhydras inhibitor acetazolamid topiram , lesser extent zonisamid , use manag iih 1 previous clinic observ reduc weight . method acetazolamid caus weight loss could due propens caus dysgeusia ( salti , rancid metal tast sensat persist mouth ) , nausea , dyspepsia , vomit diarrhoea . acetazolamid well toler patient group 40 % peopl discontinu medicin 41. systemat review , interest observ magnitud reduct weight icp 6 month follow direct use acetazolamid 33. copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . bariatr surgeri greatest sustain weight loss 24 month 20. clinician manag iih may reluct refer patient bariatr surgeri , due fund access misconcept regard safeti bariatr surgeri , oper mortal , excess skin , nutrit optic atrophi . physician may concern csf shunt subsequ bariatr surgeri ; howev bariatr surgeri shown safer cost-effect csf shunt 42. gastric bypass sleev gastrectomi surgic procedur superior gastric band , term weight loss icp reduct peopl iih . obes , gastric bypass found clinic effect cost-effect intervent compar weight manag programm highest quality-adjust life year ( qali ) gain 43. superior gastric bypass sleev gastrectomi iih may explain enhanc postprandi glucagon-lik peptide-1 ( glp-1 ) secret , emerg data found exogen administ glp-1 significantli reduc icp without weight loss 44. anoth key consider understand impact intervent natur histori diseas includ diseas durat . could impact outcom , exampl peopl diseas mani year may possibl revers visual loss occur due axon loss henc studi long diseas durat visual field measur may improv 45. likewis , papilloedema may acut present , without intervent may regress ean . strength studi includ methodolog rigour systemat review , prospect regist prospero screen , data extract qualiti assess blind conduct two review . evid translat clinic recommend made multi-disciplinari expert obes iih , copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . henc support translat research clinic applic . certain limit studi . includ studi use differ outcom measur , varieti weight loss method . meant meta-analysi abl perform , due studi heterogen . heterogen iih studi evalu weight loss method need consid plan futur clinic trial iih . also includ publish studi , mean potenti public bia . meta- analysi preclud , appropri quantifi potenti public bia use funnel plot 46. studi popul includ studi predomin femal , reflect iih less preval male 47 , howev find therefor generalis male . specif , need research examin effect bariatr surgeri iih male popul , gender lower bmi 30- 35kg\/m2 . none studi includ women pregnant , area need evalu , recommend weight manag pregnanc receiv specialist weight manag input 44. studi short durat , one studi report outcom longitudin 9 year . longer report period , miss data occur . howev , futur studi encourag includ long term outcom , determin cost-effect intervent durabl . peopl iih obes , compar healthi weight , significantli lower health-rel qualiti life score 48. moreov , obes weight gain found independ predictor poorer mental health-rel qualiti life 49. psychiatr symptom associ iih usual poorli describ underestim literatur , preval report high 86 % 50. given psychiatr symptom control influenc patient \u2019 engag adher weight manag intervent , inde iih treatment , requir investig . henc , futur studi collect qualiti life copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . psychiatr outcom measur evalu influenc weight manag intervent , includ long term outcom data collect , assess durabl intervent . conclus advoc obes view chronic diseas complex contributori associ prognost implic iih , rather mere risk factor . weight loss seen import tool manag iih . biolog driver obes may explain short-term weight manag intervent often insuffici long-term diseas remiss . hierarchi effect weight loss method seem analog reduct icp , bariatr surgeri robust evid effect treatment obes iih popul . howev , patient qualifi bariatr surgeri intervent . case , multi-compon lifestyl intervent provid ; acknowledg weight loss like modest iih diseas remiss therefor unlik may still offer improv iih symptom . wnl- 2023- 001847_eapp1 -- -http : \/\/links.lww.com\/wnl\/d147 wnl- 2023- 001847_eapp2 -- -http : \/\/links.lww.com\/wnl\/d148 wnl- 2023- 001847_etab1 -- -http : \/\/links.lww.com\/wnl\/d149 wnl- 2023- 001847_etab2 -- -http : \/\/links.lww.com\/wnl\/d150 wnl- 2023- 001847_etab3 -- -http : \/\/links.lww.com\/wnl\/d151 copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . refer 1. mollan sp , davi b , silver nc , et al . idiopath intracrani hypertens : consensu guidelin manag . j neurol neurosurg psychiatri [ onlin serial ] . bmj publish group ltd ; 2018 ; 89:1088 \u20131100 . access : http : \/\/jnnp.bmj.com\/content\/89\/10\/1088 . access march 3 , 2023 . 2. adderley nj , subramanian , nirantharakumar k , et al . associ idiopath intracrani hypertens risk cardiovascular diseas women unit kingdom . jama neurol [ onlin serial ] . american medic associ ; 2019 ; 76:1088. access : \/pmc\/articles\/pmc6618853\/ . access march 3 , 2023 . 3. mollan sp , mytton j , tsermoula g , sinclair aj . idiopath intracrani hypertens : evalu admiss emerg readmiss hospit episod statist dataset 2002 \u20132020 . life 2021 , vol 11 , page 417 [ onlin serial ] . multidisciplinari digit publish institut ; 2021 ; 11:417. access : http : \/\/www.mdpi.com\/2075-1729\/11\/5\/417\/htm . access march 3 , 2023 . 4. szewka aj , bruce bb , newman nj , biouss v. idiopath intracrani hypertens : relat obes visual outcom . journal neuro- ophthalmolog [ onlin serial ] . 2013 ; 33:4 \u20138 . access : http : \/\/journals.lww.com\/jneuro- ophthalmology\/fulltext\/2013\/03000\/idiopathic_intracranial_hypertension__rel ation.2.aspx . access march 30 , 2023 . 5. ang jl , teo kz , fraser cl . weight loss idiopath intracrani hypertens : retrospect review outcom clinic set . j neuroophthalmol [ onlin serial ] . nlm ( medlin ) ; 2021 ; 41 : e458 \u2013e463 . access : http : \/\/journals.lww.com\/jneuro- ophthalmology\/fulltext\/2021\/12000\/weight_loss_in_idiopathic_intracranial.25 . aspx . access march 3 , 2023 . 6. sinclair aj , burdon , nightingal pg , et al . low energi diet intracrani pressur women idiopath intracrani hypertens : prospect cohort studi . bmj [ onlin serial ] . bmj ; 2010 ; 341:138. access : http : \/\/pubmed.ncbi.nlm.nih.gov\/20610512\/ . access march 3 , 2023 . 7. mollan sp , mitchel jl , yiangou , et al . associ amount weight lost bariatr surgeri intracrani pressur women idiopath intracrani hypertens . neurolog [ onlin serial ] . wolter kluwer health , inc. behalf american academi neurolog ; 2022 ; 99 : e1090 \u2013e1099 . copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . access : http : \/\/n.neurology.org\/content\/99\/11\/e1090 . access march 3 , 2023 . 8. westgat csj , botfield hf , alimajstorov z , et al . system adipocyt transcript metabol dysregul idiopath intracrani hypertens . jci insight [ onlin serial ] . american societi clinic investig ; 2021 ; 6. access : http : \/\/doi.org\/10.1172\/jci . access march 30 , 2023 . 9. puustinen , tervonen j , avellan c , et al . psychiatr disord common prognost marker wors outcom patient idiopath intracrani hypertens . clin neurol neurosurg . elsevi ; 2019 ; 186:105527 . 10. kim yk , na ks , myint , leonard . role pro-inflammatori cytokin neuroinflamm , neurogenesi neuroendocrin system major depress . prog neuropsychopharmacol biol psychiatri . elsevi ; 2016 ; 64:277 \u2013284 . 11. loo rjf , yeo gsh . genet obes : discoveri biolog . natur review genet 2021 23:2 [ onlin serial ] . natur publish group ; 2021 ; 23:120 \u2013133 . access : http : \/\/www.nature.com\/articles\/s41576-021- 00414 -z. access may 4 , 2023 . 12. hall kd , kahan s. mainten lost weight long-term manag obes . medic clinic north america [ onlin serial ] . w.b . saunder ; 2018 ; 102:183\u2013 197. access : http : \/\/www.medical.theclinics.com\/article\/s0025712517301360\/fulltext . access januari 14 , 2023 . 13. greenway fl . physiolog adapt weight loss factor favour weight regain . int j obe [ onlin serial ] . natur publish group ; 2015 ; 39:1188. access : \/pmc\/articles\/pmc4766925\/ . access februari 20 , 2023 . 14. daniel ab , liu gt , volp nj , et al . profil obes , weight gain , qualiti life idiopath intracrani hypertens ( pseudotumor cerebri ) . j ophthalmol [ onlin serial ] . elsevi inc. ; 2007 ; 143:635-641.e1 . access : http : \/\/www.ajo.com\/article\/s0002939407000049\/fulltext . access march 3 , 2023 . 15. ko mw , chang sc , ridha , et al . weight gain recurr idiopath intracrani hypertens . neurolog [ onlin serial ] . wolter kluwer health , inc. behalf american academi neurolog ; 2011 ; 76:1564 \u20131567 . access : http : \/\/n.neurology.org\/content\/76\/18\/1564 . access march 3 , 2023. copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . 16. mollan , hem k , herd cp , denton , williamson , sinclair aj . research prioriti idiopath intracrani hypertens ? prioriti set partnership patient healthcar profession . bmj open [ onlin serial ] . british medic journal publish group ; 2019 ; 9 : e026573 . access : http : \/\/bmjopen.bmj.com\/content\/9\/3\/e026573 . access march 3 , 2023 . 17. page mj , mckenzi je , bossuyt pm , et al . prisma 2020 statement : updat guidelin report systemat review . bmj [ onlin serial ] . british medic journal publish group ; 2021 ; 372. access : http : \/\/www.bmj.com\/content\/372\/bmj.n71 . access march 3 , 2023 . 18. ware je , gandek b. overview sf-36 health survey intern qualiti life assess ( iqola ) project . j clin epidemiol [ onlin serial ] . elsevi ; 1998 ; 51:903 \u2013912 . access : http : \/\/www.jclinepi.com\/article\/s089543569800081x\/fulltext . access march 3 , 2023 . 19. scottish intercollegi guidelin network . sign 50 : guidelin develop \u2019 handbook [ onlin ] . 2019. access : http : \/\/www.sign.ac.uk\/media\/2038\/sign50_2019.pdf . access may 3 , 2023 . 20. mollan sp , mitchel jl , ottridg rs , et al . effect bariatr surgeri vs commun weight manag intervent treatment idiopath intracrani hypertens : random clinic trial . jama neurol [ onlin serial ] . american medic associ ; 2021 ; 78:678 \u2013686 . access : http : \/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2778650 . access march 3 , 2023 . 21. wall , kupersmith mj , kieburtz kd , et al . idiopath intracrani hypertens treatment trial : clinic profil baselin . jama neurol [ onlin serial ] . american medic associ ; 2014 ; 71:693 \u2013701 . access : http : \/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/1861749 . access march 3 , 2023 . 22. herm , bharadwaj , miller n , et al . long-term outcom bariatr surgeri idiopath intracrani hypertens patient . neurologist [ onlin serial ] . neurologist ; epub 2022. access : http : \/\/pubmed.ncbi.nlm.nih.gov\/35593904\/ . access march 3 , 2023 . 23. egan r , meredith h , coulston j , bennetto l , morgan j , norton s. effect laparoscop adjust gastric band idiopath intracrani hypertens . obe surg [ onlin serial ] . obe surg ; 2011 ; 21. access : http : \/\/pubmed.ncbi.nlm.nih.gov\/21088927\/ . access march 3 , 2023. copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . 24. sugerman h , felton w , sismani , kellum j , demaria e , sugerman e. gastric surgeri pseudotumor cerebri associ sever obes . ann surg [ onlin serial ] . ann surg ; 1999 ; 229. access : http : \/\/pubmed.ncbi.nlm.nih.gov\/10235521\/ . access march 3 , 2023 . 25. glueck cj , golnik kc , aregawi , goldenberg n , siev l , wang p. chang weight , papilledema , headach , visual field , life statu respons diet metformin women idiopath intracrani hypertens without concurr polycyst ovari syndrom hyperinsulinemia . translat research [ onlin serial ] . elsevi ; 2006 ; 148:215 \u2013222 . access : http : \/\/www.translationalres.com\/article\/s1931524406003136\/fulltext . access march 3 , 2023 . 26. koc f , isik mr , sefi-yurdakul n. weight reduct better visual outcom idiopath intracrani hypertens . arq bra oftalmol [ onlin serial ] . conselho brasileiro de oftalmologia ; 2018 ; 81:18 \u201323 . access : http : \/\/www.scielo.br\/j\/abo\/a\/7cpbsrkhzwxjynxkygjj3st\/ ? lang=en . access march 3 , 2023 . 27. abdelbaki tn , gomaa m. outcom idiopath intracrani hypertens laparoscop sleev gastrectomi . surgeri obes relat diseas [ onlin serial ] . elsevi ; 2020 ; 16:1195 \u20131201 . access : http : \/\/www.soard.org\/article\/s1550728920301805\/fulltext . access march 3 , 2023 . 28. laina p , soueidi el , amor ben , et al . laparoscop sleev gastrectomi treatment idiopath intracrani hypertens patient sever obes . surgeri obes relat diseas [ onlin serial ] . elsevi ; 2020 ; 16:1971 \u20131977 . access : http : \/\/www.soard.org\/article\/s1550728920304639\/fulltext . access march 3 , 2023 . 29. skau , sander b , milea , jensen r. diseas activ idiopath intracrani hypertens : 3-month follow-up studi . journal neurolog 2010 258:2 [ onlin serial ] . springer ; 2010 ; 258:277 \u2013283 . access : http : \/\/link.springer.com\/article\/10.1007\/s00415-010- 5750-x . access march 3 , 2023 . 30. mulla , markey ka , woolley rl , patel , mollan sp , sinclair aj . headach determin qualiti life idiopath intracrani hypertens . j headach pain [ onlin serial ] . j headach pain ; 2015 ; 16. access : http : \/\/pubmed.ncbi.nlm.nih.gov\/25982204\/ . access march 3 , 2023. copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . 31. friedman di , quiro pa , subramanian ps , et al . headach idiopath intracrani hypertens : find idiopath intracrani hypertens treatment trial . headach [ onlin serial ] . headach ; 2017 ; 57:1195 \u20131205 . access : http : \/\/pubmed.ncbi.nlm.nih.gov\/28752894\/ . access march 3 , 2023 . 32. weil r , kovac b , miller n , et al . 6-month telephone-bas weight loss intervent overweight obes subject idiopath intracrani hypertens . obe sci pract [ onlin serial ] . obe sci pract ; 2016 ; 2:95 \u2013103 . access : http : \/\/pubmed.ncbi.nlm.nih.gov\/29071096\/ . access march 3 , 2023 . 33. wall , mcdermott mp , kieburtz kd , et al . effect acetazolamid visual function patient idiopath intracrani hypertens mild visual loss : idiopath intracrani hypertens treatment trial . jama [ onlin serial ] . american medic associ ; 2014 ; 311:1641 \u20131651 . access : http : \/\/jamanetwork.com\/journals\/jama\/fullarticle\/1861803 . access march 8 , 2023 . 34. yiangou , mitchel jl , nichol , et al . obstruct sleep apnoea wome n idiopath intracrani hypertens : sub-studi idiopath intracrani hypertens weight randomis control trial ( iih : wt ) . j neurol [ onlin serial ] . springer scienc busi media deutschland gmbh ; 2022 ; 269:1945 \u20131956 . access : http : \/\/link.springer.com\/article\/10.1007\/s00415-021- 10700-9. access march 8 , 2023 . 35. zigmond , snaith rp . hospit anxieti depress scale . acta psychiatr scand [ onlin serial ] . acta psychiatr scand ; 1983 ; 67:361 \u2013370 . access : http : \/\/pubmed.ncbi.nlm.nih.gov\/6880820\/ . access march 3 , 2023 . 36. c , avenel , bolland , et al . effect weight loss intervent adult obes mortal , cardiovascular diseas , cancer : systemat review meta-analysi . bmj [ onlin serial ] . british medic journal publish group ; 2017 ; 359 : j4849 . access : http : \/\/www.bmj.com\/content\/359\/bmj.j4849 . access march 30 , 2023 . 37. madigan cd , graham , sturgiss e , et al . effect weight manag intervent adult deliv primari care : systemat review meta-analysi randomis control trial . bmj [ onlin serial ] . british medic journal publish group ; 2022 ; 377. access : copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . http : \/\/www.bmj.com\/content\/377\/bmj- 2021-069719. access march 30 , 2023 . 38. nation institut health care excel . weight manag : lifestyl servic overweight obes adult . nice ; epub 2014. access : http : \/\/www.nice.org.uk\/guidance\/ph53\/chapter\/1-recommend . access march 27 , 2018 . 39. paix\u00e3o c , dia cm , jorg r , et al . success weight loss mainten : systemat review weight control registri . obes review [ onlin serial ] . john wiley & son , ltd ; 2020 ; 21 : e13003 . access : http : \/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/obr.13003 . access march 30 , 2023 . 40. leblanc es , patnod cd , webber em , redmond n , rushkin , \u2019 connor ea . behavior pharmacotherapi weight loss intervent prevent obesity-rel morbid mortal adult : updat evid report systemat review us prevent servic task forc . jama [ onlin serial ] . american medic associ ; 2018 ; 320:1172 \u20131191 . access : http : \/\/jamanetwork.com\/journals\/jama\/fullarticle\/2702877 . access may 3 , 2023 . 41. ball ak , howman , wheatley k , et al . randomis control trial treatment idiopath intracrani hypertens . j neurol [ onlin serial ] . springer ; 2011 ; 258:874 \u2013881 . access : http : \/\/link.springer.com\/article\/10.1007\/s00415-010- 5861-4. access march 30 , 2023 . 42. merola j , selezneva l , perkin r , lang j , barri j , leach p. cerebrospin fluid divers versu bariatr surgeri manag idiopath intracrani hypertens . br j neurosurg [ onlin serial ] . taylor & franci ; 2019 ; 34:9 \u201312 . access : http : \/\/www.tandfonline.com\/doi\/abs\/10.1080\/02688697.2019.1698012 . access may 3 , 2023 . 43. boyer , retat l , jacobsen e , et al . cost-effect bariatr surgeri non-surg weight manag programm adult sever obes : decis analysi model . intern journal obes 2021 45:10 [ onlin serial ] . natur publish group ; 2021 ; 45:2179 \u20132190 . access : http : \/\/www.nature.com\/articles\/s41366- 021-00849-8. access march 30 , 2023 . 44. mitchel jl , lyon hs , walker jk , et al . effect glp-1ra exenatid idiopath intracrani hypertens : random clinic trial . brain [ onlin copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . serial ] . oxford academ ; 2023 ; 146:1821 \u20131830 . access : http : \/\/academic.oup.com\/brain\/advance- article\/doi\/10.1093\/brain\/awad003\/7065075 . access may 3 , 2023 . 45. mollan sp , bodoza , mh\u00e9al\u00f3id \u00e1n , et al . visual field pointwis analysi idiopath intracrani hypertens weight trial ( iih : wt ) . transl vi sci technol [ onlin serial ] . associ research vision ophthalmolog ; 2023 ; 12:1 \u20131 . access : http : \/\/tvst.arvojournals.org\/article.aspx ? articleid=2785582 . access may 4 , 2023 . 46. mueller kf , meerpohl jj , briel , et al . method detect , quantifi , adjust dissemin bia meta-analysi describ . j clin epidemiol . pergamon ; 2016 ; 80:25 \u201333 . 47. al abdulsalam hk , ajlan . idiopath intracrani hypertens male . neurosci [ onlin serial ] . medic servic divis , ministri defenc ; 2017 ; 22:220. access : \/pmc\/articles\/pmc5946368\/ . access may 3 , 2023 . 48. kleinschmidt jj , digr kb , hanov r. idiopath intracrani hypertens . neurolog [ onlin serial ] . wolter kluwer health , inc. behalf american academi neurolog ; 2000 ; 54:319 \u2013319 . access : http : \/\/n.neurology.org\/content\/54\/2\/319 . access may 4 , 2023 . 49. daniel ab , liu gt , volp nj , et al . profil obes , weight gain , qualiti life idiopath intracrani hypertens ( pseudotumor cerebri ) . j ophthalmol . elsevi ; 2007 ; 143:635-641.e1 . 50. de oliveira mf , yamashita rhg , boa sort aa , et al . psychiatr symptom frequent idiopath intracrani hypertens patient . neurosurg rev [ onlin serial ] . springer scienc busi media deutschland gmbh ; 2021 ; 44:1183 \u20131189 . access : http : \/\/link.springer.com\/article\/10.1007\/s10143-020- 01321-3. access may 4 , 2023. copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog y. tabl 1 : studi design studi set studi design inclus criteria exclus criteria iih diagnosi diseas state abdelbaki et al . 2020 egypt . singl - centr prospect cohort - - laparoscop sleev gastrectomi march 2016 \u2013 march 2018 ( bmi > 40 bmi > 35 least 1 obes relat co -morbid ) ang et al . 2021 australia , multi - centr retrospect cohort modifi dandi criteria4 - - - incomplet weight record - < 3 follow visit . egan et al . 2011 uk , singl centr prospect cohort neurologist diagnosi bariatr surgeri databas 2005 - 2011 glueck et al . 2006 usa , multi - centr non-randomis intervent friedman criteria ( 2002 ) 1 - \uf02d convent pharmacotherapi treatment ( acetazolamid , furosemid topiram ) \uf02d minimum 6 month follow met - diet combin diet alon \uf02d bmi > 25 - previou shunt -fenestr surgeri iih - evid iih associ secondari c aus ( behcet \u2019 diseas , hypervitaminosi , minocyclin , recombin human growth hormon therapi connect tissu diseas ) herm et al . 2022 global , multi - centr cross -section , retrospect revis friedman criteria ( 2013 ) 5 - intracrani hypert ension registri - incomplet questionnair - inadequ medic record allow confirm iih diagnosi - secondari intracrani hypertens - diagnosi childhood - bariatr surgeri prior iih diagnosi - particip > 1 type bariat ric surgeri - asymptomat iih - < 4 year follow koc et al . 2018 turkey , singl -retrospect , non - intervent , cross -section modifi dandi criteria4 - - treatment iih limit weight reduct medic associ rais icp . copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog y. centr cohort and\/or acetazolamid use - singl lp perform - consist ophthalm examin record weight measur throughout studi period - bmi > 25 kg\/m2 - referr dietitian weight reduct laina et al . 2020 franc , multi - centr prospectiv e cohort ( retrospect analysi ) revis friedman criteria ( 2013 ) 5 - laparoscop sleev gastrectomi ( bmi > 40 bmi > 35 least 1 obes relat co -morbid despit lifestyl behaviour modif comprehens motiv surgeri ) mollan et al . 2021 mollan el . 2022 uk , multi - centr randomis control trial revis friedman criteria ( 2013 ) 5 activ diseas - baselin lpop > 25 cmh20 - papilloedema baselin - bmi > 35 - weight gain previou optic nerv sheath fenestr sinclair e al . 2010 mulla et al . 2015 uk , multi - centr non-randomis , cross -over intervent dandi criteria2 activ diseas ( lpop > 25 cmcsf , papilloedema ) diseas durat 3 month - previou cerebrospin fluid divers . - previou optic nerv sheath fenest ration . skau et al . 2011 denmark , singl centr prospect cohort ichd -ii ( criteria b ) 3 - > 18 year - lpop > 25 bmi > 30 - lpop > 20 bmi < 30 concurr signific - medic diseas . - psychiatr disord . - ocular condit sugerman et al.1999 usa , singl centr non-randomis intervent persist , sever headach , neg brain imag studi , elev csf pressur ( > 20 cm h2o ) . - bariatr surgeri ( bmi > 35 sever obes co - morbid bmi > 40 ) wall et al . 2014 weil et al . 2016 friedman et al . usa\/can ada , multi -randomis control trial modifi dandi criteria4 activ diseas ( elev lpop , papilloedema ) reproduc mild visual loss ( -2 -7 db perimetr mean deviat ) treat iih copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . 1. friedman di , jacobson dm . diagnost criteria idiopath intracrani hypertens . neurolog . 2002 nov 26 ; 59 ( 10 ) :1492 -5. doi : 10.1212\/01.wnl.0000029570.69134.1b . pmid : 12455560 . 2. dandi . intracrani pressur without brain tumor . ann surg 1937 ; 106:492 -513 . 3. headach classif subcomitte intern headach societi intern classif headach disord , 2nd edit cephalalgia 2004 ; 24 ( suppl 1 ) : 9-160 4. smith jl . whenc pseudotumor cerebri ? j clin neuroophthalmol . 1985 mar ; 5 ( 1 ) :55 -6. pmid : 315689 0 . 5. friedman di , liu gt , digr kb . revis diagnost criteria pseudotumor cerebri syndrom adult children . neuro logi . 2013 sep 24 ; 81 ( 13 ) :1159 -65. doi : 10.1212\/wnl.0b013e3182a55f17 . epub 2013 aug 21. pmid : 23966248 . 2017 centr copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . tabl 2 : baselin particip characterist studi n = gender femal , n= ( % ) age , year bodi mass index ( bmi ) , ethnic , n= ( % ) abdelbaki et al . 2020 16 femal 16 ( 100.0 ) 31 ( sd 2 ) 46 ( sd 4 ) - ang et al.2021 39 femal male 37 ( 94.9 ) median 35.0 ( iqr 10.5 ) 36.0 ( sd 7.6 ) - egan et al . 2011 4 femal 4 ( 100.0 ) mean 32 ( rang 29 \u2013 39 ) mean 46.1 ( 38.2 \u2013 54 ) - glueck et al . 2006 36 femal 36 ( 100.0 ) 35 ( sd 9 ) diet : 37.2 ( sd 8.1 ) pco : 38.2 ( sd 5.7 ) hyperinsulinemia : 36.8 ( sd 5.5 ) white : 34 ( 94.4 ) , black : 2 ( 5 .6 ) herm et al . 2022 30 femal 30 ( 100.0 ) 37.3 ( sd 7.3 ) median 45 ( iqr 7.2 ) white : 28 ( 93.3 ) , black : 1 ( 3.3 ) , : 1 ( 3.3 ) koc et al . 2018 19 20 femal male 18 ( 94.7 ) 18 ( 90.0 ) 36.5 ( sd 0.5 ) 39.6 ( sd 1.7 ) 32.6 ( sd 0.6 ) 32.4 ( sd 0.1 ) - laina et al.2020 15 femal 15 ( 100.0 ) median 31 ( rang 22 - 53 ) median 42.1 ( 36.7 \u2013 53.5 ) - mollan et al.2021 mollan et al.2022 \uf020\uf020yiangou et al . 2022 66 femal 66 ( 100.0 ) 32.0 ( sd 7.9 ) mean lifestyl : 43.7 ( 7.1 ) surgic : 44.2 ( 7.1 ) white : 55 ( 83.3 ) , black : 5 ( 7.6 ) , south asian : 1 ( 1.5 ) , mix : 5 ( 7.6 ) sinclair et al . 2010 mulla et al . 2015 25 femal 25 ( 100.0 ) 34.4 ( sd 9.2 ) 38.2 ( sd 5 ) white : 20 ( 80 ) , black : 3 ( 12 ) , south asian : 2 ( 8 ) skau et al . 2011 37 femal male 16 ( 94.1 ) control 19 ( 95 % ) 27.2 ( sd 8.2 ) 36.1 ( sd 7.4 ) - sugerman et al.1999 24 femal 24 ( 100.0 ) 34.0 ( sd 10 ) 47.0 ( sd 6 ) - wall et al . 2014 weil et al . 2016 \uf020friedman et al . 2017 165 femal male 161 ( 97.6 ) acetazolamid : 28.2 ( sd 6.9 ) placebo : 30.0 ( sd 8.0 ) mean acetazolamid : 40.0 ( sd 8.5 ) placebo : 39.9 ( sd 8.1 ) white : 108 ( 65 ) , black : 41 ( 25 ) , : 16 ( 10 ) copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . tabl 3 : weight loss outcom studi time ( month ) excess weight loss ( % ) , p-valu weight loss ( kg ) , p -valu total weight loss ( % ) , p-valu bmi loss ( kg\/m2 ) , p-valu evid level non-surg ( patient choic ) ang 2021 24.7 ( sd 13.5 ) - 10 ( iqr 8 ) , < 0.001 - - 3 non-surg ( diet ) glueck 2 006 10.0 ( sd 1.9 ) 11.0 ( sd 2.5 ) b 10.1 ( sd 3.2 ) c - - 3.9 ( sd 6.7 ) , 0.13a 8.2 ( sd 6.9 ) , 0.0015b 6.9 ( sd 9.0 ) , 0.04c - 2+ koc 2018 6 - - - 2.0 ( sd 3.1 ) , nr 2- sinclair 2010 mulla 2015 3 - 15.7 ( sd 8.0 ) , < 0.001 15.3 ( sd 7.0 ) , < 0.001 - 2+ skau 2011 3 - - - 2.3 ( sd nr ) , 0.005 2+ non-surg ( multi -compon ) mollan 2021 12 - 2.1 ( se 2.0 ) , 0.29 - 0.7 ( se 0.7 ) , 0.35 1++ mollan 2021 24 - 1.4 ( se 2.2 ) , 0.53 - 0.4 ( se 0.8 ) , 0.62 1++ yiangou 2022 24 - 0.1 ( 95 % ci 11.8 , -4.0 ) , 0.756 - -0.1 ( 95 % ci 1.3 , -4.0 ) , 0.824 1- wall 2014 friedman 2017 weil 2016 6 - 3.45 ( sd nr ) 7.50 ( sd nr ) e - - 2+ surgic ( pool procedur ) mollan 2021 12 - 23.4 ( se 1.9 ) , < 0.001 - 8.5 ( se 0.7 ) , < 0.001 1++ mollan 2021 24 - 27.8 ( se 2.1 ) , < 0.001 - 10.4 ( se 0.8 ) , < 0.001 1++ yiangou 2022 24 - 27.2 ( 95 % ci 34.7 , 16.8 ) , 0.012 - 9.3 ( 95 % ci 12.6 , 5.6 ) , 0.012 1- surgic ( gastric band ) egan 2011 19.8 ( sd nr ) 64.1 ( sd nr ) , nr 33.7 ( sd nr ) , nr - 12.7 ( sd nr ) , nr 3 herm 2022 108 ( iqr 48 ) 27.1 ( iqr 40.6 ) , nr - 14.5 ( iqr 17.0 ) , nr - 2- mollan 2022 24 - -1.0 ( se 5.7 ) , 0.868 - 0.0 ( se 2.1 ) , 0.985 1- surgic ( gastric bypass ) herm 2022 91 ( iqr 59 ) 69.9 ( iqr 28.3 ) , nr - 34.7 ( iqr 17.1 ) , nr - 2- mollan 2022 24 - 42.5 ( se 2.8 ) , < 0.001 - 16.0 ( se 1.0 ) , < 0.001 1- sugerman 1999h 12 71.0 ( sd 18 ) , < 0.001 45.0 ( sd 12 ) , < 0.001 - - 2- surgic ( sleev ) abdelbaki 2020 12 75.2 ( sd 2.0 ) , nr - - - 3 herm 2022 68 ( iqr 8 ) 40.2 ( iqr 25.0 ) , nr - 24.9 ( iqr 11.4 ) , nr - 2- copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . laina 2020 12 87.4 ( sd 9.4 ) , nr 39.0 ( iqr nr ) , 0.003 37.3 ( sd 5.2 ) , nr 14.4 ( iqr nr ) , 0.003 3 mollan 2022 24 - 32.2 ( se 4.6 ) , < 0.001 - 11.8 ( se 1.7 ) , < 0.001 1- diet alon , b diet + metformin ( pco ) , c diet + metformin ( hyperinsulinemia ) , placebo , e acetazolamid , h 11\/12 particip gastric bypass , neg valu indic weight gain , nr = report copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . tabl 4 : icp outcom intracrani pressur baselin measu mean ( sd ) , n ( cm h20 ) intracrani pressur end point mean ( sd ) , n ( cm h20 ) time end point differ ( cm h20 ) note level evid lifestyl intervent abdelbaki 2020 41.2 ( 21 ) , 16 ( rang 30 \u201364 ) - - - - - grade ang 2021 median ( rang ) , n 30 ( 5.5 ) , 39 - - - - - grade glueck 2006 - - - - - - grade koc 2018 32.2 ( 8.0 ) , 19 34.6 ( 8.4 ) , 20 - - - - - grade mollan 2021 34.6 ( 5.6 ) , 33 32.0 ( 5.2 ) , 25 12 month mean ( se ) [ 95 % ci ] -2.5 ( 1.4 ) [ -5.2 0 .3 ] p=.084 - 1++ mollan 2021 34.6 ( 5.6 ) , 33 31.0 ( 5.7 ) , 18 24 month mean ( se ) [ 95 % ci ] -3.5 ( 1.6 ) [ 6.6 -0.3 ] p=.03 - 1++ skau 2011 median ( ran ge ) , n 31.0 ( 23.4 > 50 ) , 13 median ( rang ) , n 24.0 ( 20.2 \u201342.5 ) , 13 3 month report p=.02 posit linear associ proport chang bmi icp ( 5.2 cmh20\/ ( m2\/kg ) ) , p=.0002 2++ sinclair 2010 38.0 ( 5.0 ) , 37 30.0 ( 4.9 ) , 20 3 month mean ( sd ) -8.0 ( 4.2 ) p < 0.001 - 2++ wall 2014 acetazolamid placebo 34.9 ( 94.1 ) , 86 34.2 ( 70.7 ) , 79 24.5 , 47 30.5 , 38 6 month mean -11.2 -5.2 .. treatment effect -6.0 [ 95 % ci , -9.6 2.3 ] p= .002 1+ surgic intervent copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . egan 2011 report - - - - - grade herm 2020 report - - - - - grade laina 2020 median ( rang ) 31 ( 25 \u201350 ) report - - - - grade mollan 2021 34.8 ( 5.8 ) , 33 mean ( sd ) , n 26.9 ( 8.1 ) , 18 2 week mean ( se ) [ 95 % ci ] -7.9 ( 2 .0 ) [ -11.8 -4.0 ] p=.0002 - 1- mollan 2021 34.8 ( 5.8 ) , 33 mean ( sd ) , n 26.4 ( 8.7 ) , 29 12 month mean ( se ) [ 95 % ci ] -8.7 ( 1.3 ) [ -11.3 , -6.1 ] p < .001 - 1++ mollan 2021 34.8 ( 5.8 ) , 33 mean ( sd ) , n 22.8 ( 7.8 ) , 22 24 month mean ( se ) [ 95 % ci ] -11.9 ( 1.5 ) [ -14.8 , -9.0 ] p < .001 - 1++ sugerman 1999 32.4 ( 8.3 ) ( rang 23.0 \u2013 52.0 ) report - - - - grade copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . tabl 5 : grade recommend weight manag iih recommend grade ( evid level rang ) assess screen osa r outin use stop -bang due high preval osa adult live iih b ( el 1 - ) sleep studi osa consid low threshold stop -bang score b ( el 1 - ) screen overweight obes take weight height measu rement calcul bmi . repeat measur taken determin long -term weight trajectori effect weight manag treatment . gpp obtain complet drug histori . anti -psychot medic caus weight gain precipit iih . tempor relationship note weight gain caus medicin clinic team discuss mental health team patient . gpp goal weight loss weight mainten discuss sensit patient tha obes complex metabol disord weight manag shown improv symptom iih may support iih diseas remiss . gpp discuss patient goal weight manag maintain lower bodi weight long term . gpp counsel patient obes chronic , relaps diseas therefor total lifelong remiss obes may achiev . gpp advis patient weight loss 15 -24 % contribut iih diseas remiss , howev counsel p atient may achiev via intervent bariatr surgeri . c ( el 2+ ) advis patient multi -compon lifestyl intervent ( dietari therapi + physic activ + behaviour ) altern treatment may support modest weight loss 5 -10 % gpp lifestyl advis patient multi -compon intervent ( diet + physic activ + behaviour ) may effect medium -term ( 6 month ) modest weight loss , weight loss may maintain lo nger-term ( > 24 month ) . b ( el 1++ 2+ ) advis patient dietari approach alon creat energi deficit 500 - 1,000kcals\/day may effect short -term modest weight loss ( 6 month ) . c ( el 2+ ) recommend low energi diet ( vled ) < 800kcals\/day patient access intens dietari support patient present immedi risk worsen papilloedema . c ( el 2+ ) pharmacotherapi acetazolamid conjunct multi -compon lifestyl intervent may support weight manag , howev may due side -effect medic caus dysgeusia . b ( el 1+ ) metformin conjunct multi -compon lifestyl intervent patient iih pco may support weight manag . c ( el 2+ ) glp-1 ra licens weight manag may use immedi manag iih requir weight loss , howev cessat glp -1 ra demonstr result weight regain therefor sh ould consid long - term intervent . glp -1 ra prescrib short -term , patient counsel weight regain like medic stop . gpp topiram prescrib iih may result weight loss due side -effect appetit reduct , howev prescrib sole purpos weight loss gpp bariatr surgeri copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . women live iih bmi > 35kg\/m2 , bariatr surgeri consid . ( el 1++ ) men live iih bm > 35kg\/m2 , bariatr surgeri consid gpp consid select bariatr surgic procedur , gastric bypass sleev gastrectomi may preferenti c ( el 1 - 3 ) bariatr surgeri may consid earli intervent fo r iih icp demonstr reduc 2 week follow procedur c ( el 2++ ) patient activ iih may warrant prioriti referr bariatr surgeri given import weight loss mainten diseas gpp multi -discip linari assess patient suitabl bariatr surgeri undertaken bariatr specialist unit gpp el = evid level , gpp = good practic point copyright \u00a9 2023 author ( ) . publish wolter kluwer health , inc. behalf american academi neurolog . figur : prisma flowchart doi 10.1212\/wnl.0000000000207866 publish onlin octob 9 , 2023 neurolog salli abbott , fiona chan , abd tahrani , et al . hypertens : systemat review practic recommendationsweight manag intervent adult idiopath intracrani inform current octob 9 , 2023 servicesupd inform & 866.fullhttp : \/\/n.neurology.org\/content\/early\/2023\/10\/09\/wnl.0000000000207includ high resolut figur , found : subspecialti collect http : \/\/n.neurology.org\/cgi\/collection\/optic_nerveopt nerv onhttp : \/\/n.neurology.org\/cgi\/collection\/idiopathic_intracranial_hypertensiidiopath intracrani hypertens http : \/\/n.neurology.org\/cgi\/collection\/all_neuroophthalmologyal neuro-ophthalmolog http : \/\/n.neurology.org\/cgi\/collection\/all_clinical_neurologyal clinic neurologyfollow collect ( ) : articl , along other similar topic , appear permiss & licens http : \/\/www.neurology.org\/about\/about_the_journ # permissionsit entireti found onlin : inform reproduc articl part ( figur , tabl ) reprint http : \/\/n.neurology.org\/subscribers\/advertiseinform order reprint found onlin : issn : 0028-3878. onlin issn : 1526-632x.wolter kluwer health , inc. behalf american academi neurolog .. right reserv . print1951 , weekli 48 issu per year . copyright copyright \u00a9 2023 author ( ) . publish \u00ae offici journal american academi neurolog . publish continu sinc neurolog",
  "\u2018 surgeri hope \u2019 : qualit studi explor percept live obes prospect bariatr surgeri keyt , r. , mantzio , m. , hussain , m. , tahrani , a. a. , abbott , s. , strachan , r. , singhal , r. & egan , h publish pdf deposit coventri univers \u2019 repositori origin citat : keyt , r , mantzio , , hussain , , tahrani , aa , abbott , , strachan , r , singhal , r & egan , h 2024 , ' \u2018 surgeri hope \u2019 : qualit studi explor percept live obes prospect bariatr surgeri ' , clinic obes , vol . ( in-press ) , e12643 , pp . ( -press ) . http : \/\/doi.org\/10.1111\/cob.12643 doi 10.1111\/cob.12643 issn 1758 -8103 essn 1758 -8111 publish : wiley \u00a9 2024 author . clinic obes publish john wiley & son ltd behalf world obes feder . open access articl term creativ common attribut -noncommerci -noderiv licens , permit use distrib ution medium , provid origin work properli cite , use non - commerci modif adapt made . origin research \u2018 surgeri hope \u2019 : qualit studi explor percept live obes prospect bariatr surgeri rebecca keyte1| michail mantzios1| misba hussain1| abd a. tahrani2| salli abbott3| rachel strachan4| rishi singhal5| helen egan1 1depart psycholog , school social scienc , birmingham citi univers , birmingham , uk 2institut metabol system research , univers birmingham , birmingham , uk 3faculti health life scienc , coventri univers , coventri , uk 4black countri healthcar nh foundat trust , west bromwich , uk 5univers hospit birmingham , birmingham , uk correspond rebecca keyt , depart psycholog , birmingham citi univers , curzon build , 4 cardigan street , birmingham b4 7bd , uk.email : rebecca.keyt @ bcu.ac.uksummari health benefit bariatr surgeri well document ; howev , occur- renc weight-regain surgeri , along develop mental health difficulti pose question contemporari psycholog could assist preparepeopl live obes prior undergo bariatr surgeri . research explor individu ' ( immedi pre-op post-op popul ) attitud , belief experi toward obes journey bariatr sur- geri . seventeen adult particip ( male n=4 ; age rang : 26 \u201364 year ) recruit particip semi-structur interview . twelv individu partici-p prior undergo bariatr surgeri . five individu particip earli post-op period ( < 3 month post-surgeri ) . peopl live obes display high optim posit outcom , particip hope bariatr surgeri would differ previou attempt weight regul , clear shift locu control weight manag self healthcar profes-sion . whilst adapt , presenc seemingli unrealist opti- mism , mani pre-surgeri particip relay realist possibl post- surgeri weight-regain . despit optim individu feel bariatr surgeri , particip felt psycholog factor influenc eat behaviour address healthcar . find suggest mind , mind eat- ing , self-compass approach incorpor clinic practic support weight regul adapt physiolog chang bariatricsurgery.receiv : 8 august 2023 revis : 21 decemb 2023 accept : 2 januari 2024 doi : 10.1111\/cob.12643 open access articl term creativ common attribution-noncommercial-noderiv licens , permit use distribut medium , provid origin work properli cite , use non-commerci modif adapt made . \u00a9 2024 author . clinic obes publish john wiley & son ltd behalf world obes feder . clinic obes . 2024 ; e12643 . wileyonlinelibrary.com\/journal\/cob 1o f9 http : \/\/doi.org\/10.1111\/cob.12643 keyword bariatr surgeri , mind eat , mind , obes , qualit method , self-compass alreadi known subject ? \u0081bariatr surgeri highli effect weight loss , averag 27 % weight loss 15 year recommend treatment individu sever obes . \u0081despit benefit bariatr surgeri term physic health , literatur report psycholog benefit bariatr surgeri may limit time effect approxi-m 2 year return level observ pre-surgeri . \u0081henc , pre-surgeri behaviour psycholog intervent essenti facilit post-surgeri period physiolog chang adjust life bariatr surgeri . studi add ? \u0081thi studi explor attitud , belief , experi individu live obes prepar undergo bariatr surgeri recent undergon bariatr sur-geri procedur . \u0081thi studi provid insight patient perspect guid healthcar profession provid earli intervent strategi support patient bariatr surgeri jour-ney , focus behaviour psycholog driver may impact eat behaviour adjust life bariatr surgeri . \u0081the find studi support integr mind , mind eat , self- compass bariatr surgeri could benefici patient support pos-it adapt cope mechan promot help eat behaviour optimis respons bariatr surgeri , especi individu experi self-blam self- stigmatis . 1|introduct preval obes rise global associ neg impact metabol , physic mental health peo- ple live obes . estim 29 % adult england ( approxim 13 % adult worldwid ) classifi havingobes . 1obes treatment offer opportun reduc dis- eas 's impact individu , societi , health economi . beha- vioural lifestyl intervent modestli effect , result 3 % \u2013 10 % weight loss , weight regain common patients.2 bariatr surgeri effect weight loss intervent , result averag weight loss 27 % 15 years3and , uk , recommend individu sever obes ( i.e. , bmi\u226540 kg\/m 2or bmi 35 \u201339 kg\/m2with obes complic ) .4bar- iatric surgeri associ favour impact obesity-rel complic , type 2 diabet , obstruct sleep apnoea , hyperlipidaemia , hypertens , cancer , cardiovascular diseas . 5 addit , bariatr surgeri shown posit effectson psycholog health , includ improv qualiti life andimprov anxieti depress . 6 despit benefit bariatr surgeri , increas weight regain occur 21 % patient follow initi weight loss bar- iatric surgery.7a recent literatur review indic divers report weight regain ( wr ) outcom studi variat wr measur , assess time , surgic procedur , studydesign characterist . factor small sampl size , low partici- pation rate , incomplet data , use binari wr measur contribut unreli estim , suggest proport ofindividu gain specif percentag weight defin period reliabl definit measur weight regain . 7factor contribut weight regain fulli understood involv combin biolog , psycholog , lifestyledetermin . 8daw et al . 's9meta-analysi 68 public reveal depress ( 19 % ) bing eat disord ( 17 % ) common mental health condit among patient seekingor undergo bariatr surgeri . , howev , conflict evi- denc regard associ pre-op mental health condit extent post-op weight loss . impor-t explor psycholog implic live obes undergo bariatr surgeri , particularli surgeri , develop pre- post-surgeri psycho-social-behaviour supportplan relaps prevent . support plan also assist individ- ual maladapt eat behaviour like emot eat bing eat . furthermor , literatur report psycholog benefit bariatr surgeri limit time effect approxi- mate 2 year return level observ pre-surgeri . 10 whilst uncommon , increas risk suicid self-harm post-surgeri , probabl suicid self-harm two three time higher follow surgeri compar matched2o f9 keyt et al . 17588111 , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/cob.12643 coventri univers , wiley onlin librari [ 12\/02\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens controls.11,12mor commonli , risk alcohol addict increas post-surgeri , henc appropri psycholog support treatmenti need offer alongsid bariatr surgeri . 12it plausibl individu replac food ( i.e. , emot eat ) new ( maladapt ) cope mechan post-surgeri signifi potentialof weight regul wellb . research therefor need investig contemporari psycholog could assist pre-op prepar peopl liv- obes plan undergo bariatr surgeri . research aim inform healthcar profession interven earli , manag expect , predominantli aim supportphys psycholog wellb individu pre- andpost-bariatr surgeri . 2|materi method 2.1 |particip adult age 18 year immedi pre-opera- tive\/post-op bariatr popul ( < 3 month post-surgeri ) elig particip ( exclus criteria includ diagnos eat disord ) . elig particip recruit use opportun sampl , lead research approach peopledur clinic appoint ( either pre-op appoint , post-op follow-up appoint ) hospit west midland , uk . elig individu identifi multi- disciplinari team ( mdt ) . pre- post-op aftercar forpeopl undergo bariatr surgeri privat sector less like access psycholog support relat live bariatricsurgeri , compar peopl undergo bariatr surgeri fund nation health servic ( nh ) . worth note present research explor divers sampl comparison toa privat sector sampl , would serv patient favour socioeconom background . recruit ran data sat- urat occur . total 22 particip recruit , 17 particip com- plete interview ( male n=4 , femal n=13 ; age rang : 26 \u2013 64 year ; mean age particip : 46 year ) . twelv individu par-ticip undergo bariatr surgeri ( 4 month \u20143 week prior surgeri ) mean bmi 45.9 kg\/m 2 ; five partici- pant schedul sleev gastrectomi ( sg ) , five schedul roux-en-i gastric bypass ( rygb ) twower schedul adjust gastric band ( agb ) . five individ- ual particip post-bariatr surgeri ( 3 week \u20143 month post-sur- geri ) mean bmi 41.5 kg\/m 2 ; three particip sg , two agb ( see tabl 1 ) . 2.2 |semi-structur interview semi-structur interview start investig particip ' belief obes impact obes theirliv , explor reason behind lifestyl choic health behaviour . interview schedul move discuss view toward , experi , weight manag . tabl 1 particip demograph . pseudonym sex age bmi type surgeri pre-op\/post-op laura f 26 year 40 sg pre-op ( 6 week surgeri ) charlott f 36 year 56.1 sg pre-op ( 6 week surgeri ) elli f 36 year 37.3 sg pre-op ( surgeri within next 4 month ) angela f 64 year 35.7 sg post-op ( 3 week sinc surgeri ) paul 39 year 49.03 rygb pre-op ( 6 week surgeri ) maxin f 53 year 61 sg pre-op ( 6 week surgeri ) louis f 32 year 44.7 sg pre-op ( 4 week surgeri ) kevin 50 year 60.1 rygb pre-op ( 4 week surgeri ) pam f 64 year 39.3 agb pre-op ( 4 week surgeri ) dian f 57 year 40.4 agb pre-op ( 4 week surgeri ) shelli f 61 year 45.4 sg post-op ( 1 month sinc surgeri ) peter 52 year 46.7 rygb pre-op ( 2 month surgeri ) alan 44 year 32.9 rygb pre-op ( offer surgeri june'19 refus want lose weight ) helen f 46 year 37.5 sg post-op ( 3 month sinc surgeri ) nicol f 39 year 49.2 agb post-op ( 2 month sinc surgeri ) stephani f 31 year 42.9 rygb pre-op ( 3 week till surgeri ) ami f 48 year 39.7 agb post-op ( 1 month sinc surgeri ) abbrevi : agb , adjust gastric band ; rygb , roux-en-i gastric bypass ; sg , sleev gastrectomy.keyt et al . 3o f9 17588111 , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/cob.12643 coventri univers , wiley onlin librari [ 12\/02\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens includ discuss regard barrier weight manag particip experienc , discuss participants'thought feel toward bariatr surgeri . research qualit , allow explor defin area , elabo- ration particip relat topic , question wordingand order contextu respons particip devel- ope account . qualit interview enabl research team take interpret perspect life like dealingwith obes prospect bariatr surgeri , research acknowledg import individu differ . semi-structur interview schedul ( see support informa- tion ) develop consult exist literatur . interviewswer conduct either via telephon face-to-fac depend upon particip ' avail prefer . interview last maximum 60 min . particip answer ques-tion want . particip voluntari confi- dential , particip provid pseudonym . particip could withdraw research time ; howev , none chose . 2.3 |ethic approv ethic approv obtain via east england \u2014essex nre committe ( rec refer : 18\/ee\/0090 ) , r & depart atth research site . written inform consent obtain individu particip includ studi . 2.4 |analysi record interview transcrib verbatim . data analys use themat analysi follow braun clark 's ( 2006 ) model,13a flexibl method . reason engag- ing health behaviour context-depend , themat analysi wasus contextualist method , acknowledg particip attribut mean experi obes , alongsid social mean , e.g. , stigma shame ; indic mean- experi social produc reproduc rather inher . themat analysi provid detail induc- tive construct entir data set , provid valuabl informationto current under-research area within weight manag . conduct themat analysi , code initi gener one research , subsequ revis evalu everyoneon research team reach agreement code . theme construct togeth confirm agreement represent data reach . similarli , research evalu- code fit ( ) within theme . valid offind therefor support research agre common interpret data . method triangul dem- onstrat theori challeng integr toproduc clear understand particip ' experi obe- siti percept toward bariatr surgery.3|result three theme construct data set provid explo- ration particip ' attitud , belief , experi obe- siti ( in-depth insight theme , pleas refer tosupplementari materi s1 ) . particip describ life-long \u2018 battl \u2019 attempt con- trol weight , consist variou \u2018 diet \u2019 exercis regimen , particip express frustrat sad respons weight clear desir chang . particip discours highlight awar biolog obes weight , instead highlight wealth differ motiv felthad influenc eat behaviour ( therefor weight ) , socioeconom statu , cultur , work . food deem provid function role particip , appar particip ' discours eat provid form comfort , particip give rang reason obes , includ sexual abus , famili death , anddifficulti accept sexual . addit distress trauma describ partici- pant person life perceiv influenc eat- behaviour , mani particip discuss attitud belief regard ( particularli respons weight ) explain partli influenc societ reaction . mani par-ticip recal situat expos verbalabus due weight impact confid self-esteem , case result psycholog distress . discrimin , critic , judgement particip receivedfrom other , along psycholog distress , impact willing engag activ pre-surgeri ( e.g. , social event attend gym ) often initi motiv con-sid bariatr surgeri . mani believ post-surgeri would abl lead perceiv \u2018 normal life \u2019 engag social activ without feel judg fortheir weight . particip also discuss benefici impact theybeliev bariatr surgeri would physic health ( e.g. , improv comorbid associ obes ) . par- ticip excit hope futur post-surgeri , how-ev , explain take accept need surgeri , frustrat upset could lose weight , demonstr element self-critic . particip interview perceiv \u2018 long journey \u2019 fill deem person \u2018 fail- ure \u2019 weight manag attempt held strong belief bariatr surgeri would differ . howev , notwithstand excit associ prospect surgeri , pre- oper particip experi neg emot . instanc , sever particip describ anticip griev offood , awar eat habit chang post- surgeri despit \u2018 love \u2019 food , particularli evid food comfort particip . particip alsoexplain fear toward surgeri risk associ . consequ anxieti individu experience4o f9 keyt et al . 17588111 , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/cob.12643 coventri univers , wiley onlin librari [ 12\/02\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens wait bariatr surgeri , difficulti encoun- ter post-surgeri , mani particip suggest need supportgroup integr process undergo bariatr sur- geri , discuss benefici would abl commun other similar situat . overal , particip due , recent undergon , bariat- ric surgeri express given great deal support dietitian chang eat behaviour , e.g. , focus onport size food consum . howev , appar data particip felt lack psycholog support respons person suffer trauma experienc theybeliev influenc eat behaviour therefor weight.particip perceiv psycholog support time would assist \u2018 work \u2019 bariatr surgeri , pre- post-surgeri psycho-social-behaviour support plan thepotenti act relaps prevent . 4|discuss current research provid qualit explor impact obes upon individu ' live , encompass physic psycholog wellb , well particip ' percep- tion toward bariatr surgeri , research emphasis theindividu particip . research provid novel insighta recruit individu immedi pre-operative\/ post-op popul . data gener therefor gener prospect , present understand attitud , belief andexperi toward bariatr surgeri real-tim , whilst ret- rospect focu regard particip believ influenc weight eat behaviour life . import tounderstand percept patient immedi pre-opera- tive\/post-op stage ultim support longer term , find current studi provid insight howhealthcar provid interven earli support peopl livingwith obes work bariatr surgeri ( e.g. , focus behaviour psycholog motiv prior bariatr surgeri influenc eat behaviour ) . clear fromth data difficulti individu experi accept need bariatr surgeri , often demonstr self-critic regard fact lose weight . frustrat experiencedbi mani particip suggest still internalis stigma blame associ obes oppos understand- ing obes chronic diseas . overal , research illustr depth , complex , indi- vidual mean individu attribut food eat ( e.g. , biolog , social , behaviour psycholog motiv ) . inlin previou research , appear mani participantstheir eat behaviour ( prior bariatr surgeri ) larg emo- tional driven , eat provid pleasur comfort individu , e.g. , experienc distress within live . addi-t psycholog motiv influenc eat behaviour , portion size food choic highlight particip anissu impact weight , individu choos calorie-dens palat food consum prior bariatr surgeri . commonlyreport literatur individu consum high quantiti calorie-dens palat food cope mechan , line emot eat . 14 peopl live obes develop accept regard need bariatr surgeri , particip opti- mistic futur post-surgeri . high optim display isinterest given surgeri consid previou attempt weight regul unsuccess . see , surgeri understood entir \u2018 differ \u2019 treatment weight regul attempt . howev , none partici-p discuss realist possibl may increas weight follow initi weight loss post-surgeri may lose signific weight . averag weight loss at20 year post-surgeri still 25 % , 12and although may seem \u2018 success \u2019 , patient often elicit self-blam regain weight , often wish weight lightest post-surgery.furthermor , weight loss trajectori individu level vari , individu lose weight inde gain weight . 15consequ , need healthcar profession manag patient expect , counsel weight regain expect emphasis individu 's weight loss trajec- tori surgeri differ . despit optim display life post-surgeri , wait bariatr surgeri seen emot challeng period . par- ticip , therefor , suggest need support group , explain benefici would found hear individu whohav alreadi gone process bariatr surgeri . would particularli welcom experienc anxieti thought surgeri , due fear post-op complica-t , research acknowledg gener anxieti individu feel surgeri , difficult adjust recoveri like surgeri . 16research illustr benefici impact commun other \u2018 similar posit \u2019 oneself psycholog wellb , e.g.,17\u201319with communi- cation individu undergon medic procedur associ reduct anxieti posit adjust , support group often empow individu . integr support group bariatr pre-op post-op care therefor recommend clinic practic employ . 20\u201322 addit social support requir , guidelin psycho- logic therapi bariatr surgery,23endors british obes metabol surgeri societi ( bomss ) , recommend patientshav psycholog screen assess 6 9 month post-surgeri identifi need psycholog intervent mitig poorer outcom , eat disord mental illness.mor recent , ratcliff bant 24conduct exploratori studi aim address lack clariti regard role psy- chologist bariatr multi-disciplinari team ( mdt ) unit kingdom . survey psychologist , patient , mdtreveal psychologist uk bariatr servic primarili focu pre-op assess , differ percept emergingkeyt et al . 5o f9 17588111 , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/cob.12643 coventri univers , wiley onlin librari [ 12\/02\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens psychologist mdt regard purpos assess . studi highlight high demand servic , lim-it psycholog resourc , need educ , consensu , adequ resourc enhanc coher psycholog servic context bariatr surgeri uk . despit guidelin recent find , particip report despit psycholog driver , believ influ- enc eat behaviour therefor weight , notreceiv psycholog support alongsid bariatr surgeri ( wait surgeri ) . therefor clear new inter- vention requir focu wellb psychologicalmotiv influenc eat behaviour , encourag long-termchang eat behaviour help individu work bariatr surgeri . instanc , despit particip report motiv maintain weight loss post-surgeri , com-mun healthcar profession suggest bariatr surgeri work alon , absenc data psy- cholog support provid particip , theservic particip recruit provid post- surgeri psycholog support . surgeri offer physic restrict , depend procedur , hormon appetit control , mayb suffici reduc energi intak initi post-surgeri ; psycho- logic support could benefici use post-surgeri assist indi- vidual maintain weight loss adjust experiencedphysiolog chang post-surgeri . plausibl individu replac previou eat behaviour new ( maladapt ) cope mechan post-surgeri . instanc , whilst risk compar small , suicid , self-harmand alcohol-us disord report post-surgeri warrant- ing investig . 12psycholog intervent could encour- age individu adopt help adapt cope mechan inrespons psycholog distress\/trauma encount , obes stigma . research highlight need intervent focu upon stigma due neg effect onphys psycholog wellb , lead avoidanceof healthcar disrupt doctor-pati relationship . 25,26 cope mechan could way overcom emotionaland psycholog distress experienc live withobes . addit , peopl undergo bariatr surgeri sampl exhibit self-critic self-blam , therefor imperativefor bariatr surgeri patient understand obes diseas order aid resolut critic address interna- lise weight bia . mind self-compassion-bas interven-t area warrant investig bariatr surgeri patient popul . research , shift respons individu , judgement , stigma isola-t felt peopl tri tackl higher weight ele- may tackl compassion-bas intervent . sever research clinician propos compass benefici peopl , therapeut context , enhanc thesupport peopl enter bariatr surgeri . 27,28self-stigmatis also seen individu appear self-crit current use food treat ( either pre- post-op ) .consequ , data suggest intervent focus self- compass could integr overcom self-stigmatisingburden barrier success weight-regul , 27alongsid mindfulness\/mind eat . research illustr high level self-compass associ- ate individu eat mind way,29with self-compass mind eat integr practic promot adapt healthier eat behaviours.28,30 \u201333self-compass con- ceptualis take kinder approach toward oneself person- alli challeng time , mind awar understand one 's experi part peopl go . self-compass consist three main element : self-kind , commonhuman , mind , 34,35creat theoret bridg reinstat- ing basic function mind eat fulli experienc eat . practic mind defin awar emerg purpos pay attent present moment , non-judgmentally,36with intervent , associ reduc stress neg emot within individu . suchintervent typic practic form medit individu learn awar present moment non- judgment way , research report posit impact theyhav psycholog wellb . 37,38 mantzio wilson28suggest mind eat interven- tion may relev weight regul eat behav-iour modif . mind eat integr interventionsalongsid bariatr surgeri , complement exist dietari beha- vioural modif . involv purpos pay attent meal non-judgment attitud . 39mind eat promot healthier eat habit , increas fruit veget intake40 reduc consumpt sugari energy-dens foods.41,42 research show mind eat associ lower fat andsugar intak , 43reduc grazing,44weight maintenance,45decreas motiv indulg foods,46and improv self-regul experiment designs.47\u201350th signific weight mainten , graze , regul motiv eat key factor bariatricsurgeri 51,52and potenti assist presenc mind eat intervent convent treatment . whilst partici- pant report account eat accord mind eat , intervent deliv part healthcar , explicit attempt investig mind eat . recent evid barley et al. , 53who conduct randomis control trial test feasibl accept accept com- mitment therapi ( act ) bariatr surgeri indic mix find- ing . low attend act usual care arm thestudi provid preliminari evid attend act report benefit , suggest trial process feasibl , adjust recruit intervent deliveri wereneed enhanc accept . 4.1 |strength limit whilst research provid insight patient perspect guid healthcar profession provid earli intervention6o f9 keyt et al . 17588111 , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/cob.12643 coventri univers , wiley onlin librari [ 12\/02\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens strategi support patient bariatr surgeri journey , limit identifi . particip currentresearch recruit one surgic centr , limit transfer find . five recruit particip post-op patient ; thu , research requir investi-g thoroughli experi undergon bariatr surgeri recov earli post-op period . research also requir explor eat behaviourschang post-surgeri , live experi differ time period post-surgeri . 4.2 |conclus research explor live obes percept undergo- ing bariatr surgeri . pre-surgeri intervent necessari sup- port individu post-op period . integr mind self-compass alongsid bariatr surgeri carecould allevi self-blam stigma support develop help adapt cope mechan eat behaviour ; opti- mise respons bariatr surgeri . author contribut conceptu : rebecca keyt , michail mantzio , misba hussain , abd tahrani , salli abbott , rachel strachan , rishi singhal helenegan . data curat : rebecca keyt , salli abbott rachel strachan . formal analysi : rebecca keyt , michail mantzio , misba hussain helen egan . project administr : rebecca keyt . valid : rebecca keyt , michail mantzio , misba hussain , abd tahrani , salli abbott , rachel strachan , rishi singhal helen egan . write \u2014origin draft : rebecca keyt . write \u2014review edit : rebecca keyt , michail mantzio , misba hussain , abd tahrani , salli abbott , rachel strachan , rishi singhal helen egan . conflict interest statement author declar conflict interest . sa receiv consult fee speaker honorarium johnson & johnson . sa also hold un-paid role integr health professionalrepres bomss council bariatr offic british dietet associ obes specialist group . aat current employe novo nordisk , denmark . novo nordisk role inthi work . ethic statement procedur perform within research involv human particip accord ethic standard insti- tution and\/or nation research committe ( busi , law socialsci ethic committe birmingham citi univers ; east ofengland \u2014essex nre committe ) 1964 helsinki decla- ration later amend . inform consent obtain individu particip includ studi . orcid rebecca keyt http : \/\/orcid.org\/0000-0002-5720-5184refer 1. world health organ . obes overweight . world health organ ; 2021 . 2. yanovski , yanovski ja . long-term drug treatment obes : sys- temat clinic review . jama . 2014 ; 311:74-86. doi : 10.1001\/ jama.2013.281361 3. arterburn de , courcoula ap . bariatr surgeri obes meta- bolic condit adult . bmj . 2014 ; 349:3691. doi : 10.1136\/bmj . g3961 4. nice . obes : identif , assess manag . 2022. retriev : overview jobes : identif , assess manag jguidanc jnice . 5. singh p , subramanian , adderley n , et al . impact bariatr surgeri cardiovascular outcom mortal : population-bas cohort studi . br j surg . 2020 ; 107:432-442. doi : 10.1002\/bjs.11433 6. jumb , hamlet c , meyrick j. psycholog aspect bariatr sur- geri treatment obes . clin obe rep . 2017 ; 6:71-78 . 7. king wc , hinerman , courcoula ap . weight regain bariatr surgeri : systemat literatur review comparison across studi use larg refer sampl . surg obe relat di . 2020 ; 16:1133-1144 . 8. heinberg lj , bond ds , carrol , et al . identifi mechan predict weight trajectori bariatr surgeri : rational design biobehavior trial . surg obe relat di . 2020 ; 16:1816-1826 . 9. daw aj , maggard-gibbon , maher ar , et al . mental health con- dition among patient seek undergo bariatr surgeri : ameta-analysi . jama . 2016 ; 315 ( 2 ) :150-163 . 10. buddeberg-fisch b , klaghof r , krug l , et al . physic psycho- social outcom morbidli obes patient without bariatr surgeri : 4 \u00bd year follow . obe surg . 2006 ; 16:321-330 . 11. castaneda , popov vb , wnder p , thompson cc . risk suicid self-harm increas bariatr surgeri \u2013a systemat review meta-analysi . obe surg . 2019 ; 29:322-333 . 12. wilson r , aminian , tahrani aa . metabol surgeri : clinic updat . diabet obe metab . 2021 ; 23:63-83. doi : 10.1111\/dom.14235 13. braun v , clark v. use themat analysi psycholog . qual re psychol . 2006 ; 3:77-101. doi : 10.1191\/1478088706qp063oa 14. mantzio , egan h , keyt r , bahia h , hussain m. graze , motiv eat palat food , fat sugar consumpt : exploratori investig . j public health . 2018 ; 27:143-149. doi : 10.1007\/ s10389-018-0944-2 15. karmali , brar b , shi x , sharma , de gara c , birch dw . weight recidiv post-bariatr surgeri : systemat review . obe surg . 2013 ; 23:1922-1933 . 16. salzmann , rienmul , kampmann , euteneu f , rusch d. pre- oper anxieti associ patient ' desir forsupport \u2013an observ studi adult . bmc anesthesiol . 2021 ; 21 : 149. doi : 10.1186\/s12871-021-01361-2 17. keyt r , egan h , mantzio m. explor knowledg , atti- tude belief toward riski health behaviour paediatr cys-tic fibrosi popul . clin med insight circ respir pulm med . 2019 ; 13:1-10. doi : 10.1177\/1179548419849427 18. keyt r , egan h , mantzio m. cystic fibrosi health care profes- sional ' percept riski health behaviour . chronic illn . 2019 ; 1 \u2013 12:205-216. doi : 10.1177\/1742395319856395 19. keyt r , egan h , nash e , regan , jackson c , mantzio m. explo- ration experi attitud regard riski health behav- iour adult cystic fibrosi popul . psychol health med . 2020 ; 25:1013-1019. doi : 10.1080\/13548506.2019.1706750 20. athanasiadi , carr ra , smith c , et al . social support provid bariatr surgeri patient facebook group may improv weight loss outcom . surg endosc . 2022 ; 36:7652-7655. doi : 10 . 1007\/s00464-022-09067-3 21. tolvanen l , svensson , hemmingsson e , christenson , lagerro yt . perceiv prefer social support patientsexperienc weight regain bariatr surgeri \u2013a qualit studi . obe surg . 2021 ; 31:1256-1264.keyt et al . 7o f9 17588111 , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/cob.12643 coventri univers , wiley onlin librari [ 12\/02\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens 22. torrente-sanchez mj , ferrer-marquez , estebanez-ferrero b , et al . social support peopl morbid obes bariatr surgeryprogramm : qualit descript studi . int j environ respir public health . 2021 ; 18:6530 . 23. ogden j , ratcliff , snowdon-carr v. british obes metabol sur- geri societi endors guidelin psycholog support pre-andpost-bariatr surgeri . clin obe . 2019 ; 9 ( 6 ) : e12339 . 24. ratcliff , bant e. role psycholog bariatr sur- geri ? survey differ view psychologist , multidisci- plinari team , patient uk . clin obe . 2023 ; 13 ( 6 ) : e12612 . 25. alburi c , strain wd , le brocq , et al . import languag engag health-car profession peopl live withobes : joint consensu statement . lancet diabet endocrinol . 2020 ; 8 ( 5 ) :447-455 . 26. hazlehurst jm , logu j , parretti hm , et al . develop integr clinic pathway manag clinic sever adult obe-s : critiqu nh england polici . curr obe rep . 2020 ; 9:1-14 . 27. forb yn , moffitt rl , van bokkel , donovan cl . unburden weight stigma : find compassion-focus group program women overweight obes . j cogn psychoth . 2020 ; 34 ( 4 ) :336-357 . 28. mantzio , wilson jc . mind , eat behaviour obes : review reflect current find . curr obe rep . 2015 ; 4 : 141-146. doi : 10.1007\/s13679-014-0131-x 29. keyt r , egan h , mantzio m. mind eat without non- judgement , mind , self-compass relat motiv toeat palat food student popul ? nutr health . 2020 ; 26:27- 34. doi : 10.1177\/0260106019888367 30. mantzio , wilson jc . make concret construal mind : novel approach develop mind self-compass assistweight loss . psychol health . 2014 ; 29:422-441. doi : 10.1080\/ 08870446.2013.863883 31. mantzio , wilson jc . explor mind mind self-compassion-cent intervent assist weight loss : theoret- consider preliminari result random pilotstudi . mind . 2015 ; 6:824-835. doi : 10.1007\/s12671-014-0325-z 32. shaw r , cassidi t. self-compass , mind eat , eat attitud wellb among emerg adult . j psychol . 2021 ; 156 ( 1 ) :33-47 . 33. zervo k , koletsi , mantzio m. eight week mind eat pro- gram appli mediterranean popul overweight obe-s : eatt intervent studi . psychol rep . 2021 ; 125:1011-1040. doi : 10.1177\/0033294120988104 34. neff kd . develop valid scale measur self- compass . self ident . 2003 ; 2:223-250. doi : 10.1080\/ 15298860309027 35. neff kd . self-compass : altern conceptu healthi attitud toward oneself . self ident . 2003 ; 2:85-101. doi : 10 . 1080\/15298860309032 36. kabat-zinn j. full catastroph live ; cope stress , pain ill use mind medit . littl , brown book group ; 1990 . 37. hussein , egan h , mantzio m. mind construal diari : less anx- iou , mind , self-compassion method eat . sage open . 2017 ; 7 ( 2 ) :1-11 . 38. mantzio , giannou k. real-world applic short mindfulness-bas practic : review reflect literatureand practic proposit effortless mind lifestyl . j lifestyl med . 2019 ; 13 ( 6 ) :520-525 . 39. mantzio m. ( ) defin mind eat mind eat behav- iour advanc scientif enquiri . nutr health . 2020 ; 27:367-371. doi : 10.1177\/0260106020984091 40. jordan c , wang w , donatoni l , et al . mind eat : trait state mind predict healthier eat behavior . person individ differ . 2015 ; 68:107-111. doi : 10.1016\/j.paid.2014.04.013 41. mason ae , epel es , kristel j , et al . effect mindfulness-bas intervent mind eat , sweet consumpt , fastingglucos level obes adult ; data shine random con- troll trial . j behav med . 2016 ; 39:201-213. doi : 10.1007\/s10865- 015-9692-8 42. mason ae , epel es , aschbach k , et al . reduc reward-driven eat- ing account impact mindfulness-bas diet exerciseintervent weight loss : data shine random con-trol trial . appetit . 2016 ; 100:86-93. doi : 10.1016\/j.appet.2016 . 02.009 43. mantzio , egan h , hussain , keyt r , bahia h. mind , self- compass , mind eat relat fat sugar consump-t : exploratori investig . eat weight disord . 2018 ; 23 ( 6 ) : 833-840 . 44. mantzio , egan h , bahia h , hussain , keyt r. graze relat bodi mass index , self-compass , mind , mind eat student popul ? health psychol open . 2018 ; 5 ( 1 ) : 2055102918762701 . 45. mantzio , wilson jc , linnel , morri p. role neg cog- nition , intoler uncertainti , mind , self-compass weight regul among male armi recruit . mind . 2015 ; 6:545- 552. doi : 10.1007\/s12671-014-0286-2 46. mantzio , egan hh . exploratori examin mind , self-compass , mind eat relat motiv eatpalat food bmi . health psychol rep . 2018 ; 6:207-215. doi : 10 . 5114\/hpr.2018.73052 47. hussain , egan h , keyt r , mantzio m. mind construal reflec- tion : reduc unhealthi eat choic . mind . 2021 ; 12:1-11. doi : 10.1007\/s12671-021-01638-0 48. hussain , egan h , keyt r , mantzio m. explor effect mind self-distanc chocol intak negativest affect . j cognit enhanc . 2021 ; 5 ( 1 ) :15-24. doi : 10.1007\/s41465- 020-00181-5 49. mantzio , egan h , asif t. randomis experi evalu mind raisin practic method reduc chocol consump- tion mindless activ . j cognit enhanc . 2019 ; 4 : 250-257 . 50. mantzio , skillett k , egan h. examin effect two mind eat exercis chocol consumpt : experiment studi . eur j health psychol . 2019 ; 26 ( 4 ) :120-128. doi : 10.1027\/2512-8442\/ a000040 51. mitchel je , selzer f , kalarchian , et al . psychopatholog surgeri longitudin assess bariatr surgery-3 ( labs-3 ) psychosoci studi . surg obe relat disord . 2012 ; 8:533-541 . 52. riccioppo , redaelli v. psychosoci behaviour aspect bar- iatric surgeri . : gome , corda dm , ed . eat disord obes . springer ; 2019:115-127 . 53. barley ea , bovel , bennett-eastley k , et al . address critic need : randomis control feasibl trial accept com- mitment therapi bariatr surgeri patient 15 \u201318 month post- surgeri . plo one . 2023 ; 18 ( 4 ) : e0282849 . support inform addit support inform found onlin support- ing inform section end articl . cite articl : keyt r , mantzio , hussain , et al . \u2018 surgeri hope \u2019 : qualit studi explor percept live obes prospect bariatr surgeri . clinic obes . 2024 ; e12643 . doi : 10.1111\/ cob.126438o f9 keyt et al . 17588111 , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/cob.12643 coventri univers , wiley onlin librari [ 12\/02\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens appendix a.1 |sampl interview schedul a.1.1 . |ice breaker question 's \u0081thank take part \u0081what first thought ask take part research ? \u0081did hesit agre take part ? \u0081so begin , tell bit life ? \/c14what spare time ? \/c14do work\/studi ? a.1.2 . |impact obes upon individu 's person life \u0081could tell challeng face life regard weight manag ? \u0081ha alway aspects\/th found chal- leng , aspects\/th difficult cope previous ? \/c14impact obes upon mental health well physic health \u0081whi want lose\/did want lose weight ? \/c14when motiv commenc ? \u0081how long tri lose weight ? \/c14what method tri ? \u0081how find stick e.g. , diets\/exercis plan ? \/c14are aspect difficult ? \/c14ha chang time\/circumst ? \u0081what \u2018 method \u2019 weight manag tend \u2018 miss \u2019 ? \u0081at end day e.g. , miss exercis session\/ ate someth n't , make feel ? \u0081when wake morn , plan stick regimen ? \u0081are day wake know 're go everyth ? a.1.3 . |barrier weight manag \u0081what thing make difficult stick regimen ( e.g. , diet\/ exercis ) ? area elabor may includ : \u0081not enough time day job , etc . \u0081not see improv \u0081not lose weight \u0081use food cope mechan \u0081are situat less like follow weight manag regimen ( e.g. , diet\/exercis ) ? \u0081what make harder follow regimen situat ? a.1.4 . |thoughts\/feel toward bariatr surgeri \u0081what thoughts\/feel toward bariatr surgeri ? \/c14optim \/c14fear \u0081when start consid bariatr surgeri ? \/c14how learn bariatr surgeri ? \/c14what impact weight upon health ( physic psycholog ) ? \u0081 thoughts\/feel toward bariatr surgeri first becam option ? \/c14how chang time ? \/c14what caus chang time ? \u0081how think find maintain weight loss surgery\/how found maintain weight loss post-surgeri think go forward ? \/c14ha discuss part care ? \/c14what tools\/strategi place ? \/c14what tools\/strategi would like place ? a.1.5 . |reaction other \u0081are open famili friend thought toward weight ? \/c14what reaction ? \/c14what thought toward bariatr surgeri ? \u0081how think societi view overweight\/obes bar- iatric surgeri ? \/c14what reaction receiv throughout life ? \u0081who go concern regard weight ? \/c14what impact weight upon mental health ? \/your physic health ? a.1.6 . |conclus \u0081what would want tell someon struggl con- troll weight ? \u0081what consid bariatr surgeri ? \u0081what would tell famili rel struggl weight\/consid bariatr surgeri ? \u0081i addit support feel would benefici throughout \u2018 weight manag journey \u2019 ? \u0081honestli discuss anoth person also due undergo\/had undergon bariatr surgeri , think answer would differ ? \u0081do anyth els add ? keyt et al . 9o f9 17588111 , 0 , download http : \/\/onlinelibrary.wiley.com\/doi\/10.1111\/cob.12643 coventri univers , wiley onlin librari [ 12\/02\/2024 ] . see term condit ( http : \/\/onlinelibrary.wiley.com\/terms-and-condit ) wiley onlin librari rule use ; oa articl govern applic creativ common licens"
]